יומן הפטנטים והמדגמים - patents and designs journal

December 29, 2011 1-התשע"ב טבתב 'ג

12/2011 ג'/תשע"ב

December 29, 2011 התשע"ב טבתב 'ג

יומן הפטנטים והמדגמים

PATENTS AND DESIGNS JOURNAL

Page/עמוד Patents פטנטים

Applications filed 4 ות שהוגשובקש Applications accepted 149 בקשות שקובלו

Patents granted 416 פטנטים שניתנו Patents renewed 416 פטנטים שחודשו

Patents not in force 416 פטנטים שתוקפם פקע

Patents renewed for 20 years 419 פטנטים שחודשו לעשרים שנה Country codes 465 קודים למדינות

Indices of applications accepted 455 מפתחות לבקשות שהתקבלו

Designs מדגמים

Designs registered 437 מדגמים שנרשמו

Designs canceled 453 מדגמים שבוטלו


ידיעות כלליות

מכתבים, מסמכים, וכו' בענייני פטנטים ומדגמים יש לשלוח אל: ירושלים.מלחה, 5רשם הפטנטים והמדגמים, גנים טכנולוגיים ירושלים, בנין

אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הרשות בבנק הדואר מס' . יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה 0-24145-2

שולמה.

GENERAL INFORMATION

Letters, documents, etc. concerning Patents and Designs should be addressed to: The Patent Authority, Jerusalem Technology Park, Building5, Malcha., Jerusalem.

Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the

Authority, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office

together with the application for the action for which the fee has been paid.

זכות היוצרים בתקצירים אלה שמורה למדינת ישראל, אין להעתיק מתקצירים אלה אלא

ברשות לשכת הפטנטים.

Copyright by the State of Israel. No

Extracts may be published except with the

permission of the Patent Office.


PATENTS פטנטים-, תשכ"זלחוק הפטנטים 16הודעה לפי סעיף

1967

NOTICE UNDER SECTION 16 OF THE

PATENTS LAW, 5727-1967

להלן רשימת בקשות חדשות הממלאות אחר )א( לתקנות 32הדרישות שנקבעו בתקנה

:1968-הפטנטים, תשכ"ח

In the following there are listed new

applications complying with the provisions

of rule 32(a) of the Patent Regulations, 5728-

1968:

Particulars of the applications are given in פרטי הבקשות מובאים לפי סדר זה:

the following order:

ותאריך הגשתה וארבעה –מספר הבקשה הסמנים הראשונים של הסיווג הבינלאומי

Number and date of application and the first

four symbols of the International

Classification.

Title of invention (as proposed by applicant) שם האמצאה )כפי שהוצע ע"י המבקש(

Applicant המבקש

:Convention country- Priority right –מדינת האיגוד דין קדימה:

Number and date of תאריך ומספר

Foreign application בקשת החוץ

International Application Number מספר בקשה בינלאומית

International Publication Number מספר פרסום בינלאומי


(2011.01 )F41H 768<;; 01//4/0/22

יחידה אנרגטית המבוססת על גשר מוליך למחצה

ENERGETIC UNIT BASED ON

SEMICONDUCTOR BRIDGE

RAFAEL ADVANCED DEFENSE רפאל מערכות לחימה מתקדמות בע"מ

SYSTEMS LTD.

(2011.01 )F41H 768=;: 1///4/0/22

ANTIBALLISTIC ARTICLE AND בליסטי ושיטה לייצורו–מוצר אנטי

METHOD OF PRODUCING SAME .ISRAEL MILITARY INDUSTRIES LTD התעשייה הצבאית לישראל בע"מ

(2011.01 )H01L 76:5>; 20//1/0/2/

מתקנים לריכוז והולכת אנרגיה סולארית ע"י סטימולציה של פליטה לומינסנטית

STIMULATED EMISSION

LUMINESCENT LIGHT-GUIDE SOLAR

CONCENTRATORS .MORGAN SOLAR INC מורגן סולאר בע"מ

12/03/2009 2,658193 CA 04//2/0/2/ 42/07624/ US PCT/CA/2010/000363 WO/2010/102408

(2011.01 )C07C 76:5>= 27//1/0/2/

ALCOHOL AS SANDALWOOD ODORANT אלכוהול בניחוח אלגום

FIRMENICH SA 24/03/2009 PCT/IB2009/051223 IB PCT/IB/2010/051199

http://www.ilpatsearch.justice.gov.il/UI/MainPage.aspx?kind=2&reqno=213766




http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/CA/2010/000363


http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/IB/2010/051199



WO/2010/109391

(2011.01 )H01H 76:5>> 26//1/0/2/

( בעל MEMSמבנה מיקרו אלקטרו מכני )הממברנה גמישה ואמצעי הפעלה

אלקטרוניים משופרים

MEMS STRUCTURE WITH A

FLEXIBLE MEMBRANE AND

IMPROVED ELECTRIC ACTUATION

MEANS DELFMEMS 20/03/2009 09370007.8 EP PCT/EP/2010/001701 WO/2010/105827

(2011.01 )C07D 76:655 26//1/0/2/

שיפור סינטזה כימית של דיאזאינדולים על ידי ציקליזציה של חיחיבאבין

IMPROVED CHEMICAL SYNTHESIS

OF DIAZAINDOLES BY CHICHIBABIN

CYCLIZATION SANOFI 19/03/2009 61/161440 US 23/20/0//7 /736753 FR PCT/US/2010/027755 WO/2010/107969

(2011.01 )A61B 76:656 20//1/0/2/

מכשיר ושיטה לשילוב קריותרפיה עם ברכיתרפיה

COMBINED CRYOTHERAPY AND

BRACHYTHERAPY DEVICE AND

METHOD ICECURE MEDICAL LTD אייסקיור מדיקל בע"מ

12/03/2009 61/159497 US PCT/US/2010/027142 WO/2010/105158

(2011.01 )C07D 76:658 23//1/0/2/

http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/EP/2010/001701


http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/US/2010/027755




http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/FR/2010/050448



–[אוקט1.2.3ביציקלו]–אזא–N–[(6נגזרות הטרובנזאמיד, –מתיל[–אריל–איל(–1

הכנתן, ושימוש רפואי שלהן

N-[(6-AZA-bicyclo[3.2.1]OCT-5-YL]-

ARYL-METHYL]-

HETEROBENZAMIDE DERIVATIVES,

PREPARATION THEREOF, AND

THERAPEUTIC USE OF SAME SANOFI 16/03/2009 09/01220 FR PCT/FR/2010/050448 WO/2010/106270

(2011.01 )C07D 76:659 23//1/0/2/

–1–[ הקס1.1.2אזאביצקלו]–N–[(2נגזרות הטרובנזאמיד, הכנתן, –מתיל[–אריל–אין(

ויישום שלהן ברפואה

DERIVATIVES OF N-[(2-AZA-

BICYCLO[2.1.1]HEX-1-YL)-ARYL-

METHYL]-HETEROBENZAMIDE,

PREPARATION THEREOF AND

APPLICATION OF SAME IN

THERAPEUTICS SANOFI 16/03/2009 09/01219 FR 22//2/0//7 /7//262/ FR PCT/FR/2010/050447 WO/2010/106269

(2011.01 )C07D 76:65: /2//3/0/2/

NEMATOCIDAL SULFONAMIDES סולפונאמידים קוטלי תולעים

E.I. DU PONT DE NEMOURS AND

COMPANY 04/05/2009 61/175206 US PCT/US/2010/033471 WO/2010/129500

(2011.01 )A61K 76:65< /6//2/0/2/

תולדות בנזודיאזפין לטיפול בנאופלסמה ההמטופואטית ולויקמי

BENZODIAZEPINE DERIVATIVE FOR

THE TREATMENTOF

HEMATOPOIETIC NEOPLASM AND

LUEKEMIA ELI LILLY AND COMPANY








14/04/2009 61/169094 US PCT/US/2010/030315 WO/2010/120614

(2011.01 )A61K 76:65= /6//2/0/2/

אמאטוקסין –מטרה מצוידי–חלקים קושרי לטיפול בסרטן

AMATOXIN-ARMED TARGET-

BINDING MOIETIES FOR THE

TREATMENT OF CANCER FAULSTICH, HEINZ 08/04/2009 61/167690 US PCT/EP/2010/002206 WO/2010/115630

(2011.01 )C07D 76:65> 06//2/0/2/

ISOXAZOLE-PYRIDAZINE פירידאזין–תולדות איזוקסאזול

DERIVATIVES F. HOFFMANN-LA ROCHE AG 05/05/2009 09159412.7 EP PCT/EP/2010/055669 WO/2010/127968

(2011.01 )A21D 76:668 01//2/0/2/

טריות של מאפה בצק –תהליך נגד אי שטוח

ANTISTALING PROCESS FOR FLAT

BREAD

NOVOZYMES NORTH AMERICA, INC. 24/04/2009 61/172515 US PCT/US/2010/032233 WO/2010/124206

(2011.01 )F17C 76:669 00//2/0/2/

METHOD AND DEVICE FOR GASSING שיטה ומכשיר לאספקת גז

LINDE AG 13/03/2009 102009013133.7 DE










PCT/EP/2010/000397 WO/2010/102693

(2011.01 )C12N 76:66; 24//1/0/2/

מערכת לייצור חלבון כריסוספוריום לוקנוונס

CHRYSOSPORIUM LUCKNOWENSE

PROTEIN PRODUCTION SYSTEM

DYADIC NEDERLAND B.V. 16/03/2009 09003750 EP PCT/NL/2010/000045 WO/2010/107303

(2011.01 )A61K 76:66> 20//1/0/2/

SUBSTITTED FUSED PYRIMIDINE תרכובות פירימידין דחוסות ומותמרות

COMPOUNDS

ADVINUS THERAPEUTICS PRIVATE

LIMITED 13/03/2009 0571/CHE/2009 IN PCT/IN/2010/000145 WO/2010/103547

(2011.01 )C07D 76:675 /3//2/0/2/

הידרוקסיתיאנוקווינולונים ותרכובות ומייםזיה–קשורות כגורמים אנטי

HYDROXYTHIENOQUINOLONES

AND RELATED COMPOUNDS AS

ANTI-INFECTIVE AGENTS

ACHILLION PHARMACEUTICALS,

INC 03/04/2009 61/166371 US PCT/US/2010/029938 WO/2010/115184

(2011.01 )H04W 76:676 25//1/0/2/

http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/NL/2010/000045

http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/NL/2010/000045

http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/IN/2010/000145







שיטה ומערכת לבקרת כח שידור אות (SRSהתייחסות צלילי )

METHOD AND APPARATUS FOR

POWER CONTROL OF SOUNDING

REFERENCE SIGNAL (SRS)

TRANSMISSION

INTERDIGITAL PATENT HOLDINGS,

INC. 17/03/2009 61/160979 US PCT/US/2010/027617 WO/2010/107880

(2011.01 )A61K 76:677 07//1/0/2/

FAST-ACTING INSULIN הרכב אינסולין הפועל במהירות

FORMULATION ADOCIA 27/03/2009 61/202692 US 05//1/0//7 /7//2256 FR PCT/IB/2010/000711 WO/2010/122385

(2011.01 )A61K 76:678 04//1/0/2/

גורם, חלקיקים, תכשירים –תצמידי פולימר ושיטות קשורות לשימוש

POLYMER-AGENT CONJUGATES,

PARTICLES, COMPOSITIONS, AND

RELATED METHODS OF USE CERULEAN PHARMA INC. 30/03/2009 61/164734 US 1///1/0//7 42/242500 US 1///1/0//7 42/24250/ US 1///1/0//7 42/242503 US 1///1/0//7 42/242506 US 1///1/0//7 42/242512 US 0//22/0//7 42/040771 US 0//22/0//7 42/040772 US PCT/US/2010/028770 WO/2010/117668

(2011.01 )C10G 76:679 21//1/0//7








מיצוי של פחמימנים מחומרים המכילים פחמימנים ו/או עיבוד של חומרים

המכילים פחמימנים

EXTRACTION OF HYDROCARBONS

FROM HYDROCARBON-

CONTAINING MATERIALS AND/OR

PROCESSING OF HYDROCARBON-

CONTAINING MATERIALS GREEN SOURCE ENERGY LLC PCT/US/2009/037112 WO/2010/104516

(2011.01 )A61K 76:67; 02//1/0/2/

משחה תרופתית נגד חיידקים ותהליך לייצורה

A MEDICINAL ANTIBACTERIAL

CREAM AND A PROCESS TO MAKE IT

VANANGAMUDI, SULUR,

SUBRAMANIAM 25/03/2009 701/MUM/2009 IN PCT/IB/2010/051280 WO/2010/109417

(2011.01 )C07C 76:67= 07//1/0/2/

METHOD FOR PRODUCING שיטה לייצור תרכובת אלכוהולית

ALCOHOL COMPOUND

SUMITOMO CHEMICAL COMPANY,

LIMITED

31/03/2009 2009-

084832 JP

PCT/JP/2010/056109 WO/2010/114137

(2011.01 )A61K 76:686 00//1/0/2/

METHODS OF TREATMENT USING שיטות לטיפול תוך שימוש בריפוי משולב

COMBINATION THERAPY AMBIT BIOSCIENCES CORPORATION 23/03/2009 61/202647 US 07//2/0//7 42/2516/1 US /2/20/0//7 42/044767 US PCT/US/2010/028129



http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/JP/2010/056109





WO/2010/111172

(2011.01 )H04N 76:688 25//1/0/2/

התקן ושיטות להפצת וידאו לפי ביקושAPPARATUS AND METHODS FOR

SYNDICATION OF ON-DEMAND

VIDEO ACTIVEVIDEO NETWORKS INC 17/03/2009 61/160880 US PCT/US/2010/027724 WO/2010/107954

(2011.01 )G01C 76:689 20//0/0/2/

CARRIER MODULATING תאוצה מאפנן נשא–מד

ACCELEROMETER RAYTHEON COMPANY 04/05/2009 12/435098 US PCT/US/2010/024183 WO/2010/129079

(2011.01 )F16K 76:68: /6//1/0/2/

REGULATING VALVE DEVICE התקן שסתום מווסת

FUJIKIN INCORPORATED

17/03/2009 2009-

064546 JP

PCT/JP/2010/053749 WO/2010/106935

(2011.01 )H01Q 76:68; 01//0/0/2/

בעלת פס VHF/UHFערוצית –משושה דו רחב

VHF/UHF BROADBAND DUAL

CHANNEL ANTENNA

THALES 13/03/2009 0901187 FR PCT/EP/2010/052302










WO/2010/102901

(2011.01 )A61K 76:68= 26//1/0/2/

לטיפול בפקקת ורידית 5026AVEמנה של בחולים עם אי ספיקת כליות חמורה

A DOSE OF AVE5026 FOR THE

TREATMENT OF VENOUS

THROMBOEMBOLISM IN PATIENTS

WITH SEVERE RENAL IMPAIRMENT SANOFI 19/03/2009 09290202.2 FR PCT/IB/2010/051186 WO/2010/106519

(2011.01 )C07D 76:68> 26//1/0/2/

, תכשירים HSP90נגזרות אינדזול מעכבות המכילים אותן ושימוש שלהן

HSP90 INHIBITING INDAZOLE

DERIVATIVES, COMPOSITIONS

CONTAINING SAME AND USE

THEREOF SANOFI 19/03/2009 0901274 FR 27//2/0/2/ 2/3/122 FR PCT/FR/2010/050483 WO/2010/106290

(2011.01 )F24J 76:695 27//1/0/2/

אור עבור קולט משטח המחזיר קרני אנרגיה סולרית

REFLECTIVE SURFACE FOR SOLAR

ENERGY COLLECTOR

SKYLINE SOLAR INC. 20/03/2009 61/162125 US PCT/US/2010/028047 WO/2010/108141

(2011.01 )C12N 6:6967 27//1/0//7










טראוסטוציטרידים, תכשירים של חומצות שומן ושיטות להכנה ושימושים בהם

THRAUSTOCHYTRIDS, FATTY ACID

COMPOSITIONS, AND METHODS OF

MAKING AND USES THEREOF

MARTEK BIOSCIENCES

CORPORATION PCT/US/2009/001720 WO/2010/107415

(2011.01 )C09K 76:697 24//1/0/2/

נוזלי קידוח בעלי ביצועים גבוהים עם מיקרון כגורם –חלקיקים בגודל תת

הכבידה

HIGH PERFORMANCE DRILLING

FLUIDS WITH SUBMICRON-SIZE

PARTICLES AS THE WEIGHTING

AGENT

HALLIBURTON ENERGY SERVICES

INC 23/03/2009 12/409240 US PCT/GB/2010/000469 WO/2010/109163

(2011.01 )A01N 76:698 03//1/0/2/

PROCESS FOR THE PREPARATION תהליך להכנת אלוגליפטין

OF ALOGLIPTIN MAPI PHARMA LTD מאפי פארמה בע"מ

26/03/2009 61/163481 US PCT/IL/2010/000260 WO/2010/109468

(2011.01 )C01G 76:699 22//7/0/22

METHOD OF RECOVERING שיטה למיצוי מתכות קבוצה פלטינה

PLATINUM GROUP METAL BORIS GOLDIN

http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/GB/2010/000469


http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/IL/2010/000260





(2011.01 )B24B 76:69; 12/20/0//7

–כלי ממרט לשימוש כפד החלקה כימי צבמכני מיי

ABRASIVE TOOL USE AS A

CHEMICAL MECHANICAL

PLANARIZATION PAD

CONDITIONER Saint-Gobain ABRASIFS 24/03/2009 61/162893 US 02//6/0//7 42/01376/ US PCT/US/2009/069961 WO/2010/110834

(2011.01 )C07D 76:69< 27//1/0/2/

COMPOUNDS תרכובות

MEDICAL RESEARCH COUNCIL

TECHNOLOGY 19/03/2009 0904746.5 GB 0///1/0//7 42/240/02 US 22//5/0//7 /72001691 GB 06//2/0/2/ 2//222692 GB PCT/GB/2010/000498 WO/2010/106333

(2011.01 )G06T 76:69= 07//4/0//7

CONTENT PROTECTION MESSAGE חילוץ מודעות מתכנים מוגנים

EXTRACTION NDS LIMITED PCT/IB/2009/052784 WO/2011/001204

(2011.01 )A61M 76:69> 26//1/0/2/










מתאם למשאף עבור מערכת דיפרקצית לייזר ושיטה למדידת התפלגות של גדלי

חלקיקים

INHALER ADAPTOR FOR A LASER

DIFFRACTION APPARATUS AND

METHOD FOR MEASURING

PARTICLE SIZE DISTRIBUTION MANNKIND CORPORATION 18/03/2009 61/161379 US PCT/US/2010/027880 WO/2010/108046

(2011.01 )C04B 76:6:5 26//1/0//7

לוח או טבלה המוצרים מצבור אבן ילים דבק אורגני ממוצא צמחיוהמכ

BOARD OR SLAB FORMED BY

STONE AGGLOMERATE

CONTAINING AN ORGANIC BINDER

OF VEGETABLE ORIGIN COSENTINO, S.A. PCT/ES/2009/000153 WO/2010/106196

(2011.01 )F42B 76:6:6 01//2/0/2/

שיטה לבקרת טורפדו, טורפדו עבורה וקטע אנטנה של טורפדו כזה

METHOD FOR CONTROLLING A

TORPEDO, TORPEDO THEREFOR AND

ANTENNA SECTION OF SUCH A

TORPEDO ATLAS ELEKTRONIK GMBH 02/05/2009 102009019790.7 DE PCT/EP/2010/055475 WO/2010/127953

(2011.01 )C07D 76:6:8 23//1/0/2/

תרכובות נגזרות אמיד, תכשירים המכילים אותן ושימושים בהן

AMIDE DERIVATIVE COMPOUNDS,

COMPOSITIONS COMPRISING THE

SAME AND USES THERE OF

DAIICHI SANKYO COMPANY,

LIMITED

17/03/2009 2009-

065029 JP

http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/ES/2009/000153







PCT/JP/2010/054291 WO/2010/106988

(2011.01 )A61K 76:6:9 02/2//0//7

PHOTODYNAMIC DISINFECTION ושימושים בהםתכשירי חיטוי פוטודינמי,

COMPOSITIONS AND USES THEREOF ONDINE INTERNATIONAL LTD. 16/03/2009 61/160435 US PCT/US/2009/061442 WO/2010/107454

(2011.01 )A23L 76:6:: 24//1/0/2/

תכשיר תזונתי המכיל כורכומינואידים ושיטות ייצור

NUTRITIONAL COMPOSITION

COMPRISING CURCUMINOIDS AND

METHODS OF MANUFACTURE ABBOTT LABORATORIES 26/03/2009 61/163688 US 04//1/0//7 42/241461 US PCT/US/2010/027477 WO/2010/111070

(2011.01 )A01N 76:6:; 27//1/0/2/

נוקליאוזיד מותמר ואנלוגים של נוקליאוטיד

SUBSTITUTED NUCLEOSIDE AND

NUCLEOTIDE ANALOGS

ALIOS BIOPHARMA INC. 20/03/2009 61/162198 US 2///5/0//7 42/002623 US 22//6/0//7 42/012247 US PCT/US/2010/028046 WO/2010/108140

(2011.01 )C25D 76:6:< 12//1/0/2/










הרכב לציפוי מתכתי המכיל גורם הסתרה מיקרוני–לל חופשי תתעבור מילוי של ח

COMPOSITION FOR METAL PLATING

COMPRISING SUPPRESSING AGENT

FOR VOID FREE SUBMICRON

FEATURE FILLING BASF SE 07/04/2009 09157540.7 EP 1//2//0//7 42/034106 US PCT/EP/2010/054281 WO/2010/115796

(2011.01 )C07D 76:6:= /2//2/0/2/

[ 4,3,1][B–1,2תולדות אימידאזו ] תיאדיאזול

IMIDAZO [2,1-B] [1,3,4]

THIADIAZOLE DERIVATIVES

CENTRO NACIONAL DE

INVESTIGACIONES ONCOLOGICAS

(CNIO) 02/04/2009 09380069.6 EP PCT/GB/2010/000674 WO/2010/112874

(2011.01 )B32B 76:6:> 26//1/0/2/

THIN FILM COATING AND METHOD שכבת ציפוי דקה ושיטה לייצורה

OF MAKING THE SAME AGC GLASS EUROPE 18/03/2009 61/161186 US /2//6/0//7 42/0120/7 US PCT/US/2010/027806 WO/2010/107998

(2011.01 )H01L 76:6;5 01//1/0/2/

SLIP CHIP DEVICE AND METHODS התקן להחלקת שבב ושיטות

THE UNIVERSITY OF CHICAGO 24/03/2009 61/162922 US 26/22/0//7 42/040153 US 00//1/0/2/ 42/12/650 US PCT/US/2010/028316








WO/2010/111265

(2011.01 )C07D 76:6;6 02//2/0/2/

ALKYNYL-PYRIDINES-5 פירידינים–אלקיניל–5

BOEHRINGER INGELHEIM

INTERNATIONAL GMBH 21/04/2009 09158327.8 EP PCT/EP/2010/055293 WO/2010/122069

(2011.01 )B01J 76:6;7 27//1/0/2/

שיטות יעילות לפעולה עם נוזלים בלחץ גבוה

EFFICIENT METHODS FOR

OPERATION WITH HIGH PRESSURE

LIQUIDS ENERGY RECOVERY, INC. 20/03/2009 61/161977 US PCT/US/2010/027918 WO/2010/108070

(2011.01 )B05D 76:6;8 02//1/0/2/

רצועה מצופה ע"י שיחול עבור אריזות קשיחות

EXTRUSION-COATED STRIP FOR RIGID

PACKAGINGS

HYDRO ALUMINIUM DEUTSCHLAND

GMBH 26/03/2009 102009003683.0 DE PCT/EP/2010/053833 WO/2010/108953

(2011.01 )C12Q 76:6;9 23//1/0/2/

תהליך להגברת אותות המבוסס על זיהוי מוליקולרי

ABSCRIPTION BASED MOLECULAR

DETECTION

RIBOMED BIOTECHNOLOGIES, INC. 15/03/2009 61/160335 US










PCT/US/2010/027367 WO/2010/107716

(2011.01 )C07K 76:6;: 26//1/0/2/

שיטה להכנת פוליפפטיד קוניוגאנט פעיל פיזיולוגית באתר ספציפי

METHOD FOR PREPARING A SITE-

SPECIFIC PHYSIOLOGICALLY

ACTIVE POLYPEPTIDE CONJUGATE HANMI HOLDINGS CO., LTD.

20/03/2009 10-2009-

0023953 KR

PCT/KR/2010/001674 WO/2010/107256

(2011.01 )A61K 76:6;; 02//1/0/2/

טן השד העושה שימוש משטר טיפול לסר בנראטיניב

TREATMENT REGIMEN UTILIZING

NERATINIB FOR BREAST CANCER

WYETH LLC 06/04/2009 61/166796 US PCT/US/2010/028448 WO/2010/117633

(2011.01 )C07K 76:6;= 01//2/0/2/

תכשירים ושיטות להגברת גדילת שרירCOMPSITIONS COMPOSITIONS AND

METHODS FOR INCREASING

MUSCLE GROWTH NOVARTIS AG 27/04/2009 61/173004 US 27//0/0/2/ 42/1/4215 US PCT/EP/2010/055458 WO/2010/125003

(2011.01 )C07D 76:6;> 06//2/0/2/

http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/KR/2010/001674









פירידין כמאפנני –תולדות איזוקסאזולGABA

ISOXAZOLE -PYRIDINE

DERIVATIVES AS GABA

MODULATORS F. HOFFMANN-LA ROCHE AG 07/05/2009 09159631.2 EP PCT/EP/2010/055701 WO/2010/127978

(2011.01 )A01N 76:6<5 01//2/0/2/

אלכוהול אלקוקסילאטים כחומר מסייע לתכשירים אגרוכמיקליים

ALCOHOL ALKOXYLATES AS

ADJUVANTS FOR AGROCHEMICAL

FORMULATIONS SYNGENTA LIMITED 23/04/2009 0907003.8 GB PCT/GB/2010/000821 WO/2010/122313

(2011.01 )F27B 76:6<6 24//1/0/2/

A PYROLYTIC REACTOR כור פירוליטי

T.D.E. RECOVERY TECHNOLOGIES טי.די.אי. טכנולוגיות מיחזור בע"מ

LTD 17/03/2009 61/160842 US PCT/IL/2010/000217 WO/2010/106538

(2011.01 )F23K 76:6<7 24//1/0/2/

FEEDING APPARATUS AND METHOD מכשיר הזנה ושיטה לכור פירוליטי

FOR A PYROLYTIC REACTOR


LTD 17/03/2009 61/160842 US PCT/IL/2010/000218 WO/2010/106539








(2011.01 )C08J 76:6<8 24//1/0/2/

תהליך נקי סביבתית לשימוש במוצרי פירוליזה

ENVIRONMENTALLY CLEAN

PROCESS FOR UTILIZING

PYROLYSIS PRODUCTS


LTD 17/03/2009 61/160842 US PCT/IL/2010/000219 WO/2010/106540

(2011.01 )C07D 76:6<9 00//1/0/2/

קטון אפוקסי טריפפטיד קריסטלי מעכבי פרוטאז

CRYSTALLINE TRIPEPTIDE EPOXY

KETONE PROTEASE INHIBITORS

ONYX THERAPEUTICS, INC. 20/03/2009 61/162196 US 00//3/0//7 42/26/342 US PCT/US/2010/028126 WO/2010/108172

(2011.01 )C07D 76:6<: 01//1/0/2/

נגזרות של תיאנופירימידינדיאון 1TRPAכמאפנני

THIENOPYRIMIDINEDIONE

DERIVATIVES AS TRPA1

MODULATORS GLENMARK PHARMACEUTICALS S.A. 23/03/2009 665/MUM/2009 IN 02//2/0//7 42/252133 US 01//7/0//7 0021/MUM/2009 IN 23/2//0//7 42/032772 US 24/20/0//7 07/4/MUM/2009 IN 20//2/0/2/ 42/07225/ US PCT/IB/2010/000930 WO/2010/109334

(2011.01 )B62B 76:6<; /7//1/0/2/

CART עגלה










FINE, AMOS 16/03/2009 12/382410 US PCT/IB/2010/051009 WO/2010/106464

(2011.01 )C07D 76:6<< 00//1/0/2/

נגזרות של פורופירימידינדיאון 1TRPAכמאפנני

FUROPYRIMIDINEDIONE DERIVATIVES

AS TRPA1 MODULATORS

GLENMARK PHARMACEUTICALS S.A. 23/03/2009 665/MUM/2009 IN 02//2/0//7 42/252133 US 01//7/0//7 0021/MUM/2009 IN 23/2//0//7 42/032772 US 24/20/0//7 07/4/MUM/2009 IN 20//2/0/2/ 42/07225/ US PCT/IB/2010/000840 WO/2010/109329

(2011.01 )C07D 76:6<= 25//1/0/2/

נגזרות מאוחות של פירימידינדיאון 1TRPAכמאפנני

FUSED PYRIMIDINEDIONE

DERIVATIVES AS TRPA1 MODULATORS

GLENMARK PHARMACEUTICALS S.A. 23/03/2009 665/MUM/2009 IN 02//2/0//7 42/252133 US 01//7/0//7 0022/MUM/2009 IN 01//7/0//7 0020/MUM/2009 IN 23/2//0//7 42/032722 US 0//2//0//7 42/031041 US 23/20/0//7 0672/MUM/2009 IN 23/20/0//7 0670/MUM/2009 IN 20//2/0/2/ 42/072241 US /2//0/0/2/ 42/1//022 US PCT/IB/2010/000553 WO/2010/109287

(2011.01 )C07D 76:6<> 00//1/0/2/








פירימידינדיאון –נגזרות של איזותיאזולו 1TRPAכמאפנני

ISOTHIAZOLO-PYRIMIDINEDIONE

DERIVATIVES AS TRPA1

MODULATORS GLENMARK PHARMACEUTICALS S.A. 23/03/2009 665/MUM/2009 IN 02//2/0//7 42/252133 US PCT/IB/2010/000834 WO/2010/109328

(2011.01 )A61L 76:6=5 00//2/0/2/

BIOCOMPATIBLE COMPOSITE AND מרוכב מתאים לשימוש בגוף ושימוש שלו

ITS USE VIVOXID OY 23/04/2009 09158597.6 EP PCT/EP/2010/055335 WO/2010/122098

(2011.01 )C03C 76:6=6 0///2/0/2/

תכשירי סיבי זכוכית הניתנים לספיגה חוזרת ומתאימים לשימוש בגוף ושימושים

שלהם

RESORBABLE AND BIOCOMPATIBLE

FIBRE GLASS COMPOSITIONS AND

THEIR USES

VIVOXID OY 23/04/2009 09158608.1 EP PCT/EP/2010/055192 WO/2010/122019

(2011.01 )C12Q 76:6=7 25//1/0/2/

IMPROVED DETECTION OF GENE גילוי משופר של ביטוי גנים

EXPRESSION MDxHEALTH S.A. 17/03/2009 61/160935 US PCT/EP/2010/001674 WO/2010/105815








(2011.01 )C07C 76:6=8 26//1/0/2/

–2–בנזיל–V7–(Rתהליך להכנת )–S–)בנזילאוקסיקרבונילאמינו(

ופיונאמידמתוקסיפר

PROCESS FOR PREPARING (R)-7V-

BENZYL-2-

(BENZYLOXYCARBONYLAMINO)-S-

METHOXYPROPIONAMIDE PLIVA HRVATSKA D.O.O. 18/03/2009 61/161181 US 05//2/0//7 42/2507/1 US PCT/US/2010/027800 WO/2010/107993

(2011.01 )F01N 76:6=9 06//1/0/2/

EXHAUST GEOMETRY FOR פליטה גיאומטרית של קבוצת חלקיקים

PARTICLE GROUPING RUZAL MICHAL ערן שר

30/03/2009 61/164477 US PCT/IL/2010/000269 WO/2010/113156

(2011.01 )C07C 76:6=> 1///1/0/2/

שיטה לייצור תרכובת אלכוהולית וזרז עבורה

METHOD FOR PRODUCING

ALCOHOL COMPOUND AND

CATALYST THEREFOR

SUMITOMO CHEMICAL COMPANY,

LIMITED

31/03/2009 2009-

084833 JP

PCT/JP/2010/056130 WO/2010/114151

(2011.01 )A23L 76:6>5 01//1/0/2/

טעם טבעי המגביר את התיבול הבסיסי והליך להכנתו

A NATURAL TASTE ENHANCING

SAVOURY BASE AND A PROCESS FOR ITS

PREPARATION NESTEC S.A. 25/03/2009 PCT/EP2009/053530 EP










PCT/EP/2010/053735 WO/2010/108901

(2011.01 )B65D 76:6>6 04//1/0/2/

IMPROVED CONTAINERS מיכלים משופרים

GARMOND PTY. LIMITED 03/04/2009 2009901455 AU PCT/AU/2010/000340 WO/2010/111729

(2011.01 )C23C 76:6>7 02//1/0/2/

תהליך לסינטור ננו חלקיקים בטמפרטורה נמוכה

PROCESS FOR SINTERING

NANOPARTICLES AT LOW

TEMPERATURES

יישום חברה לפיתוח המחקר של האוניברסיטה העברית בירושלים בע"מ

YISSUM RESEARCH DEVELOPMENT

COMPANY OF THE HEBREW

UNIVERSITY OF JERUSALEM LTD. 24/03/2009 61/162744 US PCT/IL/2010/000249 WO/2010/109465

(2011.01 )F16D 76:6>8 /4//2/0/2/

מכשיר מכאני לשידור כח עם סףMECHANICAL DEVICE FOR THE

TRANSMISSION OF A FORCE WITH A

THRESHOLD MESSIER-BUGATTI-DOWTY 06/04/2009 09/01683 FR PCT/EP/2010/054538 WO/2010/115895

(2011.01 )A61K 76:6>9 24//1/0/2/

NOVEL ANTI-INFLAMMATORY דלקתיים–גורמים חדשים אנטי

AGENTS

http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/AU/2010/000340









RESVERLOGIX CORP 18/03/2009 61/161089 US PCT/IB/2010/000826 WO/2010/106436

(2011.01 )A61K 76:6>: 24//1/0/2/

עם מינונים עולים NASH–שיטה לטיפול ב של חומצה אורסודיאוקסיכולית

METHOD OF TREATING

NONALCOHOLIC STEATOHEPATITIS

WITH ELEVATED DOSES OF

URSODEOXYCHOLIC ACID AXCAN PHARMA INC 17/03/2009 61/160955 US PCT/IB/2010/000551 WO/2010/106420

(2011.01 )A61K 76:6>; 03//1/0/2/

טרום מוות של גורמים זיהוי מהיר זיהומיים

RAPID ANTEMORTEM DETECTION

OF INFECTIOUS AGENTS

THE RESEARCH FOUNDATION OF

STATE UNIVERSITY OF NEW YORK 25/03/2009 61/211264 US 03//1/0//7 42/022043 US PCT/US/2010/028698 WO/2010/111514

(2011.01 )C07D 76:6>> 02//2/0/2/

ציקלופנטאזולנים כמעכבי –טריאזא–תיה3PI–קינאזות לטיפול בסרטן

THIA-TRIAZA-

CYCLOPENTAZULENES AS PI3-

KINASES INHIBITORS FOR THE

TREATMENT OF CANCER


INTERNATIONAL GMBH 22/04/2009 09158493.8 EP PCT/EP/2010/055295 WO/2010/122071








(2011.01 )A61K 76:755 02//1/0/2/

DRUG FUSIONS AND CONJUGATES מיזוגי ותצמידי תרופות

GLAXO GROUP LIMITED 27/03/2009 61/163917 US PCT/EP/2010/053806 WO/2010/108937

(2011.01 )E01F 76:756 27//1/0/2/

IMPROVED ROAD BARRIER מחסום כביש משופר

INDUSTRIAL GALVANIZERS

CORPORATION PTY LTD 19/03/2009 2009901186 AU 25//2/0//7 0//77/2436 AU 22//4/0//7 0//77/0475 AU 21/22/0//7 0//77/3343 AU PCT/AU/2010/000321 WO/2010/105307

(2011.01 )A01N 76:757 03//1/0/2/

C FUSED RING INHIBITORS OF–מעכבים טבעתיים מאוחים של צהבת

HEPATITIS C PRESIDIO PHARMACEUTICALS, INC. 27/03/2009 61/164342 US 06//2/0//7 42/022661 US PCT/US/2010/028730 WO/2010/111534

(2011.01 )A61B 76:758 27//0/0/2/

שיטה להתקן להעברת פריט זוכר צורה לאתר ניתוח


DELIVERING A SHAPE MEMORY

ARTICLE TO A SURGICAL SITE

CORE ESSENCE ORTHOPAEDICS,

LLC










19/03/2009 61/161604 US PCT/US/2010/024728 WO/2010/107549

(2011.01 )G01R 76:759 1///1/0/2/

–תפעול אוטומטי של מכשיר בדיקה רב נקודתי

AUTOMATED MULTI-POINT PROBE

MANIPULATION

CAPRES A/S 31/03/2009 09388007.8 EP PCT/EP/2010/054180 WO/2010/115771

(2011.01 )A61K 76:75: 03//1/0/2/

עיניות למתן תרופות –מערכות תוךבשחרור ממושך ושיטות לטיפול במחלות

עיניים

INTRAOCULAR SUSTAINED

RELEASE DRUG DELIVERY

SYSTEMS AND METHODS FOR

TREATING OCULAR CONDITIONS ALLERGAN, INC. 25/03/2009 12/411250 US PCT/US/2010/028584 WO/2010/111449

(2011.01 )C07D 76:75; 27//2/0/2/

SOLID FORMS OF AN AZOCYCLIC צורות מוצקות של אמיד אזוציקלי

AMIDE


COMPANY 22/04/2009 61/171573 US /6//1/0/2/ 42/122320 US PCT/US/2010/031546 WO/2010/123791

(2011.01 )H04W 76:75< 03//2/0/2/







http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/SE/2010/050063



שיטה וציוד לטיפול בתיחול בקשת תזמוןMETHOD AND USER EQUIPMENT

FOR HANDLING A SCHEDULING

REQUEST TRIGGER

TELEFONAKTIEBOLAGET L M

ERICSSON (PUBL) 05/05/2009 61/175668 US PCT/SE/2010/050063 WO/2010/128927

(2011.01 )C07K 76:75= 25//1/0/2/

נוגדנים הנקשרים לפלאק טרשת עורקים כלילית, שיטות להכנתם ושימושם בהם

ANTIBODIES BINDING

ATHEROSCLEROTIC CORONARY

PLAQUE, PROCESSES FOR THE

PREPARATION OF THE SAME AND

USES THEREOF BRACCO IMAGING S.P.A. 19/03/2009 09155614.2 EP PCT/EP/2010/053430 WO/2010/106088

(2011.01 )C07C 76:75> 20//1/0/2/

–טרו–לייצור תולדות קארבוקסילישיטה יוד ארומטייות

PROCESS FOR THE PREPARATION

OF TRIIODINATED CARBOXYLIC

AROMATIC DERIVATIVES BRACCO IMAGING S.P.A. 20/03/2009 09155695.1 EP PCT/EP/2010/053186 WO/2010/105983

(2011.01 )A61M 76:765 04//1/0/2/

התקן לשחרור תרופה עם מקל בוכנה משופר

DRUG DELIVERY DEVICE WITH AN

IMPROVED PISTON ROD

SANOFI-AVENTIS DEUTSCHLAND

GMBH 30/03/2009 09004570.9 EP PCT/EP/2010/053968 WO/2010/112409








(2011.01 )A61M 76:766 12//1/0/2/

מתן מינון להתקן לשחרור תרופה ושיטות לייצור מתג המינון

DOSE BUTTON FOR A DRUG

DELIVERY DEVICE AND METHOD

FOR MANUFACTURING A DOSE

BUTTON


GMBH 31/03/2009 09004674.9 EP 24//2/0//7 42/24766/ US PCT/EP/2010/054352 WO/2010/112565

(2011.01 )A61M 76:767 12//1/0/2/

FIXING MEANS אמצעי קיבוע


GMBH 31/03/2009 09004673.1 EP 24//2/0//7 42/247655 US PCT/EP/2010/054351 WO/2010/115822

(2011.01 )A61M 76:768 12//1/0/2/

אי בעל מנגנון ושימוש בחומר התקן רפו בעל חיכוך נמוך בתוך ההתקן הרפואי

MEDICAL DEVICE HAVING A

MECHANISM AND USE OF A LOW-

FRICTION SYNTHETIC MATERIAL

WITHIN A MEDICAL DEVICE










(2011.01 )B29C 76:769 12//1/0/2/

שיטות לייצור חלק העשוי מחומר מרוכב להתקן לשחרור תרופה ושימוש בחלק זה

להתקן לשחרור תרופה

METHOD FOR MANUFACTURING A

COMPOSITE WORK PIECE FOR A

DRUG DELIVERY DEVICE AND

COMPOSITE WORK PIECE FOR A

DRUG DELIVERY DEVICE



(2011.01 )A61M 76:76: 12//1/0/2/

PEN CAP מכסה עט



(2011.01 )G09F 76:76; 12//1/0/2/

שיטות ליצירת גוף של התקן לשחרור תרופה בשימוש בחומר דביק והתקן

לשחרור תרופה

METHOD FOR MANUFACTURING A

DRUG DELIVERY DEVICE BODY

USING AN ADHESIVE AND DRUG

DELIVERY DEVICE BODY



(2011.01 )A61M 76:76< 12//1/0/2/










התקן רפואי בעל מנגנון עם קפיץ ושימוש בקפיץ גלי או בטבעת אוטמת גלית בהתקן

הרפואי

MEDICAL DEVICE HAVING A

MECHANISM WITH A SPRING AND

USE OF A WAVE SPRING OR WAVE

WASHER WITHIN A MEDICAL

DEVICE



(2011.01 )A61M 76:76= 12//1/0/2/

סידור הרכבה ומיכלול צימוד להתקן לשחרור תרופה

MOUNTING ARRANGEMENT AND

COUPLING ASSEMBLY FOR A DRUG

DELIVERY DEVICE



(2011.01 )A61M 76:76> 12//1/0/2/

DRUG DELIVERY DEVICE התקן לשחרור תרופה



(2011.01 )A61M 76:775 12//1/0/2/



GMBH 31/03/2009 09004665.7 EP








24//2/0//7 42/247630 US PCT/EP/2010/054342 WO/2010/115817

(2011.01 )F16F 76:776 12//1/0/2/

מרכיב קפיצי להתקן לשחרור תרופה, שימוש בו והתקן לשחרור תרופה

SPRING ELEMENT FOR A DRUG

DELIVERY DEVICE, USE THEREOF

AND DRUG DELIVERY DEVICE


GMBH 31/03/2009 09004663.2 EP 22//2/0//7 42/24676/ US PCT/EP/2010/054339 WO/2010/112559

(2011.01 )A61M 76:777 12//1/0/2/




(2011.01 )C07D 76:77; 27//1/0/2/

נגזרות אמיד כליגנדים לקולטן ניורופפטיד 5Y

AMIDE DERIVATIVES AS

NEUROPEPTIDE Y5 RECEPTOR

LIGANDS H. LUNDBECK A/S 20/03/2009 61/161802 US PCT/US/2010/027892 WO/2010/108052








(2011.01 )C07D 76:77< 04//1/0/2/

טריאזיניל בנזאימידזול –1,3,5–פירימידין וסולפונאמידים ושימושים שלהם בטיפול

בסרטן

PYRIMIDINYL AND 1,3,5-TRIAZINYL

BENZIMIDAZOLE SULFONAMIDES

AND THEIR USE IN CANCER

THERAPY PATHWAY THERAPEUTICS, INC. 27/03/2009 61/164359 US /5//5/0//7 42/001465 US 1///7/0//7 42/025232 US PCT/NZ/2010/000060 WO/2010/110685

(2011.01 )C12N 76:77= 04//1/0/2/

בעזרת שימוש בתאי הרג דיכוי גידול ביניים טבעיים שמקורם בשליה אנושית

ותרכובות אימונומודולטוריות

TUMOR SUPPRESSION USING

HUMAN PLACENTA-DERIVED

INTERMEDIATE NATURAL KILLER

CELLS AND IMMUNOMODULATORY

COMPOUNDS ANTHROGENESIS CORPORATION 25/03/2009 61/163449 US PCT/US/2010/028885 WO/2010/111631

(2011.01 )C07D 76:77> 06/2//0/2/

CARBINOL COMPOUND HAVING תרכובת קרבינול עם מקשר הטרוציקלי

HETEROCYCLIC LINKER KOWA COMPANY, LTD. 29/04/2009 61/173690 US PCT/JP/2010/003039 WO/2010/125811

(2011.01 )A61K 76:785 /5//2/0/2/

פורמולצית פראציפקסול למתן פומי CR/IR פעם ביום

ONCE-DAILY ORAL IR/CR

PRAMIPEXOLE FORMULATION

PURDUE PHARMA

http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/NZ/2010/000060

http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/NZ/2010/000060








09/04/2009 61/167980 US PCT/CA/2010/000482 WO/2010/115267

(2011.01 )B25B 76:786 27//1/0/2/

התקן לקביעה של חפץ מעובד על יועדים מנשא ושיטה לעיבוד חפצים המ

לעיבוד

DEVIE FOR FIXING WORKPIECES ON A

WORKPIECE CARRIER AND METHOD

FOR MACHINING WORKPIECES

MTU AERO ENGINES GMBH 20/03/2009 102009013726.2 DE PCT/DE/2010/000308 WO/2010/105612

(2011.01 )C07K 76:789 /2//2/0/2/

METHOD FOR PURIFYING רקומביננטי FSHשיטה לטיהור

RECOMBINANT FSH BIOGENERIX AG 01/04/2009 09157133.1 EP PCT/EP/2010/002111 WO/2010/115586

(2011.01 )C07D 76:78: 03//1/0/2/

PYRAZOLE COMPOUND תרכובת פיראזול

TAKEDA PHARMACEUTICAL

COMPANY LIMITED

26/03/2009 2009-

077078 JP

PCT/JP/2010/055257 WO/2010/110378

(2011.01 )H01R 76:78; 00//2/0/2/

ELECTRICALLY CONDUCTIVE מחזיקי מיסבים מוליכים חשמלית

BEARING RETAINERS

http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/DE/2010/000308









RAYTHEON COMPANY 25/03/2009 12/411168 US PCT/US/2010/021745 WO/2010/110933

(2011.01 )A61N 76:78< 01//1/0/2/

אנליזה של נתוני פיזור לאחור בזמן אמת רפואי HIFUליצירת אות ליקוי בהתקן

ANALYSIS OF REAL TIME

BACKSCATTER DATA FOR FAULT

SIGNAL GENERATION IN A

MEDICAL HIFU DEVICE

MEDICIS TECHNOLOGIES

CORPORATION 23/03/2009 61/162641 US PCT/US/2010/028254 WO/2010/111233

(2011.01 )F01C 76:78= 03//1/0/2/

מנוע בעל העברת מיקום הפכית, (IDARוסיבוביות אסימטרית )

INVERSE DISPLACEMENT

ASYMMETRIC ROTARY (IDAR)

ENGINE LUMENIUM LLC 25/03/2009 61/211192 US PCT/US/2010/028754 WO/2010/111557

(2011.01 )C12N 76:78> 03//1/0/2/

–אן JEJUNI.Cהמציגה סלמונלת המעיים גליקן או נגזרות מתאימות

SALMONELLA ENTERICA

PRESENTING C.JEJUNI N-GLYCAN

OR DERIVATIVES THEREOF

EIDGENOSSISCHE TECHNISCHE

HOCHSCHULE ZURICH 27/03/2009 09004445.4 EP PCT/EP/2010/001884 WO/2010/108682








(2011.01 )F41G 76:795 07//1/0/2/

ASSIGNING WEAPONS TO THREATS הקצאת כלי נשק לסכנות

BAE SYSTEMS PLC 31/03/2009 0905563.3 GB 12//1/0//7 /703/7639/ EP PCT/GB/2010/050530 WO/2010/112907

(2011.01 )F16L 76:796 /7//1/0/2/

לחיבור צינור לצינור עם CIPPטכנולוגית מחסום מסטירן

CURED IN PLACE PIPE LINER WITH

STYRENE BARRIER

LUBRIZOL ADVANCED MATERIALS,

INC. 24/03/2009 61/162725 US PCT/US/2010/026580 WO/2010/111025

(2011.01 )A61F 76:798 26//1/0/2/

APPARATUS AND METHOD FOR מכשיר ושיטה ליצירת חתך מעגלי

MAKING A CIRCULAR INCISION V.R, HEXIS LTD קסיס בע"מוי.אר. ה

23/03/2009 12/408841 US PCT/IL/2010/000225 WO/2010/109447

(2011.01 )G11B 76:799 12//1/0/2/

מכשיר ושיטה אינטראקטיביות לבקשות תתוכן במדיה דיגיטלי

APPARATUS AND METHOD FOR

INTERACTIVE DIGITAL MEDIA

CONTENT REQUESTS AKOO INTERNATIONAL, INC. 31/03/2009 12/415096 US PCT/US/2010/029306 WO/2010/117828










(2011.01 )A61K 76:79: 26//1/0/2/

USE OF NKP46 FOR PREVENTING למניעת סוכרת 46NKP–שימוש ב

DIABETES

יישום חברה לפיתוח המחקר של האוניברסיטה העברית בירושלים בע"מ

YISSUM RESEARCH DEVELOPMENT


UNIVERSITY OF JERUSALEM LTD 19/03/2009 61/202629 US /7/22/0//7 42/03712/ US PCT/IL/2010/000228 WO/2010/106542

(2011.01 )C07D 76:79= 04//0/0/2/

תהליך להפרדת אננטיומרים של טריאזין–5,3,1–דיהידרו–6,3נגזרות של

PROCESS FOR SEPARATING

ENANTIOMERS OF 3,6-DIHYDRO-1,3,5-

TRIAZINE DERIVATIVES MERCK PATENT GMBH 25/03/2009 102009014898.1 DE PCT/EP/2010/001219 WO/2010/108583

(2011.01 )C07D 76:79> 1///2/0/2/

–בתא 11מעכבים ציקליים של 1הידרוקסיסטירואיד דהידרוגנאז

CYCLIC INHIBITORS OF 11BETA-

HYDROXYSTEROID DEHYDROGENASE 1

VITAE PHARMACEUTICALS, INC. 30/04/2009 PCT/US09/002653 US 01//5/0//7 PCT/US09/004261 US PCT/US/2010/033157 WO/2010/127237

(2011.01 )F28D 76:7:5 20//1/0/2/










יריעה מעבירה חום עבור ממיר חם משובי סיבובי

HEAT TRANSFER SHEET FOR

ROTARY REGENERATIVE HEAT

EXCHANGER ALSTOM TECHNOLOGY LTD. 08/05/2009 12/437914 US PCT/US/2010/027076 WO/2010/129092

(2011.01 )C07D 76:7:6 02//1/0/2/

–3–פוריניל–2אטרופאיזומרים של תולדות קווינאזולינון ושיטות לשימוש בהן–טוליל

ATROPISOMERS OF2-PURINYL-3-

TOLYL-QUINAZOLINONE

DERIVATIVES AND METHODS OF

USE GILEAD CALISTOGA LLC 24/03/2009 61/162980 US /3//6/0//7 42/01233/ US PCT/US/2010/028554 WO/2010/111432

(2011.01 )C25B 76:7:7 26//3/0/2/

CATHODE FOR ELECTROLYTIC קטודה עבור תהליכים אלקטרוליטיים

PROCESSES INDUSTRIE DE NORA S.P.A 19/05/2009 MI2009A000880 IT PCT/EP/2010/056797 WO/2010/133583

(2011.01 )C12Q 76:7:8 /5//2/0/2/

שיטות לחיזוי סיכון לסרטן ע"י שימוש ממאירה–בביטוי גני ברקמה טרום

METHODS OF PREDICTING CANCER

RISK USING GENE EXPRESSION IN

PREMALIGNANT TISSUE GENOMIC HEALTH, INC. 07/04/2009 61/167503 US 26//7/0//7 42/0215/6 US PCT/US/2010/030285 WO/2010/118166








(2011.01 )G10L 76:7:9 /1//0/0/22

מפענח אודיו ושיטה פענוח המשתמשת בערבוב יעיל

AUDIO DECODER AND DECODING

METHOD USING EFFICIENT

DOWNMIXING

DOLBY LABORATORIES LICENSING

CORPORATION 18/02/2010 61/305871 US 07//4/0/2/ 42/137541 US PCT/US/2011/023533 WO/2011/102967

(2011.01 )G02B 76:7:: 00//2/0/2/

אמת של השפעות עיוות קיזוז אופטי בזמן מסלול במדמים בעלי זמן –נגרמות

אינטגרציה ארוך

REAL-TIME OPTICAL

COMPENSATION OF ORBIT-

INDUCED DISTORTION EFFECTS IN

LONG INTEGRATION TIME IMAGERS RAYTHEON COMPANY 26/03/2009 12/412118 US PCT/US/2010/021748 WO/2010/110934

(2011.01 )A61B 76:7:; 03//1/0/2/

התקן תפירה כירורגי, שיטה וכלים שמשתמשים בהם אתו

SURGICAL SUTURING DEVICE,

METHOD AND TOOLS USED

THEREWITH ALPHA SCIENTIFIC CORPORATION 02/04/2009 12/384326 US PCT/US/2010/000891 WO/2010/114591

(2011.01 )C07D 76:7:= /1//1/0/2/

תרכובות הטרוציקליות כמעכבי אוטוטקסין

HETEROCYCLIC COMPOUNDS AS

AUTOTAXIN INHIBITORS










MERCK PATENT GMBH 02/04/2009 09004858.8 EP PCT/EP/2010/001324 WO/2010/112116

(2011.01 )C07D 76:7:> /7//1/0/2/

AUTOTAXIN INHIBITORS מעכבי אוטוטקסין

MERCK PATENT GMBH 02/04/2009 09004866.1 EP PCT/EP/2010/001457 WO/2010/112124

(2011.01 )C07D 76:7;5 /1//1/0/2/

נגזרות של פיפרידין ופיפראזין כמעכבי אוטוטקסין

PIPERIDINE AND PIPERAZINE

DERIVATIVES AS AUTOTAXIN

INHIBITORS MERCK PATENT GMBH 02/04/2009 09004856.2 EP PCT/EP/2010/001323 WO/2010/115491

(2011.01 )C07D 76:7;6 27//1/0/2/

מאפנני הרגולטור למוליכותהטרנסממברני של סיסטיק פיברוזה,

תכשירים המכילים אותם ושימושים בהם

MODULATORS OF CYSTIC FIBROSIS

TRANSMEMBRANE CONDUCTANCE

REGULATOR, COMPOSITIONS

CONTAINING THE SAME AND USES

THEREOF

VERTEX PHARMACEUTICALS

INCORPORATED 20/03/2009 61/162130 US PCT/US/2010/028062 WO/2010/108155








(2011.01 )C07D 76:7;7 27//1/0/2/

שיטה לייצור מאפנני הרגולטור למוליכות הטרנסממברני של סיסטוק פיברוזה,

מוצרים שלהם ושימושים בהם

PROCESS FOR PRODUCING A

CYSTIC FIBROSIS

TRANSMEMBRANE CONDUCTANCE

MODULATOR, PRODUCTS THEREOF

AND USES OF THE SAME


INCORPORATED 20/03/2009 61/162148 US 06//7/0//7 42/0241/1 US /3/2//0//7 42/026343 US PCT/US/2010/028069 WO/2010/108162

(2011.01 )C07D 76:7;9 06//1/0/2/

HIV LIPOPEPTIDE INHIBITORS OF HIV-1–1ליפופפטידים מעכבי

YEDA RESEARCH AND ידע חברה למחקר ופיתוח בע"מ

DEVELOPMENT CO. LTD. 01/04/2009 61/165536 US PCT/IL/2010/000271 WO/2010/113157

(2011.01 )C07K 76:7>6 01//1/0/2/

NOVEL ANTI-a5?1 ANTIBODIES AND חדשים ושימושים בהם a5?1נוגדנים אנטי

USES THEREOF GENENTECH, INC. 25/03/2009 61/163241 US PCT/US/2010/028291 WO/2012/111254

(2011.01 )A61K 76:7>7 00//1/0/2/

תרכובות ושיטות לאפנון תגובה חיסוניתCOMPOUNDS AND METHODS FOR

MODULATING AN IMMUNE

RESPONSE

THE WALTER AND ELIZA HALL

INSTITUTE OF MEDICAL RESEARCH










23/03/2009 61/162616 US PCT/AU/2010/000325 WO/2010/108215

(2011.01 )G06F 76:7>8 /2//2/0/2/

מתן גישה לפריט נתונים באמצעות גרפי גישה

PROVIDING ACCESS TO A DATA

ITEM USING ACCESS GRAPHS

MICROSOFT CORPORATION 01/04/2009 12/416164 US PCT/US/2010/029712 WO/2010/115059

(2011.01 )A63F 76:7>9 04//2/0/2/

מערכות ושיטות ליישום מודל מעקב ללכידת תנועה


APPLYING MODEL TRACKING TO

MOTION CAPTURE MICROSOFT CORPORATION 01/05/2009 61/174950 US 24//4/0//7 20/26351/ US PCT/US/2010/032366 WO/2010/126816

(2011.01 )C12Q 76:7>; 24//0/0/2/

לאפיון האיזור הלא מתורגם PCRשיטות 2FMR–ו 1FMRשל הגנים 5'

PCR METHODS FOR

CHARACTERIZING THE 5'

UNTRANSLATED REGION OF THE

FMR1 AND FMR2 GENES ASURAGEN, INC. 24/03/2009 61/162977 US PCT/US/2010/000426 WO/2010/110835

(2011.01 )C07D 76:7>< 24//2/0/2/










אימידאזופיראזינים לשימוש כמעכבי קינאז

IMIDAZOPYRAZINES FOR USE AS

KINASE INHIBITORS

CENTRO NACIONAL DE

INVESTIGACIONES ONCOLOGICAS

(CNIO) 16/04/2009 09380079.5 EP PCT/GB/2010/000773 WO/2010/119264

(2011.01 )C07D 76:7>= 02//1/0/2/

–(R3,R4])–7מלחי רוקחות שימושיים של

–פירולידין–הידרוקסימתיל–4–הידרוקסי–3–2,3פירולו]–דיהידרו–5,3–אילמתיל[–1Dאון–4–[פירימידין

USEFUL PHARMACEUTICAL SALTS

OF 7[(3R,4R)-3-HYDROXY-4-

HYDROXYMETHYL-PYRROLIDIN-1-

YLMETHYL]-3,5-DIHYDRO-

PYRROLO[3,2-D]PYRIMIDIN-4-ONE

BIOCRYST PHARMACEUTICALS ,

INC. 24/03/2009 61/162805 US PCT/US/2010/028490 WO/2010/111381

(2011.01 )A01N 76:7>> 01//1/0/2/

[דקאנים 5,4]–אזאספירו–8–דיאוקסא–4,1המותמרים משמשים כקוטלי פטריות

ותהליך להכנתם

SUBSTITUTED 1,4-DIOXA-8-

AZASPIRO[4,5]DECANES USEFUL AS

FUNGICIDES AND A PROCESS FOR

THE PREPARATION THEREOF

COUNCIL OF SCIENTIFIC AND

INDUSTRIAL RESEARCH 27/03/2009 612/DEL/2009 IN PCT/IB/2010/000648 WO/2010/109299

(2011.01 )H04N 76:855 25//1/0/2/

מערכת ושיטה לדחיסת וידאו המבוססות על מדידות זמן המתנה או היזון חוזר אחר

SYSTEM AND METHOD FOR

COMPRESSING VIDEO BASED ON

LATENCY MEASUREMENTS AND

OTHER FEEDBACK








ONLIVE, INC. 23/03/2009 61/210,888 US /5//6/0//7 20/3165/62 US PCT/US/2010/027692 WO/2010/111092

(2011.01 )A63F 76:856 25//1/0/2/

מערכת ושיטה עבור מיתוג מכונה מואץSYSTEM AND METHOD FOR

ACCELERATED MACHINE

SWITCHING ONLIVE, INC. 23/03/2009 61/210,888 US /5//6/0//7 20/3165/55 US PCT/US/2010/027730 WO/2010/111102

(2011.01 )H04N 76:857 25//1/0/2/

מערכת ושיטה לדחיסת וידאו ע"י שימוש בהיזון חוזר הכולל נתונים הקשורים

לה מוצלחת של תוכן וידאולקב

SYSTEM AND METHOD FOR VIDEO

COMPRESSION USING FEEDBACK

INCLUDING DATA RELATED TO THE

SUCCESSFUL RECEIPT OF VIDEO

CONTENT ONLIVE, INC. 23/03/2009 61/210,888 US /5//6/0//7 20/3165/74 US PCT/US/2010/027712 WO/2010/111095

(2011.01 )H04B 76:858 25//1/0/2/

מערכת ושיטה להצפנת וידאו ע"י שימוש בקטע נבחר ותבנית רוטצית קטע


ENCODING VIDEO USING A

SELECTED TILE AND TILE

ROTATION PATTERN ONLIVE, INC. 23/03/2009 61/210,888 US /5//6/0//7 20/3165/54 US PCT/US/2010/027718








WO/2010/111097

(2011.01 )H04N 76:859 25//1/0/2/

ן שגיאה מערכת ושיטה לשימוש בתיקו מתמשך בדחיסת וידאו


UTILIZING FORWARD ERROR

CORRECTION WITH VIDEO

COMPRESSION ONLIVE, INC. 23/03/2009 61/210,888 US /5//6/0//7 20/3165/40 US PCT/US/2010/027727 WO/2010/111101

(2011.01 )G06K 76:85: 25//1/0/2/

מערכת ושיטה לדחיסת וידאו מרובה זרמים

SYSTEM AND METHOD FOR MULTI-

STREAM VIDEO COMPRESSION

ONLIVE, INC. 23/03/2009 61/210,888 US /5//6/0//7 20/3165/22 US PCT/US/2010/027725 WO/2010/111100

(2011.01 )G06K 76:85; 25//1/0/2/

מערכת ושיטה לדחיסת וידאו מרובה זרמים ע"י שימוש בפורמטי הצפנה

מרובים

SYSTEM AND METHOD FOR MULTI-

STREAM VIDEO COMPRESSION

USING MULTIPLE ENCODING

FORMATS ONLIVE, INC. 23/03/2009 61/210888 US /5//6/0//7 20/316/70 US PCT/US/2010/027723 WO/2010/111099








(2011.01 )G06K 76:85< 25//1/0/2/

TEMPORARY DECODER APPARATUS ערכת ושיטה לפענוח זמנימ

AND METHOD ONLIVE, INC. 23/03/2009 61/210,888 US /5//6/0//7 20/3165/64 US PCT/US/2010/027720 WO/2010/111098

(2011.01 )H04N 76:85= 25//1/0/2/

מערכת ושיטה לבחירת פורמט הצפנה לוידאו המבוססות על היזון חוזר של

נתונים


SELECTING A VIDEO ENCODING

FORMAT BASED ON FEEDBACK

DATA ONLIVE, INC. 23/03/2009 61/210,888 US /5//6/0//7 20/3165/7/ US PCT/US/2010/027699 WO/2010/111093

(2011.01 )H04N 76:85> 25//1/0/2/

מערכת ושיטה לדחיסת פרימים בוידאו או חלקים מהם המבוססות על היזון חוזר של

מידע ממכשיר לקוח


COMPRESSING VIDEO FRAMES OR

PORTIONS THEREOF BASED ON

FEEDBACK INFORMATION FROM A

CLIENT DEVICE ONLIVE, INC. 23/03/2009 61/210,888 US /5//6/0//7 20/3165/32 US PCT/US/2010/027716 WO/2010/111096

(2011.01 )C07D 76:865 /7//2/0/2/

ORGANIC COMPOUNDS AND THEIR תרכובות אורגניות ושימושן

USES NOVARTIS AG










10/04/2009 61/168,408 US 04//3/0//7 42/2625/16 US PCT/IB/2010/000784 WO/2010/116248

(2011.01 )C07K 76:869 00//1/0/2/

HUMANIZED ANTIBODIES AGAINST נוגדנים אנושיים כנגד לייט ושימושהם

LIGHT AND USES THEREOF

TEVA BIOPHARMACEUTICALS USA,

INC. 24/03/2009 61/202,661 US PCT/US/2010/028144 WO/2010/111180

(2011.01 )C07D 76:86: 04//1/0/2/

SOLID STATE FORMS OF מבנים גבישיים של מלחי סיטאגליפטין

SITAGLIPTIN SALTS

TEVA PHARMACEUTICAL טבע תעשיות פרמצבטיות בע"מ

INDUSTRIES LTD. 30/03/2009 61/164,563 US 0///2/0//7 42/25/5475 US 1///2/0//7 42/2525/51 US /2//4/0//7 42/2605550 US 22//4/0//7 42/2645/12 US /7//0/0/2/ 42/1/05404 US 23//0/0/2/ 42/1/25423 US /2//1/0/2/ 42/1/75/02 US 2///1/0/2/ 42/1205154 US 26//1/0/2/ 42/1235227 US PCT/US/2010/029098 WO/2010/117738

(2011.01 )A61K 76:86; 01//1/0/2/

פעילים TAT HIVפוליפפטידים נגזרים מ אימונית, לטיפול בסרטן

TREATMENT OF CANCER WITH

IMMUNOSTIMULATORY HIV TAT

DERIVATIVE POLYPEPTIDES NANIRX INC.








23/03/2009 61/162605 US 27//0/0/2/ 42/1/4056 US /1//1/0/2/ 42/12/002 US PCT/US/2010/028347 WO/2010/111292

(2011.01 )F24J 76:86< 2///2/0/2/

התקן תמיכה, מערכת ושיטה עבור מסגרת של מראה סולארית

STRUT, SYSTEM AND METHOD FOR

A SOLAR MIRROR FRAME

WERNER EXTRUSION SOLUTIONS

LLC 16/04/2009 61/212854 US PCT/US/2010/001062 WO/2010/120349

(2011.01 )H02M 76:86= 07//2/0/2/

מערכות ושיטות של חיבורי דיודה במעגלים חשמליים בטרנזיסטורים

TRANSISTOR JUNCTION DIODE

CIRCUITRY SYSTEMS AND

METHODS ENTROPIC COMMUNICATIONS, INC. 01/05/2009 61/174813 US 02//4/0//7 20/27/125 US PCT/US/2010/032917 WO/2010/127078

(2011.01 )H04B 76:86> 04//1/0/2/

הסדר לניהול תקשורת אלחוטית בין מכשירים

AN ARRANGEMENT FOR MANAGING

WIRELESS COMMUNICATION

BETWEEN DEVICES XPED HOLDINGS PTY LTD 26/03/2009 2009901298 AU PCT/AU/2010/000358 WO/2010/108235








(2011.01 )B42D 76:875 01//1/0/2/

מכשיר ושיטה לאימות אוטומטי של תמונות בגרסת פולריזאציה

DEVICE AND METHOD FOR

AUTOMATED VERIFICATION OF

POLARIZATION-VARIANT IMAGES LATENT IMAGE TECHNOLOGY LTD. LATENT IMAGE TECHNOLOGY LTD.

07/04/2009 12/419360 US PCT/IB/2010/051250 WO/2010/116279

(2011.01 )G01N 76:876 12//1/0/2/

שיטה לגילוי חומר בדגימה ביולוגיתMETHOD FOR DETECTING

SUBSTANCE IN BIOLOGICAL

SAMPLE VIRUS IKAGAKU KENKYUSHO INC

31/03/2009 2009-

087839 JP

PCT/JP/2010/055887 WO/2010/114031

(2011.01 )G01N 76:877 12//1/0/2/

בדגימה SITH–1שיטה לגילוי נוגדן נגד ביולוגית

METHOD FOR DETECTING

ANTIBODY AGAINST SITH-1 IN

BIOLOGICAL SAMPLE VIRUS IKAGAKU KENKYUSHO INC

31/03/2009 2009-

087816 JP

PCT/JP/2010/055884 WO/2010/114029

(2011.01 )G09G 76:879 02//1/0/2/

סכימת מניע בעל וולטאג' נמוך למאפננים אינטרפרומטריים

LOW VOLTAGE DRIVER SCHEME

FOR INTERFEROMETRIC

MODULATORS

QUALCOMM MEMS TECHNOLOGIES,

INC. 27/03/2009 12/413336 US










0///2/0/2/ 20/47/172 US PCT/US/2010/028552 WO/2010/111431

(2011.01 )A61K 76:87: /2//2/0/2/

LYOPHILIZATION CAKES OF נתחי ליופיליזציה של מעכבי פרוטיאזום

PROTEASOME INHIBITORS CEPHALON. INC. 03/04/2009 61/166529 US /5//2/0//7 /71/307296 EP 00/20/0//7 42/066733 US PCT/US/2010/029597 WO/2010/114982

(2011.01 )A01N 76:87; 04//1/0/2/

תכשיר כימי המשפר את היבול לבקרת מזיקים ושיטה לבקרת מזיקים

AGROCHEMICAL COMPOSITION FOR

PEST CONTROL AND PEST CONTROL

METHOD ISHIHARA SANGYO KAISHA LTD.

31/03/2009 2009-

084618 JP

PCT/JP/2010/055314 WO/2010/113775

(2011.01 )C25D 76:87< 03//1/0/2/

–התקן ושיטה לניהול ריאקציה אלקטרושטח של מצע מוליך –כימית על פני

למחצה

DEVICE AND METHOD TO CONDUCT

AN ELECTROCHEMICAL REACTION

ON A SURFACE OF A SEMI-

CONDUCTOR SUBSTRATE ALCHIMER 27/03/2009 0901518 FR PCT/EP/2010/053955 WO/2010/108996








(2011.01 )C12N 76:87= 07//1/0/2/

שיטה להשריית מוות תאי בתאי גזע פלוריפוטנטיים ובתאים שעברו התמיינות

מלבד קרדיומיוציטים

METHOD FOR INDUCING CELL

DEATH IN PLURIPOTENT STEM

CELLS AND DIFFERENTIATED

CELLS OTHER THAN CARDIAC

MYOCYTES KEIO UNIVERSITY

30/03/2009 2009-

083553 JP

PCT/JP/2010/056108 WO/2010/114136

(2011.01 )A01B 76:87> 01//1/0/2/

זרעים ושיטות להנחת תכשירים לציפויחומרים פעילי שטח לאדמה על קרקע

דוחת מים

SEED COATING COMPOSITIONS AND

METHODS FOR APPLYING SOIL

SURFACTANTS TO WATER-

REPELLENT SOIL BRIGHAM YOUNG UNIVERSITY 23/03/2009 61/210868 US PCT/US/2010/028371 WO/2010/111309

(2011.01 )A61K 76:885 01//1/0/2/

פוליפפטידים ותכשירים מחסנים המכילים פוליפפטידים גראם חיוביים ושיטות

לשימוש

POLYPEPTIDES AND IMMUNIZING

COMPOSITIONS CONTAINING GRAM

POSITIVE POLYPEPTIDES AND

METHODS OF USE EPITOPIX, LLC 23/03/2009 61/210772 US PCT/US/2010/028326 WO/2010/111273

(2011.01 )H01B 76:886 01//1/0/2/

סרטי תחמוצת מתכת דיאלקטרי ושיטות להכנתם

DIELECTRIC METAL OXIDE FILMS

AND PROCESSES FOR PRODUCING

THE SAME










SBA MATERIALS, INC. 23/03/2009 61/162549 US PCT/US/2010/028374 WO/2010/111311

(2011.01 )A61L 76:88: 00//1/0/2/

CARTILAGE REPAIR תיקון סחוס

GENZYME CORPORATION 23/03/2009 61/162447 US PCT/US/2010/028086 WO/2010/111161

(2011.01 )C07D 76:88; /4//2/0/2/

און –(2H) 3–אנאלוגים של איזוקסאזול כחומרים טיפוליים

ISOXAZOL-3(2H)-ONE ANALOGS AS

THERAPEUTIC AGENTS

ASTRAZENECA AB 07/04/2009 61/167224 US 01//2/0//7 42/252734 US PCT/SE/2010/050375 WO/2010/117323

(2011.01 )C07K 76:88< 04//1/0/2/

פפטידים שעברו ציטרוליניזציה לאבחון וצפי של דלקת מפרקים שיגרונית

CITRULLINATED PEPTIDES FOR

DIAGNOSING AND PROGNOSING

RHEUMATOID ARTHRITIS PROMETHEUS LABORATORIES INC. 30/03/2009 61/164840 US 25//7/0//7 42/021274 US 04/2//0//7 42/033/36 US PCT/US/2010/028946 WO/2010/117694

(2011.01 )C07K 76:88= 02//1/0/2/










PROTEIN (1CAPהחלבון )

ASSOCIATED–CYCLASE ADENYLYL לאימונומודולציה ושימושיו כמטרה

ADENYLYL CYCLASE-ASSOCIATED

PROTEIN (CAP1) AND USES

THEREOF AS A TARGET FOR

IMMUNO-MODULATION PROTAB LTD פרוטאב בע"מ

30/03/2009 61/164489 US PCT/IL/2010/000231 WO/2010/113148

(2011.01 )F24J 76:88> /1//7/0/2/

מרכזת פרבולית עם חלקי סיבוב עקמומים פרבולית

PARABOLIC CONCENTRATOR WITH

PARABOLICALLY CURVED ROTATING

SECTORS FARINA, GIUSEPPE 09/09/2009 RM2009A000457 IT PCT/IT/2010/000384 WO/2011/030364

(2011.01 )C12M 76:896 /7//1/0/2/

כור פוטוסינטטי לתרבות מיקרואורגניזמים ושיטה לתרבות מיקרואורגניזמים

A PHOTOSYNTHETIC REACTOR FOR

CULTURE OF MICROORGANISMS

AND METHOD FOR CULTURE OF

MICROORGANISMS MICROPHYT 25/03/2009 09/51917 FR PCT/FR/2010/050395 WO/2010/109108

(2011.01 )C07J 76:897 12//1/0/2/

תולדות אמיד חדשות של תרכובות [פיראזול עם פעילות C–2,3סטרואידל ]

גלוקוקורטיקואיד

NOVEL AMIDE DERIVATIVES OF

STEROIDAL[3,2-C]PYRAZOLE

COMPOUNDS WITH

GLUCOCOTRICOID ACTIVITY ASTRAZENECA AB 03/04/2009 61/166324 US PCT/SE/2010/050354 WO/2010/114471

http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/IT/2010/000384







(2011.01 )B29C 76:898 01//1/0/2/

שכבה לייצור חפצים מחומרים מורכבים, שיטת ייצור של אותה שכבה ושיטת ייצור של החפצים

מהחומרים המורכבים תוך שימוש באותה שכבה

FILM FOR PRODUCTION OF COMPOSITE

MATERIAL ARTEFACTS, PRODUCTION

METHOD OF SAID FILM AND

PRODUCTION METHOD OF COMPOSITE

MATERIAL ARTEFACTS USING SAID

FILM A. PERUZZA S.R.L. 23/03/2009 TV2009A000056 IT PCT/EP/2010/053768 WO/2010/108916

(2011.01 )B61F 76:899 /7//1/0/2/

VEHICLE HAVING ROLLING רכב בעל מנטרל טלטול

COMPENSATION

BOMBARDIER TRANSPORTATION

GMBH 30/03/2009 102009014866.3 DE PCT/EP/2010/052978 WO/2010/112306

(2011.01 )G06T :89:76 /2//2/0/2/

מערכות ושיטות לזיהוי חריגות במידעSYSTEMS AND METHODS FOR

DETECTING ANOMALIES FROM

DATA I-CETANA PTY LTD 01/04/2009 2009901406 AU /2/20/0//7 0//77/3715 AU PCT/AU/2010/000379 WO/2010/111748

(2011.01 )A61P 76:89; 20//3/0/2/










תכשירים ושיטות לעיכוב ביטוי של גנים של קולטן גלוקוקורטיקואיד

COMPOSITIONS AND METHODS FOR

INHIBITING EXPRESSION OF

GLUCOCORTICOID RECEPTOR (GCR)

GENES F. HOFFMANN-LA ROCHE AG 15/05/2009 09160411.6 EP PCT/EP/2010/056527 WO/2010/130771

(2011.01 )B01D 76:89< /2//0/0/2/

GAS STREAM PROCESSING עיבוד זרם גז

ALSTOM TECHNOLOGY LTD. 27/03/2009 61/164185 US 1//2//0//7 20/4/7/54 US PCT/US/2010/022710 WO/2010/110939

(2011.01 )A61K 76:89= /2//2/0/2/

חומצה דיקרבוקסילית חדשה הקשורה דים לחומצת אמינו ומטרימי תרופות פפטי

של אופיאוידים ושימושים בהם

NOVEL DICARBOXYLIC ACID

LINKED AMINO ACID AND PEPTIDE

PRODRUGS OF OPIOIDS AND USES

THEREOF SHIRE LLC 02/04/2009 61/211831 US 00//5/0//7 42/005524 US PCT/GB/2010/050584 WO/2010/112942

(2011.01 )A61K 76:89> 02//1/0/2/

תרכובות מאפננות הפריה ותהליך ליישומם

FERTILIZATION MODULATION

COMPOUNDS AND PROCESS FOR

IMPLEMENTING THEM UNIVERSITE JOSEPH FOURIER 24/03/2009 09305261.1 EP PCT/EP/2010/053815 WO/2010/108942








(2011.01 )F25B 76:8:5 03//1/0/2/

SUPERSONIC COOLING SYSTEM מערכת קירור סופרסונית

CAITIN, INC. 25/03/2009 61/163438 US 03//5/0//7 42/006335 US PCT/US/2010/028761 WO/2010/111560

(2011.01 )G01N 76:8:6 04//1/0/2/

שיטת הדמיה על ממשק דק במצב מוצק בין שני זורמים

METHOD FOR IMAGING ON THIN

SOLID-STATE INTERFACE BETWEEN

TWO FLUIDS TRUSTEES OF BOSTON UNIVERSITY 26/03/2009 61/211260 US PCT/US/2010/028845 WO/2010/111602

(2011.01 )C07C 76:8:7 24//2/0/2/

MESYLATEסינתזה של

PENTAMETHYLCYCLOHEXANE–

1,3,3,5,5–AMINO–1

SYNTHESIS OF 1-AMINO-1,3,3,5,5-

PENTAMETHYLCYCLOHEXANE

MESYLATE

MERZ PHARMA GMBH & CO. KGaA 17/04/2009 09005471.9 EP 25//2/0//7 42/022/23 US PCT/EP/2010/002361 WO/2010/118889

(2011.01 )A61K 76:8:9 24//2/0/2/

נוסחה לייצוב חלבונים, נקייה מחומרים לא פעילים שמקורם ביונקים

FORMULATION FOR STABILIZING

PROTEINS, WHICH IS FREE OF

MAMMALIAN EXCIPIENTS MERZ PHARMA GMBH & CO. KGaA










17/04/2009 09005470.1 EP 25//2/0//7 42/020730 US PCT/EP/2010/002360 WO/2010/118888

(2011.01 )A61M 76:8:: 04//1/0/2/

שיפורים להתקן, חפץ ושיטה להקטנה כאב במהלך תהליכי

דיקור עור

IMPROVEMENTS TO APPARATUS,

ARTICLE AND METHOD FOR REDUCING

PAIN DURING SKIN PUNCTURING

PROCESURES BING INNOVATIONS, LLC 27/03/2009 61/163945 US 07/22/0//7 PCT/US2009/066033 US PCT/US/2010/028858 WO/2010/111611

(2011.01 )F41A 76:8:; 22//2/0/2/

A MOBILE MISSILE LAUNCH SYSTEM מערכת שיגור טילים ניידת ושיטה לכך

AND METHOD THEREOF

DIRECTOR GENERAL, DEFENCE

RESEARCH & DEVELOPMENT

ORGANISATION 30/03/2009 00648/DEL/2009 IN 12//1/0//7 //462/DEL/2009 IN 12//1/0//7 //463/DEL/2009 IN /4//2/0//7 //5/1/DEL/2009 IN PCT/IN/2010/000018 WO/2010/113171

(2011.01 )C07C 76:8:< 03//1/0/2/

–Y–שיטה לייצור נגזרת חומצת ביציקלו אמינו

A METHOD FOR PRODUCING

BICYCLIC Y-MINO ACID

DERIVATIVES


LIMITED

26/03/2009 2009-

075792 JP








PCT/JP/2010/055202 WO/2010/110361

(2011.01 )C07C 76:8:= 03//1/0/2/

יות ושיטות תרכובות חומצות קארבוקסיל לייצורן

CARBOXYLIC ACID COMPOUNDS

AND PROCESSES FOR PRODUCING

THE SAME JAPAN TOBACCO INC.

26/03/2009 2009-

077601 JP

/0//2/0//7 42/022520 US PCT/JP/2010/055160 WO/2010/110352

(2011.01 )C07D 76:8:> 03//1/0/2/

COMPOUND CONTAINED IN A BLUE תרכובת הנמצאת בוורד כחול

ROSE SUNTORY HOLDINGS LIMITED

27/03/2009 2009-

080524 JP

20//3/0//7 0//7-223500 JP 02//5/0//7 0//7-251/74 JP PCT/JP/2010/055262 WO/2010/110382

(2011.01 )C08L 76:8;6 04//1/0/2/

PROCESS FOR PRODUCING PLASTIC שיטה לייצור בקבוקים מפלסטיק

BOTTLES ADEKA CORPORATION

27/03/2009 2009-

078851 JP

PCT/JP/2010/055366 WO/2010/110422








(2011.01 )A61K 76:8;7 24//2/0/2/

פורמולציות נוזליות של מלחים –4,2)–2]–1של

דימתילפנילסולפניל(פניל[פיפרזין

LIQUID FORMULATIONS OF SALTS OF 1-[2-(2,4-

DIMETHYLPHENYLSULFANYL)PHENYL]PIPERAZINE

H. LUNDBECK A/S 24/04/2009 PA200900531 DK PCT/DK/2010/050084 WO/2010/121621

(2011.01 )A61K 76:8;8 /4//2/0/2/

EGFR–די חומרי אנטיי–טיפול משולב על 1R–IGF–ומעכבים ספציפיים ל

COMBINATION THERAPY USING AN

ANTI-EGFR AGENT(S) AND IGF-1R

SPECIFIC INHIBITORS MERCK SHARP & DOHME CORP 16/04/2009 61/169768 US PCT/US/2010/030022 WO/2010/120592

(2011.01 )D04H 76:8;9 03//1/0/2/

APPARATUS FOR COMPACTING A התקן לדחיסת רשת סיבית

FIBROUS WEB TRUTZSCHLER NONWOVENS GMBH 08/04/2009 102009016996.2 DE 22//2/0//7 2/0//7/2550797 DE PCT/DE/2010/000337 WO/2010/115400

(2011.01 )H04N 76:8;: 26//1/0/2/

שיטה ומערכת מסתגלות לחילוץ דמות בהירה מדמות תרמית

ADAPTIVE METHOD AND SYSTEM

FOR EXTRACTING A BRIGHT IMAGE

FROM A THERMAL IMAGE

ITT MANUFACTURING

ENTERPRISES, INC. 25/03/2009 12/410714 US PCT/US/2010/027791

http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/DK/2010/050084









WO/2010/111110

(2011.01 )H04L 76:8;; /2//2/0/2/

נסיגה המשתמשת בבחירת תחום גישה יוע התקן ניידמסיים בס

FALL BACK USING MOBILE DEVICE

ASSISTED TERMINATING ACCESS

DOMAIN SELECTION QUALCOMM INCORPORATED 01/04/2009 61/165717 US 04//1/0/2/ 20/5106/4 US PCT/US/2010/029692 WO/2010/115045

(2011.01 )G02B 76:8;< 25//1/0/2/

מראה המשקפת אור השמש בעלת ציפוי מגן ושיטה להכנתה

SOLAR REFLECTING MIRROR

HAVING A PROTECTIVE COATING

AND METHOD OF MAKING SAME PPG INDUSTRIES OHIO, INC. 27/03/2009 61/164047 US 27//0/0/2/ 20/5/7/23 US 27//0/0/2/ 20/5/7/72 US PCT/US/2010/027556 WO/2010/111075

(2011.01 )A61K 76:8;= 03//1/0/2/

THERAPEUTIC USES OF שימושים רפואיים של נגזרות קונאזולין

QUINAZOLINEDIONE DERIVATIVES SANOFI 27/03/2009 0901460 FR PCT/FR/2010/050549 WO/2010/109148

(2011.01 )A61K 76:8;> 12//1/0/2/










INHIBITION OF BIOFILM דיכוי יצורי ביופילם

ORGANISMS NOVABIOTICS LTD 01/03/2009 61/165396 US /2//1/0//7 /7/323292 GB PCT/GB/2010/000631 WO/2010/112848

(2011.01 )B62D 76:8<5 27//1/0/2/

י, במיוחד רכב רכב בעל היגוי מפרק משוריין

VEHICLE HAVING ARTICULATED

VEHICLE STEERING, IN PARTICULAR

ARMORED VEHICLE SKOFF, GERHARD 26/03/2009 102009014401.3 DE PCT/EP/2010/001735 WO/2010/108629

(2011.01 )C01B 76:8<6 03//1/0/2/

METHOD AND DEVICE FOR זרחתית–שיטה ומתקן לייצור חומצה רב

PRODUCING POLYPHOSPHORIC ACID PRAYON TECHNOLOGIES 26/03/2009 BE2009/0186 BE PCT/EP/2010/053947 WO/2010/108991

(2011.01 )C12Q 76:8<7 24//2/0/2/

שיטות וכלים לניבוי היעילות של אנתראציקלינים בסרטן

METHODS AND TOOLS FOR PREDICTING

THE EFFICIENCY OF ANTHRACYCLINES

IN CANCER UNIVERSITE LIBRE DE BRUXELLES 17/04/2009 PCT/EP2009/054606 EP PCT/EP/2010/055067 WO/2010/119133








(2011.01 )C12N 76:8<; 02//1/0/2/

שיטות ומיקרואורגניזימים לייצור של דיקארבוקסיליות 4Cחומצות

METHODS AND MICROORGANISMS

FOR PRODUCTION OF C4-

DICARBOXYLIC ACIDS DSM IP ASSETS B.V. 24/03/2009 61/163019 US PCT/US/2010/028429 WO/2010/111344

(2011.01 )C12Q 76:8<< 03//1/0/2/

METHOD OF GENOTYPING שיטה לגנוטיפיזציה

MERCK SERONO S.A. 27/03/2009 09156487.2 EP 12//1/0//7 42/243222 US PCT/EP/2010/053871 WO/2010/127906

(2011.01 )C08C 76:8=5 /0//0/0/2/

לברומינציה של תרכובות תהליך –אורגניות בלתי רוויות עם הפחתה של חד

כלורידים בעלי אמוניום או פוספוניום רביעוני

PROCESS FOR BROMINATING

UNSATURATED ORGANIC

COMPOUNDS WITH REMOVAL OF

QUATERNARY AMMONIUM OR

QUATERNARY PHOSPHONIUM

MONOCHLORIDES DOW GLOBAL TECHNOLOGIES LLC 31/03/2009 61/165402 US PCT/US/2010/022802 WO/2010/114637

(2011.01 )B65D 76:8=6 04//7/0/22

A WATER DISPENSER WITH A מתקן מים עם מיכל מים הניתן להסתה

TILTED CONTAINER NEVIOT NATURE GALILEE LTD










(2011.01 )B01J 76:8=7 1///1/0/2/

שיטות ומערכות ליצור מימן בשימוש לסיליצידי נטרן ג'ל וחומרי מסיליקט נתרן

HYDROGEN GENERATION SYSTEMS

AND METHODS UTILIZING SODIUM

SILICIDE AND SODIUM SILICA GEL

MATERIALS SIGNA CHEMISTRY, INC. 30/03/2009 61/164888 US /7//4/0//7 42/263357 US PCT/US/2010/029257 WO/2010/114849

(2011.01 )G06K 76:8=8 12//1/0//7

מאיר מנחה או טבעתי וסורק אופטיANNULAR LIGHT GUIDE

ILLUMINATOR AND OPTICAL

SCANNER SICPA HOLDING SA PCT/IB/2009/005137 WO/2010/112950

(2011.01 )H04N 76:8=9 20//2/0/2/

שיטות והתקנים להנחת תוכן על זרם וידאו משותף

METHODS AND APPARATUS FOR

OVERLAYING CONTENT ONTO A

COMMON VIDEO STREAM ECHOSTAR TECHNOLOGIES L.L.C. 13/04/2009 12/422398 US PCT/US/2010/030752 WO/2010/120693

(2011.01 )G06F 76:8=< 00//1/0/2/

APPLICATION SHARING יישום שיתוף










SOCIAL COMMUNICATIONS

COMPANY 03/04/2009 12/418270 US PCT/US/2010/028088 WO/2010/114724

(2011.01 )C07D 76:8== 00//2/0/2/

–פלואורו–2–כלורו–3)–4תהליך להכנת –N)–1]–6–מתוקסי–7–אנילינו(

–4–פיפרידינ–מתילקרבמוילמתיל( יל[קווינזולין


OF 4-(3-CHLORO-2-FLUORO-

ANILINO)-7-METHOXY-6-[1-(N-

METHYLCARBAMOYLMETHYL)-

PIPERIDIN-4-YL]QUINAZOLINE ASTRAZENECA AB 23/04/2009 61/171994 US PCT/GB/2010/050653 WO/2010/122340

(2011.01 )A61K 76:8=> 25//1/0/2/

PNEUMOCOCCAL VACCINE AND מושיוחיסון פנאומקוקאלי ושי

USES THEREOF

COLEY PHARMACEUTICAL GROUP,

INC. 30/04/2009 61/174068 US 12//6/0//7 42/016121 US PCT/IB/2010/051150 WO/2010/125480

(2011.01 )C02F 76:8>5 07//1/0/2/

מטהר מי שתייה מסוג זרימה מתמשכת מופעל ידנית המשתמש בקרינה

סולארית מרוכזת

A MANUALLY OPERATED

CONTINUOUS FLOW TYPE DRINKING

WATER DISINFECTOR USING

CONCENTRATED SOLAR RADIATION


INDUSTRIAL RESEARCH 27/03/2009 615/DEL/2009 IN PCT/IN/2010/000323 WO/2010/119457








(2011.01 )C01C 76:8>6 07//1/0/2/

–תהליך להכנה בו זמנית של אשלגן–סולפט, מגנזיום–סולפט, אמוניוםמגנזיום אוקסיד ממלח הידרוקסיד ו/או

קיינייט מעורב ואמוניה

PROCESS FOR SIMULTANEOUS

PRODUCTION OF POTASSIUM

SULPHATE, AMMONIUM SULFATE,

MAGNESIUM HYDROXIDE AND/OR

MAGNESIUM OXIDE FROM KAINITE

MIXED SALT AND AMMONIA


INDUSTRIAL RESEARCH 27/03/2009 618/DEL/2009 IN PCT/IN/2010/000194 WO/2010/109492

(2011.01 )C12Q 76:8>7 06//1/0/2/

שיטות לקביעת מהלך קליני וטיפול בטרשת נפוצה

METHODS OF PREDICTING

CLINICAL COURSE AND TREATING

MULTIPLE SCLEROSIS

מחקרים ,תשתית ושירותים -תל השומר רפואיים בע"מ

TEL HASHOMER MEDICAL

RESEARCH INFRASTRUCTURE AND

SERVICES LTD. 30/03/2009 61/202703 US PCT/IB/2010/051344 WO/2010/113096

(2011.01 )A61K 76:8>8 07//1/0/2/

THERAPY FOR PROMOTING CELL טיפול להגברת גדילת תאים

GROWTH MOLEAC PTE. LTD 27/03/2009 61/164352 US PCT/SG/2010/000122 WO/2010/110755

(2011.01 )G03H 76:8>9 12//1/0/2/





http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/SG/2010/000122





–שיטה ומערכת להדמיית עצם באור לא קוהרנטי

METHOD AND SYSTEM FOR

IMAGING AND OBJECT USING

INCOHERENT LIGHT

אוניברסיטת בן גוריון בנגב הרשות למחקר ופיתוח

BEN-GURION UNIVERSITY OF THE

NEGEV RESEARCH AND

DEVELOPMENT AUTHORITY 01/04/2009 61/202763 US PCT/IB/2010/051401 WO/2010/113123

(2011.01 )C07C 76:8>> /2//2/0/2/

שיטות וחומרי ביניים להכנת גורמים רוקחיים

METHODS AND INTERMEDIATES

FOR PREPARING PHARMACEUTICAL

AGENTS GILEAD SCIENCES, INC. 03/04/2009 61/166498 US PCT/US/2010/029633 WO/2010/115000

(2011.01 )C07K 76:957 12//1/0/2/

ותצמידים חיסוניים 5FCRH–נוגדנים אנטי ושיטות לשימוש

ANTI-FCRH5 ANTIBODIES AND

IMMUNOCONJUGATES AND

METHODS OF USE GENENTECH, INC. 01/04/2009 61/211695 US /0//2/0//7 42/244025 US /2/20/0//7 42/044750 US PCT/US/2010/029516 WO/2010/120561

(2011.01 )H04N 76:958 /1//2/0//7

שיטה לעיבוד קובץ דיגיטלי, בעיקר הדמות, וידיאו ו/או מסוג אודיו

METHOD FOR PROCESSING A

DIGITAL FILE NOTABLY OF THE

IMAGE, VIDEO AND/OR AUDIO TYPE

I-CES (INNOVATIVE COMPRESSION

ENGINEERING SOLUTIONS)








PCT/IB/2009/005550 WO/2010/112957

(2011.01 )C07K 76:959 12//1/0/2/

ותצמידים חיסוניים 5FCRH–נוגדנים אנטי ת לשימושושיטו

ANTI-FCRH5 ANTIBODIES AND

IMMUNOCONJUGATES AND

METHODS OF USE GENENTECH, INC. 01/04/2009 61/211754 US /0//2/0//7 42/244022 US PCT/US/2010/029521 WO/2010/114940

(2011.01 )A61C 76:95: 02//4/0/2/

O-RING INSERYION TOOL AND מכשיר החדרה טבעתי ושיטה

METHOD ZEST IP HOLDINGS LLC 24/06/2009 61/220086 US PCT/US/2010/039830 WO/2010/151676

(2011.01 )B01D 76:95< 12//1/0/2/

חמצני עם –תהליך ללכידת פחמן דו ביצועים משופרים

PROCESS FOR CO2 CAPTURE WITH

IMPROVED STRIPPER

PERFORMANCE ALSTOM TECHNOLOGY LTD. 31/03/2009 61/164944 US 04//1/0/2/ 20/510742 US PCT/US/2010/029420 WO/2010/120527

(2011.01 )F16D 76:95= /4//2/0/2/










מכשיר כח הילוכים בררני ותושבת הכוללת יישום שלו

A SELECTIVE FORCE

TRANSMISSION DEVICE AND AN

UNDERCARRIAGE CONSISTING OF

AN APPLICATION THEREOF MESSIER-BUGATTI-DOWTY 06/04/2009 0901684 FR PCT/EP/2010/054536 WO/2010/115893

(2011.01 )G06F 76:969 01//2/0/2/

אופטימיזצית ביצוע של תוכנית להדמיית יםנתונ

DATA VISUALIZATION PLATFORM

PERFORMANCE OPTIMIZATION


(2011.01 )G06F 76:96: 01//2/0/2/

תמיכה למיזוג מהיר עבור מסמכים במערכות מסורתיות

FAST MERGE SUPPORT FOR LEGACY

DOCUMENTS


(2011.01 )G06F 76:96; 1///2/0/2/

תזמון עבודה משותפת במחברת אלקטרונית

SHARED JOB SCHEDULING IN

ELECTRONIC NOTEBOOK









(2011.01 )G06F 76:96< 1///2/0/2/

CROSS-CHANNEL COAUTHORING עקביות בכתיבה משותפת בין ערוצים

CONSISTENCY MICROSOFT CORPORATION 01/05/2009 12/433929 US PCT/US/2010/033241 WO/2010/127291

(2011.01 )G06F 76:96= 2///3/0/2/

HIERARCHICALLY-ORGANIZED גלריות בקרה מאורגנות באופן היררכי

CONTROL GALLERIES MICROSOFT CORPORATION 12/05/2009 12/464584 US PCT/US/2010/034277 WO/2010/132376

(2011.01 )A63B 76:96> 07//1/0/2/

MONITORING OF PHYSICAL ניטור אירועי אימון פיזיים

TRAINING EVENTS

INFOMOTION SPORTS

TECHNOLOGIES, INC. 27/03/2009 61/164277 US /5/2//0//7 42/027304 US PCT/US/2010/029068 WO/2010/111705

(2011.01 )B64C 76:975 21//2/0/2/

כלי רכב אווירי ושיטה להפעלת כלי רכב אווירי

AIR VEHICLE METHOD FOR

OPERATING AN AIR VEHICLE

ISRAEL AEROSPACE INDUSTRIES התעשייה האוירית לישראל בע"מ

LTD. 16/04/2009 198124 IL PCT/IL/2010/000298 WO/2010/119442










(2011.01 )C08J 76:976 12//1/0/2/

NON-DEWETTING POROUS ות שאינן נרטבותממברנות נקבובי

MEMBRANES SOLVAY SOLEXIS S.P.A 06/04/2009 61/166879 US PCT/US/2010/029344 WO/2010/117845

(2011.01 )G02B 76:977 /0//1/0/2/

הדמיה עם תצוגה פעילה מערכת המסופקת עם עינית

ACTIVE DISPLAY IMAGING SYSTEM

PROVIDED WITH AN EYECUP

THALES 27/03/2009 0901502 FR PCT/EP/2010/052627 WO/2010/108764

(2011.01 )A61K 76:985 04//1/0/2/

METHODS AND COMPOSITIONS FOR שיטות ותכשירים לחיסון נגד וירוס

ACADEMIA SINICA 27/03/2009 61/164385 US 06//1/0//7 42/242165 US 06//1/0//7 42/242166 US 06//1/0//7 42/242167 US 20//1/0/2/ 42/121454 US PCT/US/2010/028968 WO/2010/111687

(2011.01 )C07D 76:988 /0//2/0/2/

ACRYLAMIDE COMPOUNDS AND תרכובות אקרילמיד והשימוש בהן

THE USE THEREOF SHIONOGI & CO. LTD. 02/04/2009 61/166206 US










PCT/JP/2010/056404 WO/2010/114181

(2011.01 )E01F 76:989 23//1/0/2/

מעקה בטיחות, עמוד תמיכה עם מכלול ניתוק ושיטות לחיבורים ולשימוש בהם

GUARDRAIL ASSEMBLY,

BREAKAWAY SUPPORT POST FOR A

GUARDRAIL AND METHODS FOR

THE ASSEMBLY AND USE THEREOF ENERGY ABSORTION SYSTEMS, INC. 31/03/2009 61/211522 US 02//6/0//7 42/014065 US /0/20/0//7 20/407162 US PCT/US/2010/027331 WO/2010/114693

(2011.01 )A23L 76:98: /4//2/0/2/

שיטה להענקת חדירות לממברנות של תאים ביולוגיים על ידי שדה חשמלי פועם

METHOD FOR RENDERING THE

MEMBRANES OF BIOLOGICAL

CELLS PERVIOUS BY USING A

PULSED ELECTRIC FIELD

COMMISSARIAT A L'ENERGIE

ATOMIQUE ET AUX ENERGIES

ALTERNATIVES 07/04/2009 0952262 FR PCT/EP/2010/054511 WO/2010/115875

(2011.01 )G06K 76:98; /4//2/0/2/

זיהוי ווידאו על ידי שימוש בסימני חומר גבישי נוזלי פולימרי

IDENTIFICATION AND AUTHENTICATION

USING POLYMERIC LIQUID CRYSTAL

MATERIAL MARKINGS SICPA HOLDING SA 02/04/2009 PCT/EP2009/002434 EP /0//2/0//7 20/16212/ US PCT/EP/2010/054515 WO/2010/115879








(2011.01 )H04L 8=76:9 12//1/0/2/

שיטות והתקן לייצור ושימוש באיתותים יחוסיים במערכת תקשורת


GENERATION AND USE OF

REFERENCE SIGNALS IN A

COMMUNICATIONS SYSTEM QUALCOMM INCORPORATED 31/03/2009 61/165456 US 1///1/0/2/ 20/53/334 US PCT/US/2010/029437 WO/2010/120530

(2011.01 )C12N 76:98> /2//2/0/2/

נוגדן מונוקלונול שיכול לקשור לאפיטופ 1ADרציף מסוים שנמצא באיזור –בלתי

גלקוחלבון, וקטע GBשל ציטומגלווירוס אנטיגן–מקשר

MONOCLONAL ANTIBODY

CAPABLE OF BINDING TO SPECIFIC

DISCONTINUOUS EPITOPE

OCCURRING IN AD1 REGION OF

HUMAN CYTOMEGALOVIRUS GB

GLYCOPROEIN, AND ANTIGEN-

BINDING FRAGMENT THEREOF EVEC INCORPORATED

01/04/2009 2009-

089442 JP

PCT/JP/2010/056037 WO/2010/114106

(2011.01 )A61F 76:995 04//1/0/2/

מערכות ושיטות להגנה על פצע וטיפול בהפרשות


WOUND PROTECTION AND

EXUDATE MANAGEMENT AALNEX, INC. 01/04/2009 12/416826 US PCT/US/2010/028785 WO/2010/120470








(2011.01 )G01N 76:996 01//2/0/2/

אמצעים ושיטות להגדרת כמות הפוליפפטיד נוירוטוקסין ואת פעילות

שבו PROTEOYTIC–החומר המזרז וה

MEANS AND METHODS FOR THE

DETERMINATION OF THE AMOUNT

OF NEUROTOXIN POLYPEPTIDE AND

OF ITS CATALYTIC AND

PROTEOLYTIC ACTIVITIES MERZ PHARMA GMBH & CO. KGaA 27/04/2009 09158788.1 EP 05//2/0//7 42/02243/ US PCT/EP/2010/055432 WO/2010/124998

(2011.01 )F01K 76:997 26//0/0/2/

עד להמרת אנרגיה תרמית התקן המיו סביבתית לאנרגיה מועילה

INSTALLATION DESIGNED TO

CONVERT ENVIRONMENTAL

THERMAL ENERGY INTO USEFUL

ENERGY COHEN, YOAV 08/04/2009 09157592.8 EP PCT/EP/2010/052027 WO/2010/115654

(2011.01 )H01L 76:998 01//1/0/2/

INFRARED DETECTOR אדום–גלאי אינפרא

UD HOLDINGS, LLC 12/04/2009 61/168601 US PCT/US/2010/028293 WO/2010/120447

(2011.01 )C07D 76:999 22//1/0/2/

והשימוש R7X2Pאנטגוניסטים חדשים ל בהם

NOVEL P2X7R ANTAGONISTS AND

THEIR USE

AFFECTIS PHARMACEUTICALS AG 14/04/2009 09005324.0 EP PCT/EP/2010/053097










WO/2010/118921

(2011.01 )G01R 76:99: 12//1/0/2/

,A COMMUNICATIONS PROCESS תהליך, התקן ומערכת לתקשורת

DEVICE AND SYSTEM FREESTYLE TECHNOLOGY PTY LTD 31/03/2009 2009901397 AU PCT/AU/2010/000367 WO/2010/111738

(2011.01) C12N 76:99= 27//4/0//7

בידוד של תאי גזע מזנכימאליים שמקורם בדם תבורי אנושי

ISOLATION OF HUMAN UMBILICAL

CORD BLOOD-DERIVED

MESENCHYMAL STEM CELLS

THE BOARD OF REGENTS OF THE

UNIVERSITY OF TEXAS SYSTEM 31/03/2009 61/165193 US PCT/US/2009/047981 WO/2010/114572

(2011.01 )A61K 76:99> /2//2/0/2/

L–אורניטין פניל אצטט ושיטות להכנתו L-ORNITHINE PHENYL ACETATE

AND METHODS OF MAKING

THEREOF OCERA THERAPEUTICS, INC. 03/04/2009 61/166676 US PCT/US/2010/029708 WO/2010/115055

(2011.01 )A61K 76:9:6 /2//2/0/2/

PHARMACEUTICAL COMPOSITION חותתכשיר רוק

K.U. LEUVEN RESEARCH &

DEVELOPMENT










03/04/2009 09157303.0 EP PCT/EP/2010/054418 WO/2010/115843

(2011.01 )B23K 76:9:7 04//1/0/2/

ל נתיב לייזר חופף, שיטה רכיב בע ליצור רכיב כזה

COMPONENT HAVING AN

OVERLAPPING LASER TRACK;

METHOD FOR PRODUCING SUCH A

COMPONENT CERAMTEC GMBH, 31/03/2009 102009015087.0 DE PCT/EP/2010/053972 WO/2010/112412

(2011.01 )A61K 76:9:8 01//2/0/2/

הרכב לתרסיס תת לשוני המכיל דיהידרוארטמסינין

SUBLINGUAL SPRAY FORMULATION

COMPRISING DIHYDROARTEMESININ

LONDONPHARMA LTD 23/04/2009 0906971.7 GB 01//2/0//7 PCT/GB09/050415 GB PCT/GB/2010/050672 WO/2010/122356

(2011.01 )A61K 76:9:9 01//2/0/2/

תכשיר רוקחות תת לשוני המכיל שמן ניטראלי

SUBLINGUAL PHARMACEUTICAL

COMPOSITION COMPRISING A NEUTRAL

OIL LONDONPHARMA LTD 23/04/2009 0906977.4 GB 01//2/0//7 PCT/GB09/050416 GB PCT/GB/2010/050671 WO/2010/122355








(2011.01 )A61K 76:9:: /3//2/0/2/

METHODS AND MATERIALS FOR שיטות וחומרים למתן מולקולות

DELIVERING MOLECULES

MAYO FOUNDATION FOR MEDICAL

EDUCATION AND RESEARCH 06/04/2009 61/166929 US PCT/US/2010/029985 WO/2010/117957

(2011.01 )C08G 76:9:; 03//1/0/2/

תהליך לייצור תמיסה של מלחי דיחומצה/דיאמין

PROCESS FOR THE MANUFACTURE

OF A SOLUTION OF SALTS OF

DIACIDS/ DIAMINE (S) RHODIA OPERATIONS 09/04/2009 0952333 FR PCT/EP/2010/053946 WO/2010/115727

(2011.01 )F41A 76:9:< 21//3/0/2/

מערכת מסילה משולבת ושיטה ליצורה ושימוש בה

INTEGRATED RAIL SYSTEM AND

METHOD FOR MAKING AND USING

SAME THE OTIS PATENT TRUST 15/05/2009 12/466857 US PCT/US/2010/034673 WO/2010/132643

(2011.01 )F41A 76:9:= 21//3/0/2/

מערכת מסילה משולבת ושיטה ליצורה ושימוש בה

INTERGATED RAIL SYSTEM AND

METHOD FOR MAKING AND USING

SAME THE OTIS PATENT TRUST 15/05/2009 12/466905 US PCT/US/2010/034681 WO/2010/132649










(2011.01 )B64F 76:9:> 27//2/0/2/

צלצל עיגון המיועד במיוחד עבור מטוס ומערכת עיגון הכוללת צלצל אחד כזה

ANCHORING HARPOON INTENDED

IN PARTICULAR FOR AN AIRCRAFT

AND ANCHORING SYSTEM

INCLUDING ONE SUCH HARPOON DCNS 03/04/2009 0952177 FR PCT/FR/2010/050076 WO/2010/112717

(2011.01 )A61K 76:9;5 /4//2/0/2/

COMPOSITIONS AND METHODS FOR תכשירים ושיטות לטיפול בלייפת ותינית

TREATMENT OF AORTIC FIBROSIS VECTUS BIOSYSTEMS PTY LIMITED 02/04/2009 2009901425 AU PCT/AU/2010/000391 WO/2010/111753

(2011.01 )C08G 76:9;6 12//1/0/2/

מדללים עבור תרחיפים מימיים של חלקיקי מינרלים ומשחות כורכן

הידראוליות

THINNERS FOR AQUEOUS

SUSPENSIONS OF MINERAL

PARTICLES AND HYDRAULIC

BINDER PASTES CHRYSO 02/04/2009 0952132 FR PCT/FR/2010/050614 WO/2010/112775

(2011.01 )C12Q 76:9;7 /0//2/0/2/

שיטה להגברת ריבוי תחלים עבור ברקוד של חומצות מיועדות

MULTI-PRIMER AMPLIFICATION

METHOD FOR BARCODING OF

TARGET NUCLEIC ACIDS FLUIDIGM CORPORATION










02/04/2009 61/166105 US /0//2/0//7 42/244262 US 22//4/0//7 42/264105 US 26//0/0/2/ 42/1/37/5 US PCT/US/2010/029854 WO/2010/115154

(2011.01 )A61K 76:9;8 12//1/0/2/

סלולריזציה של –סלולריזציה ורה–דה איברים ורקמות

DECELLULARIZATION AND

RECELLULARIZATION OF ORGANS

AND TISSUES

REGENTS OF THE UNIVERSITY OF

MINNESOTA, 31/03/2009 61/211613 US PCT/US/2010/029463 WO/2010/120539

(2011.01 )B64F 76:9;9 /2//2/0/2/

צלצל עיגון, לדוגמא עבור מטוס, ומערכת עיגון הכוללת צלצל אחד כזה

ANCHORING HARPOON, FOR

EXAMPLE FOR AN AIRCRAFT, AND

ANCHORING SYSTEM INCLUDING

ONE SUCH HARPOON DCNS 03/04/2009 0952175 FR PCT/FR/2010/050625 WO/2010/112780

(2011.01 )A61L 76:9;: 02//1/0/2/

מכשיר, מערכת ושיטה למניעת זיהום ביולוגי לחומרים במהלך אחסון ע"י

שימוש באנרגיה חשמלית פועמת

AN APPARTUS, SYSTEM AND

METHOD FOR PREVENTING

BIOLOGICAL CONTAMINATION TO

MATERIALS DURING STORAGE

USING PULSED ELECTRICAL

ENERGY

רמות ליד אוניברסיטת תל אביב בע"מYISSUM RESEARCH DEVELOPMENT


UNIVERSITY OF JERUSALEM LTD.








30/03/2009 61/164502 US PCT/IL/2010/000251 WO/2010/113150

(2011.01 )G01N 76:9;; /4//2/0/2/

METHOD FOR ASSAYING INOSITOL שיטה לבדיקת אינוסיטול הקסאפוספט

HEXAPHOSPHATE (IHP) ERYTECH PHARMA 03/04/2009 0952208 FR PCT/EP/2010/054516 WO/2010/115880

(2011.01 )C07K 76:9;< /4//2/0/2/

גורמים טיפוליים לטיפול במחלות הקשורות עם התרבות מהירה בלתי רצויה

םשל תאי

THERAPEUTIC AGENTS FOR THE

TREATMENT OF DISEASES

ASSOCIATED WITH UNDESIRED

CELL PROLIFERATION

FUNDACIO PRIVADA INSTITUT

D'INVESTIGACIO ONCOLOGICA DE

VALL HEBRON 03/04/2009 P200900928 ES PCT/EP/2010/054499 WO/2010/115868

(2011.01 )B64F 76:9;= 22//2/0/2/

צלצל עיגון המיועד במיוחד עבור מטוס ומערכת עיגון הכוללת צלצל אחד כזה

ANCHORING HARPOON INTENDED

IN PARTICULAR FOR AN AIRCRAFT

AND ANCHORING SYSTEM

INCLUDING ONE SUCH HARPOON DCNS 03/04/2009 0952183 FR PCT/FR/2010/050030 WO/2010/112716








(2011.01 )C08J 76:9;> 00//1/0/2/

OXYGEN SCAVENGING FILMS שכבות טיהור באמצעות חמצן

MULTISORB TECHNOLOGIES, INC. 01/04/2009 12/416685 US PCT/US/2010/028102 WO/2010/120435

(2011.01 )C08G 76:9<5 12//1/0/2/

חומרים שמקנים פלסטיות עבור תרחיפים ומשחות מימיים של חלקיקי מינרלים

כורכן הידראוליות

PLASTICIZERS FOR AQUEOUS

SUSPENSIONS OF MINERAL

PARTICLES AND HYDRAULIC

BINDER PASTES CHRYSO 02/04/2009 0952132 FR PCT/FR/2010/050614 WO/2010/112775

(2011.01 )F24F 76:9<6 /4//2/0/2/

מערכת מיזוג אויר המונעת על ידי חום שיורי

WASTE HEAT AIR CONDITIONING

SYSTEM

LINUM SYSTEMS LTD לינום סיסטמס בע"מ 01/04/2009 61/165533 US PCT/IL/2010/000272 WO/2010/113158

(2011.01 )C07D 76:9<7 1///2/0/2/

SALT OF ABT-263 AND SOLID-STATE וצורותיו במצב מוצק ABT–263מלח של

FORMS THEREOF ABBOTT LABORATORIES 30/04/2009 61/174274 US PCT/US/2010/033072 WO/2010/127190










(2011.01 )A61K 76:9<8 1///2/0/2/

פורמולציה ליפידית של מקדם לאפופטוזהLIPID FORMULATION OF APOPTOSIS

PROMOTER

ABBOTT LABORATORIES 30/04/2009 61/174245 US PCT/US/2010/033074 WO/2010/127192

(2011.01 )A61K 76:9<9 1///2/0/2/

פורמולציה ליפידית מיוצבת של מקדם אפופטוזה

STABILIZED LIPID FORMULATION

OF APOPTOSIS PROMOTER

ABBOTT LABORATORIES 30/04/2009 61/174299 US 00/20/0//7 42/067032 US PCT/US/2010/033075 WO/2010/127193

(2011.01 )A61B 76:9<: /2//2/0/2/

APPARATUS AND METHOD FOR FAT מנגנון ושיטה להסרת שומן

REMOVAL

THE GENERAL HOSPITAL


(2011.01 )H04N 76:9<; /2//2/0//7

CONTENT SUB-ITEM SUBSTITUTION פריט של תוכן–החלפת תת

NDS LIMITED PCT/IB/2009/051370 WO/2010/112978










(2011.01 )A61B 76:9<< 1///1/0/2/

שימוש בשינויים בקצב הלב להתאמת שינויים בשדה מגנטי לרגישות

ה תואמתפיזיולוגית ושיט

USE OF THE HEART RATE

VARIABILITY CHANGE TO CORRELATE

MAGNETIC FIELD CHANGES WITH

PHYSIOLOGICAL SENSITIVITY AND

METHOD THEREFOR PLANK, ELISABETH 02/04/2009 102009002134.5 DE PCT/EP/2010/054191 WO/2010/112503

(2011.01 )B09C 76:9<> 1///1/0//7

שיטה להתאוששות של שטחים מפוררים על ידי שימוש בזני צמחים מותאמים

גנטית

METHOD FOR THE RECOVERY OF

DEGRADED AREAS USING

GENETICALLY MODIFIED PLANT

SPECIES JUAN PEDRO NAVARRO AVINO PCT/ES/2009/070080 WO/2010/112622

(2011.01 )C07K 76:9=5 23//2/0/2/

שליטה בגליקוזילציה של חלבון ותרכובות ושיטות הקשורות לכך

CONTROL OF PROTEIN

GLYCOSYLATION AND

COMPOSITIONS AND METHODS

RELATING THERETO PFIZER INC. 20/04/2009 61/170897 US PCT/IB/2010/051650 WO/2010/122460

(2011.01 )A61K 76:9=6 /5//2/0/2/










IMPROVED GLUCOCORTICOID ואיד משופרטיפול גלוקוקורטק

THERAPY DUOCORT PHARMA AB 07/04/2009 PA200900470 DK PCT/EP/2010/002178 WO/2010/115615

(2011.01 )C07K 76:9=7 1///1/0/2/

דנים מונוקלוניים הכנה של נוג אדאר מבודדדים–אגוניסט אנטי

PREPARATION OF ISOLATED AGONIST

ANTI-EDAR MONOCLONAL ANTIBODIES

UNIVERSITE DE LAUSANNE 30/03/2009 PCT/IB2009/005118 IB PCT/IB/2010/051385 WO/2010/113117

(2011.01 )A61K 76:9=8 /0//2/0/2/

–N–[6–(1–טריפלואורו–6,4,2תכשיר של –2–פירימידין–קרבוניל(–4–פיפרידין–מתיל

בנזאמיד–יל[

COMPOSITION OF 2,4,6-TRIFLUORO-

N-[6-(1-METHYL-PIPERIDIN-4-

CARBONYL)-PYRIDIN-2-YL]-

BENZAMIDE COLUCID PHARMACEUTICALS, INC. 02/04/2009 61/166097 US PCT/US/2010/029810 WO/2010/115125

(2011.01 )G02F 76:9=9 12//1/0//7

שיטה ומערכת הכרעת מקדמים אופטיים שני–לינאריים מסדר–בלתי


DETERMINING SECOND-ORDER

NONLINEAR OPTICAL

COEFFICIENTS SELEX SISTEMI INTEGRATI S.P.A PCT/IT/2009/000131 WO/2010/113190








(2011.01 )F24J 76:9=: 12//1/0/2/

העברת מומנט הפיתול בין מודולי אבוס מאסף

TORQUE TRANSFER BETWEEN

TROUGH COLLECTOR MODULES

ABENGOA SOLAR INC. 01/04/2009 12/416536 US PCT/US/2010/029481 WO/2010/120545

(2011.01 )A61K 76:9=; /0//2/0/2/

COMPOSITIONS OF תכשירים של מעכבי קולינאסטרייס

CHOLINESTERASE INHIBITORS COLUCID PHARMACEUTICALS, INC. 02/04/2009 61/166143 US PCT/US/2010/029809 WO/2010/115124

(2011.01 )A61K 76:9=> /0//2/0/2/

SYSTEMS AND METHODS FOR מערכות ושיטות לייצור מימן

GENERATING NITROGEN ST. RENATUS, LLC 03/04/2009 61/166680 US PCT/US/2010/001002 WO/2010/114622

(2011.01 )C07D 76:9>5 /2//4/0/2/

AMINO PYRIMIDINE ANTICANCER תרכובות אמינו פירימידין אנטי סרטניות

COMPOUNDS OSI PHARMACEUTICALS, LLC 01/06/2009 61/182898 US 04//2/0/2/ 42/076127 US PCT/US/2010/036808 WO/2010/141406










(2011.01 )A61K 76:9>6 /7//4/0//7

הרכב תאי גזע משתית עצמיים וחיצונים ממקור שומני לטיפול בפסיטולות

AUTOLOGOUS AND ALLOGENIC

ADIPOSE-DERIVED STROMAL STEM

CELL COMPOSITION FOR TREATING

FISTULAS ANTEROGEN CO, LTD

28/04/2009 10-2009-

0036942 KR

PCT/KR/2009/003078 WO/2010/126194

(2011.01 )A61F 76:9>8 /2//2/0/2/

GRAFTסוג פתיחת פתחים בתומכן מ

STENT STENT GRAFT FENESTRATION

קרן מחקרים רפואיים פיתוח תשתית ושירותי בריאות ע"י המרכז הרפואי תל

אביב

SERVICES FUND OF THE TEL AVIV

MEDICAL CENTER THE MEDICAL

RESEARCH, INFRASTRUCTURE AND

HEALTH 02/04/2009 61/165946 US PCT/IB/2010/051438 WO/2010/113138

(2011.01 )A61K 76:9>9 06//0/0/2/

שיטה לבקרת ריבוי והתמיינות של קראטינוציטים

A METHOD OF REGULATING

PROLIFERTATION AND

DIFFERENTIATION OF

KERATINOCYES

ים רפואיים פתוח תשתית קרן מחקרושרותי בריאות ליד המרכז הרפואי תל

אביב

THE MEDICAL RESEARCH AND

INFRASTRUCTURE FUND OF THE

TEL-AVIV SOURASKY MEDICAL

CENTER 01/04/2009 61/202760 US PCT/IL/2010/000167 WO/2010/113146








(2011.01 )C12N 76:9>: 02//1/0/2/

תירכובות ושיטות להגברת תכולת שומן באצות


INCREASING OIL CONTENT IN

ALGAE ROSETTA GREEN LTD רוסטה גרין בע"מ

02/04/2009 61/165912 US PCT/IL/2010/000247 WO/2010/113149

(2011.01 )C07D 76:9>< 07//1/0/2/

תולדות אוקסאדיאזול ותכשירי רוקחות המכילים אותן

OXADIAZILE DERIVATIVES AND

PHARMACEUTICAL COMPOSITIONS

CONTAINING THEM MERCK SERONO S.A. 03/04/2009 09157301.4 EP 24//2/0//7 42/247551 US PCT/EP/2010/054100 WO/2010/115751

(2011.01 )C07D 76:9>= 07//1/0/2/

תולדות אוקסאדיאזול ותכשירי רוקחות מכילים אותןה

OXADIAZOLE DERIVATIVES AND


CONTAINING THEM MERCK SERONO SA, 03/04/2009 09157301.4 EP 24//2/0//7 42/247551 US PCT/EP/2010/054103 WO/2010/112461

(2011.01 )E04D 76:9>> 20//3/0/2/

CONNECTOR ASSEMBLIES FOR מערכת חיבור עבור לוחות מחוברים

CONNECTING PANELS










SABIC INNOVATIVE PLASTICS IP

B.V. 13/05/2009 61/177693 US PCT/US/2010/034485 WO/2010/132529

(2011.01 )E05F 76::57 0///2/0//7

PNEUMATIC DOOR ASSIST SYSTEM מערכת עזר עם מנעול לדלת פניאומטית

WITH LOCK

INTERNATIONAL TRUCK

INTELLECTUAL PROPERTY

COMPANY, LLC. PCT/US/2009/041073 WO/2010/123486

(2011.01 )C07K 76::58 24//2/0/2/

פפטידים לשימוש בטיפול בעור ו/או בשיער והשימוש בהם בתכשירים

קוסמטיים או של רוקחות

PEPTIDES USED IN THE TREATMENT

AND/OR CARE OF THE SKIN AND/OR

HAIR AND THEIR USE IN COSMETIC

OR PHARMACEUTICAL

COMPOSITIONS LIPOTEC S.A. 20/04/2009 61/170891 US 25//2/0/22 0//7/2/20 ES PCT/EP/2010/002348 WO/2010/118880

(2011.01 )A61K 76::59 2///1/0/2/

המודיאליזה ופתרונות להפרדה של הצפק המכיל אחת או יותר של קריאטין

HEMODIALYSIS AND PERITONEAL

DIALYSIS SOLUTIONS COMPRISING

ONE OR MORE CREATINE

COMPOUNDS CREARENE LTD 06/04/2009 09005038.6 EP PCT/CH/2010/000065 WO/2010/115291





http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/CH/2010/000065

http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/CH/2010/000065


(2011.01 )A23L 76::5: /5//2/0/2/

WHOLEGRAIN INSTANT PASTA פסטה אינסטנט מדגנים מלאים

NESTEC S.A. 17/04/2009 09158132.2 EP PCT/EP/2010/054562 WO/2010/118974

(2011.01 )A61P 76::5; 26//3/0/2/

PROTEASE INHIBITORS מעכבי פרוטאז

ORION CORPORATION 18/05/2009 758/KOL/2009 IN PCT/FI/2010/000031 WO/2010/133748

(2011.01 )A41B 76::5= 22/20/0//7

FUNCTIONAL UNDERPANTS FOR תחתונים פונקציונליים לגברים

MEN BAEK, GYEONG-SU,

13/04/2009 10-2009-

0031932 KR

PCT/KR/2009/007459 WO/2010/120030

(2011.01 )B23B 76::5> /3//2/0/2/

ישיר עבור כלי חתיכה–קירור בלתיINDIRECT COOLING OF A CUTTING

TOOL

CREARE INCORPORATED 06/04/2009 12/418688 US PCT/US/2010/029950 WO/2011/005340



http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/FI/2010/000031







(2011.01 )C09D 76::65 /5//2/0/2/

PIEZOCHROMIC SECURITY ELEMENT אלמנט ביטחון פיאזוכרומי

SICPA HOLDING SA 07/04/2009 PCT/IB2009/005198 IB PCT/EP/2010/054597 WO/2010/115928

(2011.01 )G01J 76::66 20//0/0/2/

קונפורמי IRמשושות למערכי גלאי –ננו קוהקנטי בעל פס רחב

NANO-ANTENNA FOR WIDEBAND

COHERENT CONFORMAL IR

DETECTOR ARRAYS RAYTHEON COMPANY 30/04/2009 12/433576 US PCT/US/2010/024169 WO/2010/126641

(2011.01 )C07D 76::67 /4//2/0/2/

און –(H1)4–אלקילסינון–1נגזרות מותמרות, הכנתן ויישום רפואי שלהן

SUBSTITUTED 1-ALKYLCINNOLIN-

4(1H)-ONE DERIVATIVES,


THERAPEUTIC APPLICATION OF

SAME SANOFI 07/04/2009 0901696 FR PCT/FR/2010/050657 WO/2010/116084

(2011.01 )E04H 76::68 /5//2/0/2/

והתקן להפעלת מנקה בריכות עם שיטה מחולל כלור משולב


OPRATION OF POOL CLEANER WITH

INTEGRAL CHLORINE GENERATOR AQUATRON, INC. 08/04/2009 12/384806 US










PCT/US/2010/001071 WO/2010/117469

(2011.01 )G06K 76::6: /4//2/0/2/

מערכת הדמייה הכוללת ייצוב ופיצוי לתנועת המצלמה במרחב

VIDEO MOTION COMPENSATION

AND STABILIZATION GIMBALED

IMAGING SYSTEM

NEXTVISION STABILIZED SYSTEMS נקסט ויז'ן מערכות מיוצבות בע"מ

LTD 07/04/2009 61/167226 US PCT/IL/2010/000280 WO/2010/116366

(2011.01 )C07C 76::6; 23//2/0/2/

פלואורו –תחליבים המורכבים מפר פחמנים

EMULSIONS OF

PERFLUOROCARBONS

OXYGEN BIOTHERAPEUTICS, INC. 15/04/2009 61/212689 US 07//2/0//7 42/022770 US 27/2//0//7 42/057137 US 21/22/0//7 42/062272 US PCT/US/2010/031320 WO/2010/121082

(2011.01 )C07D 76::6< /5//2/0/2/

–יל(–3–[הקס3.1.0ביציקלו]–אזא–3)–6 פירימידינים–פניל–2

6-(3-AZA-BICYCLO[3.1.0]HEX-3-YL)-2-

PHENYL-PYRIMIDINES

ACTELION PHARMACEUTICALS LTD. 08/04/2009 PCT/IB09/051486 IB PCT/IB/2010/051499 WO/2010/116328

(2011.01 )G06F 76::6= /3//2/0/2/










REMOTE ANALYSIS AND אנליזה ותיקון מרחוק של תנאי יבול

CORRECTION OF CROP CONDITION SMARTFIELD, INC. 06/04/2009 61/166819 US /4//2/0//7 42/244606 US PCT/US/2010/029947 WO/2010/117944

(2011.01 )C07D 76::6> 07//2/0/2/

תהליך להכנת תרכובות איזוקסאזולין מותמרות וחומרים מקדימים שלהן

PROCESS FOR PREPARING

SUBSTITUTED ISOXAZOLINE

COMPOUNDS AND THEIR

PRECURSORS BASF SE 30/04/2009 09159246.9 EP PCT/EP/2010/055773 WO/2010/125130

(2011.01 )B63B 76::75 23//2/0/2/

מערכת להעברת נוזלים בין שני כלים המוצבים זה לצד זה

SYSTEM FOR TRANSFERRING

FLUIDS BETWEEN TWO VESSELS

PLACED SIDE BY SIDE TECHNIP FRANCE, 09/04/2009 0952368 FR PCT/FR/2010/050731 WO/2010/116113

(2011.01 )C07D 76::76 04//3/0/2/

–5H–דיהידרו–7,6תולדות של אמידים של חומצה –3–[אימידאזולa–2,1אימידאזו]

קרבוקסילית

DERIVATIVES OF 6,7-DIHYDRO-5H-

IMIDAZO[1,2-a]IMIDAZOLE-3-

CARBOXYLIC ACID AMIDES


INTERNATIONAL GMBH 02/06/2009 61/183098 US PCT/US/2010/036094 WO/2010/141273








(2011.01 )C07D 76::77 /2//2/0/2/

COPPER BROMIDE HUMIDITY כרטיס זיהוי ללחות המכיל נחושת ברומית

INDICATING CARD MULTISORB TECHNOLOGIES, INC. 06/04/2009 12/419116 US PCT/US/2010/029567 WO/2010/117865

(2011.01 )G06Q 76::78 /5//2/0/2/

SYSTEM AND METHOD FOR HYBRID מערכת ושיטה לנתיב הנחיה מוכלא

COURSE INSTRUCTION LEARNIG TREE INTERNATIONAL 07/04/2009 61/167364 US PCT/US/2010/030257 WO/2010/118145

(2011.01 )A61K 76::79 21//2/0/2/

METHOD FOR ON-DEMAND שיטה למתן אמצעי מניעה לפי דרישה

CONTRACEPTION LABORATOIRE HRA-PHARMA 14/04/2009 61/169149 US PCT/EP/2010/054812 WO/2010/119029

(2011.01 )C07K 76::7: 20//2/0/2/

רצפי חומצות אמיניות משופרים המכוונים פפטידים המכילים אותם ופולי R6–ILנגד

–לטיפול במחלות והפרעות הקשורות לR6–IL

IMPROVED AMINO ACID

SEQUENCES DIRECTED AGAINST IL-

6R AND POLYPEPTIDES

COMPRISING THE SAME FOR THE

TREATMENT OF IL-6R RELATED

DISEASES AND DISORDERS ABLYNX NV










10/04/2009 61/168410 US PCT/EP/2010/054764 WO/2010/115998

(2011.01 )F24J 76::7; /4//2/0/2/

SOLAR MIRROR PANLES AND THEIR לוחות מראות סולרים וייצורם

MANUFACTURE WIZARD POWER PTY LTD 06/04/2009 2009901467 AU PCT/AU/2010/000390 WO/2010/115237

(2011.01 )C07D 76::86 07//1/0/2/

תרכובות ציקליות מותמרות בקבוצת פניל, תכשירים המכילים אותן ושימושים

בהן

CYCLIC COMPOUNDS HAVING A

SUBSTITUTED PHENYL GROUP,


SAME AND USES THEREOF


LIMITED

06/04/2009 2009-

091671 JP

PCT/JP/2010/055547 WO/2010/116915

(2011.01 )B32B 76::87 /6//2/0/2/

התאמת פני השטח ממברנות אוסמוזה הפוכה באמצעות פולימרים דנדריטיים

הידרופיליים

SURFACE MODIFICATION OF

REVERSE OSMOSIS MEMBRANES BY

HYDROPHILIC DENDRITIC

POLYMERS MICHIGAN MOLECULAR INSTITUTE 08/04/2009 61/212206 US PCT/US/2010/001058 WO/2010/117460








(2011.01 )C09D 76::88 /7//2/0/2/

CLEAR MAGNETIC INTAGLIO PRINTING דיו הדפסת חריטה מגנטית שקופה

INK SICPA HOLDING SA 09/04/2009 PCT/IB2009/005227 IB PCT/EP/2010/054716 WO/2010/115986

(2011.01 )H02J 76::8: /5//2/0/2/

WIRELESS POWER TRANSMISSION מערכת העברת כוח אלחוטי ושיטה

SYSTEM AND METHOD RAYTHEON COMPANY 10/04/2009 12/421789 US PCT/US/2010/030153 WO/2010/118075

(2011.01 )C07K 76::8< 0///2/0/2/

-RECOMBINANT HUMAN ALPHA1 אנטיטרפזין רקומביננטי אנושי–1אלפא

ANTITRYPSIN CRUCELL HOLLAND B.V. 23/04/2009 61/214492 US 01//2/0//7 /723642/92 EP PCT/EP/2010/055177 WO/2010/127939

(2011.01 )C07K 76::8= 27//2/0/2/

–חלבוני איחוי נוגדנים עם אתרי קישור לFCRN שעברו שינוי

ANTIBODY FUSION PROTEINS WITH

MODIFIED FCRN BINDING SITES

MERCK PATENT GMBH 22/04/2009 61/171650 US PCT/EP/2010/002377 WO/2010/121766










(2011.01 )B29C 76::8> 22//2/0/2/

POWDER IN-MOLD COATING BY עת איבוק בתוך תבניתצבי

COMPRESSING ITEMS

ORLITE INDUSTRIES (MILLENIUM ( בע"מ2000אורלייט תעשיות )מילניום

2000) LTD. 17/04/2009 61/170280 US PCT/IB/2010/051631 WO/2010/119414

(2011.01 )F03B 76::95 /5//2/0/2/

ENERGY RELEASE BUOYANT מפעיל צף משחרר אנרגיה

ACTUATOR CETO IP PTY LTD 07/04/2009 2009901502 AU PCT/AU/2010/000398 WO/2010/115241

(2011.01 )B64C 76::96 /4//2/0/2/

מערכת, יחדיה מעופפת ושיטה להעלאת מטענים

SYSTEM, FLOATING UNIT AND

EMTHOD FOR ELEVATING

PAYLOADS SHY COHEN שי כהן

06/04/2009 61/166820 US PCT/IL/2010/000273 WO/2010/116362

(2011.01 )H04H 76::98 00//2/0//7

AUDIENCE MEASUREMENT SYSTEM מערכת למדידת קהל צופים

NDS LIMITED PCT/IB/2009/051657 WO/2010/122373










(2011.01 )A23L 76::9; 12//1/0/2/

תהליך להסרת קוטלי מזיקים מתמציות אונתי ותמציות המתקבלות –גינקגו דו

באמצעות תהליך זה

PROCESS FOR REMOVING PESTICIDES

FROM GINKGO BILOBA EXTRACTS,

AND EXTRACTS OBTAINABLE BY SAID

PROCESS INDENA S.P.A. 06/04/2009 MI2009A000548 IT PCT/EP/2010/002046 WO/2010/115566

(2011.01 )H01L 76::9< /5//2/0/2/

שיקוע משופר של שכבה דקה של סיליקון טאיעבור יישומי מכשיר פוטווול

IMPROVED SILICON THIN FILM

DEPOSITION FOR PHOTOVOLTAIC

DEVICE APPLICATIONS ASAHI GLASS COMPANY LIMITED 07/04/2009 61/167349 US PCT/US/2010/030199 WO/2010/118105

(2011.01 )H04W 76::9= 2///3/0/2/

MULTIMODAL CONVERSATION מערך מגוון להשהיית הודעות ושליפתן

PARK AND RETRIEVAL MICROSOFT CORPORATION 13/05/2009 12/465421 US PCT/US/2010/034280 WO/2010/132379

(2011.01 )C07K 76::9> /4//2/0/2/

שבטי ממקור אנושי בררני עבור –נוגדן חד 01( של סרוטייפ LPSליפופוליסאכרידים )

IATS שלAERUGINOSA

PSEUDOMONAS

PSEUDOMONAS AERUGINOSA

ANTIBODY SPECIFIC FOR

LIPOPOLYSACCARIDES (LPS) OF

SEROTYPE IATS 01 OF

PSEUDOMONAS AERUGINOSA










KENTA BIOTECH AG 09/04/2009 09005245.7 EP PCT/EP/2010/002158 WO/2010/115606

(2011.01 )C07D 76:::5 22//2/0/2/

יל –2–תהליך להכנת אסטר של ביפניל ומצה קרבמיתח


OF A BIPHENYL-2-YLCARBAMIC

ACID ESTER GLAXO GROUP LIMITED 14/04/2009 61/169046 US PCT/EP/2010/054893 WO/2010/119064

(2011.01 )C07D 76:::6 22//2/0/2/

7מאפנני נגזרת אינדולית של אלפא NACHR

INDOLE DERIVATIVE MODULATORS

OF THE ALPHA 7 NACHR

PROXIMAGEN LIMITED 16/04/2009 61/169742 US PCT/EP/2010/054910 WO/2010/119078

(2011.01 )C07D 76:::7 /7//0/0/2/

)פניל –2–בנזואיל–5–אמינו–4קרבוניטרילים מותמרים –3–אמינו(תיאופן

)פניל –2–בנזואיל–5–אמינו–4–וקרבוקסאמידים מותמרים –3–אמינו(תיאופן

כמכעבי פילמור טובולין

SUBSTITUTED 4-AMINO-5-BENZOYL-

2-(PHENYLAMINO)THIOPHENE-3-

CARBONITRILES AND SUBSTITUTED

4-AMINO-5-BENZOYL-2-

(PHENYLAMINO)THIOPHENE-3-

CARBOXAMIDES AS TUBULIN

POLYMERIZATION INHIBITORS TELIK, INC. 16/04/2009 61/169785 US PCT/US/2010/023561 WO/2010/120400








(2011.01 )C07D 76:::8 00//2/0/2/

תהליכים להכנת תרכובות מורפינאן ומורפינון

PROCESSES FOR THE PREPARATION

OF MORPHINANE AND

MORPHINONE COMPOUNDS BROCK UNIVERSITY 24/04/2009 61/172521 US PCT/CA/2010/000587 WO/2010/121369

(2011.01 )C07D 76:::9 24//2/0/2/

תרכובות דיאמיד בעלות פעילות אנטגוניסטית לקולטן מוסקריני ופעילות

אדרנרגי–?2אגוניסטית לקולטן

DIAMIDE COMPOUNDS HAVING

MUSCARINIC RECEPTOR

ANTAGONIST AND ?2 ADRENERGIC

RECEPTOR AGONIST ACTIVITY THERAVANCE, INC. 23/04/2009 61/172039 US PCT/US/2010/031356 WO/2010/123766

(2011.01 )F16K 76:::: /6//4/0/2/

VALVE שסתום

MOKVELD VALVES B.V. 09/06/2009 102009026838.3 DE PCT/EP/2010/058005 WO/2010/142677

(2011.01 )A61K 76:::; 23//2/0/2/

שיטה ותכשיר לטיפול ניוון כתמיMETHOD AND COMPOSITION FOR

TREATING MACULAR

DEGENERATION SUCAMPO AG 15/04/2009 61/169512 US 20//2/0/2/ 20/53633/ US










PCT/JP/2010/057108 WO/2010/119986

(2011.01 )C07D 76:::< 21//2/0/2/

CONDENSED PYRROLOPYRIDINE תולדת פירולופירידין דחוסה

DERIVATIVE ASTELLAS PHARMA INC.

14/04/2009 2009-

097974 JP

PCT/JP/2010/056619 WO/2010/119875

(2011.01 )B21D 76:::= 24//1/0/2/

METHOD OF MANUFACTURING A שיטה לייצור כלי מתכתי

METAL VESSEL THE COCA COLA COMPANY 06/04/2009 12/418758 US PCT/US/2010/027410 WO/2010/117564

(2011.01 )C07D 76:::> /3//2/0/2/

–תולדות אינדול ושיטות לטיפול אנטי ויראלי

INDOLE DERIVATIVES AND

METHODS FOR ANTIVIRAL

TREATMENT PTC THERAPEUTICS, INC 06/04/2009 61/166893 US PCT/US/2010/029923 WO/2010/117932

(2011.01 )G06F 76::;5 /0//2/0/2/

HYPERLINK TO COMPUTER קישור היפרטקסט לתוכן תוצרת מחשב

GENERATED CONTENT BCInnovation










05/04/2009 61/166757 US PCT/IB/2010/051450 WO/2010/116311

(2011.01 )C07K 76::;7 /5//2/0/2/

PROCESS FOR ISOLATING תהליך להפרדת פפטיד ריפויי

THERAPEUTIC PEPTIDE CORDEN PHARMA COLORADO, INC. 10/04/2009 61/168259 US PCT/EP/2010/054577 WO/2010/115916

(2011.01 )G06F 76::;8 /2//2/0/2/

UNIFIED INPUT AND DISPLAY מערכת ושיטה לתצוגה מאוחדת קלט

SYSTEM AND METHOD RADION ENGINEERING CO. LTD רדיון חברה להנדסה בע"מ

05/04/2009 61/166747 US PCT/IB/2010/051439 WO/2010/116308

(2011.01 )F04C 76::;9 /5//2/0/2/

COMPRESSOR HAVING CAPACITY מדחס הכולל מכלול ויסות קיבולת

MODULATION ASSEMBLY

EMERSON CLIMATE

TECHNOLOGIES, INC. 07/04/2009 61/167309 US /4//2/0/2/ 20/53270/ US PCT/US/2010/030248 WO/2010/118140

(2011.01 )B01J 76::;= 04//6/0/2/










שיטה למניעת סתימת מערכת כור –תעלות לתגובה רציפה ומיקרו

לביצוע השיטה

METHOD FOR PREVENTING PLUGGING OF

A CONTINUOUS-REACTION CHANNEL-

SYSTEM AND MICRO-REACTOR FOR

CARRYING OUT THE METHOD LONZA AG 28/08/2009 PCT/EP2009/061143 EP 22//7/0//7 /7/2250496 EP 01//1/0/2/ 2/23506395 EP PCT/EP/2010/062476 WO/2011/023761

(2011.01 )H04L 76::;> 23//2/0/2/

שיתוף תוכן אודיו/וידאו עם משתמש נבחר

SHARING OF AUDIO/VISUAL

CONTENT WITH A SELECTED USER

SLING MEDIA, INC. 15/04/2009 12/424249 US PCT/US/2010/031150 WO/2010/120972

(2011.01 )B01J 76::<5 20//3/0/2/

-CONTINUOUS REACTION MICRO כור לתגובה רציפה–מיקרו

REACTOR LONZA AG 12/05/2009 PCT/EP2009/055739 EP PCT/EP/2010/056594 WO/2010/130808

(2011.01 )A01H 76::<6 /7//2/0/2/

SNFI PLANT SNFI-RELATED PROTEIN–גן קינאז חלבון צמח קשור ל

KINASE GENE DOW AGROSCIENCES LLC 10/04/2009 61/168532 US PCT/US/2010/030563 WO/2010/118338








(2011.01 )B01J 76::<7 20//3/0/2/

METHOD OF MANUFACTURING A שיטה לייצור כור ומערכך כורים

REACTOR AND SET OF REACTORS LONZA AG 12/05/2009 PCT/EP2009/055740 EP PCT/EP/2010/056597 WO/2010/130811

(2011.01 )A47J 76::<8 /4/2//0/22

ספוג לרחיצת כלים הנושא סימון "חלבי", "בשרי" או "פרווה"

SCOURING SPONGE WITH SYMBOL

OF "MEET", "MILK" AND "PARVE"

MAYA ARAD מאיה ארד

(2011.01 )B62H 76::<9 /4/2//0/22

A TWO-WHEELED VEHICLE מייצב לכלי רכב דו גלגלי

STABILIZER ELIYAHU MASHIAH אליהו משיח

(2011.01 )G06F 76::<: /4/2//0/22

מערכת רב שכבתית למיפוי, ניתוח וקבלת החלטות של ארגונים, פונקציות פעילויות

ורשתות

SYSTEM FOR MULTI-LAYER

ORGANIZATIONAL, FUNCTIONAL,

ACTIVITIES AND NETWORK

MAPPING, ANALYZING AND

DECISION MAKING

T.E. COMMERCIALIZE ת.ע. ייזום וישום חידושים בע"מ

INNOVATIONS LTD










(2011.01 )G06F 76::<; /4/2//0/22

וידוא למנוע שיטה ומערכת לאימות ו דליפת מידע במחשוב ענן

A METHOD AND A SYSTEM FOR

AUTHENTICATION AND

PREVENTING DATA BREACHES IN

CLOUP COMPUTING CONCEALIUM I.T. SECURITY LTD קונסליום אבטחת טכנולוגיות מידע בע"מ

07/10/2010 61/390877 US

(2011.01 )H04N 76::<< /1//4/0//7

שיטה ומערכת לבקרת שימוש במכשיר אלקטרוני


CONTROLLING THE USE OF AN

ELECTRONIC DEVICE

VAZQUEZ DEL MERCADO HABIF,

DAVID 08/04/2009 09157658 EP PCT/MX/2009/000051 WO/2010/117252

(2011.01 )A47J 76::<= /6//2/0/2/

מתקן להכנת משקה בעל סגירה מיכנית עם אמצעי כוח שאינו מרובה

BEVERAGE PREPARATION DEVICE

HAVING A CLOSING MECHANISM

WITH FORCE DEMULTIPLYING

MEANS NESTEC S.A. 09/04/2009 09157751.0 EP PCT/EP/2010/054621 WO/2010/115946



http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/MX/2009/000051

http://www.wipo.int/pctdb/en/ia.jsp?IA=PCT/MX/2009/000051




(2011.01 )C07D 76::=5 04//3/0/2/

המעכבות תרכובות פירימידין ביציקליות K3PI 110בררניות עבורP דלתא, ושיטות

לשימוש

BICYCLIC PYRIMIDINE PI3K

INHIBITOR COMPOUNDS SELECTIVE

FOR P110 DELTA, AND METHODS OF

USE GENENTECH, INC. 27/05/2009 61/181452 US 25/20/0//7 42/0654/5 US PCT/US/2010/036199 WO/2010/138589

(2011.01 )A61K 76::=6 21//2/0/2/

תאי גזע מסנכימלים מהונדסים ושיטה לשימוש בהם לטיפול בגידולים

ENGINEERED MESENCHYMAL STEM

CELLS AND METHOD OF USING

SAME TO TREAT TUMORS APCETH GMBH & CO. KG 13/04/2009 61/168787 US PCT/EP/2010/054844 WO/2010/119039

(2011.01 )A01N 76::=8 /7//2/0/2/

שיטות למניעת ו/או טיפול בהפרעות באחסון ליזוזומלי

METHODS FOR PREVENTING

AND/OR TREATING LYSOSOMAL

STORAGE DISORDERS AMICUS THERAPEUTICS, INC. 09/04/2009 61/168109 US PCT/US/2010/030472 WO/2010/118283

(2011.01 )A01N 76::=9 /7//2/0/2/

שיטות למניעת ו/או טיפול בהפרעות ניווניות של מערכת העצבים המרכזית

METHODS FOR PREVENTING

AND/OR TREATING DEGENERATIVE

DISORDERS OF THE CENTRAL

NERVOUS SYSTEM AMICUS THERAPEUTICS, INC. 09/04/2009 61/168101 US










PCT/US/2010/030470 WO/2010/118282

(2011.01 )C10G 76::=: /0//5/0//7

התקן ושיטה לפירוק בחום של פסולת פלסטיק

APPARATUS FOR THERMOLYSIS

WASTE PLASTICS AND METHOD

FOR THERMOLYSIS WASTE

CLARITER POLAND SPOLKA Z

ORGANICZONA

ODPOWIEDZIALNOSCIA 08/04/2009 P-387742 PL PCT/IB/2009/052879 WO/2010/116211

(2011.01 )H04W 76::=; /4//2/0/2/

שיטות ומכשירים עבור השקטת ערוץ פס וגיות גישת רדיוטלוויזיה דרך טכנול


TELEVISION BAND (TVBD)

CHANNEL QUIETING ACROSS

DIVERSE RADIO ACCESS

TECHNOLOGIESS

INTERDIGITAL PATENT HOLDINGS,

INC. 06/04/2009 61/167050 US 27//2/0/2/ 42/074137 US PCT/US/2010/030063 WO/2010/117998

(2011.01 )G06F 76::=< 05/2//0//7

–מערכת לאחסון מסה המשתמשת בתת מערכת אחסון מסייעת במצב מוצק

A MASS-STORAGE SYSTEM

UTILIZING AUXILIARY SOLID-

STATE STORAGE SUBSYSTEM KAMINARIO TECHNOLOGIES LTD. 10/04/2009 61/168346 US PCT/IL/2009/001004 WO/2010/116349








(2011.01 )E06B 76::>5 /5//2/0//7

חוצץ לרווח חלונות זכוכית בחלונות זכוכיות מרובי זכוכיות, חלון מרובה

ושיטה לייצור חלון מרובה זכוכיות

SPACER FOR SPACING GLASS PANES

IN A MULTIPLE GLASS PANE, A

MULTIPLE GLASS PANE, AND A

METHOD FOR PRODUCING A

MULTIPLE GLASS PANE PROWERB ST. GALLEN AG PCT/EP/2009/054153 WO/2010/115456

(2011.01 )A61K 76::>6 01//2/0/2/

חיסון נגד שחפת למניעת התעוררות חוזרת

A TUBERCULOSIS TB VACCINE TO

PREVENT REACTIVATION

STATENS SERUM INSTITUT 24/04/2009 PA200900539 DK PCT/DK/2010/000054 WO/2010/121618

(2011.01 )C07C 76::>7 21//2/0/2/

תכשירים ושיטות לטיפול בדלקתCOMPOSITIONS AND METHODS FOR

THE TREATMENT OF

INFLAMMATION C.T. RESOLVE SARL 13/04/2009 61/168739 US /2//3/0//7 42/2526/4 US PCT/US/2010/030813 WO/2010/120719

(2011.01 )A61K 76::>8 22//2/0/2/

תכשירים לחיסון נגד סטפילוקוקוס AUREUS

COMPOSITIONS FOR IMMUNISING

AGAINST STAPHYLOCOCCUS

AUREUS










NOVARTIS AG 14/04/2009 61/212705 US 22//6/0//7 42/012/57 US PCT/IB/2010/000998 WO/2010/119343

(2011.01 )A23L 76::>9 21//2/0/2/

אמולסיות תזונתיות בעלות כמות סיבים גבוהה

HIGH FIBER NUTRITIONAL

EMULSIONS


(2011.01 )A23L 76::>: 21//2/0/2/

אמולסיות תזונתיות בעלות כמות סיבים גבוהה לבקרת רמת גלוקוז בדם


EMULSIONS FOR BLOOD GLUCOSE

CONTROL ABBOTT LABORATORIES 14/04/2009 61/169030 US PCT/US/2010/030837 WO/2010/120736

(2011.01 )A23L 76::>; 21//2/0/2/

אמולסיות תזונתיות בעלות כמות סיבים גבוה עם גליצרין


EMULSION WITH GLYCERIN


(2011.01 )H04M 76::>= 12//1/0/2/










שיטה ומערכת להשגת מידע על רשת ( של רשת תקשורת RANגישה רדיו )

סלולרית


OBTAINING RADIO ACCESS

NETWORK (RAN) INFORMATION OF

CELLULAR TELECOMMUNICATIONS

NETWORKS INTUCELL LTD אינטיוסל בע"מ

07/04/2009 198100 IL PCT/IB/2010/051400 WO/2010/116292

(2011.01 )A61M 76:;55 05//2/0/2/

שיטה והתקן לווידןא אוטומטי של אינטובציה תוך קנה הנשימתית


AUTOMATIC VERIFICATION OF

ENDOTRACHEAL INTUBATION TUBEEYE MEDICAL LTD 28/04/2009 61/173324 US PCT/IB/2010/051833 WO/2010/125520

(2011.01 )C07C 76:;56 /6//2/0/2/

נגזרות של רזורצינול שעברו סולפוריזציה, הכנתן ושימושים קוסמטיים בהן

SULPHURATED DERIVATIVES OF

RESORCINOL, PREPARATION OF

SAME AND COSMETIC USES

THEREOF

PIERRE FABRE DERMO-

COSMETIQUE 08/04/2009 0952289 FR PCT/EP/2010/054619 WO/2010/115945

(2011.01 )C12N 76:;57 /7//2/0/2/

שיטה לתרבות אוכלוסית תאים במדיום בלי נסיוב

METHOD FOR THE CULTIVATION OF

CELL POPULATION IN A SERUM

FREE MEDIUM CELLCA GMBH 09/04/2009 09005211.9 EP PCT/EP/2010/002217








WO/2010/115634

(2011.01 )A61K 76:;58 /5//2/0/2/

פרמקוקינטיקה שלדי חלבון אנושי עםבנסיוב מבוקר, תכשירים המכילים אותם

ושימושים בהם

HUMAN PROTEIN SCAFFOLD WITH

CONTROLLED SERUM

PHARMACOKINETICS,


SAME AND USES THEREOF

THE REGENTS OF THE UNIVERSITY

OF CALIFORNIA 08/04/2009 61/167844 US PCT/US/2010/030291 WO/2010/118169

(2011.01 )A01N 76:;59 /7//2/0/2/

תכשירים המכילים אמינואלקיל גלוקוסאמיניד פוספאט לשימוש בטיפול

ה–רפרפוזי–ה–בבצקת הקשורה לאיסכמי

COMPOSITIONS COMPRISING

AMINOALKYL GLUCOSAMINIDE

PHOSPHATE FOR USE IN TREATING

EDEMA RELATED TO ISCHEMIA-

REPEFUSION

THE UNIVERSITY OF NORTH

CAROLINA AT CHAPEL HILL 09/04/2009 61/168089 US PCT/US/2010/030556 WO/2010/118334

(2011.01 )H04N 76:;5; /6//2/0/2/

SYSTEM AND METHOD FOR IMAGE מערכת ושיטה לעיבוד תמונה

COMPRESSION WATCHITOO, INC. 08/04/2009 61/167536 US PCT/US/2010/030425 WO/2010/118254








(2011.01 )C22C 76:;5< /6//2/0//7

סגסוגת מבוססת נחושת שניתנת לעיבוד ושיטה לייצורה

MACHINABLE COPPER-BASED

ALLOY AND METHOD FOR

PRODUCING THE SAME

SWISSMETAL-UMS

SCHWEIZERISCHE METALL WERKE

AG PCT/EP/2009/054250 WO/2010/115462

(2011.01 )A61K 76:;5= /6//2/0/2/

DRUG DELIVERY COMPOSITION תכשיר לשחרור תרופה

ALKERMES PHARMA IRELAND

LIMITED 09/04/2009 61/168040 US PCT/US/2010/030387 WO/2010/118228

(2011.01 )C07D 76:;5> /5//2/0/2/

נגזרות קינאזולינדיאון, הכנתן ושימושים רפואיים מגוונים שלהן

QUINAZOLINEDIONE DERIVATIVES,


VARIOUS THERAPEUTIC USES

THEREOF SANOFI 09/04/2009 0901760 FR PCT/FR/2010/050664 WO/2010/116088

(2011.01 )A61K 76:;65 /5//2/0/2/

יישומים רפואיים של נגזרות קינאזולינדיאון בתחום הלב וכלי הדם

THERAPEUTIC APPLICATIONS IN

THE CARDIOVASCULAR FIELD OF

QUINAZOLINEDIONE DERIVATIVES SANOFI 09/04/2009 09/01755 FR PCT/FR/2010/050672










WO/2010/116090

(2011.01 )A01N 76:;67 21//2/0/2/

כנה מערכות למתן אנזימים ושיטות לה ושימוש

ENZYME DELIVERY SYSTEMS AND

METHODS OF PREPARATIONS AND

USE CUREMARK LLC 13/04/2009 12/386051 US PCT/US/2010/030895 WO/2010/120781

(2011.01 )H01S 76:;68 21//2/0/2/

–התקני ספיגה הניתנים לרוויה מבוססי גרפן ושיטות

GRAPHENE-BASED SATURABLE

ABSORBER DEVICES AND METHODS

NATIONAL UNIVERSITY OF

SINGAPORE 13/04/2009 61/168661 US PCT/SG/2010/000148 WO/2010/120246

(2011.01 )B29C 76:;69 00//2/0/2/

COMPRESSED SHEET יריעה דחוסה

DSM IP ASSETS B.V. 23/04/2009 09158621.4 EP PCT/EP/2010/055337 WO/2010/122099

(2011.01 )C07D 76:;6: /3//3/0/2/

–1 750תרכובות ציאנואתילהטרוציקלילקרבוקסאמיד

מותמרות

SUBSTITUTED 1-

CYANOETHYLHETEROCYCLYLCARBOXAMIDE

COMPOUNDS 750

ASTRAZENECA AB










07/05/2009 61/176279 US 2///4/0//7 42/263407 US PCT/GB/2010/050736 WO/2010/128324

(2011.01 )C07D 76:;6; 01//2/0/2/

[ הפטנים המשמשים 0.1.4אזאביציקלו[–3 כאנטגוניסטים לאורקסין

3-AZABICYCLO [4.1.0] HEPTANES

USED AS OREXIN ANTAGONISTS

GLAXO GROUP LIMITED 24/04/2009 0907112.7 GB 25//4/0//7 /72/26195 GB 00/20/0//7 /70025094 GB PCT/EP/2010/055449 WO/2010/122151

(2011.01 )C12Q 76:;6= 22//2/0/2/

PREDICTIVE MODELS AND METHOD ושיטה להערכת גיל מודלים מנבאים

FOR ASSESSING AGE CARDIODX, INC 14/04/2009 61/169241 US PCT/US/2010/031076 WO/2010/120914

(2011.01 )G11C 76:;=< 22/2//0/22

REAL-TIME RECORDING SYSTEM מערכת הקלטה בזמן אמת


LTD.

(2011.01 )A61B 76:;>= 22/2//0/22

LARYNGOSCOPE HANDLE ידית לרינגוסקוף










.TRUPHATEK INTERNATIONAL LTD תרופאטק אינטרנשיונל בע"מ

(2011.01 )A61M 76:;>> 22/2//0/22

התקן לשחזור תרופה נוזלית לשימוש עם ובקבוקון תרופה IVשקית

LIQUID DRUG RECONSTITUTION

ASSEMBLAGE FOR USE WITH IV

BAG AND DRUG VIAL .MEDIMOP MEDICAL PROJECTS LTD מדימופ פרוייקטים רפואיים בע"מ

(2011.01 )F28F 76:<55 22/2//0/22

COOLING SYSTEM AND METHOD מערכת ושיטה לקירור

.ELTA SYSTEMS LTD אלתא מערכות בע"מ

(2011.01 )G02B 76:<6: 22/2//0/22

אמצעי ביתי להפקת מדבקות לנטיקולריות אישיות

MEANS FOR PRODUCING HOME

MADE IENTICULAR STICKERS

ITZHAK BAR YONA יצחק בר יונה

(2011.01 )C25B 76:<75 22/2//0/22

DEHUMIDIFIER AND METHOD OF מייבש אוויר ושיטת שימושו

USE THEREOF .AGAM ENERGY SYSTEMS LTD אג"מ מערכות אנרגיה בע"מ










(2011.01 )G08B 76:<89 22/2//0/22

RAISABLE BED מיטה מתרוממת

AMINACH BEDDING & FURNITURE עמינח תעשיות רהיטים ומזרונות

MANUFACTURING LTD

(2011.01 )D21H 76:<8: 22/2//0/22

תהליך הדפסה על בדים רטובים לא ארוגים ומוצרים כתוצאה מכך

IN-LINE PRINTING PROCESS ON WET

NON-WOVEN FABRIC AND

PRODUCTS THEREOF .N.R. SPUNTECH INDUSTRIES LTD נ.ר. ספאנטק תעשיות בע"מ

19/10/2010 61/394407 US

(2011.01 )G06F 76:<8; 22/2//0/22

מערכת למתן אתראות התעוררות לנוסעים בתחבורה ציבורית

A SYSTEM FOR PROVIDING WAKE-

UP ALERTS TO PASSENGERS OF

PUBLIC TRANSPORTATION GRATZYA CHECHIK גרציה צ'צ'יק

(2011.01 )G06Q 76:<98 01/2//0/22










מערכת אוטומטית לבדיקת הימצאות דואר בתיבת הדואר ושליחת התראה

צלום תוכן התיבההכוללת

AUTOMATIC SYSTEM MONITORING

EXISTENCE OF MAIL IN A MAIL BOX

AND SENDING ALERT INCLUDING A

PICTURE OF THE BOX'S CONTENT AVI PARASH אבי פרש

(2011.01 )G01L 76:<99 01/2//0/22

גילוי ותיקון של סחיפת נקודת האפס במדידות של כוח מגע

ZERO-DRIFT DETECTION AND

CORRECTION IN CONTACT FORCE

MEASUREMENTS BIOSENSE WEBSTER (ISRAEL) LTD 03/11/2010 12/938458 US

(2011.01 )A61B 76:<9; 01/2//0/22

הצגת מגע בין צנתר לרקמה ע"י עיוות של מפה

VISUALIZATION OF CATHETER-

TISSUE CONTACT BY MAP

DISTORTION BIOSENSE WEBSTER (ISRAEL) LTD 04/11/2010 12/939259 US

(2011.01 )A61K 76:<=7 01/2//0/22

METHOD FOR TREATING A שיטה לטיפול במחלת חניכיים

PERIODONTAL DISEASE

DEXCEL PHARMA TECHNOLOGIES דקסל פארמה טכנולוגיות בע"מ

LTD. 25/10/2010 61/406288 US








(2011.01 )C07D 76:<== 06//2/0//4

תהליך להכנת נגזרת פוליציקלית של קרבאמוילפירידון בעלת פעילות מעכבת

של נגיף האיידס


OF POLYCYCLIC

CARBAMOYLPYRIDONE

DERIVATIVE HAVING HIV

INTEGRASE INHIBITORY ACTIVITY SHIONOGI & CO., LTD.

28/04/2005 2005-

131161 JP

05/2//0//3 0//3-120/54 JP PCT/US/2006/016604 WO/2006/116764

(2011.01 )B65D 76:=7: 01/2//0/22

SELABLE STORAGE CONTAINER מיכל איחסון הניתן לאיטום

THE STANLEY WORKS ISRAEL LTD דה סטנלי וורקס ישראל בע"מ 15/12/2010 12/969352 US

(2011.01 )A23L 76:=89 /6//1/0//4

( HMFוסף חיזוק נוזלי לחלב אנושי )ת ולתרכובות הזנה לתינוקות

LIQUID HUMAN MILLC FORTIFIER

(HMF) COMPOSITION FOR ADDING

TO HUMAN MILK OR INFANT

NUTRITIONAL FORMULA ABBOTT LABORATORIES 09/03/2005 60/660087 US PCT/US/2006/008354 WO/2006/099013

(2011.01 )C07K 76:=:7 2///1/0//4










ספציפי ללאוקמיה CD 43אפיטופ אקוטית וללימפומה לימפובלסטית

ושימוש בו

ACUTE LEUKEMIA AND

LYMPHOBLASTIC LYMPHOMA-

SPECIFIC CD43 EPITOPE AND USE

THEREOF DINONA INC. 11/05/2005 60/679910 US

02//6/0//3 2/-0//3-//557/4 KR

0//20/0//3 22/120204 US PCT/KR/2006/000870 WO/2006/121240

(2011.01 )A61F 76:=;8 20//2/0//4

יב להפעלת צנתר השתלה דרך כלי רכ דם של שסתומי לב תותבים

CATHETER FOR THE TRANSVASCULAR

IMPLANTATION OF PROSTHETIC

HEART VALVES JENAVALVE TECHNOLOGY, INC. 20/01/2005 102005003632.5 DE PCT/DE/2006/000056 WO/2006/076890

(2011.01 )G07B 76:=<8 01/2//0/22

שיטה להערכת עלות הבעלות הכוללת לדרישה

A METHOD FOR ESTIMATING THE

TOTAL COST OF OWNERSHIP (TCO)

FOR A REQUIREMENT MY SINGLE POINT LTD מיי סינגל פוינט בע"מ

(2011.01 )A61B 76:=<< 02/2//0/22

ROUTING OF PACING SIGNALS ניתוב של אותות קיצוב

BIOSENSE WEBSTER (ISRAEL) LTD 28/10/2010 12/914199 US








(2011.01 )H04J 76:==5 02/2//0/22

SIMULTANEOUS ABLATION BY זמנית–אבלציה ע"י אלקטרודות רבות בו

MULTIPLE ELECTRODES BIOSENSE WEBSTER (ISRAEL) LTD 08/11/2010 12/941165 US

(2011.01 )H04J 76:==6 02/2//0/22

MULTICHANNEL ABLATION WITH ערוצית עם הפרדת תדרים–אבלציה רב

FREQUENCY DIFFERENTIATION BIOSENSE WEBSTER (ISRAEL) LTD 08/11/2010 12/941165 US 00/22/0/2/ 20/7320// US

(2011.01 )A23L 76:==7 02/2//0/22

אריזת מזון קפוא להכנת מוצר מזון מוגמר והכנתו

A FROZEN FOOD PACKAGE FOR

PREPARING A FINISHED FOOD

PRODUCT AND ITS PREPARATION SUNFROST LTD סנפרוסט בע"מ

(2011.01 )H01R 76:==: 02/2//0/22

A ROTABLE ELECTRIC CONNECTOR ני בעל יכולת סיבוביתמחבר אלקטרו

ALON ALMOULI אלון אלמולי 21/10/2010 GB1017782.2 UA










(2011.01 )G06F 76:==; 02/2//0/22

מטית לניהול כותבי פלטפורמה אוטו תכנים לצרכי שיווק אינטרנטי והסברה

A CROWD-SOURCE BASED SYSTEM

AND METHOD OF SUPERVISING

AND DISPATCHING ON-LINE

CONTENT PRODUCTING FOR

ADVOCACY AND SEARCH ENGINE

OPTIMIZATION YECHEZKEL ZVI GREEN יחזקאל צבי גרין

25/10/2010 61406339 US

(2011.01 )C07D 76:=>5 12//6/0//2

PEPTIDOMIMETIC PROTEASE מעכבים של פרוטאז פפטידומימטיים

INHIBITORS


INCORPORATED 31/08/2000 60/229398 US 02//1/0//2 4//055422 US PCT/US/2001/026008 WO/2002/018369

(2011.01 )C07D 76:=>6 12//6/0//2

PEPTIDOMIMETIC PROTEASE מעכבים של פרוטאז פפטידומימטיים

INHIBITORS



(2011.01 )C07D 76:=>7 12//6/0//2










PEPTIDOMIMETIC PROTEASE טייםמעכבים פרוטאז פפטידומימ

INHIBITORS



(2011.01 )A61K 76:=>; 23//5/0//3

COMPOUNDS AND METHODS FOR תרכובות ושיטות לטיפול בסרטן

TREATMENT OF CANCER

THE TEXAS A&M UNIVERSITY

SYSTEM 16/07/2004 60/588596 US PCT/US/2005/025192 WO/2006/020048

(2011.01 )A61K 76:=>< 26//1/0//3

–4תכשיר רוקחי שיווי משקל המכיל הידרוקסי טאמוקסיפן ושיטה להכנתו

PHARMACEUTICAL COMPOSITION

AT THE EQUILIBRIUM STATE

COMPRISING 4-HYDROXY

TAMOXIFEN AND METHOD FOR

MAKING IT

LABORATOIRES BESINS

INTERNATIONAL 22/03/2004 04290762.6 EP 00//1/0//2 2//6/331/ US PCT/EP/2005/003455 WO/2005/092310

(2011.01 )C07D 76:>6< 03//0/0//2

P38 INHIBITORS AND METHODS OF ושיטות לשימוש בהם 38Pמדכאי

USE THEREOF ARRAY BIOPHARMA, INC 03/03/2003 10/378164 US 23/2//0//1 2//466627 US








PCT/US/2004/005693 WO/2004/078116

(2011.01 )C02F 76:>6= 1///2/0/2/

התקן לטיהור ושיטה לסילוק קסנוביוטיים ממים

PURIFYING DEVICE AND METHOD FOR

ELIMINATION OF XENOBIOTICS IN

WATER LOIRA 30/04/2009 PCT/FR2009/050800 FR PCT/IB/2010/000982 WO/2010/125450

(2011.01 )C07K 76:>6> 07//2/0/2/

ANTI CXCR4 ANTIBODIES FOR THE לטיפול בנגיף האיידס 4CXCRנוגדנים נגד

TREATMENT OF HIV PIERRE FABRE MEDICAMENT 29/04/2009 09159076.0 EP 07//2/0//7 42/25146/ US PCT/EP/2010/055863 WO/2010/125162

(2011.01 )G02C 76:>75 03/2//0/22

התקן ושיטות לפליטת אור חכמה ולבניית פולט אור חכם

APPARATUS AND METHOD FOR

SMART LIGHT EMISSION AND

SMART LIGHT EMITTER

CONSTRUCTION


LTD.

(2011.01 )A61K 76:>77 01//4/0//7










משותפים –תכשיר תוך ורידי עם גבישיםלסליצילית מסיסים במים של חומצה אצטי

ותיאנין

INTRAVENOUS FORMULATION

WITH WATER-SOLUBLE

COCRYSTALS OF

ACETYLSALICYLIC ACID AND

THEANINE

SOLUPRIN PHARMACEUTICALS,

INC. 08/05/2009 12/437735 US PCT/US/2009/048275 WO/2010/128977

(2011.01 )H01L 76:>78 04//6/0//2

OPTICAL ELEMENT AND EXPOSURE רכיב אופטי והתקן חשיפה

APPARATUS NIKON CORPORATION

26/08/2003 2003-

302122 JP

05//6/0//1 0//1-1/1210 JP 05//6/0//1 0//1-1/0327 JP 04//7/0//1 0//1-114240 JP 26//0/0//2 0//2-/22626 JP 26//0/0//2 0//2-/20235 JP 27//0/0//2 0//2-/20530 JP 0///0/0//2 0//2-/22007 JP PCT/JP/2004/012296 WO/2005/020298

(2011.01 )C07K 76:>79 05//2/0/2/

LPS–תכשיר אימונוגלובולין מועשר נגד לטיפול ו/או מניעה של הפרעה פתולוגית

ANTI-LPS ENRICHED

IMMUNOGLOBULIN PREPARATIONS

FOR THE TREATMENT AND/OR

PROPHYLAXIS OF A PATHOLOGIC

DISORDER IMMURON LIMITED 27/04/2009 61/172922 US PCT/IL/2010/000339 WO/2010/125565






(2011.01 )A61K 76:>7: 05//2/0/2/

תכשירי נוזל שעבר שינוי אלקטרוקינטי ושימוש בו לטיפול בהתנגדות לאינסולין

בסכרת

ELECTROKINETICALLY-ALTERED

FLUID COMPOSITIONS AND USE

THEREOF FOR TREATING INSULIN

RESISTANCE AND DIABETES

MELLITUS REVALESIO CORPORATION 27/04/2009 61/173134 US PCT/US/2010/032620 WO/2010/126908

(2011.01 )B02C 76:>7; 02//3/0/2/

HARD DRIVE DESTRUCTION מערכת השמדת כונן קשיח

SYSTEM SCOTT ANTHONY WOZNY 23/05/2009 61/180841 US PCT/US/2010/035881 WO/2010/138427

(2011.01 )A01H 76:>7< 22//0/0//3

חי וזרעי עגבניות המכילות אלל עמיד צמ לנגיף ושיטות להכנתם

TOMATO PLANTS AND SEEDS

COMPRISING A VIRUS RESISTANT

ALLELE AND METHODS OF

PRODUCING THE SAME SEMINIS VEGETABLE SEEDS, INC. 12/02/2004 10/777984 US PCT/US/2005/004547 WO/2005/079342

(2011.01 )A61K 76:>7= 1///2/0/2/

נוגדנן בעל איזור משתנה כפול ושימושיוDUAL VARIABLE DOMAIN

IMMUNIGLOBULINS AND USES

THEREOF ABBOTT LABORATORIES 01/05/2009 61/174711 US PCT/US/2010/033231










WO/2010/127284

(2011.01 )C07D 76:>7> /2/2//0//4

פירזולופירימידינים חדשים כמעכבים לקינאזים תלויי ציקלין

NOVEL PYRAZOLOPYRIMIDINES AS

CYCLIN DEPENDENT KINASE

INHIBITORS SCHERING CORPORATION 06/10/2005 11/245401 US PCT/US/2006/038939 WO/2007/044449

(2011.01 )C07D 76:>85 1///2/0/2/

צורה גבישית של תרכובת בנזופיראן ייצורהטריציקלית ושיטה ל

NOVEL CRYSTAL FORM OF

TRICYCLIC BENZOPYRAN

COMPOUND AND PRODUCTION

METHOD THEREOF

NISSAN CHEMICAL INDUSTRIES

LTD.

30/04/2009 2009-

111281 JP

PCT/JP/2010/057698 WO/2010/126138

(2011.01 )A01G 76:>86 03/2//0/22

LABYRINTH WITH MEMBRANE מבוך עם ממברנה

AMIRIM PRODUCTS DEVELOPMENT אמירים פיתוח מוצרים ופטנטים בע"מ

& PATENTS LTD 25/10/2010 1017985.1 GB

(2011.01 )A61K 76:>87 23//2/0/2/










COMPOSITIONS AND METHODS FOR תרכובות ושיטות לטיפול בכוויות

TREATING BURNS MINDCAKE, LLC 23/04/2009 12/429169 US PCT/US/2010/031315 WO/2010/123759

(2011.01 )C07D 76:>88 21/2//0//2

חומצות קרבוקסיליות ואצילסופונאמידים HCVמקרוציקליים כמעכבי שכפול

MACROCYCLIC CARBOXYLIC ACIDS

AND ACYLSULFONAMIDES AS

INHIBITORS OF HCV REPLICATION INTERMUNE, INC. 14/10/2003 60/511541 US 00//7/0//2 4//42024/ US PCT/US/2004/033970 WO/2005/037214

(2011.01 )C07D 76:>89 21/2//0//2

חומצות קרבוקסיליות ואצילסופונאמידים HCVכבי שכפול מקרוציקליים כמע

MACROCYCLIC CARBOXYLIC ACIDS

AND ACYLSULFONAMIDES AS

INHIBITORS OF HCV REPLICATION INTERMUNE, INC. 14/10/2003 60/511541 US 00//7/0//2 4//42024/ US PCT/US/2004/033970 WO/2005/037214

(2011.01 )C01C 76:>8: 06//2/0/2/

COMBINED PLANT מפעל משולב

YOSUKE IIDA, 05/05/2009 200910149706.3 JP PCT/JP/2010/057918 WO/2010/128682








(2011.01 )C08B 76:>8; /5//3/0/2/

–(2,1)–תכשירים ושיטות להכנת אלפא אוליגודקסטראנים–(6,1)–מסועף אלפא


MAKING ALPHA-(1,2)-BRANCHED

ALPHA-(1,6) OLIGODEXTRANS

TATE & LYLE INGREDIENTS

FRANCE SAS 07/05/2009 61/176242 US PCT/US/2010/033984 WO/2010/129839

(2011.01 )A61K 76:>8< /2//3/0/2/

FGF21 MUTANTS AND USES ושימושים שלהם 21FGFמוטנטים של

THEREOF AMGEN INC. 05/05/2009 61/175736 US /7/20/0//7 42/063226 US PCT/US/2010/033478 WO/2010/129503

(2011.01 )B21D 76:>8= /6/22/0//4

שיטה להפקת אלמנטים של לוח סלולר מסרטי משטח מתכת ושורת הפקה

METHOD FOR MANUFACTURING OF

CELLULAR BOARD, CELLULAR

BOARD, METHOD FOR PRODUCING

CELLULAR BOARD ELEMENT OF

STEEL PLATE STRIP, AND

PRODUCTION LINE OY SHIPPAX LTD 08/11/2005 20051131 FI 05/20/0//3 0//32105 FI /5//0/0//4 0//4/225 FI /6//3/0//4 0//4/221 FI /4//5/0//4 0//4/437 FI 0///7/0//4 0//4/616 FI PCT/FI/2006/000359 WO/2007/054608








(2011.01 )A61K 76:>99 22//1/0//1

שימוש בתכשיר רוקחי המכיל טסטוסטרון להכנת תרופה לטיפול או מניעה בסיכון

של התפתחות מחלה דיכאונית

USE OF A TESTOSTERONE

COMPRISING PHARMACEUTICAL

COMPOSITION IN THE

PREPARATION OF MEDICAMENT

FOR TREATING OR PREVENTING

THE RISK OF DEVELOPING A

DEPRESSIVE DISORDER UNIMED PHARMACEUTICALS, LLC 15/03/2002 10/098232 US 02//3/0//0 2//231246 US PCT/US/2003/007910 WO/2004/091631

(2011.01 )G07B 76:>;5 04/2//0/22

CASH SLIDING SLIDING ASSISTANT מתקן עזר להחלקת מזומן

HALM SHELEMEY חיים שלומי

(2011.01 )C09G 76:>;> 22//1/0//3

מכנית עם –כרית נקבובית למריקה כימית ברכיבנקבוביות מלאות

CMP POROUS PAD WITH

COMPONENT-FILLED PORES

CABOT MICROELECTRONICS


(2011.01 )E03C 76:><5 04/2//0/22

ADJUSTABLE SINK כיור מתכון

GAD TAVORI גד תבורי










(2011.01 )B62J 76:><6 05/2//0/22

MOTORCYCLE STABILITY התקן יציבות לאופנוע

OREN YAKOBIAN ארן יעקביאן

(2011.01 )B41L 76:><7 05/2//0/22

DIGITAL PRINTING METHOD AND שיטה והתקן להדפסה דיגיטאלית

APPARATUS MICHAL IVRI מיכל עברי

(2011.01 )A61K 76:><= /2/2//0//5

הכנת סטנסופורפין עם דרגת טיהור גבוהה בקנה מידה גדול

HIGH-PURITY LARGE SCALE

PREPARATION OF STANNSOPORFIN

INFACARE PHARMACEUTICAL

CORPORATION 04/10/2006 60/849641 US 06//0/0//5 4//7/24/2 US PCT/US/2007/021485 WO/2008/045377

(2011.01 )C07D 76:>>< 2///4/0//2










צת תרכובות מאוחות המכילות קבו–אוראידו המעכבות קולטן וינלואיד תת

( של הקולטן, לטיפול 1VR) 1סוג ידי פעילות של –בהפרעות הנגרמות על

קולטן וינלואיד ותהליך להכנתן

FUSED COMPOUNDS CONTAINING

AN UREIDO GROUP THAT INHIBIT

VANILLOID RECEPTOR SUBTYPE 1

(VR1) RECEPTOR ,FOR TREATING

DISORDERS CAUSED BY VANILLOID

RECEPTOR ACTIVITY AND PROCESS

FOR THEIR PREPARATION ABBOTT LABORATORIES 12/06/2003 10/459925 US /7//4/0//2 2//642/46 US PCT/US/2004/018590 WO/2004/111009

(2011.01 )G06F 76;575 05/2//0/22

IMPROVED DATA ENTRY SYSTEMS שיטות משופרות להכנסת נתונים

BENJAMIN FIROOZ GHASSABIAN בנימין פירוז גסביאן

(2011.01 )C12N 76;598 03//0/0/2/

נבט אוכלוסיות מבודדות של תאי כיליתיים ושיטות לבידוד ושימוש בהם

ISOLATED POPULATIONS OF RENAL

STEM CELLS AND METHODS OF

ISOLATING AND USING GAME

תל השומר מחקרים, תשתית ושירותים רפואיים בע"מ



SERVICES LTD. 26/02/2009 61/202425 US 04//0/0//7 42/0/0204 US PCT/IL/2010/000158 WO/2010/097793

(2011.01 )G06F 76;59: 1//2//0/22

IMPROVED DATA SYSTEMS שיטות משופרות להכנסת נתונים

BENJAMIN FIROOZ GHASSABIAN ירוז גסביאןבנימין פ








(2011.01 )C07D 76;59; 2///4/0//2

תרכובות מאוחות המכילות קבוצת –אוראידו המעכבות קולטן וינלואיד תת

ול ( של הקולטן, לטיפ1VR) 1סוג ידי פעילות של –בהפרעות הנגרמות על

קולטן וינלואיד ותהליך להכנתן

FUSED COMPOUNDS CONTAINING

AN UREIDO GROUP THAT INHIBIT

VANILLOID RECEPTOR SUBTYPE 1

(VR1) RECEPTOR ,FOR TREATING

DISORDERS CAUSED BY VANILLOID

RECEPTOR ACTIVITY AND PROCESS

FOR THEIR PREPARATION ABBOTT LABORATORIES 12/06/2003 10/459925 US /7//4/0//2 2//642/46 US PCT/US/2004/018590 WO/2004/111009

(2011.01 )B65D 76;5:: 12/2//0/22

STRONG AND ENLARGEABLE BAG חזק הניתן להגדלה סל

HARTAL GUY הרטל גיא

(2011.01 )G06F 76;5:; 12/2//0/22

COMBINED DATABASE SYSTEM מערכת ושיטה לשילוב בסיסי נתונים

AND METHOD .VERINT SYSTEMS LTD ורינט מערכות בע"מ

(2011.01 )G06T 76;5:= 12/2//0/22










מערכת ושיטה לניתוח קשרים על ידי עיבוד תמונה

SYSTEM AND METHOD FOR LINK

ANALYSIS BASED ON IMAGE

PROCESSING .VERINT SYSTEMS LTD ורינט מערכות בע"מ

(2011.01 )G06F 76;5:> 12/2//0/22

מטרות על ידי מערכת ושיטה לאפיון ניתוח רשתות חברתיות

SYSTEM AND METHOD FOR TARGET

PROFILING USING SOCIAL

NETWORK ANALYSIS .VERINT SYSTEMS LTD ורינט מערכות בע"מ

(2011.01 )G10L 76;5;= /7//4/0//1

מערכת לקידור אודיו המשתמש כמאפיינים של סיגנל מפוענח כדי לתאם

מרכיבים ספקטראליים מסונתזים

AUDIO CODING SYSTEM USING

CHARACTERISTICS OF A DECODED

SIGNAL TO ADAPT SYNTHESIZED

SPECTRAL COMPONENTS


CORPORATION PCT/US/2003/018065 WO/2003/107329

(2011.01 )G10L 76;5;> /7//4/0//1

מערכת לקידור אודיו המתשמש כמאפיינים של סיגנל מפוענח כדי לתאם

מרכיבים ספקטרואליים

AUDIO CODING SYSTEM USING

CHARACTERISTICS OF A DECODED

SIGNAL TO ADAPT SYNTHESIZED

SPECTRAL COMPONENTS


CORPORATION 17/07/2002 10/174493 US /4//7/0//0 2//016/25 US








PCT/US/2003/018065 WO/2003/107329

(2011.01 )A61M 76;5<5 03//4/0//2

DISPENSING DEVICE מתקן מינון

PFIZER LIMITED 02/07/2003 0315509.0 GB PCT/GB/2004/002748 WO/2005/002654

(2011.01 )B60L 76;5<> /2/22/0/22

ELECTRICAL POWER FOR VEHICLES עבור כלי רכב מנוע כח חשמלי

JOSEF JEFFRIES יוסף ארווין ג'פריס

(2011.01 )C07D 76;5=> 03//4/0//2

אמינומתיל –9תרופות מתרכובות –קדם טטראציקליניות

PRODRUGS OF 9-AMINOMETHYL

TETRACYCLINE COMPOUNDS

PARATEK PHARMACEUTICALS, INC. 09/07/2003 60/486017 US 03/22/0//1 4//303065 US 24/20/0//1 4//31/201 US 05//2/0//2 4//34423/ US PCT/US/2004/020305 WO/2005/009944

(2011.01 )H04L 76;5>5 /2/22/0/22

LOGICAL BRIDGING SYSTEM AND מערכת גישור לוגית ושיטה

METHOD .MARVELL ISRAEL (M.I.S.L) LTD מארוול ישראל )אמ.איי.אס.אל( בע"מ

14/02/2007 60/889809 US










/2//3/0//5 4//724/43 US

(2011.01 )B60S 76;5>8 /2/22/0/22

VEHICULAR DISPOSABLE פעמי לרכב–כיסוי הגנתי חד

PROTECTIVE COVER SHLOMO VANUNU שלמה ואנונו

(2011.01 )A61K 76;5>: 21//7/0//3

חלבוני איחוי ותכשירי רוקחות המכילים אותם

FUSION PROTEINS AND


CONTAINING THE SAME GENZYME CORPORATION 13/09/2004 60/608887 US /2//1/0//3 4//4360/7 US PCT/US/2005/032320 WO/2006/031689

(2011.01 )G02C 76;5>; /0/22/0/22

MULTI FUNCTIONAL GLASSES משקפיים רב תכליתיים

ROSHDI ASSI רושדי עאסי

(2011.01 )A61B 76;658 /0/22/0/22

CATHETER WITH OPTICAL צנתר עם חישת מגע אופטית

CONTACT SENSING BIOSENSE WEBSTER (ISRAEL) LTD










16/11/2010 12/946910 US

(2011.01 )A61K 76;659 07/22/0//3

COATED DRUG DELIVERY שחרור פורמולציות מתרופה מצופה

FORMULATIONS

WESTERN UNIVERSITY OF HEALTH

SCIENCES 30/11/2004 10/999831 US PCT/US/2005/042958 WO/2006/060325

(2011.01 )A61M 76;66; /3/22/0//2

POWDER INHALER משאף לאבקה


INTERNATIONAL GMBH 08/11/2003 10352277.8 DE PCT/EP/2004/012535 WO/2005/044353

(2011.01 )H04W 76;66< /3//5/0//3

שיטה והתקן לריבוב מוגבר בהעברת אות ללויין


ENHANCED UPLINK MULTIPLEXING

INTERDIGITAL TECHNOLOGY

CORPORATION 19/07/2004 60/588960 US 03//2/0//3 22/221541 US PCT/US/2005/023891 WO/2006/019562

(2011.01 )E02B 76;67< /1/22/0/22

FLOATING OIL RIG PROTECTION הגנה להתקנות ימיות ותשתיות










AGRO SHIPPING LTD בע"מ אגרו ספנות

(2011.01 )G08B 76;67> /1/22/0/22

שיטה ומערכת לאישור הפעלת רכבA METHOD AND SYSTEM FOR

AUTHORIZING VEHICLES

OPERATION ERM ELECTRONIC SYSTEMS LTD אר אם מערכות אלקטרוניות בע"מאי

(2011.01 )A61B 76;689 /1/22/0/22

POLYGRAPH פוליגרף

ZEEV DANIELI שאול בר לב 31/10/2011 000000 US

(2011.01 )H04L 76;68> 23//3/0//7

שיכוך הפרעה מרחבי לתקשורת אלחוטיתSPATIAL INTERFERENCE

MITIGATION FOR WIRELESS

COMMUNICATION QUALCOMM INCORPORATED 15/05/2008 61/053564 US 03/22/0//6 42/225630 US 22//3/0//7 20/241501 US PCT/US/2009/044204 WO/2009/140633

(2011.01 )A61M 76;6:= /4/22/0/22










אוטומטי אלקטרוני ומחסניות התקן מזרק לשימוש איתו

ELECTRONIC AUTOINJECTOR

APPARATUS AND CASSETTES FOR

USE THEREWITH .MEDIMOP MEDICAL PROJECTS LTD מדימופ פרוייקטים רפואיים בע"מ

(2011.01 )G06Q 76;6;6 /4/22/0/22

אינטראקציות מבוטחות על ידי מבטח אוטומטי

AUTOMATED INSURER INSURED

INTERACTIONS

DAVIDSHIELD L.I.A. (2000) LTD ( בע"מ2000דודשילד אל.אי.איי. ) 18/11/2010 12/949367 US

(2011.01 )A61B 76;6;9 /4/22/0/22

AN ORAL CONDOM קונדום אוראלי

ALON ZHABOKRITSKY אלון ז'בוקריצקי

(2011.01 )G08B 76;6;: /4/22/0/22

מערכת להתזת חומר דביק לעיכוב פורצים

AN ADHESIVE SPRAY SYSTEM THAT

HINDERS INTRUDERS

OFER HAI עופר חי

(2011.01 )G06F 76;6<5 /5/22/0/22










IMPROVED DATA ENTRY SYSTEMS שיטות משופרות להכנסת נתונים

BENJAMIN FIROOZ GHASSABIAN בנימין פירוז גסביאן

(2011.01 )B41J 76;6=6 /5/22/0/22

MOBILE PRINTER מדפסת ניידת

YEHEZKEL AHARON BORNSTEIN יחזקאל אהרון בורנשטין

(2011.01 )A01N 76;6>: 1///4/0//3

יות של חומרים תערובות סינרגיסטאנתרנילאמידיים מדבירי מזיקים חסרי

חוליות

SYNERGISTIC MIXTURES OF

ANTHRANILAMIDE INVERTEBRATE

PEST CONTROL AGENTS


COMPANY 01/07/2004 60/584601 US 07//1/0//3 4//444/51 US PCT/US/2005/023813 WO/2006/007595

(2011.01 )A01N 76;6>; 1///4/0//3

תערובות סינרגיסטיות של חומרים אנתרנילאמידיים מדבירי מזיקים חסרי

חוליות



PEST CONTROL AGENTS










(2011.01 )A01N 76;6>< 1///4/0//3

ת סינרגיסטיות של חומרים תערובואנתרנילאמידיים מדבירי מזיקים חסרי

חוליות



PEST CONTROL AGENTS



(2011.01 )A01N 76;6>= 1///4/0//3

תערובות סינרגיסטיות של חומרים אנתרנילאמידיים מדבירי מזיקים חסרי

חוליות



PEST CONTROL AGENTS



(2011.01 )H04M 76;776 /6/22/0/22

מערכת ושיטה לקורלציה של כלי רכב ונהגים


CORRELATION OF VEHICLES AND

DRIVERS MIZRACHI GIL גיל מזרחי

08/11/2010 12/941360 US

(2011.01 )C07C 76;785 27/22/0//0










פרופיוניות ותכשירי –אריל–2חומצות רוקחות המכילים אותן

2-ARYL-PROPIONIC ACIDS AND


CONTAINING THEM DOMPE S.P.A. 20/11/2001 MI2001A002434 IT PCT/EP/2002/012939 WO/2003/043625

(2011.01 )B25H 76;788 /7/22/0/22

מערכת המשלבת יחדיו אחד על פני השני חלקים גליליים מרובים

A SYSTEM FOR INTERLOCKING A

PLURALITY OF STACKABLE

CYLINDRICAL SECTIONS YUVAL COHEN יובל כהן

(2011.01 )C07D 76;79< 25//5/0//4

אריל –טטראהידרובנזאזפינים מותמריוהטרואריל והשימוש בהם כדי למנוע

קליטה מחודשת של נוראפינפרין, דופאמין וסרוטונין

ARYL-AND HETEROARYL-

SUBSTITUTED

TETRAHYDROBENZAZEPINES AND

USE THEREOF TO BLOCK REUPTAKE

OF NOREPINEPHRINE, DOPAMINE

AND SEROTONIN BRISTOL-MYERS SQUIBB COMPANY 15/07/2005 60/700057 US PCT/US/2006/027574 WO/2007/011820

(2011.01 )A61P 76;79> 20/2//0//2

מאליאט של תרכובת אמינו –מלח די קרוטונילית, תהליך להכנתו והשימוש בו

A DIMALEATE SALT OF AN AMINO

CROTONYL COMPOUND, A PROCESS

FOR PREPARING THE SALT AND

USES THEREOF


INTERNATIONAL GMBH 17/10/2003 10349113.9 DE








PCT/EP/2004/011378 WO/2005/037824

(2011.01 )E01F 76;7<< 2//22/0/22

מתקן להסתרה ושיטות שימוש

OBSTRUCTING DEVICE AND

METHODS OF USE

YIFAT HAFNER יפעת הפנר

(2011.01 )H04W 76;87; 22//5/0//3

EFFICIENT SIGNALING OVER איתות יעיל מעבר ערוץ גישה

ACCESS CHANNEL QUALCOMM INCORPORATED 21/07/2004 60/590113 US 00/20/0//2 22//0/235 US PCT/US/2005/024614 WO/2006/019710

(2011.01 )A01C 76;89; 21//1/0//5

קרקעית עם התקן –מערכת להזרקה תת נתינה משופר

SUBSURFACE SOIL INJECTION

APPARATUS WITH IMPROVED

DELIVERY DEVICE

ARYSTA LIFESCIENCE NORTH

AMERICA, LLC. 27/03/2006 11/389054 US PCT/US/2007/063839 WO/2007/117833

(2011.01 )A01H 76;8<7 /3//4/0//0










ות ושיט 15985MONאירוע גנטי בכותנה לאבחונו בהם

COTTON EVENT MON15985 AND

METHODS FOR DETECTION

THEREOF MONSANTO TECHNOLOGY LLC 11/06/2001 60/297406 US PCT/US/2002/017853 WO/2002/100163

(2011.01 )H04L 76;8<= 23/2//0//2

פרוטוקול מהיר לשליטה לגישה למדיה וקשר ישיר

HIGH SPEED MEDIA ACCESS

CONTROL AND DIRECT LINK

PROTOCOL QUALCOMM INCORPORATED 15/10/2003 60/511904 US 23/2//0//1 4//32253/ US 02/2//0//1 4//321017 US /2/20/0//1 4//304134 US /2/20/0//1 4//304125 US 01/20/0//1 4//310572 US 26//0/0//2 4//323741 US /0//4/0//2 4//354323 US /6//5/0//2 4//364622 US 22//6/0//2 4//4//74/ US 21/2//0//2 2//742122 US PCT/US/2004/034259 WO/2005/039105

(2011.01 )C07K 76;8=6 02//6/0//5

נוגדנים אנושיים מונוקלונליים לפוליפפטיד LIGHT–אנטגוניסטים מוכווני

אנושי

ANTAGONISTIC HUMAN LIGHT-

SPECIFIC HUMAN MONOCLONAL

ANTIBODIES

LA JOLLA INSTITUTE FOR ALLERGY

AND IMMUNOLOGY 28/08/2006 60/840774 US 03//2/0//5 4//675653 US PCT/US/2007/018832 WO/2008/027338






(2011.01 )A61K 76;956 27//5/0//4

SUSTAINED RELEASE OF שחרור מושהה של נוגדי זיהומים

ANTIINFECTIVES TRANSAVE, INC. 19/07/2005 11/185448 US PCT/US/2006/027859 WO/2007/011940

(2011.01 )C07C 76;958 /6//2/0//2

METHODS FOR TREATMENT OF שיטות לטיפול במחלת פרקינסון

PARKINSON'S DISEASE NEWRON PHARMACEUTICALS S.P.A. 11/04/2003 60/462205 US PCT/IB/2004/001408 WO/2004/089353

(2011.01 )C07F 76;99> 23//5/0//2

PROCESS FOR THE PREPARATION תהליך להכנת נגזרות של טטרזול

OF TETRAZOLE DERIVATIVES NOVARTIS AG 15/07/2003 0316546.1 GB PCT/EP/2004/007980 WO/2005/014602

(2011.01 )C07D 76;9:9 26/22/0//2

ושיטות MEKמעכבים הטרוציקליים של שימוש בהם

HETEROCYCLIC INHIBITORS OF

MEK AND METHODS OF USE

THEREOF ARRAY BIOPHARMA INC. 19/11/2003 60/523270 US PCT/US/2004/039060 WO/2005/051301










(2011.01 )C07D 76;9:: 26/22/0//2

ושיטות MEKשל מעכבים הטרוציקליים שימוש בהם

HETEROCYCLIC INHIBITORS OF

MEK AND METHODS OF USE

THEREOF ARRAY BIOPHARMA INC. 19/11/2003 60/523270 US PCT/US/2004/039060 WO/2005/051301

(2011.01 )C07F 76;9:> 0///0/0//5

תרכובת ושיטת הכנת חומר נפץ ראשוני נטול עופרת

LEAD-FREE PRIMARY EXPLOSIVE

COMPOSITION AND METHOD OF

PREPARATION

PACIFIC SCIENTIFIC ENERGETIC

MATERIALS COMPANY 16/05/2006 60/800816 US PCT/US/2007/004846 WO/2008/048351

(2011.01 )C22B 76;9;: 23//1/0//4

שיטה להכנת מתכת ראשונית עמידה בפני חם

METHOD OF PREPARING PRIMARY

REFRACTORY METAL

H.C. STARCK INC. 22/03/2005 11/085876 US PCT/US/2006/009174 WO/2006/101850

(2011.01 )G06K 76;:5: /2//3/0//6

כלוב בעל יכולת להידוק עצמי ומקיף מכשיר רזוננס מגנטי ושיטה לכך

A SELF-FASTENING CAGE

SURROUNDING A MAGNETIC

RESONANCE DEVICE AND

METHODS THEREOF










ASPECT MAGNET TECHNOLOGIES אספקט טכנולוגיות מגנטים בע"מ

LTD. 03/11/2005 60/732654 US 23//1/0//4 22/1544/6 US

(2011.01 )C12N 76;:68 00//0/0//6

יישומים רפואיים של הפעלה של תאים 1–אנטיגן הומניים באמצעות דקטין–מציגי

THERAPEUTIC APPLICATIONS OF

ACTIVATION OF HUMAN ANTIGEN-

PRESENTING CELLS THROUGH

DECTIN-1 BAYLOR RESEARCH INSTITUTE 23/02/2007 60/891425 US PCT/US/2008/054798 WO/2008/118587

(2011.01 )C07J 76;:6; /2//6/0//4

תולדות ניטרואוקסי של גלוקוקורטיקואידים, תהליך להכנתן

והשימוש בהן להכנת תרופות

NITROOXY DERIVATIVES OF

GLUCOCORTICOIDS, PROCESS FOR

THEIR PREPARATION AND USE

THEREOF IN THE MANUFACTURE

OF MEDICAMENTS NICOX S.A. 02/09/2005 05019155.0 EP PCT/EP/2006/007746 WO/2007/025632

(2011.01 )A61J 76;:8: 06//2/0//4

PHARMA-INFORMATICS SYSTEM אינפורמטיקה–מערכת פארמה

PROTEUS BIOMEDICAL, INC 28/04/2005 60/676145 US 02//4/0//3 4//472/56 US /2//7/0//3 4//52146/ US /5//2/0//4 4//57/113 US PCT/US/2006/016370 WO/2006/116718








(2011.01 )B08B 76;::6 04/2//0//4

התקן מדידה למדידת דרגת הניקיון של מדיום

MEASURING DEVICE FOR

MEASURING THE DEGREE OF

PURITY OF A MEDIUM SIEMENS AKTIENGESELLSCHAFT 16/12/2005 05027687.2 EP PCT/EP/2006/067791 WO/2007/071478




-לחוק הפטנטים תשכ"ז 26הודעה לפי סעיף

1976

NOTICE UNDER SECTION 26 OF THE

PATENTS LAW, 5727-1967

הבקשות שפרטיהן מתפרסמים להלן קובלו לחוק הפטנטים. כל המעונין 17לפי סעיף

להתנגד למתן פטנט על פי בקשה מהבקשות , תוך שלושה חדשים המתפרסמות רשאי

מתאריך יומן זה, להגיש לרשם הפטנטים לחוק הפטנטים 30הודעת התנגדות לפי סעיף

ואילך לתקנות 57בדרך הקבועה בתקנה .1968 –הפטנטים, תשכ"ח

The applications, particulars of which are set

out below, have been accepted pursuant to

Section 17 of the Patents Law. Any person

wishing to oppose the grant of a patent on any

of the applications published here, may,

within three months from the date of this

journal, give to the Commissioner of Patents

notice under Section 30 of the Patents Law, in

the manner prescribed in regulations 57 et seq

of the Patents Regulations, 5728-1968

פרטי הבקשות במידה ויישימים מובאים לפי סדר זה:

Particulars of the applications, where

applicable, are given in the following order:

Number of application [21] [11] מספר הבקשה

Title of invention [54] שם האמצאה

Application date [22] תאריך הבקשה

מדינת –יך של בקשות החוץ מספר ותאר האגוד

[31] [32] [33] Number and date of foreign

application – convention country.

.Int.Cl [51]* *סיווג בינלאומי

Application for patent of addition [61] בקשה לפטנט מוסף

Divisional application [62] בקשת חלוקה

Applicant [71] המבקש

Inventor [72] הממציא

International Publication Number [87] מס' פרסום של בקשה הבינלאומית

Address for service [74] מען למסירת מסמכים

Abridgement of invention (in the [57] תקציר האמצאה )בשפה בה ערוך הפירוט(

language in which the specification is drawn

up)

**הערה: בקשות הפטנטים שפורסמו ביומן זה סווגו בהתאם לגרסת הסיווג הבינלאומי

שהייתה בתוקף בעת הכנת הבקשות לפרסום.

*Note:, patent applications published in this

journal were classified according to the

International Classification version that was

in force when this journal was prepared.


493931 [21[]11]

תכשיר יציב של בנזימידאזול ושיטה להכנתו

STABLE BENZIMIDAZOLE

COMPOSITION AND A METHOD

FOR PRODUCING IT

[54]

23.11.2000 [22]

Int. Cl.(2010.01) A61K 09//10, 31//4164, A61P 01//00, C07D 40/1/12 [51]

DEXCEL LTD. [71] דקסל בע"מ, חדרה

ד"ר ד. גרייזר בע"מ, 13הסדנא

רעננה2496, ת.ד.

DR. D. GREIZER LTD.,

13 HASADNA ST., P.O.B. 2496,

RAANANA 43650

[74]

A stable composition of a benzimidazole derivative, the composition comprising:

)a) a neutral core;

)b) an alkaline coating layered on said core;

)c) an active coating, comprising the benzimidazole derivative, layered over said

alkaline coating; and

)d) a single layer comprising neutralized enteric coating material having a pH

value of at least 6.5 layered directly over said active coating, said neutralized

enteric coating material being neutralized with alkaline compound prior to

applying said single layer to said active coating, with the proviso that said

enteric coating material does not include HPMCP (hydroxypropyl

methylcellulose phthalate).

[57]

__________________

145210 [21[]11]

להכנת חומר לקישור PMBC–שימוש בסלקטיבי לתאים, שיטה לגילוי אפופטוזיס

ותכשיר רוקחי לטיפול במחלה המאופיינית ע''י נוכחות אפופטוזים בתאים, רקמות או מבנים

תאיים

USE OF PMBC IN THE

PREPARATION OF AN AGENT

FOR THE SELECTIVE BINDING

OF CELLS, A METHOD FOR THE

DETECTION OF APOPTOSIS AND

A PHARMACEUTICAL

[54]






COMPOSITION FOR THE

TREATMENT OF A DISEASE

CHARACTERIZED BY THE

PRESENCE OF APOPTOSIS IN

CELLS, TISSUES OR CELLULAR

STRUCTURES

30.08.2001 [22] IL [33] 06.12.2000 [32] 140114 [31]

IL 21.02.2001 141571

Int. Cl.(2010.01) A61K 31//18, 31//195, A61P 09//00, 35//00, 37//00, C07C 31/1/37,

C12Q 01//00

[51]

APOSENSE LTD. [71] אפוסנס בע"מ, פתח תקוה

פרל כהן צדק לצר, 5, רח' שנקר 1ים -מרכז גב

הרצליה12704, ת.ד.

PEARL COHEN ZEDEK LATZER,

5 SHENKAR ST.,

P.O.B. 12704,

HERZLIYA 46733

[74]

Use of a perturbed membrane binding compound (PMBC), in the preparation of an

agent for selective binding of cells undergoing perturbation of their normal

organization of membrane, said PMBC having the formula (XI) as depicted in the

specification including pharmaceutically acceptable salts and hydrates thereof.

[57]

__________________

146479 [21[]11]

אדנווירוס רקומביננטי המכיל חומצה גרעינית E1אדנוויראלית המכילה החסרה באזור

RECOMBINANT ADENOVIRUS

COMPRISING AN ADENOVIRAL

NUCLEIC ACID COMPRISING A

DELETION IN THE E1 REGION

[54]

16.05.2000 [22] EP [33] 17.05.1999 [32] 99201545.3 [31]

Int. Cl.(2010.01) A61K 48//00, C12N 05//10, 15//34, 15//861 [51]

CRUCELL HOLLAND B.V., THE

NETHERLANDS [71]

ABRAHAM BOUT, MENZO JANS

EMCO HAVENGA, RONALD

VOGELS

[72]

WO/2000/070071 [87]

קבוצת איתן מהולל, עורכי דין ועורכי פטנטים,

10שדרות אבא אבן

EITAN MEHULAL LAW GROUP,

10 ABBA EBEN BLVD.,

P.O.B. 2081,

HERZLIYA 46120

[74]




רצליהה2081, ת.ד. A recombinant adenovirus comprising an adenoviral nucleic acid comprising a

deletion in the E1 region, said deletion rendering the recombinant adenovirus

replication defective.

[57]

בקשות חלוקה מבקשה זו

שטרם פורסמו90222215 The applications for division

from this application have

not yet been published

__________________

147349 [21[]11]

שיטה לאיפיון של מצב דלקתי בשימוש פרופילי ביטוי גן מדודים

METHOD FOR EVALUATING AN

INFLAMMATORY CONDITION

USING CALIBRATED GENE

EXPRESSION PROFILES

[54]

28.06.2000 [22] US [33] 28.06.1999 [32] 60/141542 [31]

US 07.04.2000 60/195522

Int. Cl.(2010.01) C12Q 01//68, G01N 33//50, G06F 19//00 [51]

SOURCE PRECISION MEDICINE,

INC., U.S.A. [71]

WO/2001/025473 [87]

ד"ר שלמה כהן ושות', 124אבן גבירול

תל אביב11490, ת.ד.

DR. SHLOMO COHEN & CO.,

124 IBN GABIROL ST.,

P.O.B. 11490,

TEL AVIV 62038

[74]

The invention provides a method, for evaluating a biological condition of a subject,

comprising: a. obtaining from the subject a sample having at least one of RNAs and

proteins; b. deriving from the sample a first profile data set, the first profile data set

including a plurality of members, each member being a quantitative measure of the

amount of a distinct RNA or protein constituent in a panel of constituents selected so

that measurement of the constituents enables measurement of the biological condition;

and c. producing a calibrated profile data set for the panel, wherein each member of

the calibrated profile data set is a function of a corresponding member of the first

profile data set and a corresponding member of a baseline profile data set for the panel,

the calibrated profile data set providing a measure of the biological condition of the

subject.

[57]




__________________

515218 [21[]11]

מערכת ושיטה לקביעת זמן עד ירוט


TIME-TO-INTERCEPT

DETERMINATION

[54]

12.02.2001 [22]

Int. Cl.(2010.01) F41G 07//22 [51]

RAYTHEON COMPANY, U.S.A. [71]

WO/2002/065048 [87]

סנפורד ט. קולב ושות', , מרמורק 4שער הגיא

רחובות2273, ת.ד.

SANFORD T.COLB & CO.,

P.O.B. 2273,

REHOVOT 76122

[74]

A method and system of time-to-intercept determination for a radiation source using

passively-sensed irradiance data. The invention provides a plurality of noise reduction

features to reduce the noise present in the data and improve the accuracy of the time-

to-intercept computation. The method includes reducing data noise by defining an

acceptable noise level and eliminating any excessively noisy data from the time-to-

intercept computation. The method further includes constantly updating the time-to-

intercept computation by using irradiance values that are advanced in time. Other

features of the present invention includes averaging of irradiance values over a time

interval, filtering of the irradiance data received by the method, and triggering at a

predetermined time-to-intercept. The invention also includes a time-to-intercept

system and processor implementing the above method.

[57]




__________________

152589 [21[]11]

מקליט מידע

DATA RECORDER

[54]

20.11.2001 [22] JP [33] 08.03.2001 [32] 2001-65074 [31]

Int. Cl.(2010.01) G11B 20//10, H04N 07//24 [51]

SONY CORPORATION, JAPAN [71]

WO/2002/075739 [87]

לוצאטו את לוצאטו, גן תעשייה, עומר

באר שבע5352, ת.ד.

LUZZATTO & LUZZATTO,

INDUSTRIAL PARK, OMER,

P.O.B. 5352,

BEER-SHEVA 84152

[74]

A data recorder for adequately managing the contents of data and reproduced info even

if a part of AV data is deleted. When a part of a clip is deleted and an ATC-sequence

becomes discontinuous, the value of an offset_STC_id of the first STC sequence on

the ATC sequence is so determined that the value of the stc_id (value for identifying

an STC-sequence) of each STC-sequence contained in the part of the ATC-sequence,

after the ATC discontinuous point. The invention can be applied to a technique of

recording an AV stream on an optical disc.

[57]








__________________

153456 [21[]11]

שיטה לטיפול במים המכילים ברומיד של מתכות אלקליות או ברומיד של מתכות אלקליות

עפרוריות

METHOD OF TREATING WATER

CONTAINING AN ALKALINE

EARTH METAL BROMIDE OR

ALKALI METAL BROMIDE

[54]

15.12.2002 [22] ZA [33] 14.12.2001 [32] 2001/10311 [31]

Int. Cl.(2010.01) A01N 25//22, C01B 11//20, C02F 01//50 [51]

THE GERD BORCHERS FAMILY

TRUST, SOUTH AFRICA

JAN BASTIAAN CILLIERS, SOUTH

AFRICA

MARTHA SOPHIA CILLIERS,

SOUTH AFRICA

[71]

ג'יי אמ בי, פקטור אנד קו בע"מ, רחוב המרפא, הר חוצבים

ירושלים45087, ת.ד.

JMB, FACTOR & CO. LTD.,

HAR HOTZVIM HI-TECH PARK,

P.O.B. 45087,

JERUSALEM 91450

[74]

A method of treating water containing an alkaline earth metal bromide or alkali metal

bromide, the method including the steps of: determining the bromine demand of the

water; adding sufficient hypobromous acid solution to the water to satisfy or almost

satisfy the bromine demand; and adding sufficient alkali or alkaline earth metal

hypochlorite solution to activate the alkali or alkaline earth metal bromide in the water

[57]




and to provide residual bromine in water.

__________________

154008 [21[]11]

תכשירי רוקחות המכילים אורליסטאט כמעכב ליפאז, תהליכים לייצורם, ערכות המכילות

אותם ושימושם בהכנת תרופות לטיפול ומניעת השמנת יתר

PHARMACEUTICAL


ORLISTAT AS A LIPASE

INHIBITOR, PROCESSES FOR

THEIR PREPARATION, KITS

COMPRISING THEM AND USE

THEREOF IN THE PREPARATION

OF MEDICAMENTS FOR

TREATMENT AND PREVENTION

OF OBESITY

[54]

19.07.2001 [22] EP [33] 28.07.2000 [32] 00116393.0 [31]

Int. Cl.(2010.01) A61K 45//00, 45//06 [51]

F. HOFFMANN-LA ROCHE AG,

SWITZERLAND [71]

WO/2002/009815 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

The present invention relates to pharmaceutical combinations, compositions and

methods for treating obesity. More particularly, the invention relates to a combination

or composition comprising a lipase inhibitor, preferably orlistat and a bile acid

sequestrant.

[57]




__________________

155213 [21[]11]

קטונים ושימוש בהם להכנת תכשירים רוקחיים

KETONE COMPOUNDS AND USE

THEREOF IN PREPARATION OF

PHARMACEUTICAL

COMPOSITIONS

[54]

11.10.2001 [22] US [33] 11.10.2000 [32] 60/239232 [31]

Int. Cl.(2010.01) A61K 31//336, 31//665, C07D 47/1/02 [51]

ESPERION THERAPEUTICS, INC.,

U.S.A. [71]

WO/2002/030860 [87]

ריינהולד כהן ושותפיו, א' 26רחוב הברזל

רמת החייל

REINHOLD COHN AND PARTNERS,

26A HABARZEL ST.,

RAMAT HACHAYAL 69710

[74]

The present invention relates to novel ketone compounds, compositions comprising

ketone compounds, and methods useful for treating and preventing cardiovascular

diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders

comprising administering a composition comprising a ketone compound. The

compounds, compositions, and methods of the invention are also useful for treating

and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated

[57]




receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis,

hypertension, renal disease, cancer, inflammation, and impotence. In certain

embodiments, the compounds, compositions, and methods of the invention are useful

in combination therapy with other therapeutics, such as hypocholesterolemic and

hypoglycemic agents.

__________________

155249 [21[]11]

אוכלוסיה של תאים מועשרים בתאי אב ביפוטנטים מבודדים של הכבד ושיטות לקבלתה

POPULATION OF CELLS

ENRICHED IN ISOLATED

BIPOTENT HEPATIC

PROGENITORS AND METHODS

FOR OBTAINING THE SAME

[54]

03.10.2000 [22]

Int. Cl.(2010.01) A61K 35//407, A61P 01//16, C12N 05//0735 [51]

UNIVERSITY OF NORTH

CAROLINA AT CHAPEL HILL,

U.S.A.

[71]

WO/2002/028997 [87]


רמת החייל

REINHOLD COHN AND

PARTNERS,

26A HABARZEL ST.,


[74]

A method of obtaining a mixture of cells enriched in hepatic progenitors is developed

which comprises methods yielding suspensions of a mixture of cell types, and

selecting those cells that are classical MHC class I antigen(s) negative and ICAM-1

antigen positive. The weak or dull expression of nonclassical MHC class I antigen(s)

can be used for further enrichment of hepatic progenitors. Furthermore, the

progenitors can be selected to have a level of side scatter a measure of granularity or

cytoplasmic droplets, that is higher than that in non-parenchymal cells, such as

hemopoietic cells, and lower than that in mature parenchymal cells, such as

hepatocytes. Furthermore, the progeny of the isolated progenitors can express alpha-

fetoprotein and/or albumin and/or CK19. The hepatic progenitors, so isolated, can

grow clonally, that is an entire population of progeny can be derived from one cell.

The clones of progenitors have a growth pattern in culture of piled-up aggregates or

clusters. These methods of isolating the hepatic progenitors are applicable to any

vertebrates including human. The hepatic progenitor cell population is expected to be

useful for cell therapies, for bioartificial livers, for gene therapies, for vaccine

[57]




development, and for myriad toxicological, pharmacological, and pharmaceutical

programs and investigations.

__________________

155791 [21[]11]

להכנת תכשיר רפואי CD81שימוש בחלבון CD81ושיטה לאבחון בעזרת ביטוי של

USE OF CD81 PROTEIN FOR THE

PREPARATION OF A

PHARMACEUTICAL

COMPOSITION AND METHOD OF

DIAGNOSING USING A CD81

EXPRESSION

[54]

07.11.2001 [22] US [33] 08.11.2000 [32] 60/246868 [31]

Int. Cl.(2010.01) A61K 38//17, 48//00, A61P 35//00, G01N 33//574 [51]

ALBERT EINSTEIN COLLEGE OF

MEDICINE OF YESHIVA

UNIVERSITY, U.S.A.

[71]

WO/2002/058709 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The present invention provides methods for inhibiting proliferation of astrocytes and

astrocytic tumor cells. The present invention further provides methods for treating a

condition associated with a defect in astrocyte proliferation in a subject, and methods

for treating a condition associated with astrocytic tumor cell proliferation in a subject.

Additionally, the present invention is directed to pharmaceutical compositions

comprising CD81 protein or nucleic acid and a pharmaceutically-acceptable carrier.

Finally, the present invention provides a method for determining whether a subject has

an astrocytoma, and a method for assessing the efficacy of astrocytoma therapy in a

subject.

[57]

__________________

156090 [21[]11]






שחרור מושהה של חומר פעיל ע"י שימוש במערכת הניתנת להשתלה

SUSTAINED DELIVERY OF AN

ACTIVE AGENT USING AN

IMPLANTABLE SYSTEM

[54]

15.01.1997 [22] US [33] 02.02.1996 [32] 08/595761 [31]

Int. Cl.(2010.01) A61M 31//00 [51] DIVISION FROM 125596 [62]

INTARCIA THERAPEUTICS, INC.,

U.S.A. [71]

WO/1997/027840 [87]


רמת החייל


26A HABARZEL ST.,


[74]

An implantable device for delivering an active agent to a fluid environment of use,

said device comprising an impermeable reservoir and a back-diffusion regulating

outlet in mating relationship, wherein a flow path for the active agent comprises a

pathway formed between the mating surfaces of the reservoir and the back diffusion

regulating outlet.

[57]

__________________

156377 [21[]11]

התקן לאיכון רקמה בתוך גוף של נבדק

APPARATUS FOR LOCATING A

TISSUE WITHIN A BODY OF A

SUBJECT

[54]

10.06.2003 [22] US [33] 17.06.2002 [32] 10/173197 [31]

Int. Cl.(2010.01) A61B 05//00 [51]

BIOSENSE WEBSTER INC., U.S.A. [71]

רוחני בע"מ, ד. קליגלר שירותי קניין תל אביב33111, ת.ד.

D. KLIGLER I.P. SERVICES LTD.,

P.O.B. 33111

TEL AVIV 61330

[74]

Apparatus for locating a tissue within a body of a subject includes an acoustic tag

configured to be fixed to the tissue and adapted, responsive to acoustic waves incident

thereon, to return acoustic echoes. Acoustic tranducers are placed at respective

positions so as to direct the acoustic waves into the body toward the tissue and to

receive the acoustic echoes returned from the tag responsive to the acoustic waves,

generating first signals responsive to the received echoes. Transducer position sensors

are coupled respectively to the acoustic transducers so as to generate second signals

[57]




indicative of the repective positions of the acoustic transducers in an external frame of

reference. A processing unit processes the first signals and the second signals so as to

determine coordinates of the acoustic tag in the external frame of reference.

__________________

157326 [21[]11]

תכשירי רוקחות בצורה המתאימה לשאיפה PDE IVהמכילים מלח טיאוטרופים ומעכב

באופן ברירתי בצורת אבקה לשאיפה, גז נדיף המכיל אירוסול לשאיפה ותכשיר או תרחיף של

תכשירי רוקחות אלו

PHARMACEUTICAL

COMPOSITIONS CONTAINING

TIOTROPIUM SALTS AND PDE-IV

INHIBITOR, OPTIONALLY IN

THE FORM OF INHALABLE

POWDERS, PROPELLANT-

CONTAINING INHALABLE

AEROSOLS AND INHALABLE

SOLUTIONS OR SUSPENSIONS

COMPRISING SAID

COMPOSITIONS

[54]

26.02.2002 [22] DE [33] 07.03.2001 [32] 10110772.2 [31]

Int. Cl.(2010.01) A61K 09//12, 09//72, 31//00, 31//4745, 31//505, A61P 11//00,

11//08, C07D 45/1/00, 48/7/00

[51]


PHARMA GMBH & CO. KG,

GERMANY

[71]

WO/2002/069945 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The invention relates to novel medicament compositions on the basis of

anticholinergics and PDE IV inhibitors, and to the use thereof in the therapy of

respiratory tract diseases.

[57]

__________________

157360 [21[]11]






פורמולצית פיברינוגן נוזלית עמידה לאחסון ושימושים שלה

STORAGE-STABLE, LIQUID

FIBRINOGEN FORMULATION

AND USES THEREOF

[54]

12.08.2003 [22] DE [33] 13.08.2002 [32] 10237643.3 [31]

DE 20.12.2002 10261126.2

Int. Cl.(2010.01) A61K 38//36, 38//39 [51]

CSL BEHRING GMBH, GERMANY [71]

פרל כהן צדק לצר, 5, רח' שנקר 1 ים-מרכז גב



5 SHENKAR ST.,

P.O.B. 12704,

HERZLIYA 46733

[74]

Storage-stable, liquid or viscous liquid fibrinogen formulation, characterized in that,

besides fibrinogen, divalent metal ions in a concentration of up to 100mM and a

complexing agent are present and the fibrinogen formulation is stable at storage

temperatures between 0 and 30 C for at least 1 month.

[57]

__________________

157378 [21[]11]

תהליך להכנת פוליפפטידים

PROCESS FOR PRODUCTION OF

POLYPEPTIDES

[54]

22.02.2002 [22] US [33] 09.03.2001 [32] 60/274384 [31]

Int. Cl.(2010.01) C07K 14//245, C12N 15//09, 15//12, 15//70, 15//71, C12P 21//02 [51]

GENENTECH, INC., U.S.A. [71]

WO/2002/072847 [87]


רמת החייל


26A HABARZEL ST.,


[74]

Vectors for producing polypeptides heterologous to prokaryotes are described

comprising, along with the polypeptide-encoding nucleic acid, anti-termination nucleic

acid that inhibits intragenic transcription termination with a non-lambda promoter

therefor and/or nucleic acid encoding a GreA or GreB protein and a promoter therefor.

Also described are processes for producing a heterologous polypeptide in prokaryotic

host cells utilizing such elements to improve the quality and/or quantity of

heterologous polypeptide produced.

[57]




__________________

157443 [21[]11]

תכשירים המכילים גורם כימורפואי ואנלוג של אפותילין ושימושים בהם

COMPOSITIONS COMPRISING A

CHEMOTHERAPEUTIC AGENT

AND EPOTHILONE ANALOG AND

USES THEREOF

[54]

05.03.2002 [22] US [33] 14.03.2001 [32] 60/275801 [31]

US 31.08.2001 60/316395

Int. Cl.(2010.01) A61K 31//00, 31//335, C07D 41/3/10 [51]

BRISTOL-MYERS SQUIBB

COMPANY, U.S.A. [71]

WO/2002/072085 [87]

וולף, ברגמן וגולר, ירושלים1352, ת.ד.

WOLFF, BREGMAN AND GOLLER,

P.O.B. 1352,

JERUSALEM 91013

[74]

Compositions and methods are disclosed which are useful of the treatment and

prevention of proliferative disorders.

[57]

__________________

832515 [21[]11]

התקן להערכה תיאורטית כאוטית של מצב אנושי

CHAOS-THEORETICAL HUMAN

FACTOR EVALUATION

APPARATUS

[54]

10.04.2002 [22] JP [33] 16.04.2001 [32] 2001-116408 [31]

Int. Cl.(2010.01) A61B 10//00 [51]

ELECTRONIC NAVIGATION

RESEARCH INSTITUTE, JAPAN

KAKUICHI SHIOMI, JAPAN

MITSUBISHI SPACE SOFTWARE

CO., LTD., JAPAN

[71]

WO/2002/085215 [87]







רמת החייל

REINHOLD COHN AND

PARTNERS,

26A HABARZEL ST.,


[74]

A chaos−theoretical human factor evaluation apparatus includes a Liapunov exponent

calculator (23) for chaos−theoretically analyzing a speech signal generated by

digitizing a speech uttered by a human and calculating a Liapunov exponent and a

Liapunov exponent change detector (24) for detecting a change of the Liapunov

exponent of the speech calculated by the Liapunov index calculator (23). By

calculating the load level in a cerebrum through a change of the Liapunov exponent

detected by the Liapunov exponent change detector (24), it is possible to predict and

determine a mental/physical activity.

[57]

__________________

159426 [21[]11]

3 –ציאנואידול – 5)–'4–1צורות פולימורפיות של – 5–קרבמואילבנזופורן – 2)– 4 –איל( בוטיל –

איל( פיפראזין הידרוכלוריד

POLYMORPHIC FORMS OF 1-4'-

(5-CYANOINDOL- 3-YL) BUTYL-4-

(2-CARBAMOYLBENZOFURAN- 5-

YL)PIPERAZINE

HYDROCHLORIDE

[54]

05.06.2002 [22] EP [33] 19.06.2001 [32] 01113647.0 [31]

Int. Cl.(2010.01) A61K 31//496, A61P 01//14, 09//12, 25//18, 25//22, 25//24, C07D

40/5/00, 40/5/12

[51]

MERCK PATENT GMBH,

GERMANY [71]

WO/2002/102794 [87]



10 ABBA EBEN BLVD.,

P.O.B. 2081,

[74]




10שדרות אבא אבן הרצליה2081, ת.ד.

HERZLIYA 46120

The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-

cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine, crystalline

modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-

benzofuran-5-yl)-piperazine and amorphous 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-

carbamoyl-benzofuran-5-yl)-piperazine hydrochloride which are suitable in particular

for the preparation of solid medicaments for the treatment or prevention of depressive

disorders, anxiety disorders, bipolar disorders, mania, dementia, substance-related

disorders, sexual dysfunctions, eating disorders, obesity, fibromyalgia, sleeping

disorders, psychiatric disorders, cerebral infarct, tension, for the therapy of side-effects

in the treatment of hypogonadism, secondary amenorrhea, premenstrual syndrome and

undesired puerperal lactation.

[57]

__________________

159506 [21[]11]

פירולופירימידינים כמעכבי חלבון קינאז

PYRROLOPYRIMIDINES AS

PROTEIN KINASE INHIBITORS

[54]

21.06.2002 [22] GB [33] 23.06.2001 [32] 0115393.1 [31]

US 28.06.2001 60/301678

Int. Cl.(2010.01) A61K 31//505, A61P 29//00, 35//00, C07D 48/7/04 [51]

AVENTIS PHARMACEUTICALS

INC., U.S.A. [71]

WO/2003/000695 [87]




5 SHENKAR ST.,

P.O.B. 12704,

HERZLIYA 46733

[74]

This invention is directed to compounds of the formula (I) to N-oxides, prodrugs, acid

bioisosteres, pharmaceutically acceptable salts or solvates of such compounds, or N-

oxides, prodrugs, or acid bioisosteres of such salts or solvates, to compositions

comprising such compounds, and to methods of treatment comprising administering, to

a patient in need thereof, such compounds and compositions.

[57]




__________________

160873 [21[]11]

צינור מוליך לשימוש כעדשת מחזיר אור ושיטת שימוש בו

CONDUCTIVE TUBE FOR USE AS

A REFLECTRON LENS AND

METHOD OF USE THEREOF

[54]

15.03.2004 [22] US [33] 19.03.2003 [32] 60/455801 [31]

Int. Cl.(2010.01) H01J 49//40 [51]

BURLE TECHNOLOGIES, INC.,

U.S.A. [71]



P.O.B. 1352,

JERUSALEM 91013

[74]

A reflectron lens and method are provided. The reflectron lens comprises a tube having

a continuous conductive surface along the length of the tube for providing an electric

field interior to the tube that varies in strength along the length of the tube. The tube

may comprise glass, and in particular, a glass comprising metal ions, such as lead,

which may be reduced to form the conductive surface. The method includes a step of

introducing a beam of ions into a first end of a dielectric tube having a continuous

conductive surface along the length of the tube. The method further includes a step of

applying an electric potential across the tube to create an electric field gradient that

varies in strength along the length of the tube so that the electric field deflects the ions

to cause the ions to exit the tube through the first end of the tube.

[57]




__________________

161309 [21[]11]

שיטה וקיט לגילוי גיוס חלבונים לאזור סלולרי של קולטן בתאים שלמים –האינטרא

METHOD AND KIT FOR

MONITORING RECRUITMENT

OF PROTEINS TO THE

INTRACELLULAR DOMAIN OF A

RECEPTOR IN INTACT CELLS

[54]

14.10.2002 [22] IL [33] 14.10.2001 [32] 145918 [31]

Int. Cl.(2010.01) G01N 33//53, 33//68 [51]

HARTMUT ENGELMANN,

GERMANY [71]

HARTMUT ENGELMANN [72]

WO/2003/034073 [87]

אינטרפארם מעבדות בע"מ, 18רחוב הקישון

יבנה151, ת.ד.

INTERPHARM LABORATORIES

LTD.,

18 HAKISHON ST.,

P.O.B. 151,

YAVNE 81101

[74]




The present invention relates to an immunological method and kit for monitoring

recruitment of a protein to the intracellular domain of a receptor in intact cells.

[57]

__________________

161513 [21[]11]

תכשיר רוקחי נרתיקי הכולל לידוקאין ונשא ביואדהזי ושימושיו להכנת תרופה לטיפול

בדיסריטמיה של הרחם

PHARMACEUTICAL VAGINAL

COMPOSITION COMPRISING

LIDOCAINE AND A

BIOADHESIVE CARRIER, AND

ITS USE IN THE MANUFACTURE

OF A MEDICAMENT FOR THE

TREATMENT OF UTERINE

DYSRHYTHMIA

[54]

28.10.2002 [22] US [33] 29.10.2001 [32] 60/330684 [31]

US 24.10.2002 10/278912

Int. Cl.(2010.01) A61K 09//22, 47//00, 47//12, 47//32, A61P 15//02 [51]

COLUMBIA LABORATORIES

(BERMUDA) LIMITED, BERMUDA [71]

WO/2003/037381 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

The invention relates to a pharmaceutical composition for relieving pelvic pain or

infertility associated with uterine dysrhythmia. The composition includes a locally-

administered anti-dysrhythmic treating agent and a bioadhesive extended-release

carrier. The composition may be delivered in an extended release formulation that

includes a bioadhesive, water-swellable , water-insoluble, cross-linked polycarboxylic

acid polymer, such as polycarbophil. The treating agent may be a local anesthetic, such

[57]




as lidocaine. The invention also relates to a method of treating or preventing pelvic

pain, or treating or improving infertility, by inserting a mixture of an anti-dysrhythmic

treating agent and a bioadhesive carrier into the vagina of the patient to be treated.





__________________

161938 [21[]11]

מערכת הכוללת ספר אליקטרני פלוס תוספת שניתן להתחבר אליו

SYSTEM COMPRISING AN

ELECTRONIC BOOK AND A

PROPRIETARY APPENDAGE

[54]

12.05.2004 [22]

Int. Cl.(2010.01) G06F 03//033, 03//14, 15//02, 17//30 [51]

LIGHT BOOK LTD. [71] לייט בוק בע"מ, צפת





P.O.B. 45087,

JERUSALEM 91450

[74]

A system comprising an light book (10) and a proprietary appendage couplable to said

light book; said light book comprising a visual display screen (12), a data reader,

navigational tools and a first section of a unique identification code for identifying

said light book. Said proprietary appendage comprising a memory (46) and a second

section of unique identification code; such that data in the memory of said proprietary

appendage has a second section of unique identification code that can only be

accessed when said proprietary appendage is connected to said light book having said

first section of unique identification code.

[57]




__________________

163231 [21[]11]

מכלול נרתיק בעל בטיחות גבוהה ומערכת סגירה

HIGH SECURITY HOLSTER

ASSEMBLY AND ENCLOSURE

SYSTEM

[54]

29.01.2003 [22] US [33] 29.01.2002 [32] 60/352909 [31]

US 29.01.2002 60/352910

Int. Cl.(2010.01) F41C 33//02 [51]

JOHN N. RASSIAS, U.S.A. [71]

WO/2003/064957 [87]


רמת החייל


26A HABARZEL ST.,


[74]

A holster assembly for a firearm includes a shroud (20, 92, 168) with a muzzle

receiving space (31), a firearm holding member (100, 174, 246) and a bias activating

assembly mounted in the shroud (20, 92, 168) for biasing the firearm into a stowed

position against the holding member (100, 174, 246). A hood enclosure (166) is

movable between open and closed positions. The hood enclosure (166) includes a pair

of guide slots (188) within the shroud (20, 92, 168) , a pivot pin (182) and a guide pin

(186). The hood enclosure (166) may include an illumination device (238) mounted to

the firearm, a hip mount platform (256) to mount a hip mount assembly (34), or a

secondary stowage mount (270) to attach a magazine carrier (278), expandable baton

carrier (266), etc.. The shroud (20, 92, 168) includes a detent (178) that receives a

locking safety lever (146) of the firearm. An L-shaped slot (138, 106, 162) receives a

projection from a handle portion (132), a take down button (88), a safety lever (158),

or another side extending projection of the firearm

[57]




__________________

163312 [21[]11]

לייצור –1CPTשימוש בגורם המעורר פעילות תרופה המטפלת בהשמנת יתר כאמצעי

להורדת משקל

USE OF AN AGENT THAT

STIMULATES CPT-1 ACTIVITY FOR

THE MANUFACTURE OF A

MEDICAMENT FOR TREATING

OBESITY

[54]

10.02.2003 [22] US [33] 08.02.2002 [32] 60/354480 [31]

Int. Cl.(2010.01) A61K 31//195, 31//198, 31//34, 31//381, 45//00 [51]

THE JOHNS HOPKINS UNIVERSITY

SCHOOL OF MEDICINE, U.S.A. [71]

WO/2003/066043 [87]

ריינהולד כהן ושותפיו, א' 26הברזל רחוב

רמת החייל


26A HABARZEL ST.,


[74]

This invention provides methods and compositions for inducing weight loss and

maintaining optimum weight comprising administering an agent that stimulates

carnitine palmitoyl transferase - 1 (CPT-1) activity to the patient in need, including

human patients. These methods do not require inhibition of fatty acid synthesis. In

particular, this invention provides methods for development of therapeutics that

selectively enhance fatty acid oxidation, increase energy production, and reduce

adiposity while preserving lean mass, through the pharmacological stimulation of CPT-

1 activity. In a preferred mode, the agent is administered in an amount sufficient to

increase fatty acid oxidation. In another preferred mode, the agent is administered in an

amount sufficient to antagonize malonyl CoA inhibition of CPT-1. In yet another

preferred mode, the agent is administered in an amount sufficient to increase malonyl

CoA level.

[57]




__________________

163563 [21[]11]

נוגדנים נגד אמילואיד ביתא והשימוש בהם ברפואה

ANTI-AMYLOID BETA

ANTIBODIES AND THEIR USE IN

MEDICINE

[54]

20.02.2003 [22] EP [33] 20.02.2002 [32] 02003844.4 [31]

Int. Cl.(2010.01) A61K 39//395, C07K 14//47, 16//18, G01N 33//68 [51]


SWITZERLAND

MORPHOSYS AG, GERMANY

[71]

WO/2003/070760 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The present invention relates to antibody molecules capable of specifically recognizing

two regions of the R-A4 peptide, wherein the first region comprises the amino acid

sequence AEFRHDSGY as shown in SEQ ID NO: 1 or a fragment thereof and wherein

the second region comprises the amino acid sequence VHHQKLVFFAEDVG as

shown in SEQ ID NO: 2 or a fragment thereof. Furthermore, nucleic acid molecules

encoding the inventive antibody molecules and vectors and hosts comprising said

nucleic acid molecules are disclosed. In addition, the present invention provides for

compositions, preferably pharmaceutical or diagnostic compositions, comprising the

compounds of the invention as well as for specific uses of the antibody molecules,

nucleic acid molecules, vectors or hosts of the invention.

[57]

__________________

163609 [21[]11]

שיטה לקבלת תמונת שמיים של שדה קרב

METHOD FOR OBTAINING A

SKY VIEW OF A BATTLE SITE

[54]






19.08.2004 [22]

Int. Cl.(2010.01) F41G 07//00 [51]

ISRAEL AEROSPACE התעשייה האוירית לישראל בע"מ, לוד

INDUSTRIES LTD. [71]

ELI SHUKRUN [72] אלי שוקרון

כהן ושותפיו, ריינהולד א' 26רחוב הברזל

רמת החייל

REINHOLD COHN AND

PARTNERS,

26A HABARZEL ST.,


[74]

A method for obtaining a sky view of an event site, comprising: (a) launching an

interceptor missile (2) toward at least one detect threat (3); and (b) the interceptor

missile tracking the at least one detected threat, the interceptor missile comprising at

least one detachable vehicle (7) comprising at least one guidable local sensor (8)

configured to sense the event and to communicate the sensed data, and wherein the

tracking uses at least one remote sensor for achieving a kill of the threat at a

designated kill site (4), where the event site is different than the kill site.

[57]

__________________

163626 [21[]11]

נוגדים מאונשים המזהים פפטיד ביטא עמילאויד

HUMANIZED ANTIBODIES THAT

RECOGNIZE BETA AMYLOID

PEPTIDE

[54]

12.03.2003 [22] US [33] 12.03.2002 [32] 60/363751 [31]

Int. Cl.(2010.01) A61K 39//395, A61P 25//28, C07K 16//18, 16//46 [51]

WYETH LLC, U.S.A.

ELAN PHARMA INTERNATIONAL

LTD., IRELAND

[71]

WO/2003/077858 [87]



P.O.B. 1352,

JERUSALEM 91013

[74]




The invention provides improved agents and methods for treatment of diseases

associated with amyloid deposits of Abeta in the brain of a patient. Preferred agents

include humanized antibodies.

[57]

__________________

163763 [21[]11]

שימוש בנגזרת פפטיד להכנת תרופה לטיפול במלנומה ובהמובלסטוזיס

USE OF A PEPTIDE DERIVATIVE

IN THE MANUFACTURE OF A

MEDICAMENT FOR TREATING

MELANOMA AND

HEMOBLASTOSIS

[54]

28.02.2003 [22] RU [33] 28.02.2002 [32] 2002105392 [31]

Int. Cl.(2010.01) A61K 31//16, 31//195, 31//4164, 31//417, 31//4178, 38//05, C07K

05//00, 05//037, 05//06

[51]

OBSCHESTVO S OGRANICHENNOI

OTVETSTVENNOSTIYU

"PHARMENTERPRISES", RUSSIA

[71]

WO/2003/072124 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The invention relates to the induction method for cell differentiation which consists in

injecting peptide derivatives having the following general formula (I): and used as a

differentiation-inducing factor. Said peptide derivatives are used for curing oncological

diseases, in particular for stabilising melanoma growth, increasing the efficiency of

melanoma immunotherapy and reducing haematological toxicity of chemotherapy. The

utilisation of said peptide derivatives is also disclosed.

[57]


שטרם פורסמו90/74315 The applications for division






__________________

164003 [21[]11]

תולדות סולפונילאמיניות, תכשירים רוקחיים המכילים אותן, תהליכים להכנתן ושימושים

בהן להכנת תרופות לעיכוב היסטון דיאצטילאז

SULFONYLAMINO-DERIVATIVES,

COMPOSITIONS THEREOF,

PROCESS OF PREPARATION AND

USES FOR THE MANUFACTURE OF

MEDICAMENTS FOR INHIBITING

HISTONE DEACETYLASE

[54]

11.03.2003 [22] US [33] 13.03.2002 [32] 60/363799 [31]

WO 18.12.2002 PCT/EP02/14481

Int. Cl.(2010.01) A61K 31//4545, A61P 35//00, C07D 20/7/09, 20/7/14, 21/1/28,

21/1/58, 22/3/04, 22/3/12, 22/5/02, 40/1/04, 40/3/04, 40/3/14, 40/5/12, 40/9/12,

40/9/14, 41/3/14, 41/7/12, 47/1/04, 48/7/04, 48/7/08, 49/5/04, 51/3/04

[51]

JANSSEN PHARMACEUTICA, N.V.,

BELGIUM [71]

WO/2003/076401 [87]


רמת החייל


26A HABARZEL ST.,


[74]

This invention comprises the novel compounds of formula (I) wherein n, m, t, R1, R

2,

R3, R

4, R

5, L, Q, X, Y, Z and have defined meanings, having histone deacetylase

inhibiting enzymatic activity; their preparation, compositions containing them and their

use as a medicine.

[57]

__________________

164577 [21[]11]

תקשורת במערכת מובזרת

COMMUNICATION IN A

DISTRIBUTED SYSTEM

[54]






14.10.2004 [22]

Int. Cl.(2010.01) H04L 12//66, 29//06, H04M 07//00 [51]

TADIRAN TELECOM LTD. [71] תדיראן טלקום בע"מ, פתח תקוה

אי. סי. איי. טלקום בע"מ, 30רחוב הסיבים

פתח תקוה

ECI TELECOM LTD.,

30 HASIVIM ST.,

PETACH TIKVA 49517

[74]

A method for conducting a real-time, voice-over IP media type of communication

session between at least two peer users, each associated with a platform comprised in

a distributed communication network, wherein the method comprises: at a platform

comprised in said distributed communication network, creating a data object

associated with a specific user; iynaoroa v ilayvlolr ni ytilorvlonai ni ivor

rvlv na trl ln tvro nloty ni lot nloty ilvlinyci viinrovltr with said

distributed communication network so that that each of said plurality of replications

resides at a different platform associated with the distributed communication network;

and providing a notification at all other platforms associated with said distributed

communication network, indicating the creation or modification of said data object.

[57]

__________________

164664 [21[]11]

שימוש ברצפים פולינוקלאוטידים לייצור תרופה להמרצת תגובות חיסוניות

USE OF POLYNUCLEOTIDE

SEQUENCES IN THE

MANUFACTURE OF A

MEDICAMENT FOR

STIMULATING AN IMMUNE

RESPONSE

[54]




22.04.2003 [22] US [33] 22.04.2002 [32] 60/374,540 [31]

Int. Cl.(2010.01) A61K 31//70, A61P 35//00, 37//00, C12N 15//117 [51]

BIONICHE LIFE SCIENCES INC.,

CANADA [71]

WO/2003/089642 [87]

איתן, פרל, לצר וכהן צדק, 7רחוב שנקר


EITAN, PEARL, LATZER AND

COHEN ZEDEK,

P.O.B. 12688,

HERZLIYA 46733

[74]

The present invention relates to 3'-OH, 5'-OH polynucleotide sequence compositions

and methods for activating an immune response in an individual, and more preferably,

for activating an antigen presenting cells in the individual. In one embodiment, the

antigen presenting cell is a dendritic cell. The present invention also includes

compositions and methods for activating dendritic cells in vitro. These dendritic cells

may then be administered to an individual. Preferred 3'-OH, 5'-OH polynucleotide

sequences comprise six bases wherein at least 50% of the bases are guanine and the 5'

base is guanine. The compositions may comprise a phosphodiester or phosphorothioate

backbone.

[57]

__________________

165436 [21[]11]

– 10–טריכלורואצטיל –ביס – 10, 7 IIIדיאצטילבאקאטין

7, 10-BIS-TRICHLOROACETYL-

10 DEACTYLBACCATIN III

[54]

23.02.2000 [22]

Int. Cl.(2010.01) C07D 30/5/14 [51]

INDENA S.P.A., ITALY [71]

WO/2000/052003 [87]


החיילרמת

REINHOLD COHN AND

PARTNERS,

26A HABARZEL ST.,


[74]

A compound of the formula

[57]




__________________

191656 [21[]11]

שכבתי עבור גלאי טומוגרפיה –מחזיר אור רב ממוחשבת

MULTI-LAYER REFLECTOR

FOR CT DETECTOR

[54]

07.12.2004 [22]

Int. Cl.(2010.01) A61B 06//03, G01T 01//24 [51]

GE MEDICAL SYSTEMS GLOBAL

TECHNOLOGY COMPANY, LLC,

U.S.A.

[71]

ושות',זליגסון גבריאלי 31רח' יבנה


SELIGSOHN GABRIELI & CO.,

31 YAVNE ST.,

P.O.B. 1426,

TEL AVIV 61013

[74]

A CT detector comprising: a scintillator array having a plurality of scintillators; a

reflector interstitially disposed between at least two adjacent scintillators, the reflector

including a light absorption element disposed between a pair of reflective elements;

and a reflective layer coated to a top face of the scintillator array, wherein the light

absorption element extends in length to an upper surface of the reflective layer.

[57]

__________________

166241 [21[]11]

פירימידין דיאמין לשימוש בטיפול –4,2תרכובות של מחלות אוטואימוניות

2,4-PYRIMIDINEDIAMINE

COMPOUNDS FOR USE IN THE

TREATMENT OF AUTOIMMUNE

DISEASES

[54]

29.07.2003 [22] US [33] 29.07.2002 [32] 60/399673 [31]

US 31.01.2003 60/443949






US 06.04.2003 60/452339

US 29.07.2003 10/631029

Int. Cl.(2010.01) A61K 31//506, 31//519 [51]

RIGEL PHARMACEUTICALS, INC.,

U.S.A. [71]

WO/2004/014382 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The present invention provides methods of treating or preventing autoimmune diseases

with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or

ameliorating symptoms associated with such diseases. Specific examples of

autoimmune diseases that can be treated or prevented with the compounds include

rheumatoid arthritis and/or its associated symptoms, systematic lups erythematosis

and/or its associated symptoms and multiple sclerosis and/or its associated symptoms.

[57]

בקשות חלוקה מבקשה זו שטרם פורסמו9

0224/55 The applications for division



__________________

649416 [21[]11]

ציקלואלקנילאמינים שעברו –הטרואריל מצומדאצילציה, ושימוש שלהם לייצור תכשירי

רוקחות

ACYLATED, HETEROARYL-

CONDENSED

CYCLOALKENYLAMINES AND

THEIR USE FOR THE

MANUFACTURE OF

PHARMACEUTICALS

[54]

24.07.2003 [22] EP [33] 07.08.2002 [32] 02017586.5 [31]

Int. Cl.(2010.01) A61K 31//381, 31//428, 31//435, 31//495, A61P 03//10, 09//00,

09//10, 25//00, C07D 20/9/12, 22/1/18, 23/7/26, 23/9/70, 24/1/36, 27/5/04, 27/7/60,

33/3/50, 33/3/78, 40/1/12, 40/5/12, 40/9/14, 41/3/12, 41/3/14, 41/7/12

[51]





GMBH, GERMANY [71]

WO/2004/014372 [87]

איתן, פרל, לצר וכהן צדק, 7רחוב שנקר


EITAN, PEARL, LATZER AND

COHEN ZEDEK,

P.O.B. 12688,

HERZLIYA 46733

[74]

The present invention relates to acylated, heteroaryl-condensed cycloalkenylamines of

the formula I, (I) in which A, R1, R

2, R

3, R

4, R

5 and n have the meanings indicated in

the claims. The compounds of formula I are valuable pharmacologically active

compounds which are useful in the treatment of various disease states including

cardiovascular disorders such as atherosclerosis, thrombosis, coronary artery disease,

hypertension and cardiac insufficiency. They upregulate the expression of the enzyme

endothelial nitric oxide (NO) synthase and can be applied in conditions in which an

increased expression of said enzyme or an increased NO level or the normalization of a

decreased NO level is desired. The invention furthermore relates to processes for the

preparation of compounds of the formula I, their use, in particular as active ingredients

in pharmaceuticals, and pharmaceutical preparations comprising them.

[57]

__________________

166508 [21[]11]

מערכת להספקת תרופה

DRUG DELIVERY SYSTEM

[54]

18.07.2003 [22] GB [33] 05.08.2002 [32] 0218126.1 [31]

Int. Cl.(2010.01) A61M 05//20 [51]

GLIDE PHARMACEUTICAL

TECHNOLOGIES LIMITED, UNITED

KINGDOM

[71]

WO/2004/014468 [87]

ריינהולד כהן ושותפיו, א' 26ב הברזל רחו

רמת החייל


26A HABARZEL ST.,


[74]

A drug delivery system is disclosed which may be a throwaway or reusable device for

delivery at least one drug to a patient. Also described is a method for administering a

[57]




drug using said device and a packaged drug for use with said device. The drug delivery

device (10) comprises a housing (12), a means (14) for generating a force capable of

pushing a drug (16) from a packaging (18) into a human or animal body, a means (20)

for transmitting said force to push the drug (16) from the packaging (18) into the

human and animal body, and a means (38, 42b) for triggering the device. Where the

device is a single use drug delivery (10) a packaged drug (100) forms an integral part

of the device. The packaged drug (100) comprises packaging (18) containing a drug

(16), having a housing (18a, 18b) wit a channel (106) running there through and in

which is disposed a drive pin or other element (108), a skin piercing means (110, 112),

and the drug (16), said housing (18a, 18b) further comprising a region (102) allowing

the packaged drug (100) to be slidably mounted to the drug delivery device (10) and an

end (104) adapted to engage and tension the skin.

__________________

166584 [21[]11]

–4)–2–מתיל–1מטרימי תרופות של –בנזאימידזול –אמידינופנילאמינומתיל(

– N–2)–חומצה קרבוקסלית–איל–5 – N – 2 –פירידיל

, אמיד –הידרוקסיקרבונילאתיל(תכשירים רפואיים המכילים אותם , ושימושם בהכנת תרופות ותהליכים

להכנתם

PRODRUGS OF 1-METHYL-2(4-

AMIDINOPHENYLAMINOMETHYL)-

BENZIMIDAZOL-5-YL- CARBOXYLIC

ACID -(N-2-PYRIDYL-N-2-

HYDROXYCARBONYLETHYL)-AMIDE,


CONTAINING THEM , USE THEREOF IN

PREPARATION OF PHARMACEUTICAL

COMPOSITIONS AND PROCESSES TO

PREPARE THEM

[54]

28.07.2003 [22]




DE [33] 02.08.2002 [32] 10235639.4 [31]

Int. Cl.(2010.01) A61K 31//4439, A61P 07//02, C07D 40/1/12 [51]


INTERNATIONAL GMBH, GERMANY [71]

WO/2004/001489 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The invention relates to novel compounds of general formula (1) wherein R' and R are

defined as in claim 1, the tautomers and the salts thereof, especially the salts thereof

which are physiologically compatible with inorganic or organic acids or bases,

exhibiting valuable properties, especially a thrombin inhibiting effect.

[57]

__________________

166905 [21[]11]

שיטה לשינוי צבע של גביש יהלום, גבישי יהלום המתקבלים בשיטה האמורה ושימושים בהם

METHOD FOR ALTERING THE

COLOUR OF A SINGLE CRYSTAL

DIAMOND, CRYSTAL DIAMONDS

OBTAINED THEREBY AND USES

THEREOF

[54]

05.09.2003 [22] GB [33] 06.09.2002 [32] 0220772.8 [31]

GB 21.02.2003 0304029.2

Int. Cl.(2010.01) C30B 29//04, 33//00 [51]

ELEMENT SIX LIMITED, UNITED

KINGDOM [71]

WO/2004/022821 [87]


רמת החייל


26A HABARZEL ST.,


[74]

A method of producing a single crystal CVD diamond of a desired colour which

includes the steps of providing single crystal CVD diamond which is coloured and heat

treating the diamond under conditions suitable to produce the desired colour. Colours

which may be produced are, for example, in the pink-green range.

[57]




__________________

166911 [21[]11]

שיטה להפעלת מכונת מכירה אוטומטית ומערכת מכירה

METHOD FOR OPERATING A

VENDING MACHINE AND

VENDING SYSTEM

[54]

07.08.2003 [22] DE [33] 16.08.2002 [32] 10238341.3 [31]

Int. Cl.(2010.01) A47G 29//12, G07F 09//10, 11//62 [51]

DEUTSCHE POST AG, GERMANY [71]

WO/2004/019289 [87]




10 ABBA EBEN BLVD.,

P.O.B. 2081,

HERZLIYA 46120

[74]

The invention relates to a method for operating a vending machine, whereby goods can

be arranged in storage compartments and can be subsequently removed therefrom. The

inventive method is characterised in that offer-related data is captured in a central data

processing unit, whereby matching offers are associated with identical offer

identification codes such that offer identification codes are transmitted to a plurality of

electronic vending machines, and storage compartments which are provided for the

distribution of goods are stocked with goods, and offer identification codes associated

with the goods are captured. The invention also relates to a vending system comprising

a plurality of vending machines, in addition to individual vending machines for

carrying out said method.

[57]




__________________

167142 [21[]11]

כלי נשק ידני קר כגון אגרופן

HAND HELD COLD WEAPON

SUCH AS A KNUCKLEDUSTER

[54]

28.02.2005 [22]

Int. Cl.(2010.01) F41B 15//08 [51]

אמנון שילוני, שהם אמנון מאור, מודיעין

AMNON SHILONI

AMNON MAOR [71]

בלום, גדור ושות', מגדל הורד 23, קומה 53דרך השלום

גבעתיים

BLUM, GADOR & CO.,

53 HASHALOM RD.,

GIVATAYIM 53454

[74]

A weapon (10) comprising: a hand-grip portion (12), an independent extension (14)

from each end of said hand-grip portion having a hand-engaging extension configured

to extend partially around a hand of a user so as to extend around and protect a

pointer, a ring finger an pinky of a user, thus partially surrounding the hand and

retaining the weapon on the hand when the fingers do not grip the weapon; at least one

portion of at least one of said independent extensions being shaped to create painful

pressure when pressed against an adversary when used as a hand-held weapon; and at

least one additional extension (18) extending from said hand-grip portion in a

direction opposite from said independent extensions, said additional extension being

shaped to create painful pressure when pressed against an adversary.

[57]

__________________

167400 [21[]11]

שיטה, מכשיר ומערכת לאפיון שינה

METHOD, APPARATUS AND

SYSTEM FOR CHARACTERIZING

SLEEP

[54]

18.09.2003 [22] US [33] 19.09.2002 [32] 60/411829 [31]






US 10.01.2003 60/439029

Int. Cl.(2010.01) A61B 05//04 [51]

רמות ליד אוניברסיטת תל אביב בע"מ, ביבא-תל

RAMOT AT TEL AVIV UNIVERSITY

LTD. [71]

סולנז' אקסלרוד, ארמנדה ליה בהרב, צביקה שנער

SOLANGE AKSELROD, ARMANDA

LIA BAHARAV, ZVIKA SHINAR

[72]

WO/2004/026133 [87]

( בע"מ,1995ג'י.אי.ארליך ) 11,רחוב מנחם בגין 15מגדל איילון, קומה

רמת גן

G.E. EHRLICH (1995) LTD.,

AYALON TOWER, 15TH FLOOR,

11 MENACHEM BEGIN ST.,

RAMAT GAN 52521

[74]

A method of determining a Rapid-Eye-Movement (REM) sleep and a Non-REM

(NREM) sleep from signals of electrical activity recorded from the chest of a sleeping

subject, the signals being measured over a plurality of epochs, the method comprising:

extracting a series of cardiac R-R intervals from the signals; constructing a Poincare

plot of said series of cardiac R-R intervals; calculating a plurality of moments of

inertia with respect to a predetermined line along said Poincare plot, each of said

plurality of moments of inertia being calculated within a predetermined time-window;

and using said plurality of moments of inertia to determine REM sleep and NREM

sleep of the sleeping subject.

[57]





__________________

167410 [21[]11]

בדיקות העברת אנרגיית תהודת פלורצנטיות (FRET מבוססות )– תא לרעלנים של

קלוסטרידיום, ותאים לשימוש בהן

CELL-BASED FLUORESCENCE

RESONANCE ENERGY

TRANSFER (FRET) ASSAYS FOR

CLOSTRIDIAL TOXINS AND

CELLS FOR USE THEREIN

[54]

04.09.2003 [22] US [33] 27.09.2002 [32] 10/261161 [31]

Int. Cl.(2010.01) C12Q 01//00, G01N 33//52, 33//553 [51]

ALLERGAN, INC., U.S.A. [71]

WO/2004/029576 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

The present invention provides a method of determining clostridial toxin activity by (a)

contacting with a sample a cell containing a clostridial toxin substrate that includes a

[57]




donor fluorophore; an acceptor having an absorbance spectrum overlapping the

emission spectrum of the donor fluorophore; and a clostridial toxin recognition

sequence containing a cleavage site that intervenes between the donor fluorophore and

the acceptor, where resonance energy transfer is exhibited between the donor

fluorophore and the acceptor under the appropriate conditions; (b) exciting the donor

fluorophore; and (c) determining resonance energy transfer of the contacted cell

relative to a control cell, where a difference in resonance energy transfer of the

contacted cell as compared to the control cell is indicative of clostridial toxin activity.

__________________

167629 [21[]11]

חיים–מערכת לאיסוף ואיחסון מידע ונתוני מדעי

SYSTEM FOR COLLECTING AND

STORING LIFE SCIENCE

INFORMATION AND DATA

[54]

29.09.2003 [22] US [33] 30.09.2002 [32] 60/414637 [31]

AM 20.08.2003 10/644582

Int. Cl.(2010.01) G01N 33//48, G05B 19//42, G06F 19//00 [51]

GENSTRUCT, INC., U.S.A. [71]

WO/2004/031765 [87]

בורוכוב קורח ושות', מגדל כלל עתידים

אביב-תל58100, ת.ד.

BOROCHOV, KORAKH & CO.,

15TH FLOOR, ATIDIM TOWER,

KIRYAT ATIDIM,

P.O.B. 58100,

TEL AVIV 61580

[74]

A computer system for storing life science information in a database, the computer

system comprising: a processor; an electronic database storage module for storing in

the database a library of machine-readable symbolic representations into which life

science knowledge is adapted to be encoded according to a life sciences ontology, each

machine-readable symbolic representation comprising: at least two unspecified object

identifiers; a relationship connector, wherein the relationship connector relates two of

the at least two object identifiers to each other based on a casual relationship between

the object identifiers; and constraint information that defines which connections among

the object identifiers are permitted so that life sciences knowledge encoded into the

machine-readable symbolic representation is semantically rigorous and based on the

life sciences ontology; and a graphical user interface for managing addition of new life

[57]




sciences data to a database, the graphical user interface comprising: a display screen

that receives an input selecting one of the machine-readable symbolic representations

as a template to represent the new data based at least in part on the life science

ontology; the graphical user interface restricting input of any data element that does

not conform to the constraint information associated with the selected machine-

readable symbolic representation such that the semantically rigorous relationships for

the life sciences ontology are maintained; the graphical user interface receiving input

of at least one data element that conforms to the constraint information to instantiate

the machine-readable symbolic representation.

__________________

167774 [21[]11]

שיטה להורדה של הנצה ויראלית מתאי יונקים שהודבקו ע"י וירוס מעטפת, נוגדן המשמש

בשיטה זו ושימושים בו

METHOD FOR REDUCING VIRAL

BUDDING FROM A MAMMALIAN

CELL INFECTED BY AN

ENVELOPED VIRUS, AN

ANTIBODY USING THE METHOD

AND USES THEREOF

[54]

01.10.2003 [22] US [33] 01.10.2002 [32] 60/415299 [31]

Int. Cl.(2010.01) C07K 16//18, 16//32 [51]

FUNCTIONAL GENETICS, INC.,

U.S.A. [71]

WO/2004/031209 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The present invention provides methods of using antibodies that bind a TSG101

protein to inhibit or reduce viral production. The invention also provides methods of

using the TSG101 antibodies for the treatment of viral infections, including HIV

infection. The invention further provides methods of detecting viral infected cells

using TSG101 antibodies.

[57]




__________________

167782 [21][11]

אנטנה עבור מערכת הדמיה תוך גופית

ANTENNA FOR IN-VIVO

IMAGING SYSTEM

[54]

31.03.2005 [22]

Int. Cl.(2010.01) A61B 01//06, 05//05 [51]

GIVEN IMAGING LTD. [71] גיוון אימג'ינג בע"מ, יקנעם


ליההרצ12704, ת.ד.


5 SHENKAR ST.,

P.O.B. 12704,

HERZLIYA 46733

[74]

An in-vivo imaging device comprising: an antenna folded to form a three-dimensional

antenna; and a support, said support comprising at least one flexible portion

comprising at least one layer, said at least one flexible portion interconnecting two

rigid portions having at least one layer; wherein said antenna is embedded within said

at least one flexible portion of said support and within said two rigid portions of said

support, and wherein a transmitter is disposed on one of said rigid portions.

[57]

__________________

168121 [21[]11]

תרופה לשלפוחית שתן פעילה ביתר המכילה תולדת אניליד של חומצה אצטית כמרכיב הפעיל

REMEDY FOR OVERACTIVE

BLADDER COMPRISING ACETIC

ACID ANILIDE DERIVATIVE AS

THE ACTIVE INGREDIENT

[54]

04.11.2003 [22] JP [33] 07.11.2002 [32] 2002-323792 [31]

Int. Cl.(2010.01) C07D 27/7/00 [51]

ASTELLAS PHARMA INC., JAPAN [71]

WO/2004/041276 [87]


רמת החייל

REINHOLD COHN AND

PARTNERS,

26A HABARZEL ST.,


[74]

(R)-2-(2-aminothiazol-4-yl)-4’-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid

anilide or its salt shows a potent bladder relaxation effect in “isolated rat bladder

smooth muscle relaxation test”, dose-dependently lowers the contraction frequency of

rhythmic bladder contractions in “rat rhythmic bladder contraction measurement test”

[57]






and, moreover, prolongs the urination intervals in “urination function measurement

test on cyclophosphamide-induced overactive bladder model rat”. Owing to these

effects, the above compound is useful as a remedy for overactive bladder.

__________________

168298 [21[]11]

מתמר תקשורת לטלפון נייד, מערכת תקשורת ומערכת הפעלה למתמר תקשורת

MOBILE TELEPHONE GATEWAY

APPARATUS, COMMUNICATION

SYSTEM AND GATEWAY

OPERATING SYSTEM

[54]

01.05.2005 [22] WO [33] 02.11.2003 [32] PCT/IL03/00906 [31]

Int. Cl.(2010.01) H04W 88//06, 92//06 [51]

YOSSY SELA [71] יוסי סלע, ירושלים

יוסי סלע, 39ששת הימים

ירושלים

YOSSY SELA,

39 SHESHET HAYAMIM ST.,

JERUSALEM 97804

[74]

A mobile phone gateway apparatus for providing wireless communication capabilities

through at least second communication network in accordance with at least second

communication protocol, to a mobile phone operative on at least first communication

network in accordance with at least first communication protocol, said mobile phone

gateway comprising: means for protocol conversion between at least said first protocol

and said second protocol; means for data/signaling communication between said

mobile phone gateway and said mobile phone through an electrical signaling

transmission medium; means for controlling and wrapping SIM (subscriber

identification module) functionalities, said SIM functionalities provided to said mobile

phone and to said mobile phone gateway by one or more SIM card logics, said SIM

card logics being the same or different.

[57]

__________________

321683 [21[]11]

רעפי גג קרמים המיוצרים מחמר עתיר סידן ממשית עם מלאן גרניט וכן מלאנים אבקתיים

אחרים ותהליך ליצורם

CERAMIC ROOF TILES FROM

MAMSHIT CALCAREOUS CLAY

AND GRANITE AND OTHER

POWDERED FILLERS AND

[54]






PROCESS FOR THEIR

MANUFACTURE

02.05.2005 [22]

Int. Cl.(2010.01) C04B 14//04, 14//10, 14//20, 35//00, 35//14 [51]

HASSIN ESH INDUSTRIES LTD. [71] חסין אש תעשיות בע"מ, באר שבע

YOSEF GAL, RON BUCHMAN [72] יוסף גל, רון בוכמן

חסין אש תעשיות בע"מ, 36דרך חברון ת.ד.

באר שבע

HASSIN ESH INDUSTRIES LTD.,

P.O.B. 36 DERECH HEVRON

BEER-SHEVA

[74]

Ceramic roof tiles of red -brown color with shining golden Mica dots on their surface

manufactured by dry mixing of powdered Soft Negev Mamshit clay No.2 with

powdered Granite Eilat stone filler No.1(as described in the specification), sintered at

the temperature range from 760ºC to 950ºC and characterized by the fact that they

contain the crystallographic Gehlenite, Augite, Anorthite, Albite and orthoclase

phases, the said Gehlenite being evidenced by the X-ray reflection peak at d value of

2.859 Ångstrom, Orthoclase is evidenced by reflection peaks at d value of 4.05, 3.28,

2.23 Ångstrom, and a strong broad reflection peak being of

Anorthite+Albite+orthoclase, centered at about d value of 3.21 Ångstrom.

[57]

__________________

168355 [21[]11]

פטמה מלאכותית

ARTIFICIAL NIPPLE

[54]

05.11.2003 [22] US [33] 08.11.2002 [32] 60/424954 [31]

US 29.10.2003 10/696910

Int. Cl.(2010.01) A61J 11//00 [51]

MEDELA HOLDING AG,

SWITZERLAND [71]

WO/2004/043325 [87]

ריינהולד כהן ושותפיו, א' 26ל רחוב הברז רמת החייל


26A HABARZEL ST.,


[74]

An artificial baby-feeding nipple (310) includes a substantially solid nipple portion

(312) with one or more ducts (316) formed there through for conveying fluids through

the nipple. The nipple is radially compressible so as to prevent passage of fluids

through the one or more ducts when so compressed through use of a material having a

low durometer material.

[57]




__________________

168361 [21[]11]

התקן עם פתח למתן תרופות המכיל מספר ערוצים עם קצבי זרימה משתנים

ORIFICE DEVICE HAVING

MULTIPLE CHANNELS WITH

VARYING FLOW RATES FOR

DRUG DELIVERY

[54]

03.05.2005 [22] US [33] 27.05.2004 [32] 10/855239 [31]

Int. Cl.(2010.01) A61J 03//07, B65D 83//04 [51] 162046 [61]

CORDIS CORPORATION, U.S.A. [71]


רמת החייל


26A HABARZEL ST.,


[74]

An orifice device for delivering one or more drugs includes an innermember having a

proximal end and a distal end; and a winding helically wound around the inner

member. The winding includes a plurality of distinct wires helically wound in parallel

around the inner member. The winding and the inner member define at least three

separate channels for carrying one or more drugs therethrough. The inlet is at the

proximal end of the winding and an outlet is at the distal end of the winding for the

plurality of distinct wires. In some embodiments at least two of the plurality of distinct

wires have a different dimension. An outer member is used over the winding. Also, at

least two of the at least three separate channels have a different fluid flow rate. In some

embodiments at least two of the at least three separate channels carry a different drug.

[57]




__________________

168399 [21[]11]

קצף פרמצבטי וקוסמטי

COSMETIC AND

PHARMACEUTICAL FOAM

[54]

24.10.2003 [22] IL [33] 25.10.2002 [32] 152486 [31]

US 29.11.2002 60/429546

Int. Cl.(2010.01) A61K 08//60, 09//00, 09//12, 35//00 [51]

FOAMIX LTD. [71] פואמיקס בע"מ, רחובות

WO/2004/037225 [87]

פואמיקס בע"מ, ,פארק וייצמן לתעשיות מדע 2הולצמן


FOAMIX LTD.,

2 HOLZMAN STREET

P.O.B 4038

REHOVOT 74140

[74]

The invention relates to an alcohol-free cosmetic or pharmaceutical foam carrier

comprising water, a hydrophobic solvent, a foam adjuvant agent, a surface-active agent

and a water gelling agent. The cosmetic or pharmaceutical foam carrier does not

contain aliphatic alcohols, making it non-irritating and non-drying. The alcohol-free

foam carrier is suitable for inclusion of both water-soluble and oil soluble

pharmaceutical and cosmetic agents.

[57]

לתקנות 13פירוט זה נבחן בהתאם לתקנה 2746 –הפטנטים5 תשכ"ח

This specification was examined in accordance

with regulation 35 of the Patent Regulations,

5728 - 1968

__________________




168429 [21[]11]

מוליך בעל חומר מרוכב יהלום/נחושת –מצע חצי ושיטה לייצורו

SEMICONDUCTOR SUBSTRATE

HAVING COPPER/DIAMOND

COMPOSITE MATERIAL AND

METHOD OF MAKING SAME

[54]

24.10.2003 [22] US [33] 07.11.2002 [32] 10/291126 [31]

Int. Cl.(2010.01) H01L 21//44 [51]

KYOCERA AMERICA, INC., U.S.A. [71]

WO/2004/044950 [87]




5 SHENKAR ST.,

P.O.B. 12704,

HERZLIYA 46733

[74]

A semiconductor package for power transistors of the LDMOS type has a metallic

substrate with a die mounted directly thereon, lead frame insulators mounted thereon

adjacent the die and a plurality of leads mounted on the insulators and electrically

coupled to the die by bond wires. The substrate includes a body having opposite

surfaces comprising pure copper layers, and with the body interior being at least

partially comprised of a copper/diamond composite so as to act as a heat spreader and

provide improved heat removal and low thermal expansion, as well as an electrical

connection for the die. The body may be entirely comprised of a copper/diamond

composite, or it may be comprised of a copper/tungsten composite having a

copper/diamond composites insert therein. The copper/diamond composite is

comprised of diamond, particles within a copper matrix. In a method of making the

copper/diamond composite, diamond particles are coated with multiple layers of

element or inorganic compounds, mixed with a dry-processing binder and compacted

in a die under pressure to form a compacted body. The body is placed on a quantity of

copper, heated in a vacuum or hydrogen atmosphere to evaporate or decompose the

binder, heated in a vacuum or hydrogen atmosphere to 4ause bonding or partial

sintering of the coated diamond particles, then heated in a hydrogen atmosphere to a

temperature slightly above the melting point of copper to melt and draw the copper

into the bonded or partially sintered diamond particles. Following that, the compacted

body is cooled and cut to the desired shape.

[57]

__________________

168606 [21[]11]






צורת מינון דמויית דף לשחרור ניקוטין בחלל הפה או האף

SHEET LIKE DOSAGE FORM FOR

RELEASING NICOTINE IN THE

ORAL OR NASAL CAVITY

[54]

22.06.2001 [22] DE [33] 04.07.2000 [32] 10032456.8 [31]

Int. Cl.(2010.01) A61K 09//00 [51] DIVISION FROM 153716 [62]

LTS LOHMANN THERAPIE-

SYSTEME AG, GERMANY [71]

WO/2002/002085 [87]

צאטו את לוצאטו,לו גן תעשייה, עומר




P.O.B. 5352,

BEER-SHEVA 84152

[74]

The invention relates to an especially flat administrable form which decomposes or

dissolves rapidly in an aqueous medium, and is used to rapidly release active

ingredients in the oral cavity, in bodily openings or in bodily cavities. Said

administrable form comprises a matrix which contains at least one water-soluble

polymer in the form of a base substance; in addition to at least one active ingredient;

and is characterised in that the polymer matrix is provided with spaces or cavities, the

content thereof differing with regard to the state of aggregation of the matrix.

[57]

The parent application from which 231524 בקשת הורה לבקשה זו שטרם פורסמה

this application has been divided has


__________________

616868 [21[]11]




תכשיר לניקוי רצפות המכיל גורם לבקרה על חרקים

FLOOR CLEANING

FORMULATION COMPRISING

AN AGENT FOR CONTROLLING

INSECTS

[54]

19.05.2005 [22]

Int. Cl.(2010.01) C11D 07//32 [51]

SANO BRUNO'S ENTERPRISES סנו מפעלי ברונוס בע"מ, תל אביב

LTD. [71]


רמת החייל

REINHOLD COHN AND

PARTNERS,

26A HABARZEL ST.,


[74]

A cleaning formulation comprising a cleaning agent and an insect growth regulator

wherein said cleaning agent comprises: 2-5 wt% non-ionic surfactant; 0.5-2 wt% ETA

70; 0.001-0.1 wt% insect growth regulator; 0.3-2 wt% fragrance; and 0.01-1 wt%

stabilizer; and water up to 100 wt%.

[57]

__________________

168718 [21[]11]

נגזרות ביגואניד, תכשירים הכוללים את –הנגזרות, תהליך להכנת תרכובות אנטי

מיקרוביאליות ושימוש בנגזרות בהכנת תרופות

BIGUANIDE DERIVATIVES,


THE DERIVATIVES, PROCESS

FOR PREPARING AN

ANTIMICROBIAL COMPOUND

AND USE OF THE DERIVATIVES

IN THE PREPARATION OF

MEDICAMENTS

[54]

20.11.2003 [22] US [33] 22.11.2002 [32] 60/428306 [31]

US 18.11.2003 10/716283

Int. Cl.(2010.01) A61K 31//155, A61P 31//04, C07C 27/9/26, 31/7/22, 32/3/20, C07D

31/7/64, 31/9/20

[51]

JACOBUS PHARMACEUTICAL

COMPANY, INC., U.S.A. [71]

WO/2004/048320 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

Biguanide and dihydrotriazine derivatives, preferably substituted asymmetrical

imidodicarbonimidic diamides derived from hydroxylamines, and compositions

[57]




containing biguanide and dihydrotriazine derivatives are disclosed. In addition,

methods of using the biguanide and dihydrotriazine derivatives, inter alia, as

antimicrobial agents and methods of using the dihydrotriazine derivatives in biological

assays are disclosed. Methods of making the biguanide and dihydrotriazine derivatives

are also disclosed.


שטרם פורסמו90//0255 The applications for division



__________________

168745 [21[]11]

תכשירים הכוללים רעלן הבוטולינום ואלבומין פלזמה אנושי, שיטה להכנתם ושימוש בהם

להכנת תרופות


BOTULINUM TOXIN AND A

HUMAN SERUM ALBUMIN,

METHOD FOR PRODUCING THE

SAME AND USE THEREOF IN

THE PREPARATION OF

MEDICAMENTS

[54]

22.12.2003 [22] US [33] 20.12.2002 [32] 60/435901 [31]

Int. Cl.(2010.01) A61K 47//42, 47//48 [51]

BOTULINUM TOXIN RESEARCH

ASSOCIATES, INC., U.S.A. [71]

WO/2004/060384 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

Botulinum toxin, a well know systemic poison, produces favorable therapeutic effect

by virtue of regionally attaching to nerves within the myoneural junction and possibly

other tissues in a target region of a particular tissue. The present invention provides

compositions of botulinum toxin and a sequestration agent that increase sequestration

and delivery of the botulinum toxin to neural and associated tissues, as compared with

available formulations of botulinum toxins, and thereby produce a beneficial clinical

effect. The sequestration agents of the present invention include proteins, lipids and

carbohydrates. A preferred composition of the present invention comprises a

botulinum toxin and an albumin. The present invention also provides methods of

treating neuromuscular diseases and pain using the disclosed compositions and

methods of making the disclosed compositions.

[57]




__________________

169307 [21[]11]

נגזרות של ביפניל ושימושן כקוטלי פטריות

BIPHENYL DERIVATIVES AND

THEIR USE AS FUNGICIDES

[54]

15.12.2003 [22] GB [33] 24.12.2002 [32] 0230155.4 [31]

Int. Cl.(2010.01) A01N 43//36, 43//56, 43//78, C07C 21/1/44, 23/3/02, C07D 20/7/34,

23/1/14, 23/1/16, 27/7/56, C07F 07//08

[51]

SYNGENTA PARTICIPATIONS AG,

SWITZERLAND [71]

WO/2004/058723 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

A fungicidally active compound of formula (I): where Het is a substituted 5- or 6-

membered heterocyclic ring; R1 is hydrogen, formyl, CO-C1-4 alkyl, COO-C1-4 alkyl,

C1-4 alkoxy(C1-4)alkylene, CO-C1-4 alkylenoxy(C1-4)alkyl, propargyl or allenyl; R2, R

3,

R4 and R

5 are each, independently, hydrogen, halogen, methyl or CF3; each R

6 is,

independently, halogen, methyl or CF3; R7 is (Z)mC=C(Y

1), (Z)mC(Y

1)=C(Y

2)(Y

3) or

tri(C1-4)alkylsilyl; X is O or S; Y1, Y

2 and Y

3 are each, independently, hydrogen,

halogen, C1-6 alkyl [optionally substituted by one or more substituents each

independently selected from halogen, hydroxy, C1-4 alkoxy, C1-4 haloalkoxy, C1-4

alkylthio, C1-4 haloalkylthio, C1-4 alkylamino, di(C1-4)alkylamino, C1-4 alkoxycarbonyl,

C1-4 alkylcarbonyloxy and tri(C1-4)alkylsilyl], C2-4 alkenyl [optionally substituted by

one or more substituents each independently selected from halogen], C2-4 alkynyl

[optionally substituted by one or more substituents each independently selected from

halogen], C3-7 cycloalkyl [optionally substituted by one or more substituents each

independently selected from halogen, C1-4 alkyl and C1-4 haloalkyl] or tri(C1-

4)alkylsilyl; Z is C1-4 alkylene [optionally substituted by one or more substituents each

independently selected from hydroxy, cyano, C1-4 alkoxy, halogen, C1-4 haloalkyl, C1-4

haloalkoxy, C1-4 alkylthio, COOH and COO-C1-4 alkyl]; m is 0 or 1; and n is 0, 1 or 2;

the invention also relates to novel intermediates used in the preparation of these

compounds, to agrochemical compositions which comprise at least one of the novel

compounds as active ingredient and to the use of the active ingredients or

compositions in agriculture or horticulture for controlling or preventing infestation of

plants by phytopathogenic microorganisms, preferably fungi.

[57]




__________________

169527 [21[]11]

תולדות פירידין ותהליך להכנתן

PYRIDINE DERIVATIVES AND

PROCESS FOR THEIR

PREPARATION

[54]

12.02.2004 [22] EP [33] 19.02.2003 [32] 03356029.3 [31]

Int. Cl.(2010.01) C07D 40/5/00, 40/5/12, 40/9/12 [51]

BAYER S.A.S., FRANCE [71]

WO/2004/074280 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

Compound of general formula (I): Process for preparing this compound. Novel

intermediate of general formula (E): for the preparation of compound of general

formula (I). Fungicidal composition comprising a compound of general formula (I).

Method for treating plants by applying a compound of general formula (I) or a

composition comprising it.

[57]




__________________

169881 [21[]11]

טלאים דביקים עבור נתינת גרניסטרון דרך העור

ADHESIVE PATCHES FOR THE

TRANSDERMAL DELIVERY OF

GRANISETRON

[54]

05.02.2004 [22] GB [33] 05.02.2003 [32] 0302662.2 [31]

Int. Cl.(2010.01) A61K 09//70 [51]

STRAKAN INTERNATIONAL

LIMITED, BERMUDA [71]

WO/2004/069141 [87]



P.O.B. 1352,

JERUSALEM 91013

[74]

Adhesive patches for the transdermal administration of granisetron, comprise an

acrylic adhesive containing non-acidic nucleophilic moieties which substantially

increase flux of granisetron across the skin.

[57]

__________________

170076 [21[]11]

ר נוגדנים לחלבון מבודד פעיל ביולוגית הקשו VEGFלגורם צמחיה וסקולארי אנדותליאלי

ANTIBODIES TO ISOLATED

BIOLOGICALLY ACTIVE HUMAN

[54]






אנושי, השימוש בהם ותכשירים רפואיים המכילים אותם

VASCULAR ENDOTHELIAL

GROWTH FACTOR (VEGF)

RELATED PROTEIN, THEIR USE

AND MEDICAMENTS

COMPRISING THEM

30.08.1996 [22] US [33] 08.09.1995 [32] 60/003491 [31]

Int. Cl.(2010.01) A61K 39//395, C07K 14//52, 14//71, 16//24 [51] DIVISION FROM 123332 [62]


WO/1997/009427 [87]


רמת החייל


26A HABARZEL ST.,


[74]

A monoclonal antibody which binds to an isolated biologically active human VEGF-

related protein (VRP) and neutralizes a biological activity of said isolated biologically

active human VRP, wherein said isolated biologically active human VRP contains at

least 265 amino acids of Figure 1, as depicted in the specification, which binds

receptor tyrosine kinase Flt4.

.

[57]

__________________

170178 [21[]11]

קלטת ביטוי הכוללת אזור מקדם/מגביר מוקדם אנושי ווקטור הכולל את CMVשל 1מיידי

קלטת הביטוי הנ"ל

EXPRESSION CASSETTE

COMPRISING A HUMAN CMV

IMMEDIATE EARLY 1

PROMOTER/ENHANCER REGION

AND A VECTOR COMPRISING

SAID EXPRESSION CASSETTE

[54]

13.02.2004 [22] US [33] 14.02.2003 [32] 60/448179 [31]

Int. Cl.(2010.01) A61K 48//00, C12N 05//10, 15//79 [51]

BIOGEN IDEC MA INC., U.S.A. [71]

WO/2004/074439 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The disclosure provides an expression cassette and a vector comprising the cassette for

expression of a polynucleotide. The expression cassette includes a promoter/enhancer,

[57]




an intervening region, and a polyadenylation signal domain. Expression systems and

methods of using the expression cassette and vector are also provided.

__________________

170438 [21[]11]

תהליך לבניית מקטע של מבנה חיצוני על ידי הכנה מראש של חלקי מבנה וחלק מבנה

המוכן מראש המתייחס לתהליך זה

PROCESS FOR THE

CONSTRUCTION OF A SEGMENT

OF AN OPEN-AIR WORK BY

PREFABRICATED STRUCTURAL

MEMBERS AND PREFABRICATED

STRUCTURAL MEMBER RELATED

THERETO

[54]

24.03.2004 [22] IT [33] 28.03.2003 [32] TO2003A000243 [31]

Int. Cl.(2010.01) E02D 29//045 [51]

CARLO CHIAVES, ITALY [71]

WO/2004/085749 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

A process for the construction of a segment of an openair work by prefabricated

structural members of reinforcing concrete, comprises the steps of arranging first and

second prefabricated structural members (18, 19) including an upright portion (22) and

at least a cover portion (26), and the phase of installing the two structural members (18,

19) by resting the free ends (20) of the respective upright portions (22) on respective

foundation portions (12), in such a manner that the two structural members (18, 19) are

arranged symmetrically opposed. Each structural member (18, 19) has a cavity in

correspondence of the respective cover portion (26), the cavities of the two structural

members (18, 19) constituting a continuous channel (34) in order to allow to form a

beam superimposed to the two members (18, 19) and fastened to them, by executing a

casting (36) in said continuous channel (34) during the work.

[57]




__________________

170726 [21[]11]

UWBמערכת ושיטה לרכישת אותות מכ"מ

SIGNAL ACQUISITION SYSTEM

AND METHOD FOR ULTRA-

WIDEBAND (UWB) RADAR

[54]

07.09.2005 [22]

Int. Cl.(2010.01) G01S 07//288, 13//89 [51]

CAMERO-TECH LTD. [71] ק בע"מ, נתניהט-קמרו


רמת החייל

REINHOLD COHN AND

PARTNERS,

26A HABARZEL ST.,


[74]

A signal acquisition system configured to be used with an ultra-wideband radar and

capable of integrating at least one received signal whereby providing a desired

compensation of a signal loss; the system comprising: (a) at least one sampler

configured to sample the received signal and to provide samples of different range

cells; (b) at least one analog integrator coupled to the sampler and configured to

integrate said samples during Na>1 integration cycles whereby providing

compensation of at least part of the signal loss and giving rise to analog integrated

samples; (c) at least one analog/digital converter coupled to the analog integrator and

configured to convert said analog integrated samples into digital samples; (d) at least

one digital integrator coupled to the analog/digital converter and configured to

integrate said digital samples during Nd digital integration cycles whereby

substantially providing the rest of desired signal loss compensation.

[57]

__________________




170829 [21[]11]

ציס חומצה רטינואית–9תהליך להכנת

PROCESS FOR THE

PRODUCTION OF 9-CIS

RETINOIC ACID

[54]

02.04.2004 [22] EP [33] 11.04.2003 [32] 03008020.4 [31]

Int. Cl.(2010.01) C07C 40/3/20 [51]


SWITZERLAND [71]

WO/2004/089887 [87]

יינהולד כהן ושותפיו,ר א' 26רחוב הברזל

רמת החייל


26A HABARZEL ST.,


[74]

A new industrially applicable process for the production of 9-(Z)-retinoic acid is

described which is characterized by the conversion of an alkali metal salt of 3-methyl-

4-oxocrotonic acid with a C15-triphenyl-phosphonium salt. 9-(Z)-retinoic acid is a

versatile compound for the treatment of numerous dermatological diseases.

[57]

__________________

171177 [21[]11]

שיטה להכנת פולימרים פוטוריאקטיביים עם מולקולות מקובעות עליהם

METHOD FOR THE

PREPARATION OF

PHOTOREACTIVE POLYMERS

WITH MOLECULES

IMMOBILIZED THEREON

[54]

31.03.2003 [22]

Int. Cl.(2010.01) C12N 11//06, 11//08, G01N 33//543 [51]


INDUSTRIAL RESEARCH, INDIA [71]

WO/2004/088316 [87]

דר' אייל ברסלר עו"פ, 11תובל גן -רמת

DR. EYAL BRESSLER,

11 TUVAL ST.,

RAMAT GAN 52522

[74]

This invention relates to a quick method for preparation of photoreactive polymers and [57]






immobilization of biomolecules onto these polymers. Particularly, this invention

relates to a microwave-mediated rapid and efficient method for the preparation of

photoreactive polymer having atleast one photoactivable functional group capable of

forming a covalent bond with the biomolecule in a photochemical reaction. Any

matrix either organic or inorganic having a nucleophilic group preferably, amino,

hydroxyl or thiol group can be modified by the invented method. Immobilization of

biomolecules onto the photoreactive polymers was carried out by UV radiation. The

method has applications for immobilization of bio-molecules irrespective of their

functional groups in the fields of molecular biology, proteomics, genomics,

diagnostics, chemical or biochemical industry or other related fields.

__________________

171178 [21[]11]

חום לביצוע הליך בחינה –שיטה מהרה מתווכת אנזימים–באמצעות סורבנט אימוני קשור

RAPID HEAT-MEDIATED

METHOD FOR ENZYME-

LINKED IMMUNOSORBENT

ASSAY PROCEDURE

[54]

31.03.2003 [22]

Int. Cl.(2010.01) G01N 33//543 [51]


INDUSTRIAL RESEARCH, INDIA [71]

WO/2004/088315 [87]


DR. EYAL BRESSLER,

11 TUVAL ST.,

RAMAT GAN 52522

[74]

This invention relates to a rapid and efficient method for carrying out enzyme-linked

immunosorbent assay for detection of minute quantities of biomolecules such as

antigen, antibody etc. This invention particularly relates to heat-mediated

immobilization of antigen or antibody on to the activated surface followed by

performing subsequent steps of ELISA by controlled temperature. The invented

procedure has reduced the total time required for ELISA to around 3 h. The invented

ELISA procedure is rapid, economical, reproducible and simple. The invented

procedure is useful for carrying out ELISA required in clinical diagnostics, molecular

biology, agriculture, food technology, environmental science, etc. The invented

ELISA method is simple, time saving and obviates the time consuming procedure.

This method has the potential for automation.

[57]

__________________




171217 [21[]11]

מעבד מיקום רב מעברים

MULTIPLE PASS LOCATION

PROCESSOR

[54]

31.03.2004 [22] US [33] 15.04.2003 [32] 10/414982 [31]

Int. Cl.(2010.01) G01S 03//02 [51]

TRUEPOSITION, INC., U.S.A. [71]

WO/2004/092762 [87]



P.O.B. 1352,

JERUSALEM 91013

[74]

A multiple pass location processing method, for use in a wireless location system

(WLS), comprises identifying a received transmission as requiring multiple pass

location processing whereby the WLS produces a first, lower quality location estimate

and then subsequently produces a second, higher quality location estimate. The WLS

then produces the first location estimate and provides it to a first location application,

and then produces the second location estimate. The second location estimate may be a

more accurate estimate than the first location estimate and/or of a higher confidence

than the first location estimate. This method is suitable, but not limited, for use in

connection with locating a wireless transmitter involved in an emergency services call

and routing the call to a call center.

[57]

__________________

171363 [21[]11]






תהליך להפקת מוצרים של טיטניום

PROCESS FOR THE

PRODUCTION OF TITANIUM

PRODUCTS

[54]

11.10.2005 [22]

Int. Cl.(2010.01) A62D 01//00, C01G 23//04 [51]

JOMA INTERNATIONAL AS,

NORWAY [71]

ASHER VITNER [72] אשר ויטנר

וולף, ברגמן וגולר, יםירושל1352, ת.ד.


P.O.B. 1352,

JERUSALEM 91013

[74]

A method for the industrial purification of a titanium feed stream of purity P1, by the

formation of a titanium-double-salt precipitate of purity P2, and a titanium solution

with purity P3, wherein P2>P1>P3, said method comprising the steps of: forming,

from said feed, a medium comprising water, titanium ion, a cation selected from the

group consisting of ammonium, cations of alkali metals, protons and a combination

thereof, and an anion selected from the group consisting of OH, SO4, HSO4, and a

combination thereof, which formed medium is further characterized by the presence of

(a) a double-salt precipitate comprising titanium ion, at least one of said cations and at

least of said anions; and (b) a titanium solution; and wherein the concentration of said

anion in said titanium solution is higher than 15 wt% and the ratio between the

concentrations of said cation and said anion in said titanium solution is higher than 0.4

and lower than 1.6; and; separating at least a portion of said precipitate from said

solution

[57]

__________________

171444 [21[]11]

מערכת שמותאמת לתפקיד כמדחס, מנוע, משאבה ומנוע בעירה פנימית

APPARATUS ADAPTED TO

PERFORM AS COMPRESSOR,

MOTOR, PUMP AND INTERNAL

COMBUSTION ENGINE

[54]

22.04.2003 [22]

Int. Cl.(2010.01) F01C 01//067 [51]

DAS AJEE KAMATH, INDIA [71]

WO/2004/094787 [87]




P.O.B. 5352,

[74]




BEER-SHEVA 84152 באר שבע5352, ת.ד.

A rotary apparatus adapted to perform as, compressor, pump, motor or an internal

combustion engine; said apparatus comprising of two vanes, two hollow cylindrical

sleeves, hollow cylindrical liner, cams and associated linkages, couplings, shaft, clutch

and braking/locking arrangement; said vanes are fitted on to the curved surface of the

sleeves, one vane on each sleeve, such that the vanes are radial to sleeve's curved

surface and at one of the ends of each sleeve so that the vane's surface protrudes out of

the sleeve's end; said sleeves placed such that their ends, fitted with vanes are placed

adjacent, with the vanes angularly displaced; said vanes are placed inside a liner; said

liner's inner surface is contoured along the path traced by vane edge while rotating

about the said axis; said inner surface allows rotation of the vanes about the said axis;

said vanes divide the said enclosure formed inside the liner into two sealed chambers;

enclosure; said two sleeves, are coupled and uncoupled with a shaft by means of

coupling arrangement actuated by cams or other timing devices; said cams or timing

devices are dependent on sleeve position; said cams or timing devices actuate said

braking/locking arrangements such that each vane is held at a predetermined position

alternately, and the vanes are free to rotate through an defined angle alternately; said

cams or timing devices allow both vanes to rotate simultaneously through an

predefined angle; said cams or timing devices defines the angle by which the vanes are

separated, rotated simultaneously or independently.

[57]

__________________

171713 [21[]11]

שימוש בתולדה של חומצה פנוקסיאצטית להכנת תכשיר לטיפול בפעילות יתר של

שלפוחית השתן

USE OF A PHENOXYACETIC

ACID DERIVATIVE FOR

PREPARING A COMPOSITION

FOR TREATING HYPERACTIVE

BLADDER

[54]




24.03.2004 [22] DE [33] 05.05.2003 [32] 10320084.3 [31]

DE 23.05.2003 10323837.9

Int. Cl.(2010.01) A61K 31//191, 31//192 [51]

KISSEI PHARMACEUTICAL CO.,

LTD., JAPAN [71]

WO/2004/098586 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The present invention relates to a new field of indication for phenoxyacetic acid

derivatives as described in European Patent Application EP 1095932. It has now been

found that the compounds described therein are suitable for the preparation of a

medicament for treating hyperactive bladder (overactive bladder). Accordingly, by

means of these active substances, a method is provided for treating this urological

syndrome.

[57]

__________________

171722 [21[]11]

מערכת גישה למתן שירותי תקשורת שונים ושיטה לשימוש בה

ACCESS SYSTEM FOR THE

PROVISIONING OF DIFFERENT

COMMUNICATION SERVICES

AND METHOD FOR USING

SAME

[54]

01.11.2005 [22]

Int. Cl.(2010.01) H04M 03//42, H04Q 03//00 [51]

ECI TELECOM LTD. [71] והאי. סי. איי. טלקום בע"מ, פתח תק


פתח תקוה

ECI TELECOM LTD.,

30 HASIVIM ST.,

PETACH TIKVA 49517

[74]

An access communication system is provided which comprises at least one

aggregation device comprising at least one automated switching matrix for connecting

a plurality of communication devices with a plurality of subscribers. When a new

subscriber is to be connected through the at least one aggregation device, the at least

one automated switching matrix is operative to enable the provisioning of a required

service to the new subscriber either by using one of these communication devices or

by communicating with a communication device installed at a different location and

operative to enable the provisioning of the service required by the new subscriber. By

[57]




a preferred embodiment the at least one aggregation device and automated switching

matrix and the plurality of communication devices are managed by a single managing

entity.

__________________

172008 [21[]11]

שימוש לקביעת יכולת של אנזים לווסות את רמת הפוספורילציה של פוליפפטיד שעבר

ביוטניליזציה

METHOD FOR DETERMINING

THE ABILITY OF AN ENZYME TO

MODULATE THE

PHOSPHORYLATION STATUS OF

A BIOTINYLATED POLYPEPTIDE

[54]

27.04.2004 [22] DE [33] 22.05.2003 [32] 10323081.5 [31]

Int. Cl.(2010.01) C07K 14//435, C12Q 01//48 [51]


GMBH, GERMANY [71]

WO/2004/104220 [87]




5 SHENKAR ST.,

P.O.B. 12704,

HERZLIYA 46733

[74]

The invention relates to the use of a polypeptide for determining the ability of an

enzyme, a functional fragment or a derivative thereof, to modulate the phosphorylation

status of the polypeptide, said invention being characterised in that the polypeptide is

biotinylated.

[57]

__________________

172326 [21[]11]

שיטה להסרת פיגמנטים מחלק עור עם פיגמנטציה

METHOD FOR REMOVING

PIGMENTS FROM A PIGMENTED

SECTION OF SKIN

[54]

10.06.2004 [22] IL [33] 10.06.2003 [32] 156374 [31]

Int. Cl.(2010.01) A61B 17//00, 17//20 [51]






HAWK MEDICAL TECHNOLOGIES הוק מדיקל טכנולוג'יס בע"מ, ראשון לציון

LTD [71]

WO/2004/107995 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

The present invention relates to a method for removing pigments from a pigmented

section of a skin by puncturing the skin at the pigmented section, with a skin

puncturing device which is provided with at least one needle, and then bandaging the

punctured section with a suitable adsorbing pad. The pad contains one or more

materials, such as saline, which will cause the pigments at the punctured section to

migrate into the outer layer of the skin.

[57]

__________________

723541 [21[]11]

אפוליפופרוטאין לשימוש בתבחיך לגילוי של PrPSC

APOLIPOPROTEIN FOR USE IN

AN ASSAY FOR DETECTION OF

PRPSC

[54]

18.06.2004 [22] EP [33] 19.06.2003 [32] 03101795.7 [31]

Int. Cl.(2010.01) G01N 33//68 [51]

MERCK SERONO S.A.,

SWITZERLAND [71]

CLAUDIO SOTO-JARA, KINSEY

MAUNDRELL

[72]

WO/2004/111652 [87]

אינטרפארם מעבדות בע"מ, 18רחוב הקישון

יבנה151, ת.ד.

INTERPHARM LABORATORIES

LTD.,

18 HAKISHON ST.,

P.O.B. 151,

YAVNE 81101

[74]

The use of Apolipoprotein B, Apolipoprotein E, fragments and mimetics thereof is

provided for diagnostic, detection, prognostic and therapeutic applications in prion

diseases. More specifically, the invention provides the use of Apolipoprotein B or

fragments thereof for modulating or identifying modulators of the prion protein

replication which are implicated in thepathogenesis of transmissible spongiform

encephalopathics and other prion diseases.

[57]





שטרם פורסמו90/17/45 The applications for division



__________________

172404 [21[]11]

, תכשירים רפואיים VEGFמלכודות מיני המכילים אותן ושימושים של התכשירים

הרפואיים להכנת תרופות

VEGF MINI TRAPS,

PHARMACEUTICAL


THE SAME AND USE OF THE

PHARMACEUTICAL

COMPOSITIONS FOR

PREPARING MEDICAMENTS

[54]

29.06.2004 [22] US [33] 30.06.2003 [32] 10/609775 [31]

Int. Cl.(2010.01) A61K 38//17, C07K 14//71, 19//00, C12N 15//12, 15//62 [51]

REGENERON

PHARMACEUTICALS, INC., U.S.A. [71]

WO/2005/000895 [87]


רמת החייל


26A HABARZEL ST.,


[74]

Nucleic acid molecules and multimeric proteins capable of binding vascular

endothelial growth factor (VEGF). VEGF traps are disclosed which are therapeutically

useful for treating VEGF-associated conditions and diseases, and are specifically

designed for local administration to specific organs, tissues, and/or cells.

[57]

__________________

172457 [21[]11]

תרכובות מאוחות המכילות קבוצת אוראידו של 1סוג –המעכבות קולטן של ונילואיד תת

ידי –הקולטן, לטיפול בהפרעות הנגרמות על פעילות של קולטן וינלואיד ותהליך להכנתן

FUSED COMPOUNDS

CONTAINING AN UREIDO

GROUP THAT INHIBIT

VANILLOID RECEPTOR

SUBTYPE 1 (VR1) RECEPTOR

FOR TREATING DISORDERS

CAUSED BY VANILLOID

RECEPTOR ACTIVITY AND

[54]






PROCESS FOR THEIR

PREPARATION

10.06.2004 [22] US [33] 12.06.2003 [32] 10/459925 [31]

US 09.06.2004 10/864068

Int. Cl.(2010.01) A61K 31//416, 31//472, A61P 13//00, C07D 21/7/02, 23/1/56,

40/1/12, 40/3/12

[51]

ABBOTT LABORATORIES, U.S.A. [71]

WO/2004/111009 [87]





P.O.B. 11490,

TEL AVIV 62038

[74]

The present invention discloses novel compounds of general formula (I), or a

pharmaceutically acceptable salt or prodrug thereof (in which X1 - X5, R5 - R8b, Z1 - Z2

and Ar1 are defined herein), a method for inhibiting the VR1 receptor in mammals

using these compounds, a method for controlling pain in mammals, and

pharmaceutical compositions including those compounds and a process for making

those compounds.

[57]


024/24502377550/51135 The applications for division



__________________

262017 [21[]11]

נרתיקי של תרופות–מתקנים לאספקה תוך

INTRAVAGINAL DRUG

DELIVERY DEVICES

[54]

09.07.2004 [22]




IE [33] 10.07.2003 [32] S0515 [31]

Int. Cl.(2010.01) A61K 09//00, 45//08, 47//36, 47//38 [51]

WARNER CHILCOTT (IRELAND)

LIMITED, IRELAND [71]

WO/2005/004837 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

The invention relates to an intravaginal drug delivery device comprising at least one

reservoir, the, or each, reservoir containing at least one pharmacologically active agent

dispersed in a carrier system; and a sheath discontinuously surrounding the at least one

reservoir, so that, in use, at least part of that reservoir is directly exposed to the vaginal

environment. Preferably, the sheath defines one or more holes or openings, the, or

each, hole or opening extending through the sheath to the at least one reservoir, so that

at least part of that reservoir is exposed, in use, to the vaginal environment.

[57]

__________________

172783 [21[]11]

ההורג באופן RASGAPפפטיד הנגזר מחלבון סלקטיבי תאים סרטניים

RASGAP DERIVED PEPTIDE FOR

SELECTIVELY KILLING

CANCER CELLS

[54]

30.06.2004 [22] US [33] 30.06.2003 [32] 60/483691 [31]

Int. Cl.(2010.01) A61K 38//17, C07K 14//47 [51]

UNIVERSITE DE LAUSANNE,

SWITZERLAND [71]

CHRISTIAN WIDMANN, JIANG-

YANG YANG, DAVID MICHOD

[72]

WO/2005/000887 [87]

אגמון,-סורוקר 14טון, רחוב שנקר בית נול

הרצליה פיתוח

SOROKER-AGMON,

14 SHENKAR ST.,

HERZLIYA PITUAH 46725

[74]

The present invention relates to a peptide consisting in the N2 sequence of the [57]




RasGAP protein, a fragment thereof, or a variant thereof which enhances the ability of

a drug to selectively kill cells. Furthermore, it relates to a pharmaceutical composition

comprising as an active substance a pharmaceutically effective amount of said peptide.

__________________

172928 [21[]11]

התקן נעילה לכוונון גובה של מודול

LOCKING DEVICE FOR HEIGHT

ADJUSTMENT OF A MODULE

[54]

25.06.2004 [22] NO [33] 03.07.2003 [32] 20033053 [31]

Int. Cl.(2010.01) A47C 03//28 [51]

STOKKE AS, NORWAY [71]

WO/2005/002946 [87]




5 SHENKAR ST.,

P.O.B. 12704,

HERZLIYA 46733

[74]

Device (1) for height adjustment of a module, such as a children's seat (3) on a stem

(2) in a trolley or a chair, characterized in that the locking device (1) comprises a

movable casing (4) which partly or completely surrounds the stem (2), a friction

element (5) and a handle (6) which rotates eccentrically in order to tighten the friction

element (5) against the stem (2) and providing friction between the locking device (1)

and the stem (2). The children's seat (3) may comprise a footrest (20) characterized in

that two rails (21) are received in guides (22) integrated in the seat, such that the

footrest (20) may be displaced telescopically in relation to the seat (3).

[57]

__________________




172944 [21[]11]

קרומית פולימרית מוליכה המכילה תמיסה יונית לשימוש בתאי דלק ושיטה ליצורה

POLYMER ELECTROLYTE

MEMBRANES AND IONIC

LIQUID THEREIN FOR USE IN

FUEL CELLS AND METHOD

FOR ITS PREPARATION

[54]

02.01.2006 [22]

Int. Cl.(2010.01) H01M 08//10 [51]

אוניברסיטת בן גוריון בנגב הרשות למחקר ופיתוח, באר שבע

BEN-GURION UNIVERSITY OF

THE NEGEV RESEARCH AND

DEVELOPMENT AUTHORITY

[71]

ELI KORIN, ARMAND אלי קורין, ארמון בטלהיים

BETTELHEIM

[72]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

A method for preparing a Polymer Electrolyte Membrane (PEM), wherein said

method comprises the step of combining a polysiloxane-RTV matrix with an ionic

liquid component to form an electrically conductive membrane, said combination

being carried out by introducing said ionic liquid with a first anion in the

polysiloxane-RTV component and then exchanging said first anion with a second

anion, said second anion being provided in the form of a salt in aqueous solution.

[57]

__________________

172998 [21[]11]

זמני של אנטיגנים של –מתקן ושיטה לזיהוי בו סוג דם


SIMULTANEOUSLY

IDENTIFYING BLOOD GROUP

ANTIGENS

[54]

08.07.2004 [22] DE [33] 09.07.2003 [32] 103 30 982.9 [31]

Int. Cl.(2010.01) G01N 33//80 [51]

MEDION DIAGNOSTICS AG,

SWITZERLAND [71]

WO/2005/005991 [87]

REINHOLD COHN AND ריינהולד כהן ושותפיו,

PARTNERS,

[74]






א' 26רחוב הברזל רמת החייל

26A HABARZEL ST.,


The invention relates to a device for simultaneously, qualitatively or quantitatively

identifying a number of analytes in a liquid sample, comprising a membrane (2) with:

a charging zone (5) for applying the liquid sample; at least two indicator zones, which

can interact with the analyte(s), and at least one absorption area (3), which absorbs the

liquid after passing the indicator zones, whereby the indicator zones are located

between the charging zone (5) and an absorption area (3). The invention is

characterized in that the flowing directions from the charging zone (5) through the

respective indicator zones to an absorption area (3) (flow paths) are essentially

parallel, and at least two different flow paths exist. The invention also relates to a

method for identifying a number of analytes or the derivatives thereof in a liquid

sample, consisting in the application of the sample to the charging zone (5) of a

membrane (2) of the device according to one of cited claims 1 to 8, whereby this

sample is present in an amount sufficient for causing the sample liquid to flow through

the indicator zones toward the absorption area (3), and for causing the analytes or the

derivatives thereof in the sample liquid to form a complex in the indicator zones.

[57]

__________________

173022 [21[]11]

תרכובות טטראציקליניות, שיטה לטיפול במצב המגיב לטטראציקליות במטופל שאינו אנושי, תכשיר פרמצבטי ושימוש בהן להכנת תרופוה

TETRACYCLINE COMPOUNDS, A

METHOD OF TREATING A

TETRACYCLINE RESPONSIVE

STATE IN A NON-HUMAN

SUBJECT, A PHARMACEUTICAL

COMPOSITION AND USE

THEREOF FOR THE

PREPARATION OF A

MEDICAMENT

[54]

25.06.2004 [22] US [33] 09.07.2003 [32] 60/486017 [31]

US 25.11.2003 60/525287

US 16.12.2003 60/530123

US 27.04.2004 60/566150

Int. Cl.(2010.01) A61K 31//65, A61P 31//04, C07D 21/1/34 [51]




PARATEK PHARMACEUTICALS,

INC., U.S.A. [71]

WO/2005/009944 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

The invention pertains to prodrugs of 9-aminomethyl substituted tetracycline

compounds, methods of using the compounds, and pharmaceutical compositions

containing them.

[57]





__________________

173062 [21[]11]

אמינוטטרלינים מותמרים לייצור –2–שימוש ב תרופה לטיפול בדיכאון

USE OF SUBSTITUTED 2-

AMINOTETRALINS FOR THE

MANUFACTURE OF A

MEDICAMENT FOR THE

TREATMENT OF DEPRESSION

[54]

22.07.2004 [22] DE [33] 26.07.2003 [32] 10334187.0 [31]

Int. Cl.(2010.01) A61K 31//341, 31//381, 31//40, A61P 25//24, C07D 20/7/335,

30/7/52, 33/3/20

[51]

UCB PHARMA GMBH, GERMANY [71]

WO/2005/009425 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The invention relates to the use of a compound of general formula (I) and the

pharmaceutically acceptable salts, racemates or pure entiomers thereof for the

production of a medicament used to treat depression. The substituents are defined as in

the description.

[57]




__________________

173067 [21[]11]

תערובת אבקות הניתנת לסינטור וקבלת חומר עצמית–מוצק בעל סיכה

POWDER MIXTURE CAPABLE

OF BEING SINTERED TO

PRODUCE A SELF-LUBRICATING

SOLID SUBSTANCE

[54]

10.01.2006 [22] FR [33] 12.01.2005 [32] 0500287 [31]

Int. Cl.(2010.01) B22F 01//00, 03//12, 05//00, C10M 10/3/04, 12/5/22, C22C 01//00,

01//04, 32//00, 38//00, 38//18, F16C 33//04

[51]

SNECMA SERVICES, FRANCE

SNECMA, FRANCE [71]




10 ABBA EBEN BLVD.,

P.O.B. 2081,

HERZLIYA 46120

[74]

A powder mixture suitable for sintering to form a self-lubricating solid material,

comprising a powder of a metal alloy that is a precursor for the matrix of said self-

lubricating solid material, particles of a first solid lubricant for insertion in said matrix

without reacting with said metal alloy during sintering of the powder, and particles of a

second solid lubricant for reacting with a component of said metal alloy during

sintering of the powder in order to form a lubricating phase, characterized in that the

particles of the first solid lubricant are particles of cerium trifluoride CeF3.

[57]

__________________

342217 [21[]11]

מבנה ושיטה להכנת טרנזיסטורים מתוחים , בעלי אזורי מקור ותעלה שאין CMOSמסוג

ביניהם התאמה סימטרית

STRUCTURE AND METHOD OF

MAKING STRAINED

SEMICONDUCTOR CMOS

TRANSISTORS HAVING

LATTICE-MISMATCHED

[54]






SOURCE AND DRAIN REGIONS

04.08.2004 [22] US [33] 04.08.2003 [32] 10/604607 [31]

Int. Cl.(2010.01) H01L 21//20, 31//0328 [51]

IBM CORPORATION, U.S.A. [71]

WO/2005/017964 [87]

מעבדות יבמ מחלקת קנין רוחני, אוניברסיטת חיפה הר הכרמל

חיפה

IBM LABORATORIES,

HAIFA UNIVERSITY,

HAIFA 31905

[74]

A p-type field effect transistor (PFET) (10) and an n-type field effect transistor

(NFET) (12) of an integrated circuit are provided. A first strain is applied to the

channel region (20) of the PFET (10) but not the NFET (12) via a lattice-mismatched

semiconductor layer such as silicon germanium disposed in source and drain regions

(111) of only the PFET (10) and not of the NFET.(12) A process of making the PFET

(10) and NFET (12) is provided. Trenches are etched in the areas to become the source

and drain regions (111) of the PFET and a lattice-mismatched silicon germanium layer

(121) is grown epitaxially therein to apply a strain to the channel region of the PFET

adjacent thereto. A layer of silicon (14) can be grown over the silicon germanium layer

(121) and a salicide (68) formed from the layer of silicon to provide low-resistance

source and drain regions (111).

[57]

__________________

173638 [21[]11]

נגזרות איזוקסאזולין כמעכב קאספאס, תכשיר טיפולי המכיל אותו ושימוש בו למניעת דלקת

ואפופטוזיס

ISOXAZOLINE DERIVATIVES AS

CASPASE INHIBITORS,

THERAPEUTIC COMPOSITIONS

COMPRISING SAME AND USE

THEREOF FOR PREVENTING

INFLAMMATION AND

APOPTOSIS

[54]

26.08.2004 [22] KR [33] 27.08.2003 [32] 10-2003-

0059451

[31]




Int. Cl.(2010.01) C07D 26/1/04, 41/3/04, 41/3/12, 41/3/14 [51]

LG LIFE SCIENCES LTD.,

REPUBLIC OF KOREA [71]

WO/2005/021516 [87]

ד"ר יצחק הס ושותפיו, 279רחוב הירקון


DR. YITZHAK HESS & PARTNERS,

279 HAYARKON ST.,

P.O.B. 6451,

TEL AVIV 61063

[74]

The present invention relates to an isoxazoline derivative as an inhibitor against

various caspases, a process for preparing the same, and a therapeutic composition for

preventing inflammation and apoptosis comprising the same

[57]

__________________

173982 [21[]11]

מתקן, מערכת ושיטה לניהול תקשורת קישור הפוך

APPARATUS, SYSTEM AND

METHOD FOR MANAGING

REVERSE LINK

COMMUNICATION

[54]

08.09.2004 [22] US [33] 08.09.2003 [32] 60/501563 [31]

US 08.09.2003 60/501450

Int. Cl.(2010.01) H04B 07//005, 07//185, H04W 52//24, 52//26 [51]

QUALCOMM INCORPORATED,

U.S.A. [71]

WO/2005/027371 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

In accordance with an exemplary embodiment of the invention, an apparatus, system,

and method efficiently manage reverse link resources by allowing a mobile station to

select between transmitting a payload a standard power level and transmitting a

smaller payload at a boosted power level. The mobile station, therefore, can

autonomously select a QoS (Quality of Service) level for physical layer packets. Based

on reverse link transmission information received from a base station, the mobile

station derives a reverse link transmission guideline defining the power levels and

associated payloads for at least a standard service and boosted service. The mobile

station selects a reverse link transmission power level from a plurality of power levels

including at least a standard reverse link transmission power level associated with a

standard payload size and a boosted reverse link transmission power level associated

[57]




with a boosted payload size where the standard payload size is greater than the boosted

payload size.

__________________

173997 [21[]11]

אטמים

SEALS

[54]

26.08.2004 [22] GB [33] 05.09.2003 [32] 0320858.4 [31]

Int. Cl.(2010.01) A47B 88//04, F16J 15//02, F25D 23//08, 25//02 [51]

APPLIED DESIGN AND

ENGINEERING LIMITED, UNITED

KINGDOM

[71]

IAN DAVID WOOD [72]

WO/2005/024315 [87]

אגמון,-סורוקר 14בית נולטון, רחוב שנקר


SOROKER-AGMON,

14 SHENKAR ST.,


[74]

A storage compartment comprises a container defining an access aperture closable by a

closure that can be sealed to the container around the aperture and that can be opened

by relative movement between the container and the closure in a lateral direction with

respect to the aperture, the container having a first sealing loop around the aperture and

the closure having a second sealing loop co-operable by alignment with the first

sealing loop to maintain a seal when the closure closes the aperture. The sealing loops

are moved into and out of mutual alignment by said relative movement between the

container and the closure and at least one of the sealing loops includes magnetic means

for attracting the other of the sealing loops to maintain a seal when the sealing loops

are mutually aligned.

[57]




__________________

174075 [21[]11]

פיפרזין כמעכבי הספיגה –בנזואיל–1נגזרות של של גליצין לטיפול בפסיכוזה

1-BENZOYL-PIPERAZINE

DERIVATIVES AS GLYCINE

UPTAKE INHIBITORS FOR THE

TREATMENT OF PSYCHOSES

[54]

31.08.2004 [22] EP [33] 09.09.2003 [32] 03019682.8 [31]

Int. Cl.(2010.01) A61K 31//495, 31//496, A61P 25//28, C07D 29/5/18, 40/3/04 [51]


SWITZERLAND [71]

WO/2005/023261 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

The invention relates to compounds of formula (I) wherein Ar is substituted aryl or

unsubstituted or substituted 6-membered heteroaryl, containing one, two or three

nitrogen atoms, and wherein the aryl and the heteroaryl groups may be substituted by

one or more substituents selected from the group consisting of hydroxy, halogen, CN,

(C1C6)-alkyl, (C1-C6)-alkyl substituted by halogen, (C1-C6)-alkoxy, (C1-C6)-alkoxy

substituted by halogen, NR7R

8, C(O)R

9 or SO2R

10; R

1 is hydrogen or (C1-C6)-alkyl; R

2

is halogen, (C1-C6) -alkyl, (C2-C6) -alkenyl, wherein a hydrogen atom may be replaced

by CN, C(O)-R9 or (C1-C6)-alkyl, or is (C2-C6)alkynyl, (C1-C6)-alkyl substituted by

halogen, -(CH2)n-(C3-C7)-cycloalkyl, -(CH2)n-heterocycloalkyl, -C(O)-R9, -(CH2)n-aryl

or -(CH2)n-5 or -6membered heteroaryl containing one, two or three heteroatoms,

selected from the group consisting of oxygen, sulphur or nitrogen wherein aryl,

cycloalkyl, heterocycloalkyl and heteroaryl are unsubstituted or substituted by one or

more substituents selected from the group consisting of hydroxy, halogen, (C1-C6)-

alkyl, (C1-C6)-alkyl substituted by halogen or (C1-C6) alkoxy; R3, R

4 and R

6

independently from each other are hydrogen, hydroxy, halogen, (C1-C6)-alkyl or (C1-

C6)-alkoxy; R5 is NO2, CN, C(O)R

9, SO2R

10 or NR

11R

12 ; R

7 and R

8 independently

from each other are hydrogen or (C1-C6)-alkyl; the other substituents are defined in the

claims; and to pharmaceutically acceptable acid addition salts thereof for the treatment

of psychoses, pain, neurodegenerative disfunction in memory and learning,

schizophrenia, dementia and other diseases in which cognitive processes are impaired,

such as attention deficit disorders or Alzheimer's disease.

[57]




__________________

174148 [21[]11]

מתקן עזר לקידוח ידני אנכי

DEVICE FOR MANUAL

VERTICAL DRILLING

[54]

07.03.2006 [22]

Int. Cl.(2010.01) B23B 45//00 [51]

GIDEON ALON [71] גדעון אלון, קבוץ מעברות

גדעון אלון, קבוץ מעברות

GIDEON ALON,

KIBUTZ MAABAROT 40230

[74]

הבנוי להוביל תנועה אנכית ביחס לבסיס 2, עמוד חלול 1של חלק, הכולל: בסיס בעל שני צדדים מתקן לקידוח קדח במשטח

המותקנת בתוך בית התפסנית 5הצמוד למוביל המחליק, תפסנית למקדח 3, בית תפסנית למקדח 4וכולל מוביל מחליק

ק בתוך העמוד החלול מאפשר למקדח והניתנת להנעה סיבובית על ידי מניע חיצונית, כאשר המהלך של המוביל המחלי

המהודק בתפסנית לבצע קידוח מעבר לבסיס, כאשר העמוד החלול מותקן על גבי אחד משני הצדדים העיקריים של הבסיס

לצורך הצמדה אל המשטח 6והחלק לקידוח מיועד להיות מוצמד לצד האחר של הבסיס כאשר הבסיס כולל יחידת ואקום

של התפסנית אינו עובר דרך הבסיס.עבודה, וכאשר קו הקידוח

[57]

__________________

174172 [21[]11]

–PSGLמולקולה מולטימרית הקושרת חלבוני

, שימושים שלה וערכה המכילה אותה1

MULTIMERIC COMPOUND THAT

BINDS PSGL-1 PROTEINS, USES

THEREOF AND KITS

COMPRISING THE SAME

[54]

09.09.2004 [22] US [33] 15.09.2003 [32] 10/662906 [31]

Int. Cl.(2010.01) A61K 38//17, C07K 14//435, 14//705, 16//18, 16//28 [51]

ABGENOMICS COOPERATIEF U.A.,

THE NETHERLANDS [71]

WO/2005/027831 [87]



26A HABARZEL ST.,


[74]






רמת החייל

Multimeric compounds that bind to P-Selectin Glycoprotein 1 (PSGL-1) on the surface

of T cells or natural killer (NK) cells can be used to induce T cell or NK cell depletion

and/or to induce T cell or NK cell apoptosis. The multimeric compounds and methods

of the invention can be used to control unwanted T cell-or NK cell-mediated immune

responses in conditions such as inflammatory diseases, autoimmune diseases,

transplant rejection, and allergic diseases.

[57]

__________________

174299 [21[]11]

[ ,תכשירים 3.1.0תולדות ביציקליים ] פרמצפטיים ושימוש בהם

BICYCLIC [3.1.0] DERIVATIVES,

PHARMACEUTICAL

COMPOSITIONS AND USE

THEREOF

[54]

14.10.2004 [22] US [33] 14.10.2003 [32] 60/510846 [31]

Int. Cl.(2010.01) A61K 31//403, C07D 20/9/04, 41/3/12 [51]

PFIZER PRODUCTS, INC., U.S.A. [71]

WO/2005/037216 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

The present invention relates to a series of substituted bicyclic [3.1.0]amines of the

Formula I: Wherein A, B, D, Q, V, W, X, Y, Z, R2, R

3, R

4, R

5, R

14, R

15, R

30.o, p, s, t

and q are as defined in the specification, their pharmaceutically acceptable salts,

pharmaceutical compositions thereof, and their use for the enhancement of cognition

and the treatment of the positive and negative symptoms of schizophrenia and other

psychoses in mammals, including humans.

[57]




__________________

174373 [21[]11]

–)קרבוקסיאלקיל( –1תולדות –בנזאזאפין–ציקלופנטיל קרבונילאמינו

N – חומצה אצטית מותמרתבאמידומתיל, תהליך וחומר ביניים

להכנתן ותרופות המכילות תרכובות אלו

AMIDOMETHYL SUBSTITUTED 1-

(CARBOXYALKYL)-

CYCLOPENTYLCARBONYLAMINO-

BENZAZEPINE-N-ACETIC ACID

DERIVATIVES, PROCESS AND

INTERMEDIATE PRODUCTS FOR THEIR

PREPARATION AND MEDICAMENTS

CONTAINING THESE COMPOUNDS

[54]

23.09.2004 [22] DE [33] 26.09.2003 [32] 10344848.9 [31]

EP 12.01.2004 04100065.4

Int. Cl.(2010.01) A61K 31//55, A61P 09//10, 09//12, 15//10, C07D 22/3/16, 40/1/12,

40/9/12

[51]

SOLVAY PHARMACEUTICALS GMBH,

GERMANY [71]

WO/2005/030795 [87]


רמת החייל


26A HABARZEL ST.,


[74]

Described are novel compounds with neutral endopeptidase (NEP) and/or human

soluble endopeptidase (hSEP) inhibitory activity of the general formula (I), wherein the

substituents R1, R

2 , R

3 and R

4 have the meanings given in the description and also

medicaments containing these compounds, in particular medicaments suitable for

treating or preventing cardiovascular diseases, sexual dysfunction and/or adverse

conditions associated with apoptosis.

[57]

__________________

174374 [21[]11]






שימוש בתרכובות הדמיה להכנת הרכבים למעקב אחרי מסה אוצורה של תאי בטא של

הלבלב

USE OF IMAGING COMPOUNDS

FOR THE PREPARATION OF

COMPOSITIONS FOR

MONITORING PANCREATIC

BETA CELL MASS OR

MORPHOLOGY

[54]

16.09.2004 [22] US [33] 17.09.2003 [32] 60/503683 [31]

Int. Cl.(2010.01) A61K 10/3/10, 31//175, 31//426, 31//4439, 51//00, 51//04 [51]

BOARD OF REGENTS, THE

UNIVERSITY OF TEXAS SYSTEM,

U.S.A.

[71]

WO/2005/027981 [87]


רמת החייל


26A HABARZEL ST.,


[74]

Compositions for imaging beta cells comprise chelator-antidiabetic agent conjugates

and optionally chelated metals.

[57]

__________________

174414 [21[]11]

–( Z])–5מלח מאלאט אנהידרטי קריסטלי של

–H 3–דיהידרו–1,2אוקסו –2–פלואורו–5)–N– [(S 2 ( –2–אילידן( מתיל[–3–אינדול

–2,4–אילפירופיל[–4–מורפולינ–3–הידרוקסי קרבוקסאמיד–3–פירול–H–1–דימתיל

CRYSTALLINE ANHYDROUS

MALEATE SALT OF 5-[(Z)-(5-

FLUORO-2-OXO 1,2-DIHYDRO-

3H-INDOL-3-YLIDENE)

METHYL]-N-[(2S)-2-HYDROXY-3-

MORPHOLIN-4-YLPROPYL]-2,4-

DIMETHYL-1H-PYRROLE-3-

CARBOXAMIDE

[54]

20.09.2004 [22] US [33] 02.10.2003 [32] 60/508104 [31]

Int. Cl.(2010.01) C07D 40/3/06 [51]

PHARMACIA & UPJOHN

COMPANY LLC, U.S.A. [71]

WO/2005/033098 [87]





P.O.B. 5352,

[74]




BEER-SHEVA 84152 The invention relates to non-hygroscopic salts of 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-

3H--indol-3-ylidene)methyl]-N-[(2)-2-hydroxy-3-morpholin-4-ylpropyl]-2,4-dimethyl-

1 H-pyrrole-3--yarboxamide, shown in structural formula (1) such as maleate salts, and

to crystalline polymorphs of these salts. The invention further relates to pharmaceutical

compositions of 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3--ylidene)methyl]-N-

[(2S)-2-hydroxy carboxamide salts, and meth roxy-3-morpholin-4-ylpropyl]-2,4-

dimethyl-1 H-pyrrole-3- ds of treating disorders such as cancer using such

compositions.

[57]

__________________

174513 [21[]11]

–אזפין ובנזו –נגזרות מותמרות של דיבנזוסקרטז, –דיאזפין המשמשות כמעכבי גמא

תהליך להכנתן ושימושן בהכנת תרופות לטיפול במחלת האלצהיימר

SUBSTITUTED DIBENZO-

AZEPINE AND BENZO-

DIAZEPINE DERIVATIVES

USEFUL AS GAMMA-SECRETASE

INHIBITORS, A PROCESS FOR

THEIR PREPARATION AND USE

THEREOF IN THE PREPARATION

OF MEDICAMENTS FOR

TREATING ALZHEIMER'S

DESEASE

[54]

27.09.2004 [22] EP [33] 06.10.2003 [32] 03022650.0 [31]

Int. Cl.(2010.01) A61K 31//55, 31//5513, A61P 25//28, C07D 22/3/18, 24/3/12,

40/1/12, 40/3/12, 40/5/12, 40/9/12, 41/7/12, C07F 07//10

[51]


SWITZERLAND [71]

WO/2005/040126 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

The present invention relates to compounds of the general formula (I) Wherein R1 is -

(CHR’)q-aryl or -(CHR')q-heteroaryl, which are unsubstituted or mono, di- or tri-

[57]




substituted by lower alkyl, lower alkoxy, CF3 or halogen, or is lower alkyl, lower

alkenyl, -(CH2)n-Si(CH3)3, -(CH2)n-O-lower alkyl, -(CH2)n-S-lower alkyl, -(CH2)q-

cycloalkyl, -(CH2)n-[CH(OH)]m-(CF2)p-CHqF(3-q), or is -(CH2)n-CR2-CF3, wherein the

two R radicals form together with the carbon atom a cycloalkyl ring; R' is hydrogen or

lower alkyl; n is 1, 2 or 3; in is 0 or 1; p is 0, 1, 2, 3, 4, 5 or 6; q is 0, 1, 2 or 3; R2 is

hydrogen or lower alkyl; R3 is hydrogen, lower alkyl, -CH

2CF

2CF3, CH

2CF3,

(CH2)2CF3, CF3, CHF2, CF3, CHF2, CH2F, or is aryl, optionally mono, di or tri-

substituted by halogen, or is (CH2)nNR5R

6, wherein R

5 and R

6 are independently from

each other hydrogen or lower alkyl; R4 is one of the following groups wherein R

7is

hydrogen, lower akl, -(CH2)n-CF3 or -(CH2)n-cycloalkyl; R8 is hydrogen, lower alkyl, -

C(O)-phenyl, -C(O)-lower alkyl, -C(O)O-(CH2)n- cycloalkyl, -C(O)O-(CH2)n-lower

alkyl, -C(O)NH-(CH2)n-lower alkyl or -C(O)NH(CH2).-CyClOalkYl; R9 is hydrogen,

lower alkyl, -(CH2)n-cycloalkyl or -(CH2)n-CF3; and to pharmaceutically suitable acid

addition salts, optically pure enantiomers, racernates or diastereomeric mixtures

thereof for the treatment of Alzheimer's disease..

__________________

174670 [21[]11]

כלי חיתוך

CUTTING TOOL

[54]

30.03.2006 [22]

Int. Cl.(2010.01) B23B 27//00, 27//04, 27//08 [51]

ISCAR LTD. [71] ישקר בע"מ, תפן

GIL HECHT [72] גיל הכט

ישקר בע"מ, תפן11, ת.ד.

ISCAR LTD.,

P.O.B. 11,

TEFEN 24959

[74]

A cutting tool having a tool axis (A) establishing a forward-to-rear direction, the

cutting tool comprising a cutting insert and an insert holder, the cutting insert having

an insert axis (B), and a peripheral side surface comprising a first wall, a second wall,

a third wall and at least one operative cutting section, the insert holder comprises a

forward securing portion and a rear body portion, the forward securing portion

comprises a base and securing surface, the securing surface including a first support, a

second support and a third support which all extend transversely to the base, at least a

portion of the first support abuts at least a portion of the first wall along a first

abutment region, at least a portion of the second support abuts at least a portion of the

second wall along a second abutment region and at least a portion of the third support

[57]




abuts at least a portion of the third wall along a third abutment region, wherein: the

first and the second abutment regions diverge downwardly, the second and the third

abutment regions diverge rearwardly and the third wall generally faces upwardly.

__________________

174681 [21[]11]

שיטה לייצור מכשיר מיקרואלקטרוני ארוז בוואקום

METHOD OF MANUFACTURING

A PACKAGED VACUUM

MICROELECTRONIC DEVICE

[54]

15.08.2001 [22] US [33] 31.08.2000 [32] 09/652516 [31]

Int. Cl.(2008.04) H01J 1//62 [51] DIVISION FROM 154517 [62]

INTEVAC, INC., U.S.A. [71]

WO/2002/019365 [87]

ן ושותפיו,ריינהולד כה א' 26רחוב הברזל

רמת החייל


26A HABARZEL ST.,


[74]

A method of manufacturing a packaged vacuum microelectronic device, said device

comprising a rectangular photocathode and a rectangular semiconductor die,

comprising: fabricating a housing of a ceramic material and forming a cavity within

said housing, wherein said die and said cavity exhibit rectangular shapes and said

housing comprises an electrical isolator; inserting said semiconductor die into said

housing; orienting said die within said housing whereby the volume of said housing is

efficiently employed, said die comprising a photodiode array; bonding the rectangular

photocathode to a surface of a transparent closure member; bonding a transparent

closure member to a sealing surface of said housing ,and drawing a vacuum in said

cavity.

[57]




__________________

174764 [21[]11]

נוליטי במצב מוצק של לייזר התקן לייזר מו משאבת דיודה

LASER DIODE-PUMPED

MONOLITHIC SOLID STATE

LASER DEVICE

[54]

08.10.2004 [22] FR [33] 09.10.2003 [32] 0311809 [31]

Int. Cl.(2010.01) H01S 03//109 [51]

OXXIUS SA, FRANCE [71]

WO/2005/036703 [87]

ושותפיו,ריינהולד כהן א' 26רחוב הברזל

רמת החייל

REINHOLD COHN AND

PARTNERS,

26A HABARZEL ST.,


[74]

The invention relates to an intracavity-doubled laser device, comprising a pumping

laser-diode, a Nd:YAG amplifying medium stimulated by a laser beam with a

fundamental wavelength emitted by the laser diode, the output face of said amplifying

medium being cut at the Brewster angle for said fundamental wavelength and a

birefringent frequency-doubling KNbO3 crystal. The device further comprises an

isotropic medium (3), inserted between the input face (8) of the birefringent crystal,

the amplifying medium (2) and the birefringent crystal (4), being fixed to each other

such as to provide a monolithic resonant cavity. Furthermore, the crystal axis 'c' of the

birefringent crystal includes a non-zero angle ?c with relation to the orthogonal

direction of polarisation of the fundamental wave defined by the Brewster surface.

[57]

__________________




174786 [21[]11]

מולקולות חומצות גרעין המקודדות וריאנטים של הרגולין, תכשירים ושיטות הכנה ושימוש

NUCLEIC ACID MOLECULES

ENCODING HEREGULIN

VARIANTS, COMPOSITIONS AND

METHODS FOR THEIR

PRODUCTION AND USE

[54]

10.02.1998 [22] US [33] 10.02.1997 [32] 08/799054 [31]

Int. Cl.(2010.01) A61K 38//17, C07K 14//47, 14//475, C12N 15//12 [51] DIVISION FROM 130827 [62]


WO/1998/035036 [87]


רמת החייל


26A HABARZEL ST.,


[74]

A nucleic acid molecule encoding a heregulin variant having an amino acid sequence

not found in nature and the ability to bind an ErbB receptor, wherein said variant

comprisses a methionine residue in place of amino acid residues corresponding to

residue numbers 228 to 231 of native human heregulin-beta 1 (SEQ ID NO: 93)

numbered from the N-terminus and said heregulin variant comprises a portion that is at

least 70% identical to the portion from about residue 175 to about residue 230 of

native human heregulin-beta 1 (SEQ ID NO: 93), said heregulin variany having a

greater specificity for the ErbB4 receptor, relative to the ErbB3 receptor, than a

heregulin that differs from the heregulin variant only in that the heregulin comprises

said amino acid residues corresponding to residue numbers 228 to 231 in place of said

methionine.

[57]

__________________

174941 [21[]11]

–2–]הטרואריל)פפרידינ–Nתולדות של איל(מתיל[ בנזאמיד ותכשירים רוקחיים

המכילים אותן

DERIVATIVES OF N-

[HETEROARYL (PIPERIDINE-2-

YL) METHYL] BENZAMIDE AND

PHARMACEUTICAL


THEM

[54]

15.10.2004 [22]






FR [33] 17.10.2003 [32] 0312142 [31]

Int. Cl.(2010.01) C07D 41/7/06 [51]

SANOFI, FRANCE [71]

WO/2005/037781 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

The invention relates to compounds having general formula (I), wherein: R1 represents

H or an alkyl, cycloalkyl, cycloalkylalkyl, phenylalkyl, alkenyl, alkynyl group; R2

represents a pyridinyl, furanyl, thienyl, thiazolyl or oxazolyl group, said group being

optionally substituted; and R3 represents H, one or more substituents selected from

among the halogen atoms and the trifluoromethyl, alkyl, cycloalkyl, alkoxy, phenyl,

cyano, acetyl, benzoyl, thioalkyl, alkylsulfonyl, carboxy or alcoxycarbonyl groups, or

a group having general formula NR4R5 or SO2NR4R5 or CONR4R5 in which R4 and R5

each represent H or an alkyl group or, together with the nitrogen atom bearing same,

form a pyrrolidine, piperidine or morpholine ring, said compound taking the form of a

base, an acid addition salt, a hydrate or a solvate. The invention also relates to the use

of the compound in therapeutics.

[57]

__________________

175017 [21[]11]

משאף לאבקה

POWDER INHALER

[54]

05.11.2004 [22] DE [33] 08.11.2003 [32] 10352277.8 [31]

Int. Cl.(2010.01) A61M 15//00 [51]


INTERNATIONAL GMBH,

GERMANY

[71]




WO/2005/044353 [87]


ילרמת החי


26A HABARZEL ST.,


[74]

The invention relates to an inhaler for the inhalation of powdery medicaments in a

capsule form. Said capsules are inserted, prior to use, into a capsule holder (3)

arranged inside the inhaler (3). After the capsule is inserted into the capsule holder, the

patient can press the actuating element (8) which can be displaced from a resting

position and which co-operates with at least one needle (9) pushed into the capsule

holder. The aim of the invention is to further improve said type of inhalers with respect

to operational comfort. Said aim is achieved by providing an embodiment of an inhaler

wherein the actuating element is embodied as a multifunctional actuating element (8a),

thereby enabling the cover (5) of the lower part (1) to pivot when the closing element

(6) is inserted into a first functional position, and enabling the mouth piece (4), which

is secured to the plate (2), to be removed from the plate in a second functional position

in such a manner that the mouth piece can be pivoted away from the lower part.

[57]


0242245 The applications for division



__________________

175225 [21[]11]

, חומצת CD40–נוגדן חד שבטי אנטגוניסט אנטיגרעין המקודדת לנוגדן, שורת תאי היברידומה

המסוגלת לייצר את הנוגדן, שימושים בנוגדן ותכשירים רוקחיים המכילים אותו.

ANTAGONIST ANTI-CD40

MONOCLONAL ANTIBODY, AN

ISOLATED NUCLEIC ACID

ENCODING THE ANTIBODY, A

HYBRIDOMA CELL LINE

CAPABLE OF PRODUCING THE

ANTIBODY, USE OF THE

[54]




ANTIBODY AND

PHARMACEUTICAL

COMPOSITIONS COMPRISING IT

04.11.2004 [22] US [33] 04.11.2003 [32] 60/517337 [31]

US 26.11.2003 60/525579

US 27.04.2004 60/565710

Int. Cl.(2010.01) A61K 39//395, A61P 29//00, 35//02, 37//00, C07K 16//28, C12N

15//13

[51]

NOVARTIS VACCINES AND

DIAGNOSTICS, INC., U.S.A. [71]

WO/2005/044854 [87]


רמת החייל


26A HABARZEL ST.,


[74]

Methods of therapy for treating diseases mediated by stimulation of CD40 signaling on

CD40-expressing cells are provided. The methods comprise administering a

therapeutically effective amount of an antagonist anti-CD40 antibody or antigen-

binding fragment thereof to a patient in need thereof. The antagonist anti-CD40

antibody or antigen-binding fragment thereof is free of significant agonist activity, but

exhibits antagonist activity when the antibody binds a CD40 antigen on a human

CD40-expressing cell. Antagonist activity of the anti-CD40 antibody or antigen-

binding fragment thereof beneficially inhibits proliferation and/or differentiation of

human CD40expressing cells, such as B cells.

[57]

__________________

175521 [21[]11]

תהליך לטיפוח מיקרואורגניזמים ממין טראוסטוכיטריאלי

PROCESS FOR THE

CULTIVATION OF

MICROORGANISMS OF THE

GENUS THRAUSTOCHYTRIALES

[54]

10.11.2004 [22] DE [33] 10.11.2003 [32] 10352837.7 [31]

Int. Cl.(2010.01) C12N 01//14, C12P 07//64 [51]

NUTRINOVA NUTRITION

SPECIALTIES & FOOD

INGREDIENTS GMBH, GERMANY

[71]

WO/2005/045050 [87]







5 SHENKAR ST.,

P.O.B. 12704,

HERZLIYA 46733

[74]

The invention relates to an optimized method for the production of PUFAs by

cultivating microorganisms of the order thraustochytriales in a fermentation medium

that is pH-stabilized using calcium carbonate and comprises 3 to 15 g/L of CaCO3,

whereupon the PUFAs are isolated from the microorganisms and/or the medium. The

invention particularly relates to novel optimized media having a different CaCO3

content. By using adequate quantities of CaCO3, the process can be significantly

simplified during fermentation while greater quantities of DHA can be obtained at an

increased oil content in the biomass, allowing thraustochytriales microorganisms to be

fermented without controlling the pH, thereby substantially improving and

significantly simplifying PUFA production.

[57]

__________________

175572 [21[]11]

קינאז JAKהטרוציקלים דחוסים, מעכבי סלקטיביים ותכשירים רפואיים המכילים אותם

CONDENSED HETEROCYCLES,

JAK SELECTIVE KINASE

INHIBITORS AND

PHARMACEUTICAL


THEM

[54]

12.01.2005 [22] AU [33] 12.01.2004 [32] 2004900103 [31]

Int. Cl.(2010.01) A61K 31//497, C07D 40/3/04, 41/3/14 [51]

YM BIOSCIENCES AUSTRALIA

PTY LTD., AUSTRALIA [71]

WO/2005/066156 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

A compound of the general formula (I) or pharmaceutically acceptable prodrugs, salts,

hydrates, solvates, crystal forms or diastereomers thereof, wherein A represents a

variety of six membered nitrogen containing heterocyclic rings, Q is a bond, halogen,

C1-4 alkyl, O, S, SO2, CO or CS and X1, X2, X3 and X4 are optionally substituted by 9

specific substituents or one can be nitrogen. Compositions comprising a carrier and at

least one compound of formula (I) are also provided. Further provided are methods of

treating tyrosine kinase-associated disease states by administering a compound of

[57]




formula (I) and methods of suppressing the immune system of a subject by

administering a compound of formula (I).

__________________

175722 [21[]11]

תהליך והתקן לייצור פרורים ואבקת גומי

PROCESS AND APPARATUS FOR

MANUFACTURING CRUMB AND

POWDER RUBBER

[54]

16.11.2004 [22] US [33] 17.11.2003 [32] 10/714782 [31]

Int. Cl.(2010.01) B02C 19//18, B09B 05//00, B29B 17//04, C08J 11//04 [51]

LEHIGH TECHNOLOGIES, LLC,

U.S.A. [71]

WO/2005/049656 [87]



P.O.B. 1352,

JERUSALEM 91013

[74]

A process and apparatus for manufacturing crumb and powder rubber. The process and

apparatus include a cooling step (12), effectuated by cooling means, wherein the

temperature or cryogenically cooled preprocessed rubber particles is controlled. The

process and apparatus also include a grinding step (20), effectuated by grinding means,

in which degree of grinding, and thus the product particle size range, is controlled.

[57]

__________________

175765 [21[]11]

PROCESS FOR THE PURIFICATION [54] תהליך לטיהור של גאבאפנטין






OF GABAPENTIN

14.12.2004 [22] IT [33] 16.12.2003 [32] MI2003A002456 [31]

Int. Cl.(2010.01) C07C 22/7/40, 22/9/28 [51]

ZAMBON GROUP S.P.A., ITALY [71]

WO/2005/058797 [87]

ושותפיו,ריינהולד כהן א' 26רחוב הברזל

רמת החייל


26A HABARZEL ST.,


[74]

A process for the preparation of gabapentin comprising the passage of a salt of the

same through a ionic exchange resin of strong cationic type, the elution of the

gabapentin which has fixed onto the column and the crystallization from organic

solvent, characterized in that the resin is regenerated by using a mineral acid in a molar

quantity between 50 and 90%, is described.

[57]

__________________

175936 [21[]11]

פולימרים מבוססים על סילוקסן או מרוכבים לשימוש בחיישנים כימיים לגלות תרכובות

ניטראט

SILOXANE-BASED POLYMERS

OR COMPOSITES FOR USE IN

CHEMICAL SENSORS FOR

DETECTING NITRATE

COMPOUNDS

[54]

03.12.2004 [22] FR [33] 05.12.2003 [32] 0350984 [31]

Int. Cl.(2010.01) C08L 83//16, G01N 21//00 [51]


ATOMIQUE, FRANCE [71]

WO/2005/057198 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

The invention relates to the use of at least one type of a polymer comprising a

repetitive structural unit of formula (I), wherein X and Y = a simple link or a linear C1-

C50 group; R1 and R2 = H, CN, C(Z)3, CH(Z)2, CH2Z with Z = halogens; NH2, NHR3,

NR3R4 with R3, R4 = halogens, CH3 or a linear or branched, saturated or unsaturated

C2-C20 hydrocarbon chain, possibly comprising one or several heteroatoms and/or

chemical functions containing at least one heteroatom; at least one R1 and R2 different

[57]




from H; or a compound which comprises said polymer and one or several conductive

charges and is used as a sensitive material in a sensor for detecting nitrate compounds.

Said invention can be used for detecting explosive materials, controlling/monitoring

air pollution and the quality of environment and for monitoring industrial sites.

__________________

176147 [21[]11]

מתודולוגיה סינטתית לאלקילציה חיזורית של אינדולים C–3בעמדה

SYNTHETIC METHODOLOGY

FOR THE REDUCTIVE

ALKYLATION AT THE C-3

POSITION OF INDOLES

[54]

15.12.2004 [22] US [33] 16.12.2003 [32] 60/529797 [31]

Int. Cl.(2010.01) C07B 37//04, C07D 20/9/18 [51]

WYETH LLC, U.S.A. [71]

WO/2005/058820 [87]


רמת החייל


26A HABARZEL ST.,


[74]

A process for the reductive alkylation at the C-3 position of an indole compound in

which the indole is treated with an aldehyde in the presence of a Lewis acid and a

silicon hydride reducing agent. The process is useful for alkylating the C-3 position of

indoles that contain acid-sensitive substituents at the N-1 position.

[57]

__________________




176649 [21[]11]

שתלים פולימרים המכילים בעדיפות תערובת לשחרור מבוקר של חומר PLG –ו PEGשל

GNRHפעיל, עדיף

POLYMERIC IMPLANTS,

PREFERABLY CONTAINING A

MIXTURE OF PEG AND PLG, FOR

CONTROLLED RELEASE OF

ACTIVE AGENTS, PREFERABLY

A GNRH

[54]

23.12.2004 [22] US [33] 30.12.2003 [32] 60/533301 [31]

US 19.04.2004 60/563377

US 28.05.2004 60/575199

Int. Cl.(2010.01) A61K 09//00, 09//16, 09//20, 38//24 [51]

DURECT CORPORATION, U.S.A. [71]

JOHN W. GIBSON, ARTHUR J.

TIPTON

[72]

WO/2005/067889 [87]

שות',ד"ר שלמה כהן ו 124אבן גבירול




P.O.B. 11490,

TEL AVIV 62038

[74]

Polymeric devices for controlled release of an active agent of interest are provided.

The active agent is provided within a biodegradable polymer system to supply a

polymeric device for controlled release of the active agent. The polymer system is a

copolymer or a polymer blend comprising a hydrophobic component and a hydrophilic

component, and the polymer system does not form a hydrogel when contacted with, or

immersed in an aqueous system, for example when the device is implanted in a

subject. When the device is administered to a subject, for example, when it is

implanted, the device releases the active agent in a controlled fashion without a lag

period, or with a minimal lag period. Methods for producing the polymeric devices are

also provided, as are methods of using the polymeric devices to provide for controlled

release of an active agent in a subject. Preferred hydrophobic component is a PLG.

Preferred hydrophilic Components are a PEG or a methoxyPEG. Preferred peptides are

LHRH, goserelin, leuprolide.

[57]

__________________

231773 [21[]11]

מכונת דפוס דיגיטאלית, רב שלבית, בטכנולוגית מערכת ושיטת הדפסה –הזרקת דיו

MULTI-STAGE INK JET DIGITAL

PRINTING APPARATUS,

METHOD AND SYSTEM

[54]






10.02.2005 [22] US [33] 12.02.2004 [32] 10/776163 [31]

IL 30.05.2004 162231

Int. Cl.(2010.01) B41J 02//135, 15//04, 33//34, D06B 01//00 [51]

-קורנית דיגיטל טכנולוגיות בע"מ, ראש העין

KORNIT DIGITAL TECHNOLOGIES

LTD. [71]

OFER BEN-ZUR, YOSSI PEARL [72] צור, יוסי פרל-עופר בן

WO/2005/076730 [87]


רמת גן




RAMAT GAN 52521

[74]

A digital printing machine includes a rigid frame, a first linear motion X axis stage

mounted on the frame, a printing table assembly movable on each linear X axis stage,

a linear motion Y axis stage mounted on the frame perpendicular to the linear X axis

stages, above the printing table assemblies, and an array of inkjet nozzles mounted on

the linear Y axis stage for linear motion perpendicular to the X axis stage, also a

second linear motion X axis stage mounted on the frame parallel to the first axis stage

and arranged for operation independently of the first axis stage, and/or a curing unit

located above the printing table assembly and/or a pre-printing wetting assembly, for

printing over garments, by applying wetting composition on the printed material, prior

to printing.

[57]

__________________

177324 [21[]11]

תכשיר המכיל תאי גזע רב עוצמתיים מתרבים של יונק עליון


PROLIFERATING PRIMATE

PLURIPOTENT STEM CELLS

[54]

10.01.2001 [22] US [33] 11.01.2000 [32] 60/175581 [31]

US 22.06.2000 60/213740

US 22.06.2000 60/213739

US 07.07.2000 60/216387

US 21.07.2000 60/220064

US 10.10.2000 09/688031

Int. Cl.(2010.01) C12N 05//0789 [51] DIVISION FROM 141742 [62]

GERON CORPORATION, U.S.A. [71]




WO/2001/051616 [87]


בותרחו2273, ת.ד.


P.O.B. 2273,

REHOVOT 76122

[74]

A composition comprising proliferating primate pluripotent stem cells which is

essentially free of feeder cells and further comprises a soluble preparation from

Engelbreth-Holm-Swarm tumor cells.

[57]

__________________

177414 [21[]11]

שיטה לייצור ציפוי קשה בעל עמידות גבוהה לקורזיה על פריטים המיוצרים ממתכות או

סגסוגות הניתנות לאינוד

METHOD FOR PRODUCING A

HARD COATING WITH HIGH

CORROSION RESISTANCE ON

ARTICLES MADE OF

ANODIZABLE METALS OR

ALLOYS

[54]

05.07.2005 [22] US [33] 23.07.2004 [32] 10/898152 [31]

Int. Cl.(2010.01) C25D 11//02 [51]

אלונים אחזקות אגש"ח בע"מ, קיבוץ אלונים

ALONIM HOLDINGS

AGRICULTURAL COOPERATIVE

SOCIETY LTD.

[71]

ILYA OSTROVSKY [72] איליה אוסטרובסקי

WO/2006/007972 [87]

ד"ר מרק פרידמן בע"מ,, רחוב ז'בוטינסקי 54מגדל משה אביב, ק.

7 גן -רמת

DR. MARK FRIEDMAN LTD.,

MOSHE AVIV TOWER, 54TH

FLOOR,

7 JABOTINSKY ST.,

RAMAT GAN 52520

[74]

A method for coating, a composition suitable for coating and a coating generated with

the method of coating on anodizable metallic surfaces, especially on magnesium rich

and aluminum rich surfaces, is disclosed. The composition is an aqueous solution

including alkali metal or ammonium cations, phosphorus containing anions and silicon

containing anions as well as optionally a peroxide or a compound of Al, Ti, Zr or any

mixture of them. Preferably, the anodizing is carried out with a micro-arc oxidation

process.

[57]

__________________




177561 [21[]11]

אמינוכוהולים –3מותמר –1תהליך להכנת טהורים מבחינה איננטומרית

PROCESS FOR THE

PREPARATION OF

ENANTIOMERICALLY PURE 1-

SUBSTITUTED-3-

AMINOALCOHOLS

[54]

21.02.2005 [22] EP [33] 19.02.2004 [32] 04003809.3 [31]

EP 28.04.2004 04010043.0

Int. Cl.(2010.01) C07C 21/3/00, C07D 33/3/20, 33/3/22 [51]

LONZA LTD., SWITZERLAND [71]

WO/2005/080370 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

Provided is a process for the preparation of enantiomerically pure 1-substituted-3-

aminoalcohols, particularly of (S)-(-)- and (R)-(+)-3-N-methylamino-l-(2-thienyl)-1-

propanol, by asymmetrically hydrogenating salts of a carboxylic acids with an

aminoketone of formula (II), wherein R1 is selected from the group consisting of 2-

thienyl, 2-furanyl and phenyl, each optionally substituted with one or more halogen

atoms and/or one or more C1-4-alkoxy groups, and wherein R2 is C1-4-alkyl or phenyl,

each optionally substituted with one or more halogen atoms and/or one or more C1-4-

alkyl or C1-4-alkoxy groups, and wherein the corresponding aminoalcohols are

obtained by subsequent hydrolysis of their salts. Furthermore provided are salts of a

carboxylic acid with said aminoketones and the aminoalcohols obtained by

asymmetriacally hydrogenating said aminoketones, respectively.

[57]

__________________

177563 [21[]11]

שיטות להגנה על צמחים על ידי שימוש באבאמקטין ותיאמטוקסאם

METHODS FOR PROTECTING

PLANTS USING ABAMECTIN AND

[54]






THIAMETHOXAM

07.06.2004 [22] US [33] 16.03.2004 [32] 60/553516 [31]

Int. Cl.(2010.01) A01N 25//00, 43//00, 51//00 [51]

SYNGENTA PARTICIPATIONS AG,

SWITZERLAND [71]

WO/2005/094585 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

The present invention provides an at least binary composition for controlling

nematodes and insects or representatives of the order Acarina, which composition

comprises: (A) a nernaticidally effective amount of at least one macrolide, and (B) an

insecticidally effective amount of at least one insecticide selected from the

neonicotinoids.

[57]

__________________

177591 [21[]11]

שיטה לאיבחון סרטן השחלות על ידי השימוש בביומרקרים

METHOD FOR DIAGNOSIS OF

OVARIAN CANCER COMPRISING

BIOMARKERS

[54]

18.01.2005 [22] US [33] 19.02.2004 [32] 60/545581 [31]

US 20.02.2004 60/545900

Int. Cl.(2010.01) C12Q 01//68, G01N 33//48, 33//574 [51]

YALE UNIVERSITY, U.S.A. [71]

WO/2005/083440 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

The claimed invention describes methods to diagnose or aid in the diagnosis of cancer.

The claimed methods are based on the identification of biomarkers which are

particularly well suited to discriminate between cancer subjects and healthy subjects.

These biomarkers were identified using a unique and novel screening method

described herein. The biomarkers identified herein can also be used in the prognosis

and monitoring of cancer. The invention comprises the use of leptin, prolactin, OPN

and IGF-II for diagnosing, prognosis and monitoring of ovarian cancer.

[57]




__________________

177761 [21[]11]

–גרגרי עמילן המכילים שמן לאספקת תוספי תועלת למצע

OIL CONTAINING STARCH

GRANULES FOR DELIVERING

BENEFIT-ADDITIVES TO A

SUBSTRATE

[54]

17.03.2005 [22] US [33] 18.03.2004 [32] 10/803586 [31]

Int. Cl.(2010.01) C11D 03//50 [51]

COLGATE-PALMOLIVE


WO/2005/090538 [87]

זליגסון גבריאלי ושות', 31רח' יבנה



31 YAVNE ST.,

P.O.B. 1426,

TEL AVIV 61013

[74]

An oil containing starch granule is provided comprising: (a) a starch to form an

effective matrix for said granule; (b) a perfume oil comprising ingredients having a

calculated Clog P of at least 3, said Clog P being the calculated octanol to water

partition coefficient, said perfume oil being capable of providing a benefit-additive to a

substrate upon contact therewith, said substrate being selected from the group

consisting of fabrics, hard surfaces, hair and skin; and (c) an effective amount of a

defined organic compound for inhibiting the migration of said oil to the surface of said

starch granule.

[57]

__________________




177778 [21[]11]

הידרוקסי –4תכשירים יציבים כימית של טאמוקסיפן

CHEMICALLY STABLE

COMPOSITIONS OF 4-HYDROXY

TAMOXIFEN

[54]

18.03.2005 [22] EP [33] 22.03.2004 [32] 04290762.6 [31]

US 22.03.2004 10/805530

Int. Cl.(2010.01) A61K 31//138, A61P 35//00, C07C 21/7/64 [51]

LABORATOIRES BESINS

INTERNATIONAL, FRANCE [71]

WO/2005/092310 [87]


רמת החייל


26A HABARZEL ST.,


[74]

A class of chemically stable 4-hydroxy tamoxifen compositions is characterized by

roughly equal amounts of the Z-4-hydroxy tamoxifen and E-4-hydroxy tamoxifen

isomers, such that the potency of the compositions is not affected adversely by the

isomerization that occurs between these two forms. The inventive compositions are

useful for preventing or for treating medical conditions.

[57]





__________________

177886 [21[]11]

מכונת גלילה הקפית ומרכזית משולבת

COMBINED PERIPHERAL AND

CENTRAL REWINDING MACHINE

[54]

15.03.2005 [22] IT [33] 18.03.2004 [32] FI2004A000061 [31]

Int. Cl.(2010.01) B65H 19//30 [51]

FABIO PERINI S.P.A., ITALY [71]

WO/2005/087639 [87]

צדק לצר, פרל כהן 5, רח' שנקר 1ים -מרכז גב


5 SHENKAR ST.,

P.O.B. 12704,

[74]






HERZLIYA 46733 הרצליה12704, ת.ד.

The rewinding machine comprises: a first winding roller (11) and a second winding

roller (13) defining a nip (15) through which said cores are inserted and through which

said web material (N) is fed; and at least one pair of motorized engaging members

(57), to engage the ends of a winding core and transmit a rotational movement to the

core during at least part of the winding cycle of each log. The engaging members and

the first and second winding roller are produced and disposed so that the log being

formed is in contact with said first and said second winding roller. Moreover, a third

winding roller (17) is provided, defining a winding space with said first and said

second winding roller, said third winding roller being movable to allow increase and

completion of winding of each log in said winding space.

[57]

__________________

178002 [21[]11]

שימוש בכמות אפקטיבית של חומר בהכנת , TH2תרופות לטיפול בהפרעה המתווכת על ידי

או לטיפול TH1לקידום תגובה חיסונית של באאוזינופיליה

USE OF A THERAPEUTICALLY

EFFECTIVE AMOUNT OF AN

AGENT IN THE PREPARATION

OF MEDICAMENTS FOR

TREATING A TH2-MEDIATED

DISORDER, PROMOTING A TH1

IMMUNE RESPONSE OR

TREATING EOSINOPHILIA

[54]

14.03.2005 [22] US [33] 12.03.2004 [32] 60/552523 [31]

US 27.10.2004 60/622559

Int. Cl.(2010.01) A61K 38//17, A61P 01//00, 07//00, 11//00, 13//12, 35//00, 37//00,

C07K 14//705

[51]

THE BRIGHAM AND WOMEN'S [71]




HOSPITAL, INC., U.S.A.

BETH ISRAEL DEACONESS

MEDICAL CENTER, U.S.A. WO/2005/090573 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

The invention relates to methods of modulating immune responses in a subject, such as

by administering to the subject agents which modulate tim-1, tim-2 or tim-4 activity,

or which modulate the physical interaction between tim-1 and tim-4 or between tim-2

and a tim-2 ligand. Immune responses include, but are not limited to, autoimmune

disorders, transplantation tolerance, and Thl and Th2-mediated responses and

disorders. The invention also relates to novel assays for identifying agents which

modulate the physical interaction between tim-1 and tim-4. In addition, the invention

relates to novel soluble tim-4 polypeptides and to nucleic acids which encode them.

[57]

__________________

178041 [21[]11]

מערכת אישית להעברת הודעות מולטימדיה

PERSONALIZED MULTIMEDIA

MESSAGING SYSTEM

[54]

23.03.2004 [22]

Int. Cl.(2010.01) H04L 12//58 [51]

NDS LIMITED, UNITED KINGDOM [71]

WO/2005/091537 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

A method for providing a personalized multimedia messaging service, wherein the

method includes obtaining an MMS message (800). Recipient according to

preferences of the at least one targeted recipient (900), thereby producing a

personalized MMS message (910), and transmitting the personalized MMS message to

the at least one targeted recipient indicate (1000) that the at least one targeted recipient

is not interested in receiving the personalized MMS message.

[57]





02222450222235 The applications for

division from this

application have not yet

been published

__________________

178202 [21[]11]

מערכת ושיטה ליצור דינאמי של שלוחת חיפוש נבחרת


DYNAMICALLY GENERATING A

SELECTABLE SEARCH

EXTENSION

[54]

30.07.2004 [22] US [33] 03.05.2004 [32] 60/566947 [31]

US 09.07.2004 10/887085

Int. Cl.(2010.01) G06F 03//00, 17//30 [51]

MICROSOFT CORPORATION,

U.S.A. [71]

WO/2005/111868 [87]


רמת החייל


26A HABARZEL ST.,


[74]

A system and related techniques accept user-inputted search terms to perform a search

for files within a file system hierarchy. A user searches a current level of a file system

(120) by entering a search term in a search term input box (112) of a user interface

(104). A search box (114) is dynamically created and may present an extension of the

search to a different level (122) in the file system in an attempt to locate more or

further matching files or hits. The extension of the search may be automatically

generated when an initial search fails to produce any results. When the user does select

the selectable search box, the user's search may be seamlessly extended to other files,

folders, trees or other points or levels in the files system. Search results may be

continuously or dynamically updated as the user enters more characters or other data.

[57]




__________________

178433 [21[]11]

מותמרים בעמדה –תולדות פנול או תיאופנול חד H3היעילות כליגנדים של 4או 3

3- OR 4-MONOSUBSTITUTED

PHENOL AND THIOPHENOL

DERIVATIVES USEFUL AS H3

LIGANDS

[54]

19.04.2005 [22] EP [33] 07.05.2004 [32] 04291187.5 [31]

GB 04.03.2005 0504564.6

Int. Cl.(2010.01) C07D 30/9/06 [51]

WARNER-LAMBERT COMPANY

LLC., U.S.A. [71]

WO/2005/108384 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The invention relates to 3- or 4-monosubstituted phenol and thiophenol derivatives of

formula (1) and to processes for the preparation of, intermediates used in the

preparation of, compositions containing and the uses of, such derivatives. Said 3- or 4-

monosubstituted phenol and thiophenol derivatives are H3 ligands and are useful in

numerous diseases, disorders and conditions, in particular inflammatory, allergic and

respiratory diseases, disorders and conditions.

[57]




__________________

178446 [21[]11]

בחירת ורכישת מערכת למתקן אלחוטי

SYSTEM SELECTION AND

ACQUISITION FOR A WIRELESS

DEVICE

[54]

09.03.2005 [22] US [33] 09.04.2004 [32] 60/561019 [31]

US 25.01.2005 11/043359

Int. Cl.(2010.01) H04M 03//00, H04W 48//18, 88//06 [51]


U.S.A. [71]

WO/2005/104513 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

Wireless devices with different capabilities may use a single file containing multiple

(e.g., two) PRLs for system selection and acquisition. A first PRL in the file has a first

(e.g., IS-683-A) format and includes PRL information for, e.g., 1x systems. A second

PRL has a second (e.g., IS-683-C) format and includes PRL information for, e.g., 1x

and 1xEV-DO systems or just 1xEV-DO systems. A legacy wireless device supporting

only IS-683-A would read and use the first PRL for system selection and acquisition

and ignore the second PRL. A wireless device supporting IS-683-C would read the

second PRL and (1) use the second PRL by itself if it contains PRL information for

both 1x and 1xEV-DO systems or (2) combine the first and second PRLs to generate a

combined PRL if the second PRL contains PRL information for only 1xEV-DO

systems.

[57]




__________________

178515 [21[]11]

אוליגופפטידים להפחתת ריכוז גבוה של אוריאה בדם

OLIGOPEPTIDES FOR

REDUCING ELEVATED BLOOD

UREA CONCENTRATION

[54]

08.04.2005 [22] US [33] 08.04.2004 [32] 10/821256 [31]

Int. Cl.(2010.01) A61K 38//06, 38//07 [51]

BIOTEMPT, B.V., THE

NETHERLANDS [71]

WO/2005/097163 [87]




5 SHENKAR ST.,

P.O.B. 12704,

HERZLIYA 46733

[74]

The invention includes a method of reducing urea concentration in a subject's serum.

Such a method comprises administering to the subject (e.g., a mammal such as a

human) a composition comprising an oligopeptide (or oligopeptides) having activity in

reducing urea concentration in the subject's serum as determined by a mouse renal

reperfusion test, wherein the oligopeptide comprises the sequence QGV or MTRV

(SEQ ID NO:1) (e.g., AQGV (SEQ ID NO:2) or MTRV (SEQ ID NO:1)).

[57]

__________________

869417 [21[]11]

שיטה ומערכת לדחיסת תיקים לאחסון ופעילות על תיקים דחוסים


COMPRESSION OF FILES FOR

STORAGE AND OPERATION ON

COMPRESSED FILES

[54]

21.04.2005 [22] US [33] 26.04.2004 [32] 60/565298 [31]

Int. Cl.(2010.01) G06F 05//10, 17//30, H03M 07//30 [51]

STOREWIZ INC., U.S.A. [71]

WO/2005/103878 [87]

R&D, SUZANNE EREZ, IBM R&Dסוזן ארז, מעבדות יבמ

LABORATORIES,

[74]






אוניברסיטת חיפה, הר הכרמל חיפה

HAIFA UNIVERSITY,

HAIFA 31905

A method and system for creating, reading and writing compressed files (44) for use

with a file access storage. The compressed data of a raw file (41) are packed into

plurality of compressed units (46) and stored as compressed file (44). One or more

corresponding compressed units (46A) may be read and/or updated with no need of

restoring the entire file whilst maintaining de-fragmented structure of the compressed

file (44).

[57]

__________________

790031 [21[]11]

שיטה ומערכת לאיחסון זהויות ארעיות של WLAN–I

METHOD OF AND SYSTEM FOR

STORAGE OF I-WLAN

TEMPORARY IDENTITIES

[54]

04.05.2005 [22] US [33] 06.05.2004 [32] 60/568625 [31]

US 15.03.2005 11/080918

Int. Cl.(2010.01) H04L 09//32, 12//28, 29//06 [51]


ERICSSON (PUBL), SWEDEN [71]

WO/2005/109818 [87]



P.O.B. 1352,

JERUSALEM 91013

[74]

A temporary-identity-storage method for user equipment includes receiving

authentication challenge information and at least one temporary identity, processing

the authentication challenge information, and determining whether the processing step

results in successful authentication. The user equipment includes mobile equipment

and a subscriber identity module. Responsive to a determination that the authentication

was successful, the received at least one temporary identity is considered to be valid. If

the received at least one temporary identity is at least one pseudonym and an

appropriate data file to the store the at least one pseudonym is available in the

subscriber identity module, the at least one pseudonym is stored and any previously-

[57]




stored pseudonym is over-written in the subscriber identity module. If the received at

least one temporary identity is at least one pseudonym and an appropriate data file to

the store the at least one pseudonym is not available in the subscriber identity module,

the at least one pseudonym is stored and any previously-stored pseudonym is over-

written in the mobile equipment.

__________________

179254 [21[]11]

תילריוסיס–חיסון אנטי

ANTI-THEILERIOSIS VACCINE

[54]

12.05.2005 [22] IN [33] 14.05.2004 [32] 880/DEL/2004 [31]

IN 26.10.2004 2103/DEL/2004

Int. Cl.(2010.01) A61K 39//002, 39//018 [51]

NATIONAL RESEARCH

DEVELOPMENT CORPORATION,

INDIA

[71]

WO/2005/109991 [87]


יילרמת הח


26A HABARZEL ST.,


[74]

A process for the preparation of anti-theileriosis vaccine comprising the steps of

isolating lymphoid cells infected with schizonts of Theileria annulata present in an

infected animal, culturing the infected cells in a growth medium, subjecting said

cultured cells to the step of in-vitro propagation by-serial passaging, developing cloned

curltures from a single cell by limiting dilution technique and further passaging these,

karyotyping the cells in the medium to ascertain the diploid character, and obtaining

viable cells with maximum infectivity rates, determining macroschizont nuclear

number, subjecting a number of viable cells with diploid character to the step of

cryoprotectant in liquid nitrogen in the presence of a cryoprotectant in the said growth

medium to obtain a suspension of viable cells, testing these cultures at different

passages and in varying dose levels in groups of calves for ascertaining their

[57]




pathogencity / antigenicity, determining passage level and dose for the safety and

efficacy of candidate vaccine, its safe use in new born calves and pregnant cows, time

taken to induce immunity, serological responses and erect on haematological

parameters, and testing its efficacy under wide field conditions in the susceptible stock.

__________________

179370 [21[]11]

נגזרות נפתלן, תהליך לייצורן, תכשירים לים אותן, ושימושן בהכנת רפואיים המכי

תרופות

NAPHTHALENE DERIVATIVES,

PROCESS FOR THEIR

PREPARATION,

PHARMACEUTICAL


THEM AND USE THEREOF IN

THE PREPARATION OF

MEDICAMENTS

[54]

24.05.2005 [22] EP [33] 02.06.2004 [32] 04102460.5 [31]

Int. Cl.(2010.01) A61K 31//445, 31//47, 31//5375, 31//541, 31//546, A61P 03//04,

C07D 21/1/44, 29/5/08, 40/1/12, 41/1/12, 41/3/12, 41/7/12

[51]


SWITZERLAND [71]

WO/2005/117865 [87]


שבעבאר 5352, ת.ד.



P.O.B. 5352,

BEER-SHEVA 84152

[74]

The present invention relates to compounds of formula (I) wherein A, R1 and R

2 are as

defined in the description and claims, and pharmaceutically acceptable salts thereof, to

the preparation of such compounds and pharmaceutical compositions containing them.

The compounds are useful for the treatment and/or prevention of diseases which are

associated with the modulation of H3 receptors.

[57]

__________________




179699 [21[]11]

מדידות ביומטריות באמצעות הדמייה מולטיספקטרלית

MULTISPECTRAL IMAGING

BIOMETRICS

[54]

26.05.2005 [22] US [33] 01.06.2004 [32] 60/576364 [31]

US 11.08.2004 60/600867

US 17.09.2004 60/610802

US 18.02.2005 60/654354

US 25.04.2005 11/115075

US 25.04.2005 11/115100

US 25.04.2005 11/115101

Int. Cl.(2010.01) G06K 09//00 [51]

LUMIDIGM, INC., U.S.A. [71]

WO/2006/093508 [87]





P.O.B. 11490,

TEL AVIV 62038

[74]

Methods and systems are provided for performing a biometric measurement on an

individual. A purported skin site of the individual is illuminated under a plurality of

distinct optical conditions during a single illumination session. Light scattered beneath

a surface of the purported skin site is received separately for each of the plurality of

distinct optical conditions. A multispectral image of the purported skin site is derived

from the received light. A biometric function is performed with the derived

multispectral image.

[57]

__________________

179737 [21[]11]






תולדות אינדול, תכשירים רפואיים המכילים ת תרופות לטיפול או מניעת אותן ושימושן בהכנ

H3מחלות הקשורות למודולציה של רצפטורי

INDOLE DERIVATIVES,

PHARMACEUTICAL


THEM AND USE THEREOF IN

THE PREPARATION OF

MEDICAMENTS FOR TREATING

OR PREVENTING DISEASES

ASSOCIATED WITH

MODULATION OF H3

RECEPTORS

[54]

13.06.2005 [22] EP [33] 21.06.2004 [32] 04102839.0 [31]

Int. Cl.(2010.01) A61K 31//4439, A61P 03//04, 43//00, C07D 40/1/12, 40/1/14,

40/3/12, 40/3/14, 41/3/14

[51]


SWITZERLAND [71]

WO/2005/123716 [87]

צאטו,לוצאטו את לו גן תעשייה, עומר




P.O.B. 5352,

BEER-SHEVA 84152

[74]

The present invention relates to compounds of formula (I) wherein X, R1, R

2, R

3, R

4

and R5 are as defined in the description and claims, and pharmaceutically acceptable

salts thereof, to the preparation of such compounds and pharmaceutical compositions

containing them. The compounds are useful for the treatment and/or prevention of

diseases which are associated with the modulation of H3 receptors.

[57]

__________________

179802 [21[]11]

תמסורת תקורה לשירותי שידור נתוני בקרה ושירותי שידור מרובב במערכת תקשורת

אלחוטית

TRANSMISSION OF OVERHEAD

INFORMATION FOR

BROADCAST AND MULTICAST

SERVICES IN A WIRELESS

COMMUNICATION SYSTEM

[54]

03.06.2005 [22]




US [33] 04.06.2004 [32] 60/577083 [31]

Int. Cl.(2010.01) H04L 01//00, 05//02 [51]


U.S.A. [71]

WO/2005/122627 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

To transmit overhead information for broadcast and multicast services in a system that

utilizes multiple radio technologies, time slots used for OFDM in a super-frame are

initially ascertained. Overhead information for multiple streams to be sent in the time

slots used for OFDM is generated. The overhead information conveys the time slots

and the coding and modulation used for the streams and may be given in various

forms. Multiple records may be formed for the overhead information for the streams.

The overhead information for the streams is processed and time division multiplexed

with the data for the streams in the super-frame. Information indicating the time slots

used for OFDM in the super-frame may be sent separately or included in the overhead

information. An indicator may also be appended to each stream to indicate whether

there is any change in the overhead information for the stream in the next super-frame.

[57]

__________________

798101 [21[]11]

התקן ותהליך לקירור והזרמה מחדש של טיח קירות שנשרף

APPARATUS AND PROCESS FOR

COOLING AND DE-STEAMING

CALCINED STUCCO

[54]

19.05.2005 [22] US [33] 15.07.2004 [32] 10/891964 [31]

Int. Cl.(2010.01) F25D 23//12 [51]

UNITED STATES GYPSUM


WO/2006/019456 [87]


רמת החייל


26A HABARZEL ST.,


[74]




The present invention is an apparatus and process for cooling and de-steaming hot

calcined stucco used in the production of gypsum boards or bagged plaster. The

apparatus is a fluid bed stucco cooler and comprises a cooler housing having a plenum

having a stucco inlet and stucco outlet. The stucco cooler includes a rotating disk in the

plenum. The rotating disk includes nozzle for spraying fluid, and is attached to a

rotable shaft extending from the side of the cooler also includes a fluidization pad and

agitator to help to mix the air and the stucco powder to insure fluidization, prevent

channeling, and prevent the stucco powder from building up on the various

components. The air also forces steam from the hot calcined stucco out through an air

outlet located at the top of the stucco cooler, thereby de-steaming the stucco. The

stucco flows through the plenum and passes over the cooling coils, thereby cooling the

stucco as it reaches the stucco outlet.

[57]

__________________

179893 [21[]11]

בניות אבני חן שימושי במיוחד ליהלומים

GEMSTONE CONSTRUCTIONS

PARTICULARLY USEFUL FOR

DIAMONDS

[54]

06.12.2006 [22] IL [33] 21.11.2006 [32] 179471 [31]

Int. Cl.(2010.01) A44C 17//02 [51]

JACKOB TSROR [71] גן-יעקב צרור, רמת

ע"מ,( ב1995ג'י.אי.ארליך ) 11,רחוב מנחם בגין 15מגדל איילון, קומה

רמת גן




RAMAT GAN 52521

[74]

A gemstone construction comprising: a plurality of individual gemstones assembled

together by a common frame to define a composite gemstone unit having a girdle, a

crown on one side of the girdle and a pavilion on the opposite side of the girdle; each

of said individual gemstones defining a segment of said composite gemstone unit and

[57]




including a girdle segment of the composite gemstone unit girdle, a crown segment of

the composite gemstone unit crown and a pavilion segment of the composite gemstone

unit pavilion; the girdle and crown segments of at least some of said individual

gemstones having an outer face to serve as the outer face of the composite gemstone

unit girdle and crown; the girdle segment of at least some of said individual gemstones

having at least one flat, smooth, inner face in contact with a corresponding flat,

smooth, inner face of the girdle segment of another individual gemstone in the

composite gemstone unit; said common frame engaging the girdle segments of said

individual gemstones to press the flat, smooth, inner faces of the individual gemstones

into firm contact with each other such that the composite gemstone unit appears

substantially seamless to the naked eye.

__________________

180004 [21[]11]

שיטה והתקן לריבוב מוגבר בהעברת אות ללויין


ENHANCED UPLINK

MULTIPLEXING

[54]

05.07.2005 [22] US [33] 19.07.2004 [32] 60/588960 [31]

US 25.04.2005 11/113763

Int. Cl.(2010.01) H04B 07//00, 07//216, H04J 03//02, 03//16, H04W 28//16 [51]


CORPORATION, U.S.A. [71]

WO/2006/019562 [87]


רמת החייל


26A HABARZEL ST.,


[74]

A method and apparatus for enhanced uplink multiplexing are disclosed. A set of [57]




combinations of MAC-d flows (and/or logical channels) that are allowed to be

multiplexed within a MAC-e PDU is defined for a WTRU. The WTRU MAC-e entity

selects a combination among a set of allowed combinations for multiplexing MAC-d

flows for each MAC-e PDU. Certain MAC-d flow combinations may be defined that

can not be blocked from transmission even when the WTRU is in a transmit power

restricted state. The amount of data from each logical channel or corresponding MAC-

d flow that can be multiplexed within a MAC-e PDU may be defined to ensure

guaranteed data rates. When the WTRU is in a restricted power condition, an

indication of the restricted power condition may be passed to the Node-B with the EU

transmission.





__________________

180213 [21[]11]

מקבע לקוורץ המשמש לעיבוד נתחי מוליכים למחצה ושיטה לייצור של המקבע

QUARTZ GLASS JIG FOR

PROCESSING SEMICONDUCTOR

WAFERS AND METHOD FOR

PRODUCING THE JIG

[54]

30.03.2006 [22] DE [33] 15.04.2005 [32] 102005017739.5 [31]

Int. Cl.(2010.01) C03B 19//14, C03C 03//06, H01L 21//00 [51]

HERAEUS QUARZGLAS GMBH & CO.

KG, GERMANY [71]

WO/2006/108766 [87]

פישר וילר ג'ונס, 26הברזל

רמת החייל

FISHER WEILER JONES,

26 HABARZEL ST.,


[74]

An ideal quartz glass for a wafer holder for application in an etching environment is [57]




characterised both by high purity and also a high dry etching resistance. According to

the invention, such a quartz glass may be achieved, whereby the quartz glass is doped

with nitrogen, at least in a region near the surface, has an average content of metastable

hydroxy groups of less than 30 wt. ppm, the fictive temperature is less than 1250 °C

and the viscosity at a temperature of 1200 °C is at least 1013 dPas. A commercial

method for production of such a quartz glass comprises the following method steps:

fusion of a SiO2 raw material to give a quartz glass blank, whereby the SiO2 raw

material or the quartz glass blank is subjected to a dehydration process, heating of the

SiO2 raw material or the quartz glass blank to a nitriding temperature in the range

between 1050 °C and 1850 °C under an atmosphere containing ammonia, a

temperature treatment, by means of which the quartz glass of the quartz glass blank is

brought to a fictive temperature of 1250 °C or less and a surface treatment of the quartz

glass blank to give the quartz glass holder.

__________________

180219 [21[]11]

ערכה לגילוי חומרי נפץ

SPOT TEST KIT FOR

EXPLOSIVES DETECTION

[54]

23.06.2005 [22] US [33] 24.06.2004 [32] 60/583161 [31]

US 22.06.2005 11/159451

Int. Cl.(2010.01) G01N 01//02 [51]

THE REGENTS OF THE

UNIVERSITY OF CALIFORNIA,

U.S.A.

[71]

PHILIP F. PAGORIA, RICHARD E.

WHIPPLE, PETER J. NUNES, JOEL

DEL ECKELS, JOHN G. REYNOLDS,

ROBIN R. MILES, MARINA L.

CHIARAPPA-ZUCCA

[72]

WO/2006/093517 [87]




אגמון,-סורוקר 14בית נולטון, רחוב שנקר


SOROKER-AGMON,

14 SHENKAR ST.,


[74]

An explosion tester system comprising a body, a lateral flow membrane swab unit

adapted to be removeably connected to the body, a first explosives detecting reagent, a

first reagent holder and dispenser operatively connected to the body, the first reagent

holder and dispenser containing the first explosives detecting reagent and positioned to

deliver the first explosives detecting reagent to the lateral flow membrane swab unit

when the lateral flow membrane swab unit is connected to the body, a second

explosives detecting reagent, and a second reagent holder and dispenser operatively

connected to the body, the second reagent holder and dispenser containing the second

explosives detecting reagent and positioned to deliver the second explosives detecting

reagent to the lateral flow membrane swab unit when the lateral flow membrane swab

unit is connected to the body.

[57]

__________________

180331 [21[]11]

פירידון, תכשירים –2–קרבמואיל–3נגזרות של רפואיים המכילים אותן ושימושים שלהן

3-CARBAMOYL-2 PYRIDONE

DERIVATIVES,

PHARMACEUTICAL


THEM AND USES THEREOF

[54]

28.10.2005 [22] JP [33] 28.10.2004 [32] 2004-313947 [31]

JP 31.05.2005 2005-159995

Int. Cl.(2010.01) A61K 31//435, 31//436, 31//4365, 31//4412, 31//4436, 31//4439,

31//444, 31//4545, 31//455, 31//4704, 31//496, 31//506, 31//517, 31//5377, 31//55,

[51]




31//675, A61P 17//04, 25//02, 37//08, 43//00, C07D 21/3/80, 21/3/82, 21/3/85, 21/5/54,

21/5/56, 22/1/16, 40/1/06, 40/1/12, 40/5/06, 40/5/12, 41/3/12, 41/7/12, 49/1/052,

49/5/04, C07F 09//58

SHIONOGI & CO., LTD., JAPAN [71]

WO/2006/046778 [87]




5 SHENKAR ST.,

P.O.B. 12704,

HERZLIYA 46733

[74]

A compound represented by the general formula (I): (wherein R1 is optionally

substituted C1-8 alkyl, etc.; R2 is C1-6 alkyl and R

3 is C1-6 alkyl, etc., provided that R

2

and R3 may be bonded to each other to form an optionally substituted 5- to 10-

membered nonaromatic carbocycle; R4 is hydrogen, etc.; and G is a group selected

among, e.g., groups represented by the formula (X) (wherein R5 is hydrogen, etc.; X

1 is

a single bond, etc.; X2 is, e.g., optionally substituted C1-8 alkylene optionally having

one or two atoms or groups selected between -O- and -N(R6)- (R

6 is hydrogen, etc.);

X3 is a single bond, etc.; Y is -O-, etc.; and Z is hydrogen, etc.)), a pharmaceutically

acceptable salt of the compound, or a solvate of either. These compounds have

cannabinoid receptor agonistic activity. Also provided are a medicinal composition, an

atopic dermatitis remedy, and an anti-itching agent, especially an anti-itching agent for

oral administration or for external use, which each contains any of those compounds as

an active ingredient.

[57]

__________________

180338 [21[]11]

תצורות דינמיות של פרוטוקולי אינטרנט לציוד מסוף המחובר להתקן אלחוטי

DYNAMIC CONFIGURATION OF

IP FOR A TERMINAL

EQUIPMENT ATTACHED TO A

WIRELESS DEVICE

[54]

28.06.2005 [22]




US [33] 30.06.2004 [32] 10/882522 [31]

Int. Cl.(2010.01) H04L 29//12 [51]


U.S.A. [71]

WO/2006/004753 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

Techniques for dynamically configuring IP and providing IP connectivity for a

terminal equipment '110' attached to a wireless device '120' are described. The

wireless device obtains from a wireless network '130' a dynamically assigned IP

address, an IP gateway's IP address, a subnet mask, or none or any combination

thereof. Wireless device determines a host IP address (which may be the dynamically

assigned IP address), a router IP address (which may be the gateway IP address or a

spoofed IP address), a server IP address (which may be the router IP address), and a

subnet mask (which may be obtained from the wireless network or spoofed by the

wireless device). Wireless device, acting as a DHCP server, provides IP configuration

for the terminal equipment, acting as a DHCP client. Wireless device thereafter

forwards IP packets exchanged between the terminal equipment and wireless network

and processes DHCP packets from the terminal equipment.

[57]

__________________

180411 [21[]11]

, תכשירים PARPתולדות קווינאזולינון כמעכבי רוקחיים המכילים אותן, השימוש בהן ושיטות

להכנתן

QUINAZOLINONE DERIVATIVES

AS PARP INHIBITORS,

PHARMACEUTICAL


THEM, USES AND METHODS OF

PREPARATION THEREOF

[54]

28.06.2005 [22] EP [33] 30.06.2004 [32] 04076887.1 [31]

Int. Cl.(2010.01) A61K 31//517, 31//5375, A61P 03//10, 09//00, 09//10, 13//12,

17//00, 19//10, 21//00, 25//00, 25//28, 31//18, 35//00, 43//00, C07D 23/9/88, 40/1/12,

40/3/12, 40/3/14, 40/5/14, 41/3/14, 41/7/14

[51]

JANSSEN PHARMACEUTICA, N.V.,

BELGIUM [71]




WO/2006/003146 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The present invention provides compounds of formula (I), their use as PARP inhibitors

as well as pharmaceutical compositions comprising said compounds of formula (I)

wherein R1, R

2, R

3, L, X, Y and Z have defined meanings.

[57]

__________________

180440 [21[]11]

ת בהירות גבוההבעל Xמקור דחוס לקרן

COMPACT SOURCE OF A HIGH-

BRIGHTNESS X-RAY BEAM

[54]

28.12.2006 [22] FR [33] 03.01.2006 [32] 0650007 [31]

Int. Cl.(2010.01) H01J 35//10 [51]

ALCATEL LUCENT, FRANCE [71]


רמת החייל

REINHOLD COHN AND

PARTNERS,

26A HABARZEL ST.,


[74]

Device for the emission of X-rays, comprising: a vacuum chamber (7), limited by a

sealed wall (1f), a vacuum pump (1), including in a sealed peripheral casing (1f) a

stator (1b), a rotor (1a) and means of slaving (10a-10e) the rotor, allowing its stable

rotation at very high speed, and connected to the vacuum chamber to generate and

maintain a vacuum, a cathode (3), in the vacuum chamber, adapted to generate an

electron flux (4), a rotating anode (2), in the vacuum chamber, driven in rotation

around a rotation axis (I-I), and receiving in its periphery (2a) the electron flux coming

from the cathode to emit X-rays (6) towards an output (11), the rotating anode is

connected to the rotor of the vacuum pump, arranged coaxially with the rotor, the

sealed peripheral casing of the vacuum pump itself constitutes all or part of the sealed

wall of the vacuum chamber, and characterized in that the device also comprises at

least two cooling elements (8, 9), fixed to the stator of the vacuum pump or to the

sealed peripheral casing, arranged respectively opposite each of the main radial faces

(2b, 2c) of the rotating anode to absorb the thermal energy from radiation emitted by

[57]




the rotating anode in operation.

__________________

180486 [21[]11]

מלחים של תולדת בנזימידאזול עם אמינים ותהליך לייצרם

SALTS OF BENZIMIDAZOLE

DERIVATIVE WITH AMINES AND

PROCESS FOR PRODUCTION

THEREOF

[54]

05.08.2005 [22] JP [33] 06.08.2004 [32] 2004-230094 [31]

Int. Cl.(2010.01) A61K 31//4439, A61P 01//04, C07D 40/1/12 [51]

EISAI R&D MANAGEMENT CO.,

LTD., JAPAN [71]

WO/2006/013960 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

The invention provides (1) a process for the production of alkali metal salts of 2-[{4-

(3-methoxypropoxy)-3- methylpyridin-2-yl}methylsulfinyl]-1H-benzimidazole which

are useful as gastric acid secretion inhibitor, antiulcer agent, and other drugs and (2)

salts of 2-[{4-(3-methoxypropoxy) -3-methylpyridin-2-yl}methylsulfinyl]-1H-

benzimidazole with amines which are intermediates for the production of the alkali

metal salts and a process for the production of the same. Specifically, salts represented

by the general formula (I): wherein A+ is an isopropylammonium ion, a sec-

butylammonium ion, or a cyclopentylammonium ion.

[57]




__________________

180487 [21[]11]

גורם המשחרר קורטיקוטרופין לטיפול בהפרעות עיצביות

CORTICOTROPIN RELEASING

FACTOR (CRF) FOR TREATMENT

OF NEURAL DISORDERS

[54]

08.07.2005 [22] GB [33] 08.07.2004 [32] 0415359.9 [31]

GB 21.10.2004 0423386.2

Int. Cl.(2010.01) A61K 38//17, 38//22 [51]

AIMSCO LIMITED, UNITED

KINGDOM [71]

WO/2006/021814 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

Analysis of a goat serum product with many therapeutic effects is described. The

product is identified as containing proopiomelanocortin (POMC) and Corticotropin

releasing factor (CRF) peptides, as well as breakdown products of these peptides. We

describe methods of treatment of diseases including cancers, multiple sclerosis, and

neural disorders using these peptides and their products, as well as medicaments

including such peptides and methods of producing the peptides.

[57]

__________________

180516 [21[]11]

סלילים מיניאטוריים על בסיס עם מעגל חשמלי מודפס

MINIATURE COILS ON CORE

WITH PRINTED CIRCUIT

[54]

02.01.2007 [22] US [33] 06.01.2006 [32] 11/327058 [31]

Int. Cl.(2010.01) H04R 09//06 [51]

BIOSENSE WEBSTER, INC., U.S.A. [71]

רוחני בע"מ, ד. קליגלר שירותי קניין תל אביב33111, ת.ד.


P.O.B. 33111

TEL AVIV 61330

[74]






A method for producing a coil assembly, comprising: overlaying printed circuit traces

on a core by printing the circuit traces onto the core, the traces comprising terminals

for coupling to conductive connections on a base on which the coil assembly is to be

mounted; wrapping two or more wires around the core and printed circuit traces so as

to define two or more coils, wrapped in different, respective directions, the wires

having respective ends; and coupling the ends of the wires to the printed circuit traces,

so as to connect the wires through the traces to the terminals.

[57]

__________________

180524 [21[]11]

–5)–4]–5}–4–הידרוקסי–Nתהליך להכנת –איל(–4–תיאזול–3,1–מתיל–2–איסופרופיל

בנזאמידין–פנטוקסי{–פנוקסי[

PROCESS FOR PREPARING N-

HYDROXY-4-{5-[4-(5-ISOPROPYL-

2-METHYL-1,3-THIAZOL-4-YL)-

[54]




PHENOXY]-PENTOXY}-

BENZAMIDINE

05.07.2005 [22] KR [33] 05.07.2004 [32] 10-2004-

0052070

[31]

Int. Cl.(2010.01) C07D 27/7/22 [51]

DONG WHA PHARMACEUTICAL

CO., LTD., REPUBLIC OF KOREA [71]

JIN SOO LEE, SEOK HOON AHN,

YOUNG GOO JIN, JAE HOON

PARK, DONG HYUK SHIN, EUN

HEE CHO, HWAN BONG CHANG,

YOUNG HO JUNG

[72]

WO/2006/004368 [87]





P.O.B. 45087,

JERUSALEM 91450

[74]

This invention relates to an improved method of preparing N-hydroxy-4-{5- [4- (5-

isopropyl-2-methyl-l, 3-thiazol-4-yl) phenoxy] pentoxy}benzamidine .

[57]

__________________

180758 [21[]11]

–'3',2–פלואורו–'2פוספונאטים של אנלוג של דידאוקסיאדנוזין, תכשירים –'3',2–דידהידרו

המכילים אותם ושימושים בהם להכנת תרופות HIVלעיכוב

PHOSPHONATES OF A 2 -

FLUORO-2' ,3' -DIDEHYDRO-2' ,3'

-DIDEOXYADENOSINE

ANALOGUE, PHARMACEUTICAL


THEM AND USE THEREOF FOR

THE PREPARATION OF

MEDICAMENTS FOR INHIBITING

HIV

[54]

27.07.2005 [22] US [33] 27.07.2004 [32] 60/591811 [31]

Int. Cl.(2010.01) A61K 31//662, 31//7076, 47//48, A61P 31//18, C07F 09//6561,

C07H 19//16

[51]

GILEAD SCIENCES, INC., U.S.A. [71]

WO/2006/015261 [87]




תפיו,ריינהולד כהן ושו א' 26רחוב הברזל

רמת החייל


26A HABARZEL ST.,


[74]

The invention is related to phosphorus substituted anti-viral inhibitory compounds,

compositions containing such compounds, and therapeutic methods that include the

administration of such compounds, as well as to processes and intermediates useful for

preparing such compounds.

[57]

__________________

180781 [21[]11]

אנלוגים פוספונאטים של תרכובות מעכבות HIV

PHOSPHONATE ANALOGS OF

HIV INHIBITOR COMPOUNDS

[54]

26.07.2005 [22] US [33] 27.07.2004 [32] 60/591811 [31]

Int. Cl.(2010.01) A61K 31//662, 47//48, C07F 09//38 [51]

GILEAD SCIENCES, INC., U.S.A. [71]

WO/2006/110157 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The invention is related to phosphorus substituted anti-viral inhibitory compounds,

compositions containing such compounds, and therapeutic methods that include the

administration of such compounds, as well as to processes and intermediates useful for

preparing such compounds.

[57]

__________________

180995 [21[]11]

מתקן היברידי עבור ריפויי תא

HYBRID DEVICE FOR CELL

THERAPIES

[54]

20.07.2005 [22] US [33] 29.07.2004 [32] 60/591919 [31]






Int. Cl.(2010.01) A61F 02//02, A61K 09//22, A61M 05//142, C12M 03//00 [51]

THE UNIVERSITY OF MIAMI,

U.S.A. [71]

WO/2006/020288 [87]



P.O.B. 1352,

JERUSALEM 91013

[74]

A device for receiving implanted biological material includes a porous outer wall

defining an inner space, a fluid manifold assembly for selectively infusing at least one

immunosuppresive and growth factor media to said space, and a pump structure

operatively coupled to the manifold assembly. The device may comprise an additional

plunger body for being disposed in said space and so as to define a peripheral gap

between the plunger and the perforated wall of the device.

[57]

__________________

181024 [21[]11]

והרכבים הכוללים TRPV 1אגוניסטים של אותם

TRPV1 AGONISTS AND

FORMULATIONS CONTAINING

THEM

[54]

06.07.2005 [22] IT [33] 30.07.2004 [32] MI2004A001566 [31]

Int. Cl.(2010.01) A61K 31//16, A61P 13//00, 25//00, C07C 23/5/26, 23/5/28, C07D

30/3/46

[51]


WO/2006/010445 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The compounds of the general formula (I) in which X is represented by two hydrogen

atoms, a pi-bond, oxygen or methylene; R2 is a C6-C12 aryl, or arylalkyl residue; R3 is

hydrogen, 2-hydroxyethyl or 2-aminoethyl are useful for the treatment of pathologies

mediated by vanilloid receptors type I.

[57]

__________________




181119 [21[]11]

שלבי של גששים רפואיים–כיול דו

TWO-STAGE CALIBRATION OF

MEDICAL PROBES

[54]

01.02.2007 [22] US [33] 09.02.2006 [32] 11/351135 [31]

Int. Cl.(2010.01) G01N 01//00, 27//00, G01Q 40//00 [51]

BIOSENSE WEBSTER INC., U.S.A. [71]

וחני בע"מ,ד. קליגלר שירותי קניין ר תל אביב33111, ת.ד.


P.O.B. 33111

TEL AVIV 61330

[74]

Medical apparatus, comprising: a probe, having a proximal end and a distal

end, which is adapted for insertion into a body of subject, the probe

comprising: a sensor, which outputs a sensor signal ;a first microcircuit,

which stores first calibration data with respect to the sensor; and a first

connector at the proximal end of the probe, electrically coupled at least to the

sensor; a probe adapter, comprising: a second connector, which is arranged to

mate with the first connector; a signal processing circuit, which is coupled to

process the sensor signal so as to output a processed signal; a second

microcircuit, which stores second calibration data with respect to the signal

processing circuit; a microcontroller, which is arranged to receive the first and

second calibration data from the first and second microcircuits, respectively,

and to compute combined calibration data based on the first and second

calibration data; and a third connector, electrically coupled at least to the

signal processing circuit, and a console, comprising: a fourth connector,

which is arranged to mate with the third connector, and signal analysis

circuitry, which is coupled to receive at least the processed signal from the

fourth connector and is arranged to analyze the processed signal using the

combined calibration data provided by the probe adapter.

[57]

__________________

181274 [21[]11]

צבע –שיטה והתקן לארכיטקטורה רבת פיקסלי בעלת שליטה יחידה

METHOD AND APPARATUS

PROVIDING SINGLE BUMP,

[54]






MULTI-COLOR PIXEL

ARCHITECTURE

17.11.2005 [22] US [33] 03.12.2004 [32] 11/003637 [31]

Int. Cl.(2010.01) H01L 31//101 [51]


WO/2006/062721 [87]


רמת החייל


26A HABARZEL ST.,


[74]

An infrared detector has a multi-layer structure to simultaneously detect IR energy in

different spectral bands without changing polarity of a bias imposed across the

detector. Two absorption layers are separated by a barrier layer that imposes an

electrical potential barrier to one of the absorption layers. Under low bias in one

direction, only one layer generates a photocurrent. Under a higher bias in the same

direction, both layers generate a photocurrrent. Additional absorption layers may be

added to detect additional bands of energy, where the additional absorption layers

generate photocurrent under a bias in another direction. Two, three, and four band

detection is disclosed. Where absorbing layers within a single unit cell absorb under

different bias direction, the barrier layer between those different bias direction layers

suppresses a diffusing electron current. A method for detecting and resolving energy

absorbing in two, three, and four different energy bands is also provided.

[57]

__________________

181317 [21[]11]

דיאמינו חומצה שיקימית–5, 4תהליך להכנת

PROCESS FOR THE

PREPARATION OF 4,5-DIAMINO

SHIKIMIC ACID

[54]

24.08.2005 [22] EP [33] 02.09.2004 [32] 04104227.6 [31]

Int. Cl.(2010.01) C07C 22/7/10, 22/7/18, 22/9/48 [51]


SWITZERLAND [71]




WO/2006/024436 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The present invention relates to a process for the preparation of a 4,5-diamino shikimic

acid derivative of formula (I) and pharmaceutically acceptable addition salts thereof

wherein R1, R

1’ are independent of each other H or alkyl, R

2 is an alkyl and R

3, R

4 are

independent of each other H or an alkanoyl, with the proviso that not to both R3 and R

4

are H. 4,5-diamino shikimic acid derivatives of formula I, especially the (3R,4R,5S)-5-

amino-4-acetylamino-3- (1-ethyl-propoxy)-cyclohex-l-ene-carboxylic acid ethyl ester

and its pharmaceutically acceptable additional salts are potent inhibitors of viral

neuraminidase.

[57]

__________________

181462 [21[]11]

תהליך לייצור תולדות אמינים בעלות פעילות אופטית

PROCESS FOR PRODUCTION OF

OPTICALLY ACTIVE AMINE

DERIVATIVES

[54]

12.09.2005 [22] JP [33] 13.09.2004 [32] 2004-265307 [31]

Int. Cl.(2010.01) A61K 31//343, A61P 25//20, C07D 30/7/77 [51]


COMPANY LIMITED, JAPAN [71]

WO/2006/030739 [87]

ות',סנפורד ט. קולב וש , מרמורק 4שער הגיא



P.O.B. 2273,

REHOVOT 76122

[74]

An industrial process for producing high-purity optically active amine derivatives in

high yield while inhibiting the formation of by-products, which comprises subjecting

(E)-2- (1, 6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-ylidene)ethylamine to asymmetric

reduction, catalytically reducing the obtained product at a reaction temperature of 40 to

[57]




100 C and a pH of 3 to 9, subjecting the obtained (S)-2-(1,6,7,8-tetrahydro -2H-indeno

[5,4-b]furan-8-yl)ethylamine to propionylation, and then crystallizing the reaction

mixture.


שטרם פורסמו90/532/5 The applications for division



__________________

181510 [21[]11]

שיטת כיול של מיקום יחסי של מדידים במערכת זיהוי ירי

METHOD FOR CALIBRATING

RELATIVE SENSOR POSITIONS

OF SENSORS IN A SHOOTER

DETECTION SYSTEM

[54]

11.08.2005 [22] US [33] 24.08.2004 [32] 10/925876 [31]

Int. Cl.(2010.01) G01S 05//22 [51]

RAYTHEON BBN TECHNOLOGIES

CORP., U.S.A. [71]

WO/2006/098755 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

Shockwave-only solutions that estimate shooter position and shot trajectory are

extremely sensitive to the quality and precision of the shock time-of-arrival (TOA)

measurements as well as the accuracy to which relative sensor positions in space are

known. Over the life of a long-deployed system, the sensor positions can shift and the

performance of some sensors may degrade for various reasons. Such changes can

degrade the performance of deployed shooter estimation systems. Disclosed are

systems and methods that can be used to calibrate sensor positions based on shock and

muzzle measurements processed from a series of shots fired from a known location

and in a known direction, as well as an approach for dynamically adapting shock-only

shooter estimation algorithms to compensate for sensor degradation and/or loss.

[57]








__________________

181562 [21[]11]

כרסום בעל פעילות משופרת

HIGH-PERFORMANCE END

MILL

[54]

26.02.2007 [22]

Int. Cl.(2010.01) B23C 01//00 [51]

HANITA METAL WORKS LTD. [71] חניתה מפעלי מתכת בע"מ, שלומי





P.O.B. 5352,

BEER-SHEVA 84152

[74]

A high-performance end mill comprising a shank portion and at least one cutting

portion divided into a plurality of teeth by flutes disposed between said teeth, the

radial teeth at the cutter extremity each having a cutting edge extending outwardly

from the centre of the tool's extremity and a gash cut profile wherein the maximum

axial depth of said gash cut measured in the direction parallel to the cutter axis is less

than 0.15D where D is the outer diameter of the cutter.

[57]

__________________




181639 [21[]11]

מערכת לאינטגרציה לאחר הקלטה ראשונית

POST PRODUCTION

INTEGRATION PLATFORM

[54]

28.02.2007 [22]

Int. Cl.(2010.01) G06K 01//00 [51]

MICHAEL BRUGGEMAN [71] מייקל ברוגמן, רמת גן

אפלפלד זר פישר וילר חברת עורכי דין, 16מגדל ב.ס.ר. קומה 2בן גוריון

גן -רמת

APPELFELD ZER FISHER WEILER,

LAW FIRM,

B.S.R TOWER 1, FLOOR 16

2 BEN GURION ST.

RAMAT GAN 52573

[74]

A system for integrating video, three-dimensional animation and sound file formats

into a unified environment for performing manipulations on said files, said system

comprising a unified visual manipulation working environment, wherein said

environment comprises: an import module for receiving a plurality of visual content

objects encoded with a respective original source format within a plurality of different

media formats, wherein the plurality of visual content objects comprises at least one

two-dimensional video stream and at least one three-dimensional, time varying

animated object; a unified timeline module for combining the plurality of visual

content objects in time synchronization to be played on a single timeline; a processing

module enabling separate manipulation of at least two selected visual content objects

within the plurality of visual content in a non destructive manner retaining the

respective original source format characteristics of each of the visual content objects;

and a Visual Three-Dimensional Integration Interface adapted to simultaneously

display a combination of the plurality of visual content objects in a three-dimensional

environment, the Visual Three-Dimensional Integration Interface adapted to integrate

and manipulate respective timelines of at least one visual content object within the

plurality of visual content objects and preview a two-dimensional representation of the

combination, wherein said Visual Three-Dimensional Integration Interface includes: a

two-dimensional video surface layer adapted to display the at least one two-

dimensional video stream, a three-dimensional animation view platform adapted to

display the at least one three-dimensional, time varying animated object, and a

consolidation layer for displaying the combination, wherein the three-dimensional

animation view platform is illustrated as a space between the consolidation layer and

the video surface layer and is adapted to manipulate in three dimensions, in response

to operator input, the at least one three-dimensional, time varying animated object

with respect to the at least one two-dimensional, video stream simultaneously

displayed on the two-dimensional video surface layer, and wherein frames of the

consolidation layer and of the video surface layer are locked together and are

manipulated via a scale control adapted to at least one of either increase and decrease a

relative size of images and three-dimensional time varying objects within confines of

the consolidation layer and the two-dimensional video surface layer as compared to

one another, and change a relative positioning of images and three-dimensional, time

varying objects displayed in the consolidation layer and the two-dimensional video

surface layer as compared to one another, the images and three-dimensional, time

[57]




varying object comprising three-dimensional animation objects sitting on the three-

dimensional animation platform and at least one two-dimensional video stream sitting

on the two-dimensional video surface layer.

__________________

182170 [21[]11]

שיטה לליטוש מתכות אצילות באמצעות הרכב מכני עם תוסף פולימר–כימי

METHOD FOR POLISHING

NOBLE METALS WITH CMP

COMPOSITION CONTAINING A

POLYMER ADDITIVE

[54]

11.10.2005 [22] US [33] 12.10.2004 [32] 10/963108 [31]

Int. Cl.(2010.01) B24B 37//00 [51]



WO/2006/044417 [87]




31 YAVNE ST.,

P.O.B. 1426,

TEL AVIV 61013

[74]

The invention provides a method of polishing a substrate comprising contacting a

substrate comprising a noble metal on a surface of the substrate with a chemical-

mechanical polishing system comprising (a) a polishing component selected from the

group consisting of an abrasive, a polishing pad, and a combination thereof, (b) an

oxidizing agent, (c) an ethylene-oxide containing polymer, and (d) a liquid carrier, and

abrading at least a portion of the noble metal with the chemical-mechanical polishing

system to polish the substrate.

[57]

__________________

182301 [21[]11]

למיתוג על ידי השתקה של סיגנל שיטה והתקן נקלט


SQUELCH GATING A

RECEIVING SIGNAL

[54]

27.03.2007 [22]






EP [33] 07.04.2006 [32] 06 007 405.1 [31]

EP 04.01.2007 07 000 145.8

Int. Cl.(2010.01) H04B 01//10 [51]

ROHDE & SCHWARZ GMBH & CO.

KG, GERMANY [71]




10 ABBA EBEN BLVD.,

P.O.B. 2081,

HERZLIYA 46120

[74]

A method and an apparatus for squelch gating a receiving signal depending on the

level of phase noise in said receiving signal determines sampled amplitudes and

sampled phases of said receiving signal, determines sampled phase noise by

differentiating subsequent sampled phases, determines a squelch signal by rectifying

and averaging said sampled phase noise, determines a start point of gating after a

rising of said squelch signal above a higher threshold delayed by a first delay time,

determines an end point of gating after a dropping of said squelch signal below a lower

threshold delayed by a second delay time and gates said sampled amplitudes from said

start point of gating until said end point of gating.

[57]

__________________

182396 [21[]11]

–N–דיאצטיל –10סינטטי להכנת –תהליך חצי פקליטקסל וחומרי ביניים עבורו–דיבנזואיל

SEMISYNTHESIS PROCESS FOR

THE PREPARATION OF 10-

DEACETYL-N-DEBENZOYL-

PACLITAXEL AND

INTERMEDIATES THEREFOR

[54]

07.10.2005 [22] US [33] 08.10.2004 [32] 60/616840 [31]

EP 08.10.2004 04425752.5

EP 11.04.2005 05007888.0

Int. Cl.(2010.01) C07D 30/5/14, 41/1/12 [51]


WO/2006/037653 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The invention relates to a process for the preparation of 10-deacetyl-Ndebenzoyl-

paclitaxel, a synthon useful for the preparation of taxanes with antitumour activity, and

[57]




intermediates for the preparation thereof. The invention also discloses a process for the

preparation of Docetaxel starting from said compound of formula (I).





__________________

182473 [21[]11]

כלי טייס ממונע רקטה המכיל רכיב קינטי וקצף מתכלה

ROCKET-PROPELLED VEHICLE

COMPRISING KINETIC MEDIA

AND DECOMPOSABLE FOAM

[54]

19.10.2005 [22] US [33] 20.10.2004 [32] 10/969724 [31]

Int. Cl.(2010.01) B64G 01//00 [51]


WO/2007/001419 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

A high energy, e.g. ultraviolet (UV) catalyzed decomposing foam (124) encapsulating

kinetic media (122) forms a payload (120) to be boosted in space and provides an

ultra-light weight means for intercepting an incoming missile or other target (140,

142). The decomposed foam releases the kinetic media (at designed rates so as to

preserve a required density of media on target) to intercept the target and destroy it.

The use of the decomposing foam significantly lowers the weight and cost an improves

the probability of success of destroying the target.

[57]




__________________

182747 [21[]11]

מערכת מיצלות הפוכות הכוללת מרכיב פעיל טיפולי המסיס במים ותכשיר רפואי הכולל

אותה

REVERSE-MICELLAR SYSTEM

COMPRISING A HYDROSOLUBLE

THERAPEUTICALLY ACTIVE

AGENT AND PHARMACEUTICAL

COMPOSITION COMPRISING IT

[54]

02.11.2005 [22] EP [33] 02.11.2004 [32] 04025991.3 [31]

Int. Cl.(2010.01) A61K 09//00, 09//107, 09//48, 38//00 [51]

MEDESIS PHARMA SA, FRANCE [71]

WO/2006/048772 [87]


אר שבעב5352, ת.ד.



P.O.B. 5352,

BEER-SHEVA 84152

[74]

The present invention relates generally to reverse-micellar system comprising a

hydrosoluble therapeutically active agent. Reverse micelles according to the invention

are particularly useful to deliver drugs. The present invention also relates to

pharmaceutical composition comprising said reverse micelles and methods for

preparing the same.

[57]

__________________

182824 [21[]11]

שיטה לניהול משאבים בפלטפורמה לשירותי טלקומוניקציה ו/או ניהול רשת, פלטפורמה

METHOD FOR MANAGING [54]






ומוצר של תוכנת מחשב עבורה

RESOURCES IN A PLATFORM

FOR TELECOMMUNICATION

SERVICES AND/OR NETWORK

MANAGEMENT,

CORRESPONDING PLATFORM

AND COMPUTER PROGRAM

PRODUCT THEREFOR

28.10.2004 [22]

Int. Cl.(2010.01) H04L 12//24 [51]

TELECOM ITALIA S.P.A., ITALY [71]

GIUSEPPE COVINO, ROSARIO

ALFANO, FABRIZIO BOBBIO,

GIUSEPPE CASSONE, DANILO

GOTTA, MARISA PORTA, MARCO

UGHETTI

[72]

WO/2006/045337 [87]

ידמן בע"מ,ד"ר מרק פר 7, רחוב ז'בוטינסקי 54מגדל משה אביב, ק.

גן -רמת



FLOOR,

7 JABOTINSKY ST.,

RAMAT GAN 52520

[74]

The invention relates to a method and system for managing resources in the

telecommunications services and networks. The method and system regard execution

of processes (WF1, ..., WFn) by distributed agents (A1, A2, A3) on processing

machines (H) to perform predetermined tasks on the network, and are characterized

by: setting target data including goals on processes (WF1, …, WFn) and constraints on

resource utilization to be met by the system; monitoring computational resources

utilization and processes execution by agents, and collecting performance data

representative of resource utilization and process execution; comparing the collected

performance data with the set data, a penalty being established when performance data

do not fulfil target data; and re-allocating resources for process execution by agents

(A1, A2, A3) so as to minimize the penalty determined on the basis of said

comparison.

[57]


__________________

183013 [21[]11]

סינתזה כימית מכוונת ע"י חומצת גרעין מבנית, הרכב ושיטה לביצוע החלפת מודולת נשא

האוליגונוקליאוטיד

STRUCTURAL NUCLEIC ACID

GUIDED CHEMICAL SYNTHESIS

COMPOSITION AND METHOD

OF PERFORMING

OLIGONUCLEOTIDE CARRIER

MODULE SUBSTITUTION

[54]

08.11.2005 [22] EP [33] 08.11.2004 [32] 04105597.1 [31]

US 07.06.2005 60/687849

US 11.10.2005 60/725347

Int. Cl.(2010.01) C07B 61//00, C12N 15//10 [51]

VIPERGEN APS, DENMARK [71]

WO/2006/048025 [87]




31 YAVNE ST.,

P.O.B. 1426,

TEL AVIV 61013

[74]

Disclosed is a composition comprising a nucleic acid and a chemical compound, said

composition forming a star structure defining 3 or more stems extending from a

reaction center. The stems are formed by a nucleic acid duplex and the chemical

compound has been formed in the reaction center as the reaction product of 3 or more

chemical groups. The advantage of the composition is that a close proximity is

provided between the chemical groups in the reaction center, thereby promoting a

reaction. The invention also relates to a method for preparation of the composition.

The advantage of the method is that it does not require the pre-synthesis of a large

number of templates and that it is not dependent upon codon/anti-codon recognition

for an encoded molecule to be formed.

[57]

__________________

183028 [21[]11]






פרופילאמינופנטאן –2–איל(–2–)בנזופוראנ–1(–) לשימוש בטיפול בתלות בסמים

(-)-1-BENZOFURAN-2-YL)-2-

PROPYLAMINOPENTANE FOR

USE IN THE TREATMENT OF

SUBSTANCE DEPENDENCE

[54]

21.11.2005 [22] JP [33] 25.11.2004 [32] 2004-339996 [31]

Int. Cl.(2010.01) A61K 31//343, A61P 25//00, C07D 30/7/81 [51]

FUJIMOTO CO., LTD., JAPAN

NATIONAL UNIVERSITY

CORPORATION KYUSHU

UNIVERSITY, JAPAN

[71]

WO/2006/057211 [87]


רמת החייל


26A HABARZEL ST.,


[74]

To provide a therapeutic agent for drug dependence which prevents the flash-back of

or a relapse into a compulsive drug intake behavior based on the urge to, e.g., an

addictive substance such as amphetamine, opium, barbiturate type morphine,

psychedelic, cocaine, hemp, cannabis, alcohol, or volatile organic solvents. (-)-1-

(Benzofuran-2-yl)-2propylaminopentane or a pharmacologically acceptable acid

addition salt thereof is useful as a therapeutic agent for drug dependence which

prevents the flash-back of or a relapse into a compulsive drug intake behavior based on

the urge to, e.g., an addictive substance.

[57]

__________________

018303 [21[]11]

אלמנטים אנדופרוסטטיים עבור מחבר קרסול

ENDOPROSTHETIC ELEMENTS

FOR AN ANKLE JOINT

[54]

08.11.2005 [22] AT [33] 08.11.2004 [32] A 1862/2004 [31]

Int. Cl.(2010.01) A61F 02//24, 02//42 [51]

ALPHAMED MEDIZINTECHNIK

FISCHER GMBH, AUSTRIA [71]

WO/2006/047805 [87]




5 SHENKAR ST.,

P.O.B. 12704,

HERZLIYA 46733

[74]




The invention relates to a talus component (1) for a multi-part ankle-joint prosthesis,

said component having an underside (3), which faces the bony talus after implantation.

Said component is characterised in that the underside that faces the bony talus is

configured as a concave ball segment.

[57]

__________________

183054 [21[]11]

ותכשירי רוקחות LNAאוליגונוקלאוטידים המכילים אותם

LNA OLIGONUCLEOTIDES AND

PHARMACEUTICAL


THE SAME

[54]

09.11.2005 [22] US [33] 09.11.2004 [32] 60/626563 [31]

US 25.01.2005 60/647186

US 15.07.2005 60/699721

US 07.10.2005 60/724621

Int. Cl.(2010.01) C07H 21//00, 21//04, C12N 15//11 [51]

ENZON PHARMACEUTICALS, INC.,

U.S.A.

SANTARIS PHARMA A/S,

DENMARK

[71]

WO/2006/050734 [87]



P.O.B. 1352,

JERUSALEM 91013

[74]

The present disclosure relates to an LNA oligonucleotide consisting of a sequence

selected from the group consisting of 5'-(Tx GxGxcsasasasgscsastscscsTXGX T-3' and 5'-

(GX )TXTXascstsgscscststscsTXTX A-3', wherein capital letters designate a beta-D-oxy-

LNA nucleotide analogue, small letters designate a 2-deoxynucleotide, underline

designates either a beta-D-oxy-LNA nucleotide analogue or a 2-deoxynucleotide,

[57]




subscript 's' designates a phosphorothioate link between neighbouring

nucleotides/LNA nucleotide analogues, and subscript 'x' designates either a

phosphorothioate link or a phosphorodiester link between neighbouring

nucleotides/LNA nucleotide analogues, and wherein the sequence is optionally

extended by up to five 2-deoxynucleotide units. The LNA oligonucleotides are useful

for modulating the expression of hypoxia-inducible factor-la (HIF-1a), e.g. in the

treatment of cancer diseases, inhibiting angiogenesis, inducing apoptosis, preventing

cellular proliferation, or treating an angiogenic disease, e.g. diabetic retinopathy,

macular degeneration (ARMD), psoriasis, rheumatoid arthritis and other inflammatory

diseases.

__________________

183157 [21[]11]

תכשירים בסיסיים נטולי מים הניתנים ליצירה אמולסיות המכילים קו אנזים –עצמית של מיקרו

10Q בריכוז גבוה

HIGH CONCENTRATION SELF-

MICROEMULSIFIABLE

ANHYDROUS COENZYME Q10

BASE COMPOSITIONS

[54]

16.11.2004 [22]

Int. Cl.(2010.01) A61K 09//10, 09//48, 38//43 [51]

BIOAVAILABILITY, INC, U.S.A. [71]

WO/2006/080903 [87]




10 ABBA EBEN BLVD.,

P.O.B. 2081,

HERZLIYA 46120

[74]

A method and composition are presented for enhancing the dissolution and

bioavailable properties of CoQ10 nutritional supplements and/or therapeutic agents for

a human being and other mammals. The method includes preparing an anhydrous self-

microemulsifying base composition by combining: CoQ10, a water-immiscible, and a

non-ionic surfactant, containing polyethylene glycol. For an orally administered

CoQ10 nutritional supplement in a capsule formulation, a unit dosage from the

composition is added to a dissolvable capsule, preferably a soft gelatin capsule, in

[57]




order to form the nutritional supplement. When a capsule containing the self-

microemulsifying composition enters the digestive tract, the temperature of the body's

digestive juices warms the composition, causing any of the CoQ10 that may have re-

crystallized out of the composition to become re-dissolved into the composition before

the capsule dissolves. The re-dissolution of CoQ10 is bioavailable when the capsule

dissolves. Upon dissolution of the capsule, the self-microemulsifying composition

comes into contact with the digestive juices and naturally forms micellar-type

bioavaible microemulsions, consisting of micelles containing CoQ10. In addition to

the capsule formulation, the invention includes parenteral, liquid, topical and

ophthalmic formulations.

__________________

183200 [21[]11]

תכשיר רוקחי הכולל דפסיפפטידים קוטלי טפילים פנימיים למניעת זיהום אנכי של יונק

לא אנושי עם טפילים פנימיים

PHARMACEUTICAL


ENDOPARASITICIDAL

DEPSIPEPTIDES FOR PREVENTING

VERTICAL INFECTION OF A NON

HUMAN MAMMAL WITH

ENDOPARASITES

[54]

03.11.2005 [22] DE [33] 16.11.2004 [32] 102004055316.5 [31]

Int. Cl.(2010.01) A61K 38//15, A61P 33//00 [51]

BAYER ANIMAL HEALTH GMBH,

GERMANY [71]

WO/2006/053641 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The invention relates to the use of endoparasitic depsipeptides for the production of

medicaments for prevention of vertical endoparasite infections.

[57]

__________________




183320 [21[]11]

מיזוג מידע ממעקב ומהדמיה

TRACKING AND IMAGING

DATA FUSION

[54]

20.05.2007 [22]

Int. Cl.(2010.01) G06T 07//20 [51]

רפא"ל מערכות לחימה מתקדמות בע"מ, חיפה

RAFAEL ADVANCED DEFENSE

SYSTEMS LTD. [71]

RON ZOHAR, DAVID REINITZ [72] רון זוהר, דוד רייניץ

ד"ר מרק פרידמן בע"מ, 7, רחוב ז'בוטינסקי 54מגדל משה אביב, ק.

גן -רמת



FLOOR,

7 JABOTINSKY ST.,

RAMAT GAN 52520

[74]

A method of monitoring a target, which includes tracking the target using a tracking

modality, thereby obtaining an estimated track of the target, imaging the target using

an imaging modality, thereby obtaining an image of the target, associating the

estimated track with the image, and displaying at least one datum related to the image

along with the estimated track.

[57]

__________________

183323 [21[]11]

מערכת פנאומטית ומורכבת לניתוחים בעלת צילינדרי אויר אינטגרלים

SURGICAL SYSTEM HAVING

PNEUMATIC MANIFOLDS WITH

INTEGRAL AIR CYLINDERS

[54]

20.05.2007 [22] US [33] 19.05.2006 [32] 11/437301 [31]

US 28.06.2006 11/477035

Int. Cl.(2010.01) A61B 01//00 [51]

ALCON, INC., SWITZERLAND [71]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

A surgical system having all of the various pneumatic control sub-systems integrally

mounted on a common manifold. The various required control mechanisms such as

valves are likewise integrally mounted to the common manifold. Air cylinders for

valve actuation are directly installed into the manifolds, and pressurized air for the air

[57]






cylinders is supplied to the cylinders through the manifolds. Such a construction

eliminates the need to use external air tubing to supply the air cylinders with

pressurized air, thereby improving reliability and simplifying construction.

__________________

183368 [21[]11]

תיקון סטיות כרומטיות בעדשות תוך עיניות

INTRAOCULAR LENSES WITH

ENHANCED OFF-AXIS VISUAL

PERFORMANCE

[54]

21.05.2007 [22] US [33] 31.05.2006 [32] 11/443766 [31]




Int. Cl.(2010.01) G02C 07//06 [51]

ALCON, INC., SWITZERLAND [71]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

A multi-element or multi-surface intraocular lens (10,22) (IOL), comprising: a

posterior optical surface (24b, 14a, 14b), and an anterior optical surface (24a, 12a,

12b), wherein at least one optical surface (24b, 14a, 14b) is adapted to provide

compensation for one aberration type and at least one optical surface (24a, 12a, 12b) is

adapted to provide compensation for another aberration type characterized in that a

combination of:the degree of asphericity of the optical surfaces; the Abbe number of

the lens material; the radii of curvature of the optical surfaces; the axial separation of

the optical surfaces; the degree of alignment of the optical axes of the optical surfaces,

are selected to cooperatively reduce, or substantially eliminate, the longitudinal

chromatic aberrations exhibited by the intraocular lens (10), and/or to cooperatively

provide compensation for the natural chromatic aberrations of the eye, whereby a

plurality of monochromatic, polychromatic and oblique aberrations may be

independently corrected and off-axis visual performance is enhanced by providing

customized IOLs exhibiting compensation for different aberrations and/or different

amounts of aberration correction.

[57]

__________________

183398 [21[]11]

טריז עבור כרטיס מודול של מעגל –מנעול אלקטרוני

WEDGELOCK FOR ELECTRONIC

CIRCUIT CARD MODULE

[54]

10.11.2005 [22] US [33] 24.11.2004 [32] 10/995535 [31]

Int. Cl.(2010.01) H05K 07//14 [51]

ELTA SYSTEMS LTD. [71] אלתא מערכות בע"מ, אשדוד

WO/2006/056971 [87]


רמת החייל


26A HABARZEL ST.,


[74]




An arrangement is suggested for introducing a plate element, for which heat needs to

be dissipated by means of conduction, into a slot of a chassis which is adapted to

absorb the heat. The slot comprises a back wall adapted to contact the plate element

upon its insertion, an opposing front wall, and a base wall. The plate element

comprises margins adapted for carrying the arrangement. The arrangement comprises a

seat located on the margins. The arrangement further comprises a wedgelock moveably

attached to the seat, having two slot engaging surfaces adapted to contact the front and

base walls of the slot, and a seat engaging portion adapted to contact the seat. The

arrangement further comprises an actuating mechanism adapted to cause a movement

of the wedgelock in a direction toward the front wall and in a direction toward the base

wall of the slot until a tight contact is established between the slot engaging surfaces of

the wedgelock and the slot's front and base walls, while maintaining a tight contact

between the seat engaging portion of the wedgelock and the seat and between the

module and the back wall of the slot.

[57]

__________________

183490 [21[]11]

פורמולציות מצופות לשחרור תרופות

COATED DRUG DELIVERY

FOMULATIONS

[54]

29.11.2005 [22] US [33] 30.11.2004 [32] 10/999831 [31]

Int. Cl.(2010.01) A61K 09//127 [51]

WESTERN UNIVERSITY OF

HEALTH SCIENCES, U.S.A. [71]

WO/2006/060325 [87]

,DR. YITZHAK HESS & PARTNERS ד"ר יצחק הס ושותפיו,

279 HAYARKON ST.,

[74]




279רחוב הירקון תל אביב6451, ת.ד.

P.O.B. 6451,

TEL AVIV 61063

The invention relates generally to methods of making formulations for delivering

biological agents to a patient. In one aspect, proliposomal drug-delivery systems for

medicaments are provided. In another aspect, coated proliposomal formulations for

poorly water soluble drugs, and methods for making the same, are provided. Certain

embodiments of the present invention provide enhanced stability and bioavailability

for pharmaceutical formulations.

[57]





__________________

183492 [21[]11]

ירוט חוקי של צלילי צילצול חזרה אישיים

LAWFUL INTERCEPTION OF

PERSONALIZED RING BACK

TONES

[54]

04.11.2005 [22] EP [33] 16.12.2004 [32] 04445128.4 [31]

Int. Cl.(2010.01) H04M 03//22, 03//42, 19//02 [51]



WO/2006/063903 [87]



P.O.B. 1352,

JERUSALEM 91013

[74]

Systems and methods for legal interception of the transmission of personalized ring

back tones as they are sent from a network such as a mobile telephone network

associated with a subscriber to a caller in response to a call placed by the caller to the

subscriber to allow monitoring of personalized ring back tones and/or their associated

call content data. The personalized ring back tone is intercepted at an intercept access

[57]




point on the network, where the systems and methods of the invention then transmit

the intercepted personalized ring back tone to an authorized person or entity, such as a

law enforcement agency.

__________________

183500 [21[]11]

שיטה ומכשיר להעיר בן אדם


WAKING A PERSON

[54]

05.12.2005 [22] US [33] 03.12.2004 [32] 60/632535 [31]

Int. Cl.(2010.01) G08B 06//00, H04B 03//36 [51]

SAFEAWAKE, LLC, U.S.A. [71]

WO/2006/060679 [87]


רמת החייל


26A HABARZEL ST.,


[74]

A system and method for waking a person includes the provision of tactile stimulation

in a repeating interrupted pattern upon the detection of an alarm signal indicative of an

event for which the person should be awakened. In one embodiment, a device for

waking a person comprises a circuit for generating a driver signal in response to an

alarm signal, the driver signal having a repeating interrupted pattern; an electrically

controlled switching device having a control input, a power input and a power output,

the power input being connectable to a power source, the control input being

connected to receive the driver signal from the circuit; and a tactile stimulation device

connected to the power output of the electrically controlled switching device, the

tactile stimulation device being configured to produce a tactile stimulation.

[57]




__________________

183594 [21[]11]

פיפראזין מתאנון, תהליכים –נגזרות של פניללייצורן, תרופות המכילות אותן ושימושן בהכנת

תרופות לטיפול במחלת אלצהיימר

PHENYL-PIPERAZINE

METHANONE DERIVATIVES,

PROCESS FOR THEIR

PREPARATION, MEDICAMENTS

CONTAINING THEM AND USE

THEREOF IN THE

MANUFACTURE OF

MEDICAMENTS FOR THE

TREATMENT OF ALZHEIMER'S

DISEASE

[54]

01.12.2005 [22] EP [33] 09.12.2004 [32] 04106440.3 [31]

Int. Cl.(2010.01) A61K 31//496, 31//498, A61P 25//28, C07D 27/7/82, 40/1/04,

40/3/04, 41/3/04, 41/7/04, 41/7/14

[51]


SWITZERLAND [71]

WO/2006/061135 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

The present invention relates to compounds of the general formula (I) wherein R1 is

the group (A) or (B) or (C) or (D); R2 is a non aromatic heterocycle, or is OR' or

N(R')2; R' is lower alkyl, lower alkyl substituted by halogen or -(CH2)n-cycloalkyl; R'

is lower alkyl; R3 is NO2, CN or SO2R'; R

4 is hydrogen, hydroxy, halogen, NO2, lower

alkyl, lower alkyl, substituted by halogen, lower alkoxy, SO2R' or C(O)OR'; R5/R

6/R

7

are hydrogen, halogen, lower alkyl or lower alkyl, substituted by halogen; X1/X

1’ are

CH or N, with the proviso that X1/X

1’ are not simultaneously CH; X

2 is O, S, NH or

N(lower alkyl); n is 0, l or 2; and to pharmaceutically active acid addition salts and to

[57]




their use in the treatment of neurological and neuropsychiatric disorders.

__________________

837391 [21[]11]

תהליך להכנת מלוקסיקם ומלח אשלגן של מלוקסיקם בדרגת ניקיון גבוהה

PROCESS FOR PREPARATION OF

HIGH-PURITY MELOXICAM AND

MELOXICAM POTASSIUM SALT

[54]

16.12.2005 [22] HU [33] 18.12.2004 [32] P0402634 [31]

Int. Cl.(2010.01) C07D 41/7/12 [51]

EGIS GYOGYSZERGYAR NYRT,

HUNGARY [71]

WO/2006/064298 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The invention provides a process for the preparation of high purity meloxicam of the

Formula (II). The meloxicam raw product is reacted with the solution of potassium

hydroxide or potassium carbonate, whereby high purity meloxicam potassium sait

monohydrate is produced. Said sait is subsequently treated with minerai or organic

acid to yield high-purity meloxicam.

[57]

__________________

183773 [21[]11]

מסגרת של דלת וחלון

DOOR AND WINDOW FRAME

[54]

07.06.2007 [22] IT [33] 15.06.2006 [32] TO2006A000435 [31]






Int. Cl.(2010.01) E05C 09//18 [51]

SAVIO S.P.A., ITALY [71]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

Door and window frame, comprising: a movable quadrangular frame formed by four

section bars each having an outer side provided with a longitudinal groove, in which

the longitudinal groove comprises a base, two parallel lateral walls and two edges

oriented towards each other and defining an undercut engagement area at each of said

lateral walls, a first undercut engagement area being adjacent to a first face of the

frame and a second undercut engagement area being adjacent to a second face of the

frame, and a drive assembly comprising a plurality of actuating members and a

plurality of transmission rods that engage respective longitudinal grooves, each of said

actuating members and each of said transmission rods having a single tenon that

engages only one of said undercut engagement area, characterised in that the tenons of

the actuating member and of the transmission rods all engage said first undercut

engagement area of the respective groove.

[57]

__________________

183776 [21[]11]

שיטה להרכבת מתקן הנעה על מסגרת של דלת או חלון

METHOD FOR MOUNTING A DRIVE

ASSEMBLY FOR DOOR AND

WINDOW FRAMES

[54]

07.06.2007 [22] IT [33] 15.06.2006 [32] TO2006A000434 [31]

Int. Cl.(2010.01) E05D 15//52 [51]






P.O.B. 5352,

BEER-SHEVA 84152

[74]

Drive assembly for door and window frames, comprising at least one actuating

member and at least one transmission rod fastened to the actuating member. The

transmission rod comprises a central portion and two lateral portions positioned at

opposite sides relative to the central portion and forming two channel-shaped

longitudinal guides, the central portion having a longitudinal groove positioned

between the longitudinal guides, the longitudinal groove of the central portion being

closed by a base. The transmission member has a connecting portion including two

longitudinal ribs with ends shaped in such a way as to establish a telescopic coupling

[57]




with the longitudinal guides of the transmission rod and a central portion positioned

between said ribs and provided with a threaded hole in which is inserted a screw

having a tip that is able to cut a hole in the base of the transmission rod at said

longitudinal groove.

__________________

183777 [21[]11]

שיטה להרכבת איבר תומך על מסגרת של דלת או חלון

METHOD FOR MOUNTING AN

AUXILIARY MEMBER ON A DOOR

OR WINDOW FRAME

[54]

07.06.2007 [22] IT [33] 15.06.2006 [32] TO2006A00434 [31]

Int. Cl.(2010.01) E05D 15//52 [51]






P.O.B. 5352,

BEER-SHEVA 84152

[74]

Method for mounting an auxiliary member (130) on a window or door frame (10)

already installed and whereon is mounted a drive assembly (22) comprising at least

one actuating member (24, 25, 26, 27, 28) and at least one transmission rod (30, 32)

mounted in at least one slot (18, 20) of the frame (10). The method comprises the steps

of: providing, between the auxiliary member (130) and said rod (30, 32), a coupling

that is slidable in a longitudinal direction and fixed in any direction orthogonal to the

direction of sliding, and forming a through hole (118) in the rod by means of a screw

(106) carried by the auxiliary member (130), and fastening the auxiliary member to

said rod (30, 32) by the engagement of a tip (110) of said screw (106) with said

through hole (118).

[57]




__________________

183881 [21[]11]

–מערכת ביוריאקטור עבור טיפול ביולוגי רב שופכין–שלבי במי

BIOREACTOR SYSTEM FOR

MULTI-STAGE BIOLOGICAL

WASTEWATER TREATMENT

[54]

11.12.2005 [22] US [33] 13.12.2004 [32] 11/008922 [31]

Int. Cl.(2010.01) C02F 03//06 [51]

AQUARIUS TECHNOLOGIES INC.,

U.S.A. [71]

EFIM MONOSOV, ROMAN

NIKOLEVSKY, VLADIMIR PUZIY,

MARIA MONOSOV

[72]

WO/2006/064494 [87]

שלום למפרט אי.פ.והנדסה בע"מ, 59יקינטון

מעלות1078, ת.ד.

SHALOM LAMPERT IP &

ENGINEERING LTD.,

59 YAKINTON ST.

P.O.B. 1078

MAALOT 21520

[74]

A bioreactor system including at least one flexible substrate (10) for supporting

biomass growth having a plurality of threads (50) an at least two cross support

elements (52), wherein openings defined by adjacent threads and adjacent cross

support openings have an aspect ratio exceeding 50:1.

[57]

__________________

183891 [21[]11]

מכשיר לגילוי וספירה של יריות הנורות על ידי כלי ירי אוטומטי או חצי אוטומטי, וכלי ירי

DEVICE FOR DETECTING AND [54]






המצויד במכשיר

COUNTING SHOTS FIRED BY AN

AUTOMATIC OR SEMI-

AUTOMATIC FIRE ARM, AND

FIRE ARM EQUIPPED WITH

SUCH A DEVICE

13.06.2007 [22] BE [33] 18.07.2006 [32] 2006/0396 [31]

Int. Cl.(2010.01) F41A 09//53 [51]

FN HERSTAL S.A., BELGIUM [71]


רמת החייל


26A HABARZEL ST.,


[74]

A device adapted to form a typical signature for a fire arm and for the type of

ammunition comprises an accelerometer with a pass band which is sensitive to shocks

in the axial direction of a barrel and a microprocessor for analyzing a signal of the

accelerometer while firing. The microprocessor is equipped with an algorithm to count

the number of shots to be fired, based on the discernment and recording of a shot to be

fired on the basis of the detection, in the signal of the accelerometer, of all or part of

the characteristic elements of the acceleration signature which is typical in the type of

fire arm and of in different types of ammunition to be used. These characteristic

elements are recorded beforehand in a memory of the device.

[57]

__________________

184083 [21[]11]

שיטה ומערכת לגילוי מערכת ובחירת משתמש


SYSTEM DISCOVERY AND USER

SELECTION

[54]




17.01.2006 [22] US [33] 18.01.2005 [32] 60/645367 [31]

US 27.12.2005 11/318700

Int. Cl.(2010.01) H04W 36//14, 88//06 [51]



WO/2006/078627 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The invention includes a method and apparatus for mobility handling across different

wireless technologies by efficiently performing alternate network discovery and

enabling a mobile station to select the most desirable candidate radio access

technology, depending on parameters such as location and network policy settings.

[57]

__________________

184145 [21[]11]

מערכת לריפוי דרך העור המכילה שני תאים בעלת אפשרות הפעלה של רווית יתר וקידום

חדירה מבוקרת ותהליך לייצורה.

TRANSDERMAL THERAPEUTIC

SYSTEM COMPRISING TWO

COMPARTMENTS WITH

ACTIVATABLE OVERSATURATION

AND CONTROLLED PERMEATION

PROMOTION AND PROCESS FOR

MANUFACTURING THE SAME

[54]

08.12.2005 [22] DE [33] 24.12.2004 [32] 102004062614.6 [31]

Int. Cl.(2010.01) A61K 09//70 [51]

LTS LOHMANN THERAPIE-SYSTEME

AG, GERMANY [71]

WO/2006/072329 [87]




[74]




,P.O.B. 5352 באר שבע5352, ת.ד.

BEER-SHEVA 84152 The invention relates to a transdermal therapeutic system (TTS) that is essentially

composed of two compartments and that is provided with activatable oversaturation

and controlled permeation promotion. The invention more particularly relates to a

TTS, wherein an oversaturated active ingredient solution is produced in an active-

substance-containing polymer matrix when the system is applied to the skin, caused by

the controlled supply of one or several substances promoting permeation of the

pharmaceutical active ingredient; the two compartments which make up the inventive

transdermal therapeutic system; and the production of said transdermal therapeutic

system from the two compartments.

[57]

__________________

184161 [21[]11]

מתקן ושיטה לטיפול במוצר נוזלי


TREATMENT OF A LIQUID

PRODUCT

[54]

22.12.2005 [22] RU [33] 23.12.2004 [32] 20040137687 [31]

Int. Cl.(2010.01) A23L 03//015, B05B 17//00 [51]

MILLISECOND TECHNOLOGIES


WO/2006/067604 [87]




279 HAYARKON ST.,

P.O.B. 6451,

TEL AVIV 61063

[74]

A method and device related to a liquid product pressure and (optionally) temperature

treatment method reduces the level of microorganisms in the liquid product to a

preselected level. Utilizing the method, liquid product is diffused in a chamber with

the speed of pressure variation of liquid product in one embodiment of about 109

Pa/sec. The preferred speed of the diffused drops is about 10m/sec. The liquid product

can optionally be heated before or during diffusion, and is preferably heated as a

diffused liquid product by mixing it with superheated steams The device includes a

chamber and a diffuser in communication with the chamber. Optionally, the device

may include a heating apparatus, such as a steam generator connected via a pressure

control valve to a steam super heater, a cooling chamber connected via a pressure

control valve with a condenser, a vacuum pump in communication with the chamber,

units for condensation and collecting finished products and a vacuum control unit in

communication with the chamber.

[57]




__________________

184200 [21[]11]

משטח ביניים המתאים במיוחד למבנה אלקטרונית אורתוגגונלי של מערכת

MIDPLANE ESPECIALLY

APPLICABLE TO AN

ORTHOGONAL ARCHITECTURE

ELECTRONIC SYSTEM

[54]

23.12.2005 [22] US [33] 24.12.2004 [32] 60/638973 [31]

US 01.07.2005 11/173927

Int. Cl.(2010.01) H01R 13//648 [51]

AMPHENOL CORPORATION, U.S.A. [71]

THOMAS COHEN, MARK W.

GAILUS, JOHN R. DUNHAM

[72]

WO/2006/071890 [87]

ד"ר דוד אגרנוב, אבא-אלוני15, ת.ד.

DR. DAVID AGRANOV,

P.O.B. 15,

ALONEY-ABA

36005

[74]

A midplane has a first side to which contact ends of a first differential connector are

connected and a second side opposite the first side to which contact ends of a second

differential connector are connected. The midplane includes a plurality of vias

extending from the first side to the second side, with the vias providing first signal

launches on the fist side and second signal launches on the second side. The first signal

launches are provided in a plurality of rows, with each row having first signal launches

along a first line and first signal launches along a second line substantially parallel to

the first line. The second signal launches are provided in a plurality of columns, with

each column having second signal launches along a third line and second signal

[57]




launches along a fourth line substantially parallel to the third line.

__________________

184310 [21[]11]

–1H–מתילפרופיל(–2)–1–מתיל–2 אמין–4–[נפתירידין5,1][C–5,4אימידאזו]

PROCESS FOR PREPARING 2-

METHYL-1-(2-METHYLPROPYL)-

1H-IMIDAZO[4,5-

C][1,5]NAPHTHYRIDIN-4-AMINE

[54]

28.12.2005 [22] US [33] 30.12.2004 [32] 60/641129 [31]

US 16.08.2005 60/708679

Int. Cl.(2010.01) C07D 47/1/12 [51]

MEDA AB, SWEDEN [71]

WO/2006/074046 [87]

וולף, ברגמן וגולר, יםירושל1352, ת.ד.


P.O.B. 1352,

JERUSALEM 91013

[74]

The invention provides various processes for preparing 2-methyl-1-(2-methylpropyl)-

1H-imidazo[4,5-c][1,5]naphthyridin-4-amine.

[57]

__________________




184362 [21[]11]

מחסום רכב עם תאורה

VEHICLE BARRIER WITH

LIGHT

[54]

02.07.2007 [22]

Int. Cl.(2010.01) F21V 33//00 [51]

GAMASONIC LTD. [71] אביב -גמסוניק בע"מ, תל

LAZAR IZARDEL [72] לזר איזרדל

דקל פטנט בע"מ, 27,חדר 18מנוחה ונחלה

רחובות

DEKEL PATENT LTD.,

18 MENUHA VENAHALA ST.,

REHOVOT 76209

[74]

An assembly comprising: a vehicle barrier arranged for moving from a first

position that permits a vehicle to move past the vehicle to a second position

that prevents a vehicle from moving past the vehicle barrier; and a light

mounted on said vehicle barrier that moves with said vehicle barrier, wherein

when said vehicle is in the first position said light is illuminated in a first

color and in the second position said light is illuminated in a second color.

[57]

__________________

184438 [21[]11]

מקרולידים, תהליך להכנתם, תכשירים המכילים אותם ושימושם בהכנת רוקחיים

תרופות לטיפול במחלות דלקתיות

MACROLIDES, PROCESS FOR

THEIR PREPARATION,

PHARMACEUTICAL


THE SAME AND USE THEREOF

IN THE MANUFACTURE OF

MEDICAMENTS FOR THE

TREATMENT OF

INFLAMMATORY DISEASES

[54]

13.01.2006 [22] US [33] 13.01.2005 [32] 60/643841 [31]

US 09.09.2005 60/715828

Int. Cl.(2010.01) A61K 31//7042, 31//7048, 31//7052, A61P 29//00, C07H 17//08 [51]

GLAXO GROUP LIMITED, UNITED

KINGDOM [71]

WO/2006/087644 [87]

לוצאטו את לוצאטו, יה, עומר גן תעשי



[74]






,P.O.B. 5352 באר שבע5352, ת.ד.

BEER-SHEVA 84152 The present invention relates to novel semi-synthetic macrolides having anti-

inflammatory activity. More particularly, the invention relates to 14- and 15-membered

macrolides substituted at the 4' position, to their pharmaceutically acceptable

derivatives, to processes and intermediates for their preparation, to pharmaceutical

compositions containing them and to their activity and use in the treatment of

inflammatory diseases and conditions in humans and animals, especially those diseases

associated with excessive secretion of TNF-alpha, IL-1, IL-8, IL-2 or IL-5; and/or

inhibitor of excessive lymphocyte proliferation; and/or excessive granulocyte

degranulation.

[57]

__________________

184877 [21[]11]

סילון פלזמה בלחץ אטמוספרי

ATMOSPHERIC-PRESSURE

PLASMA JET

[54]

06.02.2006 [22] EP [33] 04.02.2005 [32] 05447017.4 [31]

Int. Cl.(2010.01) H05H 01//24 [51]

VLAAMSE INSTELLING VOOR

TECHNOLOGISCH ONDERZOEK

(VITO), BELGIUM

[71]

WO/2006/081637 [87]




5 SHENKAR ST.,

P.O.B. 12704,

HERZLIYA 46733

[74]

The present invention is related to a plasma jet apparatus for performing plasma

processing of an article, comprising: - An elongated central electrode (2,15), - An

elongated cylindrical outer electrode (1) or two outer electrodes (15,16) surrounding

said central electrode and being coaxial with said central electrode, or two electrodes

substantially parallel to the central electrode, - An electrical insulator (3) or insulators

(18,19) disposed between said outer electrode(s) and said central electrode, wherein a

discharge lumen having a distal end and a proximal end is defined between said central

electrode and said electrical insulator(s), - A supply opening (6) disposed at said distal

end of said discharge lumen for supplying a plasma producing gas to said discharge

lumen, - A power source (9) for providing a voltage between said central electrode and

said outer electrode characterised in that said electrical insulator has a radial or

outward extension (40,20) at said proximal end beyond the outer surface of said outer

electrode(s).

[57]




__________________

184887 [21[]11]

שיטה לייעול חיבורי רדיו ברשתות קציה ניידותטלקומוני

METHOD OPTIMISING RADIO

CONNECTIONS IN MOBILE

TELECOMMUNICATIONS

NETWORKS

[54]

25.01.2006 [22] GB [33] 27.01.2005 [32] 0501754.6 [31]

Int. Cl.(2010.01) H04L 12//28 [51]

HUTCHISON WHAMPOA THREE G

IP (BAHAMAS) LIMITED,

BAHAMAS

[71]

WO/2006/079802 [87]


רמת החייל


26A HABARZEL ST.,


[74]

A method of optimising radio connections in cellular mobile communications network

on the basis of the user equipment and data service being used. The network allocates

Access Point Names to various user equipment/data service combinations. In turn the

Access Point Names are allocated Quality Service parameters which are appropriate to

the corresponding user equipment and data service. When a user terminal requests a

data service with a particular Access Point Name, the radio connection is established

with a Quality of Service which is appropriate to the user equipment and data service

currently being used.

[57]




__________________

184983 [21[]11]

–פוריל(פירימידינ–2)–4–אמינו–2]–5גביש של און ותהליכים –(H 1)2–מתילפירידינ–1–איל[–5

לייצורו

CRYSTAL OF 5-[2-AMINO-4-(2-

FURYL)PYRIMIDIN-5-YL]-1-

METHYLPYRIDIN-2(1H)-ONE

AND PROCESSES FOR

PRODUCING THE SAME

[54]

20.03.2006 [22] US [33] 21.03.2005 [32] 60/663580 [31]

Int. Cl.(2010.01) A61K 31//506, C07D 40/5/14 [51]


LTD., JAPAN [71]

HITOSHI HARADA, HIROSHI

ISHIHARA, YOSHIAKI SATO,

HIROYUKI CHIBA, TEIJI

TAKIGAWA

[72]

WO/2006/101081 [87]





P.O.B. 45087,

JERUSALEM 91450

[74]

Crystal of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1- methylpyridin-2(1H)-one

exhibiting, in powder X-ray diffractometry, diffraction peaks at diffraction angles

(2&thetas;±0.2°) of 12.8°, 18.1° and/or 23.5°. This crystal excels in photostability,

thereby being suitable for use as an active ingredient of preventive/therapeutic agents

for diseases, such as costiveness.

[57]




__________________

185100 [21[]11]

פעמי המכיל גורם מנקב עור–מכלול לשימוש חד

DISPOSABLE ASSEMBLY

CONTAINING A SKIN PIERCING

ELEMENT

[54]

07.02.2006 [22] GB [33] 07.02.2005 [32] 0502840.2 [31]

Int. Cl.(2010.01) A61B 05//15, A61M 37//00 [51]


TECHNOLOGIES LIMITED, UNITED

KINGDOM

[71]

WO/2006/082439 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The invention relates to devices used in the fields of drag delivery or sampling. More

particularly, it relates to a disposable assembly which is fitted to an actuator device

which causes the skin piercing element to enter the skin to deliver a drug (or other

substance) or take a sample. Preferably the assembly is 'made safe' after actuation,

such that the disposable assembly can't be reused and more preferably still the skin

piercing element is safely housed in the assembly such that it does not constitute a

'sharps' risk.

[57]

__________________

185147 [21[]11]

נטולי יכולת שכפול כחיסונים RNAוירוסי

REPLICATION-DEFICIENT RNA

VIRUSES AS VACCINES

[54]

10.02.2006 [22] DE [33] 11.02.2005 [32] 10 2005 006 [31]






388.8

Int. Cl.(2010.01) A61K 48//00, C07K 14//005, 14//115, C12N 15//86 [51]

MAX-PLANCK-GESELLSCHAFT

ZUR FOERDERUNG DER

WISSENSCHAFTEN E.V.,

GERMANY

[71]

WO/2006/084746 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

The invention relates to a genome replication-deficient and transcription-competent

negative strand RNA virus which can be used for expressing transgenes and especially

for developing vaccines. The viral genome contains a mutation in at least one of the

genes N, L, or P.

[57]

__________________

185228 [21[]11]

מערכת לשידור רדיו ושיטה להפעלתו

RADIO TRANSMISSION SYSTEM

AND METHOD FOR THE

OPERATION THEREOF

[54]

06.02.2006 [22] DE [33] 15.02.2005 [32] 102005006909.6 [31]

DE 28.06.2005 102005030108.8

Int. Cl.(2010.01) H04L 29//06 [51]

ROHDE & SCHWARZ GMBH & CO.

KG, GERMANY [71]

WO/2006/087118 [87]

איתן מהולל, עורכי דין ועורכי קבוצת פטנטים,



10 ABBA EBEN BLVD.,

P.O.B. 2081,

HERZLIYA 46120

[74]

The invention relates to a radio transmission system comprising a plurality of

processing layers for the transmission of data packets between various radio appliances

in a radio channel. A first functional unit (11) in a physical radio transmission layer

analyses the radio channel and determines the quality (QoC) of the radio channel. A

second functional unit (12) in a back-up layer controls the access to the radio channel

according to the actual quality (QoC) of the radio channel and the priority of the data

packets to be transmitted according to the quality (QoS) of the service carried out by

[57]




the data packets. A third functional unit (14) in a switching layer controls the switching

of the data packets. A control unit (13) then releases the data packets for switching by

means of the third functional unit (14) only when the quality (QoS) of the service

carried out by the data packets corresponds sufficiently with the quality (QoC) of the

radio channel determined in the first functional unit (11).

__________________

185534 [21[]11]

מערכת ושיטה למדידת תכולה של מיכל


MEASURING CONTENT OF A BIN

[54]

27.02.2006 [22] US [33] 28.02.2005 [32] 60/656373 [31]

Int. Cl.(2010.01) G01F 17//00, 23//296 [51]

-, תלא.פ.מ. פתרונות אוטומציה בע"מ אביב

A.P.M. AUTOMATION SOLUTIONS

LTD. [71]

OFIR PERL, YOSSI ZLOTNICK [72] אופיר פרל, יוסי זלוטניק

WO/2006/090394 [87]

ד"ר מרק פרידמן בע"מ,, רחוב ז'בוטינסקי 54מגדל משה אביב, ק.

7 גן -רמת



FLOOR,

7 JABOTINSKY ST.,

RAMAT GAN 52520

[74]

A system for measuring a height of a content of a bin, comprising: (a) at least one

transmitter for transmitting a pulse of acoustic energy towards an upper surface of the

content; (b) an array of at least three non-collinear receivers for receiving an echo of

said pulse, each said receiver producing a respective signal in response to said echo;

and (c) a processing apparatus, for jointly transforming said signals into at least one

measured distance from said array to said upper surface, that includes:

i. for each said receiver, a correlator for correlating a waveform of

[57]




said pulse with said respective signal, thereby producing a correlated signal, and

ii. a beamformer for computing at least one direction of arrival of said

correlated signals from said upper surface to said array.

__________________

185631 [21[]11]

שיטה וערכה לקביעת הרגישות של דוגמא של ארלוטיניב וגורם כימותרפי ביולוגית לשילוב

METHOD AND KIT FOR

DETERMINING THE

SENSITIVITY OF A BIOLOGICAL

SAMPLE TO A COMBINATION OF

ERLOTINIB AND A

CHEMOTHERAPEUTIC AGENT

[54]

10.05.2006 [22] EP [33] 11.05.2005 [32] 05010244.1 [31]

EP 23.05.2005 05011070.9

Int. Cl.(2010.01) G01N 33//573, 33//574 [51]


SWITZERLAND [71]

WO/2006/119980 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

The present invention relates to a method of determining whether a biological sample

comprising human lung cancer cells is sensitive to a combination of an epidermal

growth factor receptor inhibitor and a chemotherapeutic agent by determining the

overexpression of a phosphorylated AKT protein and/ or a phosphorylated MAPK

protein in the biological sample. The invention is also related to methods for deriving a

candidate agent or for selecting a composition for inhibiting the progression of lung

cancer in a patient wherein a phosphorylated Akt protein and/ or a phosphorylated

MAPK protein is used.

[57]




__________________

185696 [21[]11]

מוצמדמחבר עם קצה וחלקי צד רחב

COUPLER WITH EDGE AND

BROADSIDE COUPLED

SECTIONS

[54]

01.03.2006 [22] US [33] 08.03.2005 [32] 11/075608 [31]

Int. Cl.(2010.01) H01P 05//18 [51]

WERLATONE, INC., U.S.A. [71]

WO/2006/096445 [87]


רחובות2273ת.ד. ,


P.O.B. 2273,

REHOVOT 76122

[74]

Couplers (40) are disclosed that include first and second mutually coupled conductors

(48, 50). The coupled conductors may be regular or irregular in configuration, and for

example, may be linear, including rectilinear or with one or more curves, bends or

turns (78), such as forming a ring, coil, spiral (74, 76) or other loop (70, 72). One or

more sections (42, 44 46) of a coupler (40) may be on different levels and separated by

a dielectric medium, such as air or a dielectric substrate. Coupled conductors (48, 50)

may be facing each other on the same or spaced-apart dielectric surfaces, such as

opposing surfaces of a common substrate, and each conductor (48, 50) may include

one or more portions (48c, 48d, 48e, 50c, 5Od, 5Oe) on each side or surface of a

substrate. In some examples, a coupler (40) may include plural coupled sections (42,

44, 46), with conductors (48, 50) in one section (44) being only broadside coupled, and

conductors (48, 50) in another section (42) being edge-coupled.

[57]

__________________

185874 [21[]11]

BOX AND LID [54] קופסה ומכסה






07.03.2006 [22] SE [33] 11.03.2005 [32] 0500579-8 [31]

US 11.03.2005 60/660469

Int. Cl.(2010.01) A24F 23//02, B65D 43//08 [51]

GALLAHER SNUS AB, SWEDEN [71]

WO/2006/096117 [87]




10 ABBA EBEN BLVD.,

P.O.B. 2081,

HERZLIYA 46120

[74]

A box comprising an open container (2) and a lid (3) for closing the open container

(2), the box (1) in a closed state comprising two base surfaces (4, 5), one of which

consists of the bottom wall (4) of the open container and the other of the top wall (5) of

the lid (3), together with at least one lateral surface, which is formed by a container

side (6) and a lid side (7). When the box (1) is in the closed state the container side (6)

and the lid side (7) at least partial overlap one another. An inward facing, inclined slide

surface (19) is furthermore arranged on the inside of the top wall (5) of the lid (3) in

order, when closing the open container (2), to allow displacement of the lid (3) into the

correct closing position relative to the container (2). The slide surface (19) runs along

and adjacent to the lid side (7) at an angle relative to the top wall (5) and the lid side

(7) and is remote from the lid side (7).

[57]

__________________

185888 [21[]11]

שמן עמיד בפני חום המאפשר סינרגיה המכיל DHA–ו EPAמסוג 3חומצות אומגה

SYNERGISTICALLY HEAT

STABLE OIL MEDIA

COMPRISING

EICOSAPENTAENOIC ACID

(EPA) AND

DOCOSAHEXAENOIC ACID

(DHA)

[54]

11.03.2005 [22]

Int. Cl.(2010.01) A23D 09//00, 09//06, A61P 03//06, 09//10, C11B 05//00 [51]




RECON OIL INDUSTRIES

PRIVATE LIMITED, INDIA [71]

WO/2006/095357 [87]


ילרמת החי


26 HABARZEL ST.,


[74]

A synergistically heat stable therapeutically active triglyceride and cholesterol

controlling oil composition including the usually highly unsaturated Eicosa Pentaenoic

Acid (EPA) and Docosa Hexaenoic Acid (DHA). The invention avoids limitations of

presently available impure sources of EPA / DHA such as fish oil, algae and the like

and provides for a synergistically stable edible oil formulation involving the Eicosa

Pentaenoic Acid and Docosa Hexaenoic acid of at least 50% to less than 100% purity

in a free of any encapsulated / protected form in combination with synergistically

stability contributing oil constituents / ingredients. The invention also provides for

benefit applications / uses of the surprising and unexpected heat stability of the

beneficial actives EPA and DHA. The invention is therefore directed to serve in

possible provision of variety of alternative media including heat stable media for

regular consumption of EPA / DHA and provide for maintenance of safe and healthy

lifestyle.

[57]

__________________

186203 [21[]11]

מערכת לניטור טמפרטורות נמוכות עבור טחמחסומים מתחת לפני הש

LOW TEMPERATURE

MONITORING SYSTEM FOR

SUBSURFACE BARRIERS

[54]

21.04.2006 [22] US [33] 22.04.2005 [32] 60/674081 [31]

Int. Cl.(2010.01) E21B 47//06, 47//12, G01K 11//32 [51]

SHELL INTERNATIONALE

RESEARCH MAATSCHAPPIJ B.V.,

THE NETHERLANDS

[71]

WO/2006/115945 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The invention provides a system for monitoring temperature of a subsurface low

temperature zone, that includes a plurality of freeze wells (114) configured to form the

low temperature zone; at least one monitor well; one or more lasers; a fiber optic cable

[57]




(146) coupled to at least one laser (142), and an analyzer (144) coupled to the fiber

optic cable. A portion of the fiber optic cable is positioned in at least one monitor well.

At least one laser is configured to inject light pulses into at least one end of the fiber

optic cable. The analyzer is configured to receive return signals from the light pulses.

The invention also provides methods for monitoring temperature of a subsurface low

temperature zone.

__________________

186206 [21[]11]

יצור נוזל מתהליך היפוך פנימישיטות ומערכות ל

METHODS AND SYSTEMS FOR

PRODUCING FLUID FROM AN IN

SITU CONVERSION PROCESS

[54]

21.04.2006 [22] US [33] 22.04.2005 [32] 60/674081 [31]

Int. Cl.(2010.01) E21B 36//00, 43//24 [51]



THE NETHERLANDS

[71]

WO/2006/116092 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The invention provides systems that include a plurality of heat sources (102)

configured to heat a portion of a formation; at least one production well (106) in the

formation, a pump system, and a production conduit coupled to the pump system. The

bottom portion of the production well is a sump positioned in an underburden of the

formation that is below the heated portion of the formation. Fluids are allowed to flow

from the heated portion of the formation flow into the sump. The pump system in

combination with the production conduit transport fluids in the sump out of the

formation. The invention also provides methods to remove a portion of the fluids from

the formation.

[57]




__________________

186207 [21[]11]

של מחממים אורכיים שינוי תכונות לאורכם בעלי טמפרטורה מוגבלת

VARYING PROPERTIES ALONG

LENGTHS OF TEMPERATURE

LIMITED HEATERS

[54]

21.04.2006 [22] US [33] 22.04.2005 [32] 60/674081 [31]

Int. Cl.(2010.01) E21B 36//04, 43//24 [51]



THE NETHERLANDS

[71]

WO/2006/116130 [87]


רמת החייל


26A HABARZEL ST.,


[74]

A system for heating a subsurface formation is described. The system includes an

elongated heater in an opening in the formation. The elongated heater includes two or

more portions along the length of the heater that have different energy outputs. At least

one portion of the elongated heater includes at least one temperature limited portion

(240) with at least one selected temperature at which the portion provides a reduced

heat output. The heater is configured to provide heat to the formation with the different

energy outputs . The heater heats one or more portions of the formation at one or more

selected heating rates.

[57]




__________________

186211 [21[]11]

מערכות לתהליך המרה במקומו המקורי המשתמשות בקודח בארות בלפחות שני איזורים

של הפורמציה

IN SITU CONVERSION PROCESS

SYSTEMS UTILIZING

WELLBORES IN AT LEAST TWO

REGIONS OF A FORMATION

[54]

21.04.2006 [22] US [33] 22.04.2005 [32] 60/674081 [31]

Int. Cl.(2010.01) E21B 36//04, 43//24 [51]



THE NETHERLANDS

[71]

WO/2006/116133 [87]


רמת החייל


26A HABARZEL ST.,


[74]

A system for heating a subsurface formation is described. The system includes a

plurality of elongated heaters (244) located in a plurality of openings in the formation.

At least two of the heaters are substantially parallel to each other for at least a portion

of the lengths of the heaters. At least two of the heaters have first end portions (234) in

a first region of the formation and second end portions (238) in a second region of the

formation. A source of time-varying current (254) is configured to apply time-varying

current to at least two of the heaters. The first end portions of the heaters are

configured to be applied with substantially the same voltage. The second portions of

the heaters are configured to be applied with substantially the same voltage.

[57]




__________________

186214 [21[]11]

תהליך המרה פנימי המנצל מערכת חימום פנימית סגורה

IN SITU CONVERSION PROCESS

UTILIZING A CLOSED LOOP

HEATING SYSTEM

[54]

21.04.2006 [22] US [33] 22.04.2005 [32] 60/674081 [31]

Int. Cl.(2010.01) C10L 03//08, E21B 36//00, 36//04, 43//24 [51]



THE NETHERLANDS

[71]

WO/2006/116096 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The invention provides an in situ conversion system for producing hydrocarbons from

a subsurface formation, that includes: a plurality of u-shaped wellbores in the

formation; piping positioned in at least two of the u-shaped wellbores; a fluid

circulation system coupled to the piping, and an electrical power supply. The fluid

circulation system is configured to circulate hot heat transfer fluid through at least a

portion of the piping to form at least one heated portion of the formation. The electrical

power supply is configured to provide electrical current to at least a portion of the

piping (220) located below an overburden in the formation to resistively heat at least a

portion of the piping and the heat transfers from the piping to the formation. The

invention also provides methods of using the in situ conversion system to produce

hydrocarbons from the subsurface formation.

[57]




__________________

186288 [21[]11]

מערכת להקרנת וידיאו במהירות משתנה

TRICK MODE SYSTEM

[54]

18.01.2006 [22] US [33] 07.04.2005 [32] 60/669134 [31]

Int. Cl.(2010.01) H04J 01//02, H04L 09//08, H04N 05//783, 07//167 [51]

NDS LIMITED, UNITED KINGDOM [71]

WO/2006/106498 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

A method is described for trick mode playback (10), the method including selecting a

key- frame in recording (20) substantially in the vicinity of a trick mode playback

starting position (30), preparing a decryption key associated with a key period

including the selected key-frame, sending the prepared decryption key to a

descrambler (70), thereby enabling decryption of video beginning at the selected key-

frame, sending a first number P seconds of decrypted video frames, starting a the

selected key-frame, at a predetermined speed for a predetermined number of seconds,

to a video decoder, in parallel to the sending P seconds of video frames, choosing at

least a second video section (50) to stream to the video decoder, sending a decryption

key associated with the chosen second video section to the descrambler (70), and

repeating the steps of selecting, preparing, sending the prepared decryption key, and

sending a first number P seconds of decrypted video frames.

[57]




__________________

186384 [21[]11]

מיות של מבהירים אופטיים, תמיסות מישימוש בהן עבור הרכבי ציפוי לנייר וכן תהליכי

ציפוי נייר העושים בהן שימוש

AQUEOUS SOLUTIONS OF

OPTICAL BRIGHTENERS, USE

THEREOF FOR COATING

COMPOSITIONS FOR PAPER AND

PAPER COATING PROCESSES

USING SAME

[54]

05.04.2006 [22] EP [33] 08.04.2005 [32] 05007691.8 [31]

Int. Cl.(2010.01) C07D 40/3/12, D21H 21//30 [51]

CLARIANT FINANCE (BVI)

LIMITED, BRITISH VIRGIN

ISLANDS

[71]

WO/2006/108785 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The instant invention relates to storage stable aqueous solutions of stilbene optical

brighteners with polyvinyl alcohols which can be directly used by the papermaker in

that they may be diluted with water and/or be metered directly into a coating

composition, to provide coated papers of a particularly high whiteness.

[57]

__________________




186491 [21[]11]

קולטן לטיפול –אדרנו 2–טים של בטאאגוניס עור הקשורה לרקמה מחברת–במחלת

BETA-2 ADRENOCEPTOR

AGONISTS FOR TREATING

CONNECTIVE TISSUE DISEASES

OF THE SKIN

[54]

12.04.2006 [22] DK [33] 13.04.2005 [32] PA200500529 [31]

Int. Cl.(2010.01) A61K 45//00 [51]

ASTION PHARMA A/S, DENMARK [71]

WO/2006/108424 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The present invention provides effective and safe medicaments for the treatment of

connective tissue diseases of the skin, particularly with respect to the treatment of

cutaneous forms of Lupus Erythematous. The medicaments comprise as the

therapeutically active ingredient a beta2 adrenoceptor agonist. The invention

furthermore relates to dermatological compositions without skin sensitization

properties and which contain enantiomerically pure or enriched R-enantiomers of a

beta2 adrenoceptor agonist.

[57]

__________________

186517 [21[]11]

סריגי לבטיחות כלי רכב–מעקה רב

VEHICLE SAFETY MULTI-RAIL

PARAPET

[54]

04.04.2006 [22] GB [33] 12.04.2005 [32] 0507358.0 [31]

GB 05.10.2005 0520191.8

Int. Cl.(2010.01) E01D 19//10, E01F 13//00, 15//00 [51]

VARLEY AND GULLIVER

LIMITED, UNITED KINGDOM [71]

WO/2006/109019 [87]




31 YAVNE ST.,

P.O.B. 1426,

TEL AVIV 61013

[74]

A vehicle safety parapet comprises a plurality of rails (18, 24, 28) supported at varying [57]






heights on uprights (12). A first of the rails comprises a steel box-section supported at

each upright by bracketing means (20) configured to collapse when a horizontal impact

load is applied to the rail, such that the first rail is displaced towards the upright. At

least one other rail extends from the uprights by a greater distance than the first rail

when the bracketing means has collapsed.

__________________

186577 [21[]11]

שיטה והתקן לחיזוי יחס אות להפרעה

SIR PREDICTION METHOD AND

APPARATUS

[54]

10.04.2006 [22] US [33] 14.04.2005 [32] 11/105797 [31]

Int. Cl.(2010.01) H04B 17//00, H04W 52//22 [51]



WO/2006/108587 [87]



P.O.B. 1352,

JERUSALEM 91013

[74]

The present invention provides a method and apparatus for generating SIR estimates

early in a time interval that include the benefits of interference suppression without

requiring the computation of specific interference suppression elements. In particular,

the present invention generates an SIR estimate for a RAKE receiver during a current

time interval based on channel estimates generated based on the received signal(s). By

applying an offset derived during a previous time interval to the RAKE SIR estimate,

the present invention generates a second SIR estimate for a generalized RAKE

receiver.

[57]




__________________

186680 [21[]11]

שיטה לייצור מלחי מתכת טריאלקלים של חומצה דיאתנואית עם –N,N–מתילגליצין

ל תוצרי לוואיתכולה נמוכה ש

METHOD FOR PRODUCING

METHYLGLYCINE-N,N-

DIETHANOIC ACID

TRIALKALIMETAL SALTS WITH A

LOW BY-PRODUCT CONTENT

[54]

02.05.2006 [22] DE [33] 06.05.2005 [32] 102005021055.4 [31]

Int. Cl.(2010.01) C07C 22/7/26 [51]

BASF SE, GERMANY [71]

WO/2006/120129 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The invention relates to a method for producing a light-coloured methylglycine-N,N-

diethanoic acid trialkali metal salt with a low by-product content, by the alkaline

hydrolysis of methylglycine diacetonitrile, said method comprises steps that are carried

out in the order (a) to (f): (a) mixing of the methylglycine diacetonitrile with an

aqueous alkali lye at a temperature of = 30 °C; (b) the aqueous alkali methylglycine

diacetonitrile suspension is then reacted at a temperature ranging between 10 and 30

°C for a period of 0.1 to 10 h, to form a solution; (c) the solution obtained in step (b) is

then reacted at a temperature ranging between 30 to 40 °C for a period of 0.1 to 10 h;

(d) optionally the solution obtained in step (c) is reacted at a temperature ranging

between 50 and 80 °C for a period of between 0.5 and 2 h; (e) optionally the solution

obtained in step (c) or (d) is reacted at a temperature ranging between 110 and 200 °C

for a period of between 5 and 60 min; (f) hydrolysis and isolation of ammonia from the

solution obtained in step (c), (d) or (e) by stripping at a temperature of between 90 and

105 °C.

[57]




__________________

186786 [21[]11]

מכסה להתקן תותב פנימי עבור טיפול במפרצת

COVERING FOR AN

ENDOPROSTHETIC DEVICE FOR

ANEURYSM TREATMENT

[54]

03.03.2006 [22] US [33] 19.04.2005 [32] 60/673304 [31]

Int. Cl.(2010.01) A61F 02//06 [51]

MEDINOL LTD. [71] אביב-מדינול בע"מ, תל

JACOB RICHTER [72] יעקב ריכטר

WO/2006/111801 [87]




10 ABBA EBEN BLVD.,

P.O.B. 2081,

HERZLIYA 46120

[74]

The present invention relates to covered endoprosthetic devices. Covered

endoprosthetic devices comprise an endoprosthesis and a sheath. The sheath comprises

a central portion and outer portions, wherein the central portion preferentially restricts

or causes a restriction of blood flow. Blood flow can be reduced by the central portion

of the sheath by varying the permeability of the sheath or by having projections on the

sheath that slow blood flow. Permeability may be provided by perforations or holes in

the material of the sheath or by varying the polymer structure that makes up the sheath

itself. The outer portions of the sheath do not substantially reduce blood flow. Methods

of using sheath-covered endoprosthetic devices of the invention to treat aneurysms,

especially aneurysms in proximity to small perforator vessels or arteries, are also

encompassed.

[57]








__________________

186988 [21[]11]

תאי של –תהליך ומערכת לתכנון מחדש חוץגנטי ואפיגנטי והשימוש בתא תאים באופן

מתוכנן מחדש להכנת תכשיר רוקחות

PROCESS AND SYSTEM FOR

GENETIC AND EPIGENETIC IN

VITRO REPROGRAMMING OF

CELLS AND USE OF A

REPROGRAMMED CELL IN THE

PREPARATION OF A

PHARMACEUTICAL

COMPOSITION

[54]

04.05.2006 [22] FR [33] 04.05.2005 [32] 0551180 [31]

FR 07.10.2005 0553058

FR 21.11.2005 0553533

Int. Cl.(2010.01) A61K 08//98, A61L 27//38, 27//50, A61Q 19//08, C12N 05//16 [51]

FRED ZACOUTO, FRANCE [71]

WO/2007/000523 [87]


מת החיילר


26A HABARZEL ST.,


[74]

The invention relates to an epigenetic and genetic treatment method and system. The

invention can be used to rejuvenate an adult cell nucleus without passing through an

embryonic stage and to obtain a tissue that is genetically-rejuvenated and autologous in

[57]




relation to the original nucleus, comprising the temporary introduction of a nucleus

into an enucleated oocyte (genetic rejuvenation), followed by oocyte extraction prior to

cell division. The treated nucleus can then be introduced into an adult cytoplasm

originating from the nucleus. In this way, cell divisions from the rejuvenated nucleus

take place in an adult autologous cytoplasm and the resulting cells immediately take

the form of adult, differentiated and functional cells. The rejuvenated autologous tissue

thus created can then be grafted without rejection to the adult tissue of the organism

from the treated nucleus.; Throughout the inventive procedure, the treated cytoplasms

and nuclei remain permanently in the adult state and no artificial cell differentiation is

necessary. In this way, the invention is different from standard deep cloning in which

the treated cells must return to the embryonic stage and which involves artificial cell

differentiation. In addition, the tissues derived from standard cloning are not

immunologically compatible with the original adult tissues from the treated nucleus

since the cell division thereof takes place in the oocyte which represents a foreign

cytoplasm to the nucleus. Moreover, standard cloning enables the creation of whole

organisms unlike the inventive method and system which can only be used to treat a

single tissue.; The possible applications of the invention include, for example, the

repair of necrotic tissues, such as a myocardial infarction, and damaged tissues, such as

the retina (RMD), heart failure, renal failure, liver failure and osteoporosis, the

treatment of cancers that occur with age, such as prostate cancer, rectal cancer, colon

cancer, etc. The anodyne implantation of a small volume of autologous, rejuvenated,

still-healthy cells from the affected organ should inhibit the aforementioned cancers

and the metastases thereof.

__________________

187048 [21[]11]

נעל

SHOE

[54]

30.10.2007 [22] TW [33] 30.10.2006 [32] 095140135 [31]

Int. Cl.(2010.01) A43B 09//06, 13//00, 13//28, 15//00, B29D 35//00, 35//06 [51]

CHEN MING-TE, TAIWAN R.O.C. [71]

ד"ר יורם צביון, , פארק התעשיה 2רח' הטוחן

קיסריה3148, ת.ד.

DR. YORAM TSIVION,

2 HATOCHEN ST.

P.O.B. 3148,

CAESAREA 38900

[74]

A shoe, comprising: a vamp (200), comprising a lateral vamp (210) and a bottom vamp

(220); a connecting medium apparatus (230), comprising a first plane (231) enclosing

said lateral vamp, a second plane (232) connected to said first plane and extending

outward, a third plane (233) connected to said second plane and extending downward,

and a fourth plane (234) connected to said third plane and extending inward, wherein

said second plane comprises a plurality of holes (235); and an outsole (240) enclosing

said connecting medium apparatus and said bottom vamp, wherein a material forming

[57]




said outsole fills a gap between said fourth plane of said connecting medium apparatus

and said bottom vamp and said holes in said second plane.

__________________

187093 [21[]11]

גלגל המונע בכח לרכב צבאי

POWER-DRIVEN WHEEL FOR A

MILITARY VEHICLE

[54]

01.11.2007 [22] IT [33] 15.12.2006 [32] TO2006A

000894

[31]

Int. Cl.(2010.01) B60K 07//00, 17//04 [51]

OTO MELARA S.P.A., ITALY [71]

וצאטו את לוצאטו,ל גן תעשייה, עומר




P.O.B. 5352,

BEER-SHEVA 84152

[74]

The application relates to a power-driven wheel for a military vehicle, comprising an

axial-flow electric motor and a hub connected functionally to said motor and rotating

about an axis. The motor comprises an output member housed partially inside said

hub. Further, the wheel is provided with an epicyclic reducer interposed functionally

between said hub and said output member.

[57]

__________________




187519 [21[]11]

רכיבי מכלל סיבובי לטורבינה

ROTOR ASSEMBLY FOR A

TURBINE

[54]

20.11.2007 [22] US [33] 28.11.2006 [32] 11/564064 [31]

Int. Cl.(2010.01) B23P 15//02, 15//04, F04D 29//38 [51]

GENERAL ELECTRIC COMPANY,

U.S.A. [71]




31 YAVNE ST.,

P.O.B. 1426,

TEL AVIV 61013

[74]

A rotor assembly for a turbine, said rotor assembly comprising:

a first portion (210) of a rotor component forged from a first material, said first

material being alpha/beta processed; and a second portion (230) of said rotor

component separately forged from a second material that is the same material as said

first material, said second portion being beta processed, wherein said first material and

said second material comprise titanium-based alloys and said second portion is welded

to said first portion at a first axial position.

[57]

__________________

187604 [21[]11]

תכשירי רוקחות המכילים אנטגוניסט לטיפול במחלת סטיל 6 –לאינטרלוקין

PHARMACEUTICAL


AN INTERLEUKIN-6

ANTAGONIST FOR TREATMENT

OF STILL'S DISEASE

[54]






02.04.2002 [22] JP [33] 02.04.2001 [32] 2001-103627 [31]

JP 06.04.2001 2001-109131

Int. Cl.(2010.01) A61K 38//20, 39//395, 45//00, A61P 19//02, C07K 16//28 [51] DIVISION FROM 158079 [62]

CHUGAI SEIYAKU KABUSHIKI

KAISHA, JAPAN [71]

WO/2002/080969 [87]



P.O.B. 1352,

JERUSALEM 91013

[74]

A therapeutic agent for treatment of Still's disease comprising an antibody against

interleukin-6 (IL-6) receptor as an active ingredient.

[57]

The parent application from which 236/57 בקשת הורה לבקשה זו שטרם פורסמה



__________________

187667 [21[]11]

שיטה ומערכת לניווט של מחט אל איבר בגוף של מטופל


NAVIGATING A SURGICAL

NEEDLE TOWARD AN ORGAN

OF THE BODY OF A PATIENT

[54]

26.11.2007 [22] US [33] 27.11.2006 [32] 60/861118 [31]

Int. Cl.(2010.01) A61B 17//34, 19//00 [51]

MEDIGUIDE LTD. [71] מדיגייד בע"מ, חיפה

בורוכוב קורח ושות', מגדל כלל עתידים

אביב-תל58100, ת.ד.

BOROCHOV, KORAKH & CO.,

15TH FLOOR, ATIDIM TOWER,

KIRYAT ATIDIM,

P.O.B. 58100,

TEL AVIV 61580

[74]

System (100) for navigating a surgical needle (106) toward a target organ of the body

of a patient, the system comprising: a removable mandrel (108) located within said

surgical needle, said removable mandrel to be moved in and moved out of said surgical

needle; a medical positioning system (MPS) sensor (110) located at the tip of said

removable mandrel; an electromagnetic field generator (104) for generating an

electromagnetic field; and an MPS (102) coupled with said MPS sensor and with said

electromagnetic field generator, said MPS sensor producing an output according to

said electromagnetic field, said MPS determining the position of said tip of said

[57]




removable mandrel in a coordinate system respective of said MPS, according to said

output of said MPS sensor, said MPS producing an indication respective of said

position, to enable navigation of said surgical needle toward said target organ.

__________________

187808 [21[]11]

חיישן מבוסס גריד המשלב זיהוי כריכה ללא תגית והגברת נגיהת אור ומערכת קריאה עבור

חיישן

GRATING-BASED SENSOR

COMBINING LABEL-FREE

BINDING DETECTION AND

FLUORESCENCE

AMPLIFICATION AND READOUT

SYSTEM FOR SENSOR

[54]

20.07.2006 [22] US [33] 11.08.2005 [32] 60/707579 [31]

US 02.09.2005 60/713694

US 28.02.2006 60/778160

US 07.04.2006 60/790207

Int. Cl.(2010.01) G01N 21//55 [51]

SRU BIOSYSTEMS, INC., U.S.A. [71]

WO/2007/019024 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

A grating-based sensor is disclosed that has a grating structure constructed and

designed for both evanescent resonance (ER) fluorescence detection and label-free

detection applications. Some embodiments are disclosed which are optimized for ER

detection in an air mode, in which the sample is dry. Other embodiments are optimized

for ER detection in liquid mode, in which the sample is suspended in liquid medium

such as water. One and two-dimensional gratings are also disclosed, including gratings

characterized by unit cells with central posts, central holes, and two-level, two-

dimensional gratings. A readout system for such sensors is also disclosed. One

embodiment includes a first light source optimized for collecting label -free detection

data, a second light source optimized for collecting ER fluorescence amplification

data, and at least one detector. In one embodiment, the detector is an imaging system

[57]




and includes a CCD camera for collecting both ER and label-free data. In other

embodiments, the at least one detector takes the form of a spectrometer for collection

of label-free data and a photomultiplier for collecting ER data. In other embodiments,

a single light source such as a tunable laser or broad band light source is used.

__________________

878131 [21[]11]

הרכב פרמצבטי לשמירה על רמה קבועה של 24עד 12סטרואיד ניורואקטיבי בפלסמה למשך

שעות לאחר השימוש

PHARMACEUTICAL

COMPOSITION PROVIDING A

STEADY STATE PLASMA LEVEL

OF A NEUROACTIVE STEROID

FOR 12-24 HOURS FOLLOWING

ADMINISTRATION

[54]

09.06.2006 [22] US [33] 09.06.2005 [32] 60/688905 [31]

Int. Cl.(2010.01) A61K 09//16, 09//20, 31//58, A61P 25//00 [51]

EURO-CELTIQUE S.A.,

LUXEMBOURG [71]

WO/2006/131392 [87]





P.O.B. 11490,

TEL AVIV 62038

[74]

The present invention relates to pharmaceutical compositions of the neuroactive

steroid 3alpha-hydroxy-3beta-methoxymethyl-21-(1′-imidazolyl)-5alpha-pregnan-20-

one or a pharmaceutically-acceptable salt or solvate thereof., with properties desirable

for use in treating mood disorders and the like. The pharmaceutical compositions

provide sustained therapeutic plasma levels of 3alpha-hydroxy- 3beta-methoxymethyl-

21-(1′-imidazolyl)-5alpha-pregnan-20-one. The present invention also relates to

methods of treating these disorders by administering the pharmaceutical compositions.

[57]








__________________

187840 [21[]11]

נגזרות של חומצות תיאזול קרבוקסיליות ושימושיהן בטיפול בהפרעות במערכת העצבים

ההיקפית

THIAZOLE CARBOXYLIC ACIDS

DERIVATIVES AND THEIR USE

IN THE TREATMENT OF

PERIPHERAL NERVE SYSTEM

DISORDERS

[54]

02.06.2006 [22] JP [33] 03.06.2005 [32] 2005-164458 [31]

Int. Cl.(2010.01) A61K 31//426, 45//00, C07D 27/7/20 [51]

ONO PHARMACEUTICAL CO.,

LTD., JAPAN [71]

WO/2006/129788 [87]


רמת החייל

REINHOLD COHN AND

PARTNERS,

26A HABARZEL ST.,


[74]

An EP2 agonist which may have an EP3 agonistic effect has an effect of regenerating

and/or protecting nerves, and is therefore useful as a therapeutic agent for a disease of

the peripheral nervous system, such as a lower or upper motor neuron disease, a nerve

root disease, plexopathy, thoracic outlet compression syndrome, peripheral

neuropathy, neurofibromatosis and neuromuscular transmission disease. An EP2

agonist which has an EP3 agonistic effect is a safe and effective agent for the

regeneration and/or protection of nerves which has little influence on the circulatory

system.

[57]

בקשות חלוקה מבקשה זו מו9שטרם פורס




__________________

188067 [21[]11]






שים מצינורות התקן לשבירה לרסיסים והסרת גו וחללים בגוף

DEVICE FOR FRAGMENTING

AND REMOVING

CONCRETIONS FROM BODY

DUCTS AND CAVITIES

[54]

12.12.2007 [22]

Int. Cl.(2010.01) A61B 17//22, 18//26 [51]

LITHOTECH MEDICAL LTD. [71] ליתוטק מדיקל בע"מ, קצרין

ריינהולד כהן ושותפיו, א' 26רזל רחוב הב

רמת החייל

REINHOLD COHN AND

PARTNERS,

26A HABARZEL ST.,


[74]

A medical device and method for breaking a concretion in a body into smaller pieces

and removing the pieces from the body are described. The device comprises a dilator

sheath, a lithotripsy probe, a tubular member, and a retrieval basket. The dilator sheath

is adapted to penetrate into a passage of the body to reach the location where the

concretion is located. The lithotripsy probe is configured for shattering the concretion

into smaller pieces. The tubular member is mounted within the dilator sheath adapted

to permit the lithotripsy probe to be inserted into the tubular member. The retrieval

basket is coupled to the tubular member, and configured for entrapping the concretion

and the smaller pieces for their extraction from the body. The retrieval basket

comprises a structure constituted by a plurality of filaments extending from a basket

proximal end towards a basket distal end, and then returning to the proximal end after

forming a plurality of filament loops in the basket distal portion, and a plurality of

filament strands at the basket proximal portion.

[57]

__________________

188199 [21[]11]

תרכובת ציקלובוטאן מותמרת, תהליך הכנתה ושימושה הרפואי

SUBSTITUTED CYCLOBUTANE

COMPOUND, ITS PREPARATION

PROCESS AND ITS MEDICAL USE

[54]

21.06.2006 [22] CN [33] 24.06.2005 [32] 200510027131.X [31]

Int. Cl.(2010.01) A61K 31//4412, C07C 69//74, C07D 40/1/08 [51]

SHANGHAI INSTITUTE OF MATERIA

MEDICA, CHINESE ACADEMY OF

SCIENCES, CHINA

[71]

ZHOU CAIHONG, MINGWEI WANG,

NA LI, GUANGXING WANG, XIN XIE,

QING LIU, FAJUN NAN

[72]

WO/2006/136101 [87]






SOROKER-AGMON,

14 SHENKAR ST.,


[74]

Substituted cyclic compounds of formula (I) or formula (II) are provided. The

preparation methods of said compounds and the uses of glucagons like peptide-1

receptor (GLP-1R) regulators in the prophylaxis or treatment of metabolic disorder,

which include but not limit to diabetes, insulin-resistance and obesity etc., are also

provided.

[57]

__________________

188228 [21[]11]

לאמינאט עמיד לירי וערכת טראומה

BULLET PROOF LAMINATE AND

TRAUMA PACK

[54]

16.06.2006 [22] EP [33] 23.06.2005 [32] 05013518.5 [31]

Int. Cl.(2010.01) B32B 05//26 [51]

TEIJIN ARAMID GMBH, GERMANY [71]

WO/2006/136323 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The invention relates to a trauma pack comprising at least one panel of a plastic

material and at least one textile fabric layer affixed to the panel and made of yarns with

fibres having a tensile strength of at least 900 MPa, wherein the plastic material of the

panel is a self-reinforced thermoplastic material made of filaments, fibres, tapes or

strips of a polyolefin polymer, and wherein at least one textile fabric layer is bonded

over its entire surface to the self-reinforced thermoplastic material.

[57]




__________________

188246 [21[]11]

ראש מברשת למברשת שיניים

BRUSH HEAD FOR A

TOOTHBRUSH

[54]

03.08.2006 [22] CH [33] 08.08.2005 [32] 1307/05 [31]

Int. Cl.(2010.01) A46B 09//00, 09//04, A46D 01//00 [51]

GABA INTERNATIONAL AG,

SWITZERLAND [71]

WO/2007/016802 [87]


רמת החייל

REINHOLD COHN AND

PARTNERS,

26A HABARZEL ST.,


[74]

Disclosed is a brush head (1) for a toothbrush, comprising a grip part (11), a head part

(12), and a bristle area with bunches of bristles (201, 202, 203, 204, 301, 302, 303,

304, 401, 402, 501, 502, 601, 602, 701, 702) that are inserted therein. At least one of

said bunches of bristles (301, 302, 303, 304) is inclined. The inventive brush head (1)

is characterized in that at least some of the bristles in at least one of the inclined

bunches of bristles (301, 302, 303, 304) are pointed.

[57]

__________________

188264 [21[]11]






תרבית תרחיף של תאי גזע עובריים ממקור אנוש

SUSPENSION CULTURE OF

HUMAN EMBRYONIC STEM

CELLS

[54]

20.06.2006 [22] US [33] 22.06.2005 [32] 60/693266 [31]

Int. Cl.(2010.01) C12N 05//02 [51]

GERON CORPORATION, U.S.A. [71]

WO/2007/002086 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

This disclosure provides an improved system for culturing human embryonic stem

cells. The cells are cultured in suspension so as to maximize the production capacity of

the culture environment. The new culture system of this invention allows for bulk

proliferation of hES cells in a more cost-effective manner, which facilitates

commercial production of important products for use in human therapy.

[57]

__________________

188469 [21[]11]

–מחסנית לערבוב סטרילי של תרכובת דופאזית, במיוחד לשרפים אקריליים בעלי שני

מרכיבים

CARTRIDGE FOR STERILE

MIXING OF A TWO-PHASE

COMPOUND, PARTICULARLY FOR

TWO-COMPONENT ACRYLIC

RESINS

[54]

16.05.2006 [22] IT [33] 28.06.2005 [32] VI2005A000187 [31]

Int. Cl.(2010.01) A61B 17//56, A61F 02//46 [51]

TECRES S.P.A., ITALY [71]

GIOVANNI FACCIOLI, RENZO [72]




SOFFIATTI

WO/2007/000631 [87]





P.O.B. 45087,

JERUSALEM 91450

[74]

The present invention has its application in the field of devices and methods for the

product physical and chemical mixing and refers particularly to a cartridge for sterile

mixing of a two-phase compound. The cartridge consists of a first tubular body (2)

defining a first collection chamber (3) for a solid phase, a second tubular body (4)

defining a second collection chamber (5) for a liquid phase, means for transferring (6)

the liquid phase from the second (5) to the first chamber (3), means for mixing (7) the

phases. The means for mixing (7) comprise agitator means (8) acting on the mixture

inside the first chamber (3) with the first tubular body (2) in substantially stationary

conditions, so as to favour the dispersion of the solid phase inside the liquid phase thus

obtaining a compound with uniform physical and mechanical properties.

[57]

__________________

188582 [21[]11]

מהדקים ניתוחיים והתקני הידוק

SURGICAL FASTENERS AND

DEVICES FOR SURGICAL

FASTENING

[54]

06.07.2006 [22] US [33] 06.07.2005 [32] 60/696516 [31]

Int. Cl.(2010.01) A61B 17//064 [51]

איי.בי.איי ישראל ביומדיקל אינוביישנס בע"מ

I.B.I. ISRAEL BIOMEDICAL

INNOVATIONS LTD. [71]




WO/2007/004228 [87]

ריינהולד כהן ושותפיו, א' 26הברזל רחוב

רמת החייל


26A HABARZEL ST.,


[74]

The invention provides a surgical fastener. The fastener has a first element defining an

axis of the fastener, and or more prongs attached to the first element at hinge regions.

Deploying the fastener involves bending the prongs at the hinges so as to increase the

distance of the prong tips from the axis and locking the fastener in this deployed

configuration. The invention also provides a surgical fastening device and a method

for attaching a surgical fastener to a site of a body tissue.

[57]

__________________

188600 [21[]11]

תהליך להכנת אסאומאפראזול

METHOD FOR PREPARING

ESOMEPRAZOLE

[54]

11.07.2006 [22] KR [33] 28.07.2005 [32] 10-2005-

0068761

[31]

Int. Cl.(2010.01) A61P 01//04, C07D 40/1/12 [51]

HANMI HOLDINGS CO., LTD.,

REPUBLIC OF KOREA [71]

WO/2007/013743 [87]



P.O.B. 1352,

JERUSALEM 91013

[74]

Optically pure esomeprazole and its salt can be simply prepared by dissolving (S)-(-)-

binol, a weak base and the racemic form of omeprazole in a mixture of a water-

compatible organic solvent and water at a high temperature, cooling the mixed solution

[57]




to crystallize the inclusion complex of esomeprazole and (S)-(-)-binol, and removing

the (S)-(-)-binol moiety from the crystallized inclusion complex.

__________________

188641 [21[]11]

מערכות התאמה מותאמות במיוחד לשם תיקון תנוחות כיסא

FITTING SYSTEMS ADAPTED

ESPECIALLY FOR FIXING SEAT

POSITIONS

[54]

25.07.2006 [22] US [33] 25.07.2005 [32] 60/702133 [31]

Int. Cl.(2010.01) B60N 02//08, B64D 11//06 [51]

WEBER AIRCRAFT LP, U.S.A. [71]

WO/2007/014184 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

Fitting systems and assemblies are detailed. The assemblies are designed principally

(although not necessarily exclusively) for use with aircraft seats and supply positive

adjustable positioning of a seat or other object, typically actuated with a single turn (or

less) of a single tool

[57]

__________________

188645 [21[]11]

מכשיר למדידת כף רגל

FOOT MEASURING DEVICE

[54]

07.01.2008 [22]

Int. Cl.(2010.01) A43D 01//00, 01//02, 01//06 [51]

FITRACKS INC., U.S.A. [71]

ELIAHO GERBY, NOAM אליהו ג'רבי, נועם דננברג, יובל בכור

DANENBERG, YUVAL BECHOR

[72]










P.O.B. 5352,

BEER-SHEVA 84152

[74]

An apparatus for measuring the dimensions of human feet, comprising: (a) a base (20)

which comprises and supports electrical and optical components; (b) a cover, which

fits over said base to protect said components, and defines the borders of two

essentially rectangular wells in the upper surface of said base, into which said feet to

be measured are placed; (c) pressure pads containing a sensor matrix, which are used

to provide structural and additional information of said feet; (d) a multitude of

emmiter/detector pairs )24,24',25,25'(, which are used to make length and width

measurements of said feet; (e) computational means, which calculate said dimensions

from said measurements; and (f) display means, which display said dimensions, said

structural information and other pre-determined information characterized in that said

computational means comprises an algorithm which uses information supplied by said

pressure pads to correct errors in said length and width measurments caused by

misplacement of said feet in said wells and said emitters and corresponding detector

are provided in two contiguous levels, wherein the upper is offset by one half of the

width of an individual emitter/detector.

[57]

__________________

188649 [21[]11]

השיטה לקביעה אוטונומית של קואורדינטות המיקום של אובייקט בתנועה והמכשיר ליישומו

METHOD AND DEVICE FOR

AUTONOMOUS

DETERMINATION OF THE

LOCATION COORDINATES OF A

MOVING OBJECT

[54]

08.01.2008 [22]

Int. Cl.(2010.01) G01C 21//00 [51]

מיכאל נאומוב, תל אביב אביב -גאורגי נאומוב, תל

MICHAEL NAUMOV

GEORGE NAUMOV [71]

MICHAEL NAUMOV, [74] מיכאל נאומוב,




3חצור תל אביב

3 HATZOR ST.,

TEL AVIV

Method of autonomous determination of the location of the coordinates of a moving

object comprising the following stages: determination of the true course;

determination of the projections of the linear acceleration vector onto the lines of

crossing the horizontal plane and the planes going through the vertical axis of the

moving object and through, correspondingly, the longitudinal and traverse axis of said

object through its lines parallel to said axes; determination of the projections of the

ground speed vector onto said lines of crossing; determination of the location of the

coordinates of the moving object by means of said projections.

[57]

__________________

188670 [21[]11]

נגזרות פירידין ונגזרות פירימידין ושיטות לשימוש בהן

PYRIDINE AND PYRIMIDINE

DERIVATIVES AND METHODS

OF USE THEREOF

[54]

21.08.2006 [22] US [33] 24.08.2005 [32] 60/710671 [31]

Int. Cl.(2010.01) A61K 31//4409, 31//496, 31//506, 31//5377, A61P 35//00, 35//04,

43//00, C07D 21/3/75, 23/9/47, 40/1/12

[51]


LTD., JAPAN [71]

TOMOHIRO MATSUSHIMA,

HIROSHI OBAISHI, KEIKO

TAKAHASHI, SETSUO FUNASAKA,

SHUJI SHIROTORI

[72]

WO/2007/023768 [87]

ר אנד קו בע"מ,ג'יי אמ בי, פקטו רחוב המרפא, הר חוצבים




P.O.B. 45087,

JERUSALEM 91450

[74]

A compound represented by the general formula: (I) (wherein R1 means a 3- to 10-

membered nonaromatic heterocyclic group or the like; R2 and R

3 mean a hydrogen

atom; R4, R

5, R

6 and R

7 are the same or different and mean a hydrogen atom, a halogen

atom, a C1-6 alkyl group or the like; R8 means a hydrogen atom or the like; R

9 means a

3- to 10-membered nonaromatic heterocyclic group or the like; n means an integer of 1

to 2; and X means a group represented by the formula -CH= or a nitrogen atom), a salt

thereof or a hydrate thereof has an excellent hepatocyte growth factor receptor (HGFR)

inhibitory action, and exhibits an anti-tumor action, angiogenesis inhibitory action or

cancer metastasis inhibitory action.

[57]




__________________

188757 [21[]11]

צעי להעברת רמות דחיסה, מערכת, שיטה ואמ במערכת של צורה זורמת

SYSTEMS, METHODS AND

MEDIA FOR TRANSITIONING

COMPRESSION LEVELS IN A

STREAMING IMAGE SYSTEM

[54]

13.07.2006 [22] US [33] 19.07.2005 [32] 11/184345 [31]

Int. Cl.(2010.01) H04N 07//50 [51]


WO/2007/009941 [87]


חיפה

IBM LABORATORIES,

HAIFA UNIVERSITY,

HAIFA 31905

[74]

Systems, methods and media for transitioning compression levels of a streaming image

system are disclosed. One embodiment provides a method for transitioning

compression levels between image frames in a streaming image system. Embodiments

may include receiving by a smoothing module a request for a new compression level

associated with an image frame. Embodiments may also generally include performing

by the smoothing module a smoothing heuristic by generating a multi-frame

smoothing routine based on an initial compression level, a target compression level,

and a number of frames to achieve the target compression level. Embodiments may

also include setting by the smoothing module the new compression level for the image

frame based on the generated multi-frame smoothing routine. Further embodiments

may include transmitting by the smoothing module an indication of the new

compression level to a content encoder.

[57]




__________________

189030 [21[]11]

תכשירים המכילים פטריית זנב תרנגול הודו תמצית שלהאו FERM BP–10633מיזן


TURKEY TAIL MUSHROOM

STRAIN FERM BP-10633 OR ITS

EXTRACT

[54]

28.07.2006 [22] JP [33] 28.07.2005 [32] 2005-218554 [31]

Int. Cl.(2010.01) A01G 01//04, A01H 15//00, A61K 36//07, C12N 01//14 [51]

NIKKEN SOHONSHA

CORPORATION, JAPAN [71]

WO/2007/013588 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

Disclosed is a strain of turkey tail mushroom (Trametes versicolor) having excellent

biological activities (Accession number: FERM BP-10633). The strain is excellent in

platelet aggregation inhibitory effect, chemokine gene expression inhibitory effect,

anti-mutagenic effect, anti-tumor effect, anti-hypertensive effect and

immunomodulating effect. When the strain is used in combination with a microalga or

other basidiomycete, the effect of the strain is improved synergistically. The strain has

a high safety, is less likely to cause an adverse side effect even when used

continuously for a prolonged period of time, and can be used effectively in a beverage,

cosmetic, pharmaceutical or the like that is intended to be used for the

prevention/improvement of an inflammation, an allergy, a tumor or other disease. The

strain has extremely increased hypha growth property and shows extremely higher

physiological functions compared to conventional strains and therefore can be used

stably.

[57]




__________________

189168 [21[]11]

התקן לטיפול במצעים, בפרט לגלוונם

DEVICE FOR THE TREATMENT

AND IN PARTICULAR

GALVANIZING OF SUBSTRATES

[54]

03.08.2006 [22] DE [33] 03.08.2005 [32] 102005038450.1 [31]

Int. Cl.(2010.01) C25D 17//06 [51]

GEBR. SCHMID GMBH & CO.,

GERMANY [71]

WO/2007/014778 [87]




5 SHENKAR ST.,

P.O.B. 12704,

HERZLIYA 46733

[74]

The invention relates to a contacting device for a galvanization apparatus (11),

comprising contacting rollers (20) with a continuous rigid external face (26, 27) which

is joined to a jacket section (22). The jacket section (22) is provided with an inner

opening (23) that is wider than a rotating shaft (30) on which the contacting roller (20)

sits. This allows the contacting roller (20) to be moved in a radial direction, electric

contacting and securing of a basic position being obtained via springs (32). The

movability of the contacting roller (20) ensures good contact as the contacting roller

(20) rests against substrates (16) even when the substrates (16) are uneven. The contact

pressure can be relatively small.

[57]

__________________

189206 [21[]11]

INTERRUPT CONTROLLER [54]הפרעה להפקת תועלת של תיכנות ערכי עדיפות






של בקר

UTILISING PROGRAMMABLE

PRIORITY VALUES

24.10.2006 [22] GB [33] 21.12.2005 [32] 0526007.0 [31]

Int. Cl.(2010.01) G06F 13//24 [51]

ARM LIMITED, UNITED KINGDOM [71]

WO/2007/071894 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

An interrupt controller (2) is provided with priority registers (6) storing priority values

P0-P9 used to determine prioritisation between received interrupt signals I0-I9. A

priority value accessing circuit (10) provides multiple mappings to the priority values

stored in dependence upon the priority value manager (16, 18), seeking to make an

access. In this way, a first priority value manager (18), such as a secure operating

system, can be given exclusive access to the highest priority values whilst a second

priority value manager (16), such as a non-secure operating system, can be given

access to a range of priority values as stored which are of a lower priority and yet as

written or read by the non-secure operating system appear to the non-secure operating

system to have a different, such as higher, priority level.

[57]

__________________

189284 [21[]11]

השיטה והמכשיר לקביעה אוטונומית של זווית הסחיפה של אובייקט בתנועה

METHOD AND DEVICE FOR

AUTONOMOUS

DETERMINATION OF THE

ANGLE OF DRIFT OF A MOVING

OBJECT

[54]

05.02.2008 [22]

Int. Cl.(2010.01) G01C 21//00 [51]




אביב -מיכאל נאומוב, תל אביב -גאורגי נאומוב, תל

MICHAEL NAUMOV

GEORGE NAUMOV [71]

מיכאל נאומוב, 3חצור

אביב -תל

MICHAEL NAUMOV,

3 HATZOR ST.,

TEL AVIV 69016

[74]

The present technical solution provided is intended for the accurate determination of

angle of drift only by the means located inside the moving object, without applying

any radiations and gyroscopes as well as without using any sources of information and

orientation on the Earth and on any other heavenly bodies. The determination of such

kind is provided for the first time and is considered to be of paramount importance for

navigational and meteorological purposes. The present solution is based on the

determination of the horizontal projections of the linear acceleration vector by means

of the sensors of said acceleration.

[57]

__________________

189342 [21[]11]

טכנולוגיה למתן שרותי תקשורת למספר קווי תקשורת באמצעות ציוד עודף

TECHNOLOGY FOR PROVIDING

TELECOMMUNICATION

SERVICES TO MULTIPLE

OPTICAL COMMUNICATION

LINES BY EQUIPMENT HAVING

REDUNDANCY

[54]

07.02.2008 [22]

Int. Cl.(2010.01) H04Q 11//00 [51]

ECI TELECOM LTD. [71] . איי. טלקום בע"מ, פתח תקוהאי. סי


פתח תקוה

ECI TELECOM LTD.,

30 HASIVIM ST.,

PETACH TIKVA 49517

[74]

A system for serving N optical communication lines by a redundant set of modules in

an optical network; where the set of modules comprises N >1 main modules and one

backup module, N optical splitters, 2N fiber connections and a control means. In the

system, each of the N optical splitters is connected to two different modules of the set

by two respective fiber connections out of the 2N connections, while each of the N

optical splitters is also coupled to one of the N optical communication lines. The

arrangement is such that the control means selectively activates/inactivates any of the

fiber connections for respectively enabling/blocking transfer of data therealong; the

control means thus ensures that each specific line of the N optical communication

lines is always served by either one or another of two different modules.

[57]




__________________

189514 [21[]11]

מערכת גישור לוגית ושיטה

LOGICAL BRIDGING SYSTEM

AND METHOD

[54]

13.02.2008 [22] US [33] 14.02.2007 [32] 60/889809 [31]

US 04.05.2007 60/916065

Int. Cl.(2010.01) H04L 12//28 [51]

מארוול ישראל )אמ.איי.אס.אל( בע"מ, יוקנעם

MARVELL ISRAEL (M.I.S.L) LTD. [71]




P.O.B. 2273,

REHOVOT 76122

[74]

A bridge for routing data packets on a network, the bridge comprising: a physical

ingress port to receive a data packet from the network; a classification engine to assign

source logical port information to the data packet based on characteristics of the data

packet, wherein an assigned logical ingress port is decoupled from the physical ingress

port; a bridging engine downstream of the classification engine to learn the source

logical port information and to forward the data packet to a logical egress port based

on a destination address of the data packet; and a logical port mapping engine to map

the logical egress port to a physical egress port at which the data packet is to be

egressed.

[57]





__________________

189664 [21[]11]

פירידין ותולדות –תולדות אוקסזול/תיאזולויצורן, אוקסזול/תיאזול, תהליך לי–בנזו

ותכשירים רוקחיים הכוללים אותן

OXAZOLO/THIAZOLO-PYRIDINE

DERIVATIVES AND BENZO-

OXAZOLE/THIAZOLE

DERIVATIVES, PROCESS FOR

THEIR PREPARATION AND

PHARMACEUTICAL


THE SAME

[54]






21.08.2006 [22] EP [33] 02.09.2005 [32] 05108035.6 [31]

Int. Cl.(2010.01) A61K 31//423, 31//424, 31//428, 31//429, A61P 03//00, 17//00,

19//02, C07D 41/3/12, 41/7/12, 49/8/04, 51/3/04

[51]


SWITZERLAND [71]

WO/2007/025897 [87]


באר שבע5352. , ת.ד



P.O.B. 5352,

BEER-SHEVA 84152

[74]

This invention is concerned with compounds of the formula (I) wherein X, A, B, R1,

R2 and G are as defined in the description and claims, and pharmaceutically acceptable

salts thereof. The invention further relates to pharmaceutical compositions containing

such compounds, to a process for their preparation and to their use for the treatment

and/or prevention of diseases which are associated with the modulation of SST

receptors subtype 5.

[57]

__________________

189666 [21[]11]

בנזאמידים מותמרים בפירידינאמינוסולפוניל P450 3A4 (4A3כמעכבים של ציטוכרום

CYP)

PYRIDINAMINOSULFONYL

SUBSTITUTED BENZAMIDES AS

INHIBITORS OF CYTOCHROME

P450 3A4 (CYP3A4)

[54]

11.09.2006 [22] US [33] 23.09.2005 [32] 60/720151 [31]

US 03.10.2005 60/723115

US 11.10.2005 60/725469

US 25.01.2006 60/762256

US 07.08.2006 60/821664

Int. Cl.(2010.01) A61K 31//4406, A61P 39//00, C07D 21/3/00 [51]

PFIZER PRODUCTS, INC., U.S.A. [71]

WO/2007/034312 [87]








P.O.B. 5352,

BEER-SHEVA 84152

[74]

The present invention provides compounds of formula (I), or pharmaceutically

acceptable salts or solvates thereof, methods for their preparation, methods for their

use, and pharmaceutical formulations comprising them.

[57]

__________________

189716 [21[]11]

שיטה ומערכת להשגת גישה לערוץ גישה –FDMAאקראי לקשר מהארץ ללוויין במערכת

SC


ACCESSING AN UPLINK

RANDOM ACCESS CHANNEL IN

A SINGLE CARRIER FREQUENCY

DIVISION MULTIPLE ACCESS

SYSTEM

[54]

22.08.2006 [22] US [33] 23.08.2005 [32] 60\710599 [31]

Int. Cl.(2010.01) H04B 07//204, H04J 01//00, H04W 52//48, 52//50, 74//08 [51]



WO/2007/024791 [87]


רמת החייל


26A HABARZEL ST.,


[74]

A method and apparatus for accessing a contention-based uplink random access

channel (RACH) in a single carrier frequency division multiple access (SC-FDMA)

system are disclosed. A wireless transmit/receive unit (WTRU) randomly selects a

RACH subchannel and a signature among a plurality of available RACH subchannels

and signatures. The WTRU transmits a preamble using the selected signature via the

[57]




selected RACH subchannel at a predetermined or computed transmission power. A

base station monitors the RACH to detect the preamble and sends an acquisition

indicator (AI) to the WTRU when a signature is detected on the RACH. When

receiving a positive acknowledgement, the WTRU sends a message part to the base

station. If receiving a negative acknowledgement or no response, the WTRU

retransmits the preamble.

__________________

189804 [21[]11]

רפידה תחתית נגד פצעי לחץ ותוכנית לרפידה של מיטה המכילה רפידה תחתית נגד פצעי

לחץ

ANTIDECUBITAL UNDERLAY PAD

AND BED PAD DESIGN

COMPRISING AN ANTIDECUBITAL

UNDERLAY PAD

[54]

24.07.2006 [22] DE [33] 31.08.2005 [32] 102005041520.2 [31]

Int. Cl.(2010.01) A47C 27//00, A61G 07//057 [51]

OPED AG, SWITZERLAND [71]

DANIELA HAPPEL [72]

WO/2007/025611 [87]

הנרי סיני, 4המייסדים

רעננה669, ת.ד.

HENRY SINAI,

IP-PARTNERSHIP

P.O.B 669

RAANANA 43350

[74]

An antidecubital underlay pad having a receiving casing with a top side of the casing

and a bottom side of the casing, the casing being segmented along a plurality of

segmentation axes to form underlay segments, such that the underlay segments are

provided with a moulded body filling comprising a plurality of moulded bodies and are

bordered by segmentation lines running along the segmentation axes, characterized in

that the segmentation lines (11) have multiple changes in direction in their course

along the segmentation axes (13) and at least the top side (16) of the casing is designed

to be elastic at least in a supporting area and is pre-stressed by the moulded body

filling.

[57]




__________________

189823 [21[]11]

שיטה ומערכת להכנת אריג בטכניקת SPUNBOND


MAKING A SPUNBOND WEB

[54]

28.02.2008 [22] EP [33] 08.03.2007 [32] 07004747/7 [31]

Int. Cl.(2010.01) D01D 05//088, 05//098, D04H 01//00, 03//16 [51]

REIFENHAUSER GMBH & CO. KG

MASCHINENFABRIK, GERMANY [71]


רמת החייל


26A HABARZEL ST.,


[74]

A method for the manufacture of a spunbond non-woven web fabric from filaments, in

particular of a thermoplastic plastic, wherein the filaments are spun from at least one

spinning device, wherein the filaments are subsequently cooled in a cooling chamber

and then stretched in a stretching unit, wherein the filaments are subsequently guided

through at least one diffuser and are then deposited on a deposition belt to form the

non-woven fabric web, wherein the non-woven fabric web is guided out of the wetting

unit and is subsequently initially consolidated by means of a high pressure water jet

treatment on the deposition belt, and wherein the non-woven fabric web is

subsequently drawn off from the deposition belt and is further treated.

[57]

__________________

189909 [21[]11]

אלמנטים מודולאריים, רשת, מבנה תומך, מבנה ותהליך לייצורם

MODULAR ELEMENTS,

NETWORK, SUPPORTING

STRUCTURE, CONSTRUCTION

[54]






AND PROCESS FOR OBTAINING

THEM

07.08.2006 [22] RO [33] 22.09.2005 [32] A200500806 [31]

Int. Cl.(2010.01) E04B 02//00, 02//26, E04C 02//26 [51]

LAURENTIU DUMITRU BREAZ,

ROMANIA [71]

WO/2007/081233 [87]



P.O.B. 1352,

JERUSALEM 91013

[74]

The invention relates to modular elements made of insulating materials for

constructions, provided with at least one network element in the interior; to a network

obtained by connecting modular elements; to a supporting structure achieved by

casting a hardening material in the network achieved by connecting the modular

elements and joining them through the supporting structure, as well as to the process

for obtaining thereof. The modular element has an interior network element made up

of at least two main half-joints and optionaly it may have one or more secondary half-

joints, connected through vertical and oblique channels. The network obtained by

assembling the modular elements is made up of main and secondary joints, connected

trough vertical, horizontal and oblique channels. The unitary supporting structure is

obtained by casting a material that will be harden in the unitary network for the entire

construction. The process for obtaining the construction according to the invention

consists of the following: connection of modular elements and the casting of material

that hardens in the network defined through the connection of modular elements and

the creation of a unitary supporting structure.

[57]

__________________

189972 [21[]11]




פורמולציה המכילה היילורונן והשימוש בה להכנת תרופה ומנעיה של מחלות תאיות

FORMULATION COMPRISING

HYALURONAN AND USE

THEREOF FOR PREPARING A

MEDICAMENT FOR TREATMENT

OR PROPHYLAXIS OF

CELLULAR DISEASES IN A

SUBJECT

[54]

04.09.2006 [22] US [33] 07.09.2005 [32] 60/715293 [31]

US 31.03.2006 60/788589

Int. Cl.(2010.01) A61K 31//726, 31//728, 39//395, A61P 35//00 [51]

ALCHEMIA ONCOLOGY PTY

LIMITED, AUSTRALIA [71]

WO/2007/028196 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The present invention relates generally to treatment and prophylactic protocols for

cellular diseases or disorders, such as diseases and disorders associated with abnormal

cellular proliferation. More particularly, the present invention provides compositions

comprising therapeutic antibodies and hyaluronan and their use in the treatment or

prophylaxis of cellular diseases and disorders.

[57]

__________________

190011 [21[]11]

מנעול רב שימושי

MULTIFUNCTIONAL LOCK

[54]

20.07.2006 [22] CN [33] 09.09.2005 [32] 200520075364.2 [31]

CN 25.01.2006 200620068971.0

Int. Cl.(2010.01) E05B 29//04 [51]

MALAFON ELECTRONIC (SUZHOU)

CO. LTD., CHINA [71]

VINCENT GAN, YANG SHEN [72]

WO/2007/028308 [87]

קו בע"מ,ג'יי אמ בי, פקטור אנד רחוב המרפא, הר חוצבים




P.O.B. 45087,

JERUSALEM 91450

[74]

A multifunctional lock comprises a lock shell (1), a lock bar (3), movable tooth pieces

(4), a support (5) for sliding blocks, sliding blocks (6) and a guide slot unit (8) for the

[57]




insertion of a key. Wherein, an elastic element is provided between the lock bar and

the support, the sliding blocks at least partially extend into the keyway of the unit.

When the lock is unlocked, a projection of the unit has two operating positions, in one

of which the projection is received into the cut of the shell and the upper teeth of the

tooth pieces disengage from the bottom teeth of the sliding blocks, in another it is out

of the cut and the upper teeth engage with the bottom teeth. The key of the lock can be

changed many times.

__________________

190071 [21[]11]

תמיכהמכלול איבר

SUPPORT MEMBER ASSEMBLY

[54]

12.09.2006 [22] SG [33] 16.09.2005 [32] 200505952-2 [31]

Int. Cl.(2010.01) E04B 02//00, 02//06, 02//58 [51]

DYNTEK PTE LTD., SINGAPORE [71]

WO/2007/032746 [87]


רמת החייל


26A HABARZEL ST.,


[74]

A support member system (100) is disclosed herein. In a preferred embodiment, the

system (100) comprises an elongate support member (102, 103) having an effective

length, an elongate member engagement portion (130, 135) arranged to engage with

one end of the elongate support member (102, 103) to extend the member's effective

length, and a base portion (110) for engaging with a support structure (8, 9). The base

portion (110) including connection means (114, 116) for releasably connecting the

base portion (110) selectively to the elongate member engagement portion (130, 135)

[57]




or to the elongate support member (102, 103).

__________________

190088 [21[]11]

ללא שימוש ברכיבים Aייצור וטיהור חלבון נגזרים מבעלי חיים

PROTEIN A PRODUCTION AND

PURIFICATION WITHOUT USING

ANIMAL DERIVED

COMPONENTS

[54]

14.09.2006 [22] US [33] 20.09.2005 [32] 60/718759 [31]

Int. Cl.(2010.01) C07K 14//195, 14//31, C12N 01//20 [51]

AVANTOR PERFORMANCE

MATERIALS, INC., U.S.A. [71]

WO/2007/035410 [87]




10 ABBA EBEN BLVD.,

P.O.B. 2081,

HERZLIYA 46120

[74]

Purification of vegetarian (non-animal derived) Protein A using a multidimensional

purification process to remove undesirable non-animal derived components.

[57]

__________________

190454 [21[]11]

התקן לניקוי פני שטח באמצעות כח מגהסוני

APPARATUS FOR CLEANING

SUBSTRATE USING MEGASONIC

[54]






POWER

30.09.2003 [22] US [33] 30.09.2002 [32] 10/261839 [31]

US 30.06.2003 10/611140

Int. Cl.(2010.01) H01L 21//00 [51] DIVISION FROM 161550 [62]

LAM RESEARCH CORPORATION,

U.S.A. [71]

JOHN M. DE LARIOS, JAMES P.

GARCIA, CARL A. WOODS,

MICHAEL RAVKIN, FRITZ

REDEKER, JOHN BOYD, AFSHIN

NICKHOU

[72]

WO/2004/030052 [87]





P.O.B. 45087,

JERUSALEM 91450

[74]

A head used in a substrate preparation apparatus, having a head surface, the head

configured to be disposed proximate to a surface of a substrate, comprising: at least

one first source inlet for delivering a first fluid to the surface of the substrate through

the head; at least one second source inlet for delivering a second fluid to the surface of

the substrate through the head, the second fluid being different than the first fluid; at

least one source outlet for removing each of the first fluid and the second fluid from

the surface of the substrate, at least a portion of the at least one source outlet being

located in between the at least one first source inlet and the at least one second source

inlet; and a transducer disposed in the head for applying acoustic energy at a location

between the at least one of a first source inlet and the source outlet; wherein the head

surface has flat surface regions, and the head surface is defined so that the at least one

of the first source inlet, the second source inlet and the source outlet are defined by

discrete holes that reside at the head surface and extend through the flat surface regions

of the head surface.

[57]

__________________

190585 [21[]11]

ות שיטה לאבחון תסחיפי קרישה ומחל בעורקים הכליליים של הלב

METHOD FOR THE DIAGNOSIS OF

THROMBOEMBOLIC AND

CORONARY HEART DISEASES

[54]

30.09.2006 [22] DE [33] 12.10.2005 [32] 102005048899.4 [31]




Int. Cl.(2010.01) C12Q 01//68 [51]

SANOFI AVENTIS, FRANCE [71]

WO/2007/042165 [87]




5 SHENKAR ST.,

P.O.B. 12704,

HERZLIYA 46733

[74]

The invention relates to a method for the In-vitro diagnosis of thromboembolic

disorders and/or coronary heart diseases. The nucleotide in position 470 of a nucleic

acid, coded for human EGLN2-protein, or the amino acid in position 58 of the human

EGLN2-protein of a sample from a person is determined.

[57]

__________________

190673 [21[]11]

מימן פוספאט של אנטגוניסט לרצפטור –דו–מלח 2Dפרוסטגלאנדין

DIHYDROGEN PHOSPHATE

SALT OF A PROSTAGLANDIN D2

RECEPTOR ANTAGONIST

[54]

12.10.2006 [22] US [33] 13.10.2005 [32] 60/726290 [31]

Int. Cl.(2010.01) A61K 31//505, C07D 23/9/46, 23/9/47 [51]

AVENTIS PHARMACEUTICALS

INC., U.S.A. [71]

WO/2007/047378 [87]




5 SHENKAR ST.,

P.O.B. 12704,

HERZLIYA 46733

[74]

The present invention is directed to the dihydrogen phosphate salt of 2-(3-{6-[2-(2,4-

dichloro-phenyl)-ethylamino]-2-methoxy-pyrimidin-4-yl}-phenyl)-2-methyl-propionic

acid of Formula (III), a pharmaceutical composition comprising a pharmaceutically

effective amount of the compound of Formula (III), and a pharmaceutically acceptable

carrier; and a method of treating a patient suffering from a PGD2-mediated disorder

including, but not limited to, allergic disease (such as allergic rhinitis, allergic

conjunctivitis, atopic dermatitis, bronchial asthma and food allergy), systemic

mastocytosis, disorders accompanied by systemic mast cell activation, anaphylaxis

shock, bronchoconstriction, bronchitis, urticaria, eczema, diseases accompanied by

itch (such as atopic dermatitis and urticaria), diseases (such as cataract, retinal

detachment, inflammation, infection and sleeping disorders) which is generated

secondarily as a result of behavior accompanied by itch (such as scratching and

beating), inflammation, chronic obstructive pulmonary diseases, ischemic reperfusion

[57]




injury, cerebrovascular accident, chronic rheumatoid arthritis, pleurisy, ulcerative

colitis and the like, by administering to said patient a pharmaceutically effective

amount of the compound of Formula (III).

__________________

190731 [21[]11]

ייצור של אוליגודנדרוציטים מתאי גזע שהופקו משלייה

PRODUCTION OF

OLIGODENDROCYTES FROM

PLACENTA-DERIVED STEM

CELLS

[54]

13.10.2006 [22] US [33] 13.10.2005 [32] 60/727601 [31]

Int. Cl.(2010.01) C12N 05//0735 [51]

ANTHROGENESIS CORPORATION,

U.S.A. [71]

WO/2007/047465 [87]





P.O.B. 11490,

TEL AVIV 62038

[74]

The present invention provides methods and compositions for the production of glial

cells and oligodendrocytes from placenta stem cells. The invention further provides for

the use of these glia and oligodendrocytes in the treatment of, and intervention in, for

example, trauma, ischemia and degenerative disorders of the central nervous system

(CNS), particularly in the treatment of demyelinating diseases such as multiple

sclerosis.

[57]




__________________

190869 [21[]11]

שיטה לייצור תאי גזע ממקור אנושי על ידי שפעול רביית בתולים של בייציות ממקור אנושי

METHOD OF PRODUCING

HUMAN STEM CELLS BY

PARTHENOGENIC ACTIVATION

OF HUMAN OOCYTES

[54]

19.10.2006 [22] US [33] 21.10.2005 [32] 60/729177 [31]

US 02.11.2005 60/733309

US 11.01.2006 60/758443

US 14.06.2006 60/813799

Int. Cl.(2010.01) C12N 05//0735 [51]

INTERNATIONAL STEM CELL


WO/2007/047979 [87]


רמת החייל


26A HABARZEL ST.,


[74]

)Methods of producing human stem cells are disclosed for parthenogenetically

activating human oocytes by manipulation of O2 tension, including manipulation of

Ca2+

under high O2 tension and contacting oocytes with serine threonine kinase

inhibitors under low O2 tension, isolating inner cell masses (ICMs) from the activated

oocytes, and culturing the cells of the isolated ICMs under high O2 tension. Moreover,

methods are described for the production of stems cells from activated oocytes in the

absence of non-human animal products, including the use of human feeder

cells/products for culturing ICM/stem cells. Stem cells produced by the disclosed

methods are also described.

[57]




__________________

191066 [21[]11]

יטה והתקן לטיפול במים למניעת אורגניזם ש מימיים


WATER TREATMENT TO

ELIMINATE AQUATIC

ORGANISMS

[54]

27.10.2006 [22] ZA [33] 28.10.2005 [32] 2005/10473 [31]

Int. Cl.(2010.01) C02F 01//36 [51]

RESOURCE BALLAST

TECHNOLOGIES (PROPRIETARY)

LIMITED, SOUTH AFRICA

[71]

WO/2007/049139 [87]




5 SHENKAR ST.,

P.O.B. 12704,

HERZLIYA 46733

[74]

A method and apparatus for treating water such as ballast water in ships in order to

eliminate aquatic organisms in the water. The water is led under pressure through a

conduit into a chamber of greater cross-section than that of the conduit so that an

abrupt reduction in pressure occurs. Cavitation ensues, leading to the release of

dissolved gases. Ultrasonic vibration is generated and is applied to the water, exerting

a pounding effect that weakens or destroys the organisms present. Other means may be

used to generate further mechanical, electrical, and chemical forces in the water which

attack the organisms.

[57]

__________________

191077 [21[]11]

ISOLATED ANTIBODY WHICH [54]( NTDטרמינלי )–Nנוגדן מבודד הנקשר לאזור






לגילוי IN–VITRO, שיטות γ–HRGשל העושות שימוש בנוגדן כזה γ–HRGולטיהור

ושימוש בנוגדן כזה להכנת תרופות

BINDS TO THE N-TERMINAL

DOMAIN (NTD) OF Γ-HRG, IN-

VITRO METHODS FOR

DETECTING AND PURIFYING Γ-

HRG USING SUCH ANTIBODY

AND USE OF SUCH ANTIBODY IN

THE PREPARATION OF

MEDICAMENTS

08.07.1997 [22] US [33] 12.07.1996 [32] 60/021640 [31]

Int. Cl.(2010.01) A61K 39//395, C07K 16//22, C12N 15//12, 15//13 [51] DIVISION FROM 127892 [62]


WO/1998/002541 [87]

רוביץ ושות',ש. הו 31רחוב אחד העם


S. HOROWITZ & CO.,

31 AHAD HAAM ST.,

P.O.B. 2499,

TEL AVIV 65202

[74]

An isolated antibody which binds to the N-terminal domain (NTD) of γ-HRG, which

has the ability to bind to the ErbB3 and/or ErbB4 receptor and comprises an amino

acid sequence selected from the group consisting of: (a) the amino acid sequence for γ-HRG in SEQ ID No:2; (b) naturally occuring allelic variants or isoforms of 9a) having at least 80% amino

acid sequence identity with human γ-HRG of SEQ ID No:2; and

(c) the amino acid sequence of (a) or (b) which has only one or two amino acid

substitutions.

[57]

__________________

191078 [21[]11]

–Nפוליפפטידים הכוללים רצף עוקב של אזור , חומצות גרעין, וקטורים, γ–HRGטרמינלי של

תאי מאכסן, תכשירי רוקחות, שיטות לייצור ושימוש בפוליפפטידים כאלה

POLYPEPTIDES COMPRISING A

CONSECUTIVE SEOUENCE OF

THE Γ-HRG, N-TERMINAL

DOMAIN, NUCLEIC ACIDS,

VECTORS, HOST CELLS,

PHARMACEUTICAL

COMPOSITIONS, METHODS FOR

PRODUCING AND USE OF SUCH

POLYPEPTIDES

[54]




08.07.1997 [22] US [33] 12.07.1996 [32] 60/021640 [31]

Int. Cl.(2010.01) A61K 38//18, C07K 14//47, 14//475, C12N 15//12, 15//16, 15//63,

15//70, 15//74, 15//79

[51]

DIVISION FROM 127892 [62]


WO/1998/002541 [87]

ש. הורוביץ ושות', 31רחוב אחד העם


S. HOROWITZ & CO.,

31 AHAD HAAM ST.,

P.O.B. 2499,

TEL AVIV 65202

[74]

An isolated polypeptide comprising a consecutive sequence of at least thirty amino

acids of the gamma-HRG N-terminal domain (NTD) of SEQ ID NO:4.

[57]

__________________

191417 [21[]11]

קומבינציות של מפעילי קולטן מסוג פרוקסיזום ( ומעכבי ספיגת PPARאקטיבטד )–פרוליפרטור

סטרול

COMBINATIONS OF

PEROXISOME PROLIFERATOR-

ACTIVATED RECEPTOR (PPAR)

ACTIVATOR(S) AND STEROL

ABSORPTION INHIBITOR(S)

[54]

25.01.2002 [22] US [33] 26.01.2001 [32] 60/264396 [31]

US 21.09.2001 60/323839

Int. Cl.(2010.01) A61K 31//397, 31//70, 45//06, 47//12, 47//20, 47//34, 47//38, A61P

03//04, 03//10, 09//04, 09//10, C07D 20/5/08, 20/5/12, 40/1/04, 40/3/12, 40/5/10,

40/9/04, 41/3/10, C07H 03//04, 17//02

[51]


SCHERING CORPORATION, U.S.A. [71]

WO/2002/058732 [87]





P.O.B. 11490,

TEL AVIV 62038

[74]

The present invention provides compositions, therapeutic combinations and methods

including: (a) at least one peroxisome proliferator-activated receptor activator; and (b)

at least one substituted azetidinone or substituted b-lactam sterol absorption inhibitor

which can be useful for treating vascular conditions, diabetes, obesity and lowering

plasma levels of sterols.

[57]




__________________

191606 [21[]11]

לדת כלי התקן להעמסת מערכת כלי נשק של ש רכב

DEVICE FOR MOUNTING A

WEAPON SYSTEM ON A

VEHICLE CHASSIS

[54]

13.11.2006 [22] FR [33] 21.11.2005 [32] 0511826 [31]

Int. Cl.(2010.01) F41A 23//34 [51]

NEXTER SYSTEMS, FRANCE [71]

WO/2007/057550 [87]


רמת החייל

REINHOLD COHN AND

PARTNERS,

26A HABARZEL ST.,


[74]

The invention relates to a device for mounting a weapon system on a vehicle chassis,

which device comprises a false chassis (12) which bears the weapon system and is

secured to the chassis (4) by a connection means (17). This device is characterized in

that the connection means comprises at least two attachment points (17) formed by

lugs (18) secured to the chassis (4), which lugs each bear a rod (20) on which a block

(22) secured to the false chassis (12) is mounted, which block is able both to move

translationally and pivot with respect to the rod (20).

[57]

__________________

191614 [21[]11]

MCD MCD SHELL [54]מעטפת






10.10.2006 [22] SE [33] 23.11.2005 [32] 0502564-8 [31]

Int. Cl.(2010.01) F42B 12//76 [51]

BAE SYSTEMS BOFORS AB,

SWEDEN [71]

TORSTEN RONN [72]

WO/2007/061350 [87]

פרל כהן צדק לצר, 5, רח' שנקר 1ים -במרכז ג



5 SHENKAR ST.,

P.O.B. 12704,

HERZLIYA 46733

[74]

The present invention relates to a method for firing explosive-filled, fragmentation

shells (1) that disperse fragments on the pre-programmed detonation of their own

explosive (7) so as to reduce the risk of accidental injury to unprotected personnel and

damage to materiel, which at the moment of firing are undeservedly situated between

the firing weapon and the target. The invention also encompasses shells (1) produced

or modified according to said method.

[57]

__________________

191679 [21[]11]

שיטה לאבחון מחוץ לגוף של מחלת דלקתית של עייםהמ

IN VITRO METHODS FOR

DIAGNOSING INFLAMMATORY

BOWEL DISEASE

[54]

30.11.2006 [22] US [33] 01.12.2005 [32] 11/293616 [31]

Int. Cl.(2010.01) C12N 05//16, C12Q 01//68, G01N 33//53 [51]

PROMETHEUS LABORATORIES

INC., U.S.A. [71]

WO/2007/064964 [87]



P.O.B. 1352,

JERUSALEM 91013

[74]

The present invention provides methods, systems, and code for accurately classifying

whether a sample from an individual is associated with inflammatory bowel disease

(IBD) or a clinical subtype thereof. In particular, the present invention is useful for

[57]




classifying a sample from an individual as an IBD sample using a statistical algorithm

and/or empirical data. The present invention is also useful for differentiating between a

clinical subtype of IBD such as Crohn's disease (CD) and ulcerative colitis (UC) using

a statistical algorithm and/or empirical data. Thus, the present invention provides an

accurate diagnostic prediction of IBD or a clinical subtype thereof and prognostic

information useful for guiding treatment decisions.

__________________

191720 [21[]11]

למכשיר קירור ליצירת תנאי נקודת הט

DEWPOINT COOLING DEVICE

[54]

28.11.2006 [22] NL [33] 28.11.2005 [32] 1030538 [31]

Int. Cl.(2010.01) F24F 05//00 [51]

OPTIMAIR HOLDING B.V.I.O., THE

NETHERLANDS

WILLEM MEIJER, THE

NETHERLANDS

[71]

WO/2007/061298 [87]


רמת החייל


26 HABARZEL ST.,


[74]

The invention relates to a device for cooling an airflow, comprising at least one

cooling channel with an inflow opening for the airflow for cooling and an outflow

opening for the cooled airflow, at least one evaporating channel separated from the

cooling channel by a transfer wall and having an inflow opening, which is connected

to the outflow opening of the cooling channel, and an outflow opening, means for

wetting the side of the transfer wall directed toward the evaporating channel, and

means for dehumidifying the airflow in the cooling channel. The dehumidifying means

can comprise a polymer with lower critical solution temperature (LCST polymer) with

which the side of the transfer wall directed toward the cooling channel can be covered

or from which it can be manufactured. The cooling device can further have means for

[57]




regenerating the dehumidifying means.

__________________

191738 [21[]11]

התקן לנעילת חיבור צינורות

PIPE JOINT LOCKING DEVICE

[54]

11.10.2006 [22] JP [33] 07.12.2005 [32] 2005-352883 [31]

Int. Cl.(2010.01) F16K 35//00, F16L 15//00, 19//00, 35//00 [51]

FUJIKIN INCORPORATED, JAPAN [71]

WO/2007/066452 [87]



P.O.B. 1352,

JERUSALEM 91013

[74]

A pipe joint locking device that can prevent a pipe joint from being erroneously

loosened after tightening and in which sealing ability at a seal section of the pipe joint

is not impaired even force rotating a pipe member is applied to it. The pipe joint

locking device has a first structure member (11) and a second structure member (12).

The first structure member (11) has an installation section (21) attached to an

externally threaded joint member (2) such that the installation section is not rotatable

relative to the joint member, a cover section (22) engaged from below to the outer

perimeter surface of a cap nut (5), and a connection section (23) engaged from below

to a pipe member (3). The second structure member (12) has a cover section (31)

engaged from above to the outer perimeter surface of the cap nut (5) and a connection

section (32) engaged from above to the pipe member (3). The connection section (23)

of the first structure member (11) and the connection section (32) of the second

structure member (12) are connected such that they are fixed to a portion (3a)

projecting from the cap nut (5) of the pipe member (3).

[57]




__________________

191824 [21[]11]

והשימוש בו להכנת תכשיר IL–22נוגדן כנגד רוקחי לטיפול בהפרעות הקשורות בדלקת עור

ANTI IL-22 ANTIBODY AND ITS

USE IN THE PREPARATION OF

PHARMACEUTICAL

COMPOSITIONS FOR

ALLEVIATING DISORDERS

CHARACTERIZED BY SKIN

INFLAMMATION

[54]

30.11.2006 [22] US [33] 02.12.2005 [32] 60/741640 [31]

US 16.08.2006 60/822597

Int. Cl.(2010.01) A61K 38//20, 39//395, A61P 29//00, 35//00, 37//00, C07K 16//18,

16//24, 16//28

[51]


WO/2007/126439 [87]


רמת החייל


26A HABARZEL ST.,


[74]

Compositions and methods are provided for the diagnosis and treatment of

inflammation and autoimmune disorders, such as psoriasis. Compositions and methods

for modulating IL-23 or IL-22 signaling are provided.

[57]





9שטרם פורסמו0222765 The applications for division



__________________

191839 [21[]11]

וחלונותשיטה להרכבת בקרת שליטה לדלתות

METHOD FOR MOUNTING A

CONTROL ASSEMBLY FOR

DOORS AND WINDOWS

[54]

29.05.2008 [22] EP [33] 23.07.2007 [32] 07425450.9 [31]

Int. Cl.(2010.01) E05B 63//00 [51]






P.O.B. 5352,

BEER-SHEVA 84152

[74]

Method for mounting a control assembly (12) for doors or windows, in which the door

or window comprises a frame including a metallic section bar (10) having an outer

wall (24) and a longitudinal groove (30) with an undercut section and an open edge

contained in a plane that is orthogonal to said outer face and in which the control

assembly comprises: a handle (14) having a base (32), a rotatable grip (34) and a

rotatable control pin (36) rotatably connected to the grip, a transmission device (16)

having an input member (56) able to be coupled with the control pin of the handle and

at least one carriage (74) movable in rectilinear direction and connected to the input

member by means of a mechanism (60, 62, 68, 70, 72) able to transform the rotary

motion of the input member into a rectilinear motion of said carriage, a rod (18) able to

slidably engage said groove and a connecting member (20) able to be fastened to the

rod, characterised in that the method comprises the steps of: positioning said rod in

said groove with said connecting member positioned slidably on the rod, applying the

transmission mechanism to the section bar, mutually connecting said carriage and said

connecting member so that the connecting member is fixed to said carriage for

movements in the longitudinal direction of the groove and after mutually connecting

said carriage and the connecting member, fastening the connecting member to the rod.

[57]

__________________




191897 [21[]11]

שיטה לגילוי רעלים מבוססת על ביוסנסור ומערכות לאנאליזה של איכות מים ואוויר

המבוססות עליה

BIOSENSOR-BASED METHOD

FOR THE DETECTION OF

TOXINS AND WATER AND AIR

QUALITY ANALYSIS SYSTEMS

BASED THEREON

[54]

13.12.2006 [22] US [33] 14.12.2005 [32] 11/302844 [31]

Int. Cl.(2010.01) C12Q 01//02, 01//22 [51]

UT-BATTELLE, LLC, U.S.A. [71]

WO/2007/070828 [87]

לוצאטו את לוצאטו, יה, עומר גן תעשי




P.O.B. 5352,

BEER-SHEVA 84152

[74]

A water or air quality analysis system (10) and related method is biosensor-based for

detecting toxins. The water or air to be analyzed includes a plurality of photosynthetic

organisms therein, wherein toxins including chemical, biological or radiological agents

alter a nominal photosynthetic activity of the photosynthetic organisms. A

photodetector (12) is for measuring photosynthetic activity of the plurality of

photosynthetic organisms. An electronics package (30) includes a processor coupled to

the photodetector for analyzing the photosynthetic activity to indicate a presence of a

toxin in the water or air. The analysis includes obtaining at a first time a measured

photosynthetic activity curve for the photosynthetic organisms, and comparing the

measured curve to a reference photosynthetic activity curve to determine differences

therebetween. The presence of specific toxins, or precursors thereof, are then identified

if present in the air or water using the differences.

[57]

__________________




191952 [21[]11]

קביעת פורמט לכתובת, התואם לפורמטיםאחרים של תכובות בהן נעשה שימוש לפניה

למרחבי כתובות בעלי גודל שונה

PROVIDING AN ADDRESS

FORMAT COMPATIBLE WITH

DIFFERENT ADDRESSING

FORMATS USED FOR

ADDRESSING DIFFERENT SIZED

ADDRESS SPACES

[54]

16.04.2007 [22] US [33] 04.05.2006 [32] 11/381712 [31]

Int. Cl.(2010.01) G06F 03//06 [51]


WO/2007/128652 [87]


חיפה

IBM LABORATORIES,

HAIFA UNIVERSITY,

HAIFA 31905

[74]

Provided are a method, system, and article of manufacture for providing an address

format compatible with different addressing formats used for addressing different sized

address spaces. An address format is used in an operating system to address storage

space in a storage device comprising a first region and a second region of storage

space. A first group of applicat ions uses the address format to only address the storage

space in the first region and is not coded to use the address format to access the second

region and a second group of applications uses the address format to address the

storage space in the first and second regions.

[57]

__________________




192005 [21[]11]

מערכת גיר מערכת גיר שימושית במיוחד כ משתנה המשכית

TRANSMISSION SYSTEM

PARTICULARLY USEFUL AS A

CONTINUOUSLY VARIABLE

TRANSMISSION

[54]

10.12.2006 [22] US [33] 10.12.2005 [32] 60/597567 [31]

Int. Cl.(2010.01) B62M 09//00, 09//06, F16H 15//00, 15//42 [51]

CVTRON LTD. [71] סויטרון בע"מ, ת"א

RAN SIMAN-TOV [72] טוב-רן סימן

WO/2007/066342 [87]


רמת גן




RAMAT GAN 52521

[74]

A transmission system includes first and second transmission members to be

selectively coupled to each other or decoupled from each other The first transmission

member includes at least one gripping device having a plurality of spaced gπpping

elements, and the said second transmission member includes a plurality of coupling

elements receivable in an interleaved manner between the gπpping elements of the

gripping device The gπpping elements of the gripping device being displaceable by a

lateral compressive force (a) to displace them towards each other to firmly grip the

coupling elements of the second transmission member and thereby to establish a

nonslip coupling between the two transmission members, and (b) away from each

other to decouple the two transmission members from each other In a described

preferred embodiment, the first transmission member includes a pair of rotatable

conical members over which the second transmission member is wound.

[57]

__________________

192011 [21[]11]

מערכת ושיטה לניהול תכולת מים בנוזל


MANAGING WATER CONTENT

IN A FLUID

[54]

07.12.2006 [22] US [33] 07.12.2005 [32] 60/748123 [31]

Int. Cl.(2010.01) B01D 05//00, E03B 03//28, F25D 17//00 [51]

DUCOOL LTD. [71] דוקול בע"מ, קבוץ החותרים






WO/2007/066212 [87]




10 ABBA EBEN BLVD.,

P.O.B. 2081,

HERZLIYA 46120

[74]

A system and method for managing water content in a fluid (19, 38) includes a

collection chamber (12) for collecting water from the fluid (19) with a desiccant (20),

and a regeneration chamber (14) for collecting water from the desiccant (20) and

transferring it to a second fluid (38). An evaporator (28) cools the desiccant (20)

entering the collection chamber (12), and a second evaporator 52) cools the second

fluid (38) to extract the water. The evaporators (28, 54) use a refrigerant, the flow of

which is controlled by a flow control valve (70). When the temperature in the second

evaporator (54) drops below a set point, the refrigerant flow to the second evaporator

(54) is stopped, and the refrigerant flow to the first evaporator (28) is increased. This

increases the water collection in the collection chamber (12), and causes a rise in the

temperature in the second evaporator (54). The valve (70) is then opened to increase

the cooling in the second evaporator (54).

[57]

__________________

192087 [21[]11]

מערכת מטען נפץ רבת משימות

MULTIFUNCTIONAL EXPLOSIVE

SYSTEM

[54]

06.12.2006 [22] EP [33] 12.12.2005 [32] 05027055.2 [31]

Int. Cl.(2010.01) F42B 03//02 [51]

RECCONN AG, SWITZERLAND [71]

WO/2007/068386 [87]


רמת החייל


26A HABARZEL ST.,


[74]

Explosive apparatus having at least two cuboid mouldings, which have at least one [57]




firing hole, composed of explosive material, whose edge lengths have a ratio of 1:2:4

and having a container (1) with at least one aperture (80) to an internal area (60) with a

square outline, whose side length corresponds at least approximately to the longest

edge length of the moulding, and whose height corresponds at least approximately to

the shortest edge length of the moulding, or to an integer multiple of this. The

mouldings can be placed in the internal area (60) of the container (1) such that at least

the firing hole in one of the mouldings is aligned with the aperture (80) in the container

(1), and the aperture (80) is intended for introduction of an explosive capsule into the

firing hole of the relevant moulding.

__________________

193003 [21[]11]

שיטה והתקן "מבחן פתוח" להכנסת דוגמה לאנליזת מס ספקטרומטריה

OPEN PROBE METHOD AND

DEVICE FOR SAMPLE

INTRODUCTION FOR MASS

SPECTROMETRY ANALYSIS

[54]

23.07.2008 [22]

Int. Cl.(2010.01) G01N 21//01 [51]

AVIV AMIRAV [71] אביב עמירב, הוד השרון

AVIV AMIRAV, ALEXANDER אביב עמירב, אלכסנדר גורדין

GORDIN

[72]


DR. EYAL BRESSLER,

11 TUVAL ST.,

RAMAT GAN 52522

[74]

An open probe method for sample introduction into a mass spectrometer is disclosed,

comprising the steps of: loading a sample holder with sample compounds to be

analyzed; heating a probe oven; introducing said sample compounds in said sample

holder into said heated probe oven; flowing inert gas into said heated probe oven;

vaporizing said sample in said heated probe oven by the combined effect of oven

temperature and inert gas flow; entraining said vaporized sample in said inert gas; and,

[57]




transferring said vaporized sample in inert gas into an ion source of a mass

spectrometer; wherein said heated probe oven remains open to the ambient atmosphere

during sample introduction and analysis; said inert gas is flowing in said heated probe

oven in two directions of a transfer line to a mass spectrometer ion source and to the

oven opening; said vaporized sample in inert gas is transferred through a heated

transfer line directly into the ionization chamber of an ion source of a mass

spectrometer. An apparatus for this method of sample introduction is also disclosed.

The primary advantage of this method and apparatus is that the heated probe oven

remains open to the ambient atmosphere during sample introduction and analysis

thereby enabling faster sample analysis.

__________________

193030 [21[]11]

מקדח קרמי לקדיחה במהירות גבוהה בחומר מרוכב

CERAMIC DRILL BIT FOR HIGH-

SPEED DRILLING OF

COMPOSITES

[54]

24.07.2008 [22] FR [33] 26.07.2007 [32] 0705457 [31]

Int. Cl.(2010.01) B23B 51//00, 51//02 [51]

SNECMA, FRANCE [71]




10 ABBA EBEN BLVD.,

P.O.B. 2081,

HERZLIYA 46120

[74]

A drill bit comprising a shank, a body in the form of a truncated cone extending as far

as the shank and the base of which is located at a free axial end of the drill bit, said end

having at least two main cutting edges joined together by two central edges, said body

having two lips and two flutes extending in a helical fashion alternately around a

longitudinal rotation axis of the drill bit, the lips and the flutes extending from the free

axial end to the shank of the drill bit, each lip having a land and each flute having a

main cutting face adjacent a land and adjacent a main cutting edge, said main cutting

edge forming an intersection with a flank face at the free axial end of the drill bit, the

flank faces each being extended, on the side with the lips, by a rake face, two recesses

extending from the central edges to the periphery of the drill bit and forming two

secondary cutting faces, at least one end portion of the body of the drill bit being made

of a ceramic, wherein each land is radially extended, toward the rotation axis of the

drill bit, by a curved bevel, followed by a flank face, such that the intersection between

each curved bevel and the adjacent flute is formed by an edge whose radially external

end is further away axially, along the rotation axis of the drill bit, from the shank of the

[57]




drill bit than a radially internal end of said edge, and wherein the curved bevels are

each extended, on the side with the rake faces, by a bevel.

__________________

193059 [21[]11]

תרכיז חומוס נטול חומר משמר ותהליך להכנתם

PRESERVATIVE-FREE HUMMUS

CONCENTRATE AND PROCESS

FOR ITS PREPARATION

[54]

01.02.2007 [22] IL [33] 02.02.2006 [32] 173523 [31]

Int. Cl.(2010.01) A23L 01//212 [51]

אלי הוגו בודמן חנה-מרסלו אדריאן אדטו, פרדס

ELI HUGO BUDMAN

MARCELO ADRIAN ADATTO [71]

WO/2007/088540 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

An edible paste concentrate consisting of ground chickpeas, cooked and dried, and

crushed sesame seeds is provided. The paste has a shelf life of at least three months,

and when mixed with water, provides a dip or a spread with the flavor and texture of

freshly prepared hummus. Also provided is a process for manufacturing a spread or a

dip from chickpeas or other legumes.

[57]

__________________

193071 [21[]11]

2–[3,4–TRANS-[1R, 2S]-2-[3,4-[54]–[R1,S2]–טרנס






–דיפלוארופניל[ציקלופרופנאמיניום[R2]–2–פנילאתנואט–2–חידרוקסי

DIFLUOROPHENYL]CYCLOPROPANAMINIUM-

[2R]-2-HYDROXY-2-PHENYLETHANOATE

31.05.2001 [22] GB [33] 02.06.2000 [32] 0013487.4 [31]

SE 06.06.2000 0002101-4

Int. Cl.(2010.01) C07C 21/1/40, 24/7/22, 67//347, 69//00, 69//743 [51] DIVISION FROM 152778 [62]

ASTRAZENECA AB, SWEDEN [71]

ADRIAN CLARK, ELFYN JONES, ULF LARSSON,

ANNA MINIDIS

[72]

WO/2001/092200 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

The compound trans-(1R,2S)-2-(3,4difluorophenyl)cyclopropanaminium(2R)-2-hydroxy-2-

phenylethanoate.

[57]

בקשות חלוקה מבקשה זו שטרם

פורסמו9

0225265 The applications for division from this

application have not yet been published

__________________

193223 [21[]11]

מערכת ושיטה לאימות מילים לא מזוהות OCRבמערכת


VERIFICATION OF

UNCERTAINLY RECOGNIZED

WORDS IN AN OCR SYSTEM

[54]

15.02.2007 [22] NO [33] 17.02.2006 [32] 20060787 [31]

Int. Cl.(2010.01) G06K 09//00 [51]

LUMEX AS, NORWAY [71]

WO/2007/094684 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The present invention provides a method and system for confirming uncertainly

recognized words as reported by an Optical Character or speech Recognition process

by using spelling alternatives as search arguments for an Internet search engine. The

measured number of hits for each spelling alternative is used to provide a confirmation

measure for the most probable spelling alternative. Whenever the confirmation

[57]




measure is inconclusive, a plurality of search strategies are used to reach a measured

result comprising zero hits except for one spelling alternative that is used as the correct

alternative.

__________________

193310 [21[]11]

נוגדן כנגד פוליפפטיד אשר מגיב עם פרקין ותכשירים רפואיים המכילים אותו

ANTIBODY DIRECTED AGAINST

A POLYPEPTIDE THAT

INTERACTS WITH PARKIN AND

PHARMACEUTICAL


THE SAME

[54]

15.02.2001 [22] FR [33] 17.02.2000 [32] 00/01980 [31]

US 18.04.2000 60/198489

Int. Cl.(2010.01) A61K 39//395, A61P 25//28, C07K 16//18 [51] DIVISION FROM 151211 [62]

INSERM (INSTITUT NATIONALE

DE LA SANTE ET DE LA

RECHERCHE MEDICALE), FRANCE

AVENTIS PHARMA S.A., FRANCE

[71]

WO/2001/060857 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

Antibody or antibody fragment or derivative, characterized in that it is directed against [57]




a polypeptide that interacts with parkin, said polypeptide comprising a sequence

having at least 80% identity to SEQ ID NO: 2, or comprising the sequences SEQ ID

NO: 13, SEQ ID NO: 15, SEQ ID NO: 43 OR SEQ ID NO: 45.

__________________

193387 [21[]11]

מערכת מיגון

PROTECTION SYSTEM

[54]

12.08.2008 [22] CH [33] 13.08.2007 [32] 01282/07 [31]

Int. Cl.(2010.01) B60N 02//42 [51]

MOWAG GMBH, SWITZERLAND [71]


רמת החייל

REINHOLD COHN AND

PARTNERS,

26A HABARZEL ST.,


[74]

The protection system is used especially for the protection against a fatal effect of

vertical accelerations triggered by a landmine on the passengers of an armoured

vehicle. For this, the sitting unit consisting of a seat body (7) and a backrest (8) is held

movable in vertical direction and is coupled with an end area (15) of a longitudinally

variable damping device (11), whose other end (13) is connected to the roof (4) of the

vehicle (2) through a carrying equipment (6). In addition, the sitting unit is carried

with vertical distance from the vertical guide (18) in a lower guide path (19)

transversally directed so that the sitting unit executes both a downward as well as a

tilting movement relative to the vehicle together with a passenger (3) during loading

through vertical acceleration. In this way, an improved usage of the constructively

limited effective length of the damping device (11) occurs so that the effect of the

protection system is essentially improved. It is sensible to apply the same principle for

the protection of all objects, which must be protected against the reaching or exceeding

of a maximum load due to a too large acceleration or deceleration.

[57]




__________________

193502 [21[]11]

מגבר כוח למערכת כבלים

POWER BOOSTER FOR CABLE

SYSTEMS

[54]

17.08.2008 [22]

Int. Cl.(2010.01) G05F 01//14, H02J 09//06 [51]

מונד-דויד זילברברג, תל קיבוץ חולדהש"ח שנאי חולדה,

DAVID ZILBERBERG

H.T. HULDA TRANSFORMERS [71]




31 YAVNE ST.,

P.O.B. 1426,

TEL AVIV 61013

[74]

A device for regulating the voltage level at a desired section of a telecommunications

network, said device comprising: an input port, connected to a portion of said network

and receiving an input RF telecommunications signal with an input AC voltage;

isolating circuitry, connected with said input port, for isolating said input AC voltage

from said input RF telecommunications signal; a transformer, connected with said

isolating circuitry, said transformer comprising a primary winding receiving said

isolated input AC voltage and a secondary winding; a plurality of relays, connected to

respective points of said secondary winding of said transformer, said relays operative

for providing a selected voltage gain by selectively switching on a connection from

said secondary winding of said transformer, thereby deriving a regulated AC voltage

at a predetermined level; control circuitry, connected with said transformer and with

said relays, said control circuitry operative for monitoring said input AC voltage, and

selectively activating a selected relay while deactivating the other relays, to provide

said selected voltage gain; recombining circuitry, connected with said relays, for

recombining said regulated AC voltage with said isolated input RF

telecommunications signal to produce a recombined regulated AC voltage and RF

telecommunications signal; and an output port, connected to said recombining

[57]




circuitry and to another portion of said network, said output port providing said

recombined regulated AC voltage and RF telecommunications signal to said another

portion of said network.

__________________

193789 [21[]11]

שיטה ואפנון של אור אופטי המופנה מרחבית

OPTICALLY ADDRESSED

SPATIAL LIGHT MODULATOR

AND METHOD

[54]

02.03.2007 [22] US [33] 02.03.2006 [32] 60/778704 [31]

Int. Cl.(2010.01) G02F 01//13, 01//135 [51]

COMPOUND PHOTONICS, U.S.A. [71]

WO/2007/103274 [87]




P.O.B. 2273,

REHOVOT 76122

[74]

An optical device has an electrically insulating first barrier layer disposed over a first

electrode layer, a photoconductive layer disposed over the first barrier layer, and a

carrier confining layer disposed over the photoconducting layer. The carrier confining

layer defines a volume throughout which a plurality of carrier traps are dispersed.

Further, an electrically insulating second barrier layer is disposed over the carrier

confining layer, a light blocking layer is disposed over the second barrier layer for

blocking light of a selected wavelength band. A reflective layer is disposed over the

light blocking layer for reflecting light within the selected wavelength band, a

birefringent or dispersive layer is disposed over the reflective layer, and an optically

[57]




transmissive second electrode layer is disposed over the birefringent or dispersive

layer. A method is also disclosed, as are additional layers intervening between those

detailed above.

__________________

193848 [21[]11]

סטנט היברידי מסגסוגת מתכת אמורפית וחומר ביוקומפטבילי

HYBRID STENT HAVING AN

AMORPHOUS METAL ALLOY

AND BIOCOMPATIBLE

MATERIAL

[54]

14.03.2007 [22] US [33] 15.03.2006 [32] 11/377769 [31]

Int. Cl.(2010.01) A61F 02//88, A61K 51//04, A61L 31//02, 31//10 [51]

MEDINOL LTD. [71] אביב-מדינול בע"מ, תל

WO/2007/105088 [87]




10 ABBA EBEN BLVD.,

P.O.B. 2081,

HERZLIYA 46120

[74]

An expandable stent is provided, wherein the stent is advantageously formed of at least

one amorphous metal alloy and a biocompatible material. The stent is formed from flat

metal in a helical strip which is wound to form a tubular structure. The tubular

structure is not welded but rather is wrapped or coated with a biocompatible material

in order to maintain the amorphous metal in its tubular configuration. Said stent can be

balloon expanded or self expanding.

[57]




__________________

193866 [21[]11]

שיטות והתקנים ליצירת מטרות דמי למכ"ם


GENERATING VIRTUAL RADAR

TARGETS

[54]

01.03.2007 [22] IL [33] 03.04.2006 [32] 174746 [31]

Int. Cl.(2010.01) G01S 07//40 [51]

ISRAEL AEROSPACE INDUSTRIES התעשייה האוירית לישראל בע"מ, לוד

LTD. [71]

WO/2007/113790 [87]


רמת החייל

REINHOLD COHN AND

PARTNERS,

26A HABARZEL ST.,


[74]

A virtual radar target generator, comprising: a transceiver and a controller coupled to

the transceiver, wherein the transceiver is adapted to receive a signal transmitted from

a radar antenna, store signal information representative of the received signal within a

digital radio frequency memory and transmit an output signal representative of a

virtual target such that at least a fraction of the output signal is received by the radar

antenna; wherein the controller is adapted to determine a timing of the transmission of

the output signal in response to a virtual distance between the virtual target and the

radar antenna, a required virtual target direction and direction information

representative of a direction of the radar antenna; wherein the transceiver further

comprises a transmission antenna, the transmission antenna and the radar antenna

being positioned within a space that is at least partially defined by a radome, and

wherein the transmission antenna transmits the output signal towards the radome such

that at least a fraction of the output signal is reflected towards the radar antenna.

[57]




__________________

193932 [21[]11]

התקן ושיטה להתפשטות אלמנטים מתכתיים


WIDENING METAL ELEMENTS

[54]

28.02.2007 [22] DE [33] 08.03.2006 [32] 102006010795.0 [31]

Int. Cl.(2010.01) B21D 31//04 [51]

PROTEKTORWERK FLORENZ

MAISCH GMBH & CO. KG,

GERMANY

[71]

WO/2007/101594 [87]




5 SHENKAR ST.,

P.O.B. 12704,

HERZLIYA 46733

[74]

A device and a method for widening elongated metal elements (11, 65) which move in

the longitudinal direction and are planar at least in certain regions are described. The

device comprises at least two clamping sections (19, 38, 49, 50) which are opposite

one another and of which one is arranged and designed for clamping a first

longitudinal side (22, 67) of the metal element in place and the other is arranged and

designed for clamping a second longitudinal side of the metal element in place, said

second longitudinal side being opposite the first longitudinal side of the metal element.

The clamping sections are each provided on a support unit (15, 35, 36, 39, 40), by

means of which the clamping sections, during the forward movement of the metal

element, are automatically moved apart essentially perpendicularly to the direction of

movement of the metal element.

[57]




__________________

194135 [21[]11]

מערכת מיתוג חשמלית ומתג המכיל סוגר וברגים לחיזוקו

ELECTRICAL SWITCHING

APPARATUS AND CIRCUIT

BREAKER INCLUDING A

MOLDED ENCLOSURE AND

MACHINE SCREWS

REINFORCING THE SAME

[54]

12.04.2007 [22] US [33] 12.04.2006 [32] 11/402732 [31]

Int. Cl.(2010.01) H01H 71//02 [51]

EATON CORPORATION, U.S.A. [71]

WO/2007/116307 [87]


רמת החייל


26A HABARZEL ST.,


[74]

A circuit breaker comprising: an arc chamber; separable contacts proximate said arc

chamber; an operating mechanism structured to open and close said separable contacts;

a trip unit cooperating with said operating mechanism to trip open said separable

contacts; a molded enclosure comprising a first molded portion and a second molded

portion; a plurality of thread cutting screws fastening said first molded portion to said

second molded portion; and a plurality of machine screws, wherein said first molded

portion and said second molded portion cooperate to form a plurality of exterior side

walls, wherein said exterior side walls define an interior volume, wherein said interior

volume encloses said separable 4Q contacts, said arc chamber and at least a portion of

said operating mechanism, wherein said exterior side walls include a first wall portion

[57]




proximate said operating mechanism and a second wall portion proximate said trip

unit, wherein a first one of said machine screws is intermediate the first wall portion

and the second wall portion of a first one of said exterior side walls, wherein a second

one of said machine screws is intermediate the first wall portion and the second wall

portion 50 of a second one of said exterior side walls, and wherein said first and

second ones of said machine screws hold said first molded portion to said second

molded portion and restrict expansion of said first and second ones of said exterior side

walls away from said interior volume.

__________________

194244 [21[]11]

מימי ושיטה להכנתו תרחיף רוקחי

AQUEOUS PHARMACEUTICAL

SUSPENSION AND A PROCESS

FOR PREPARATION OF THE

SAME

[54]

10.05.2007 [22] GB [33] 19.05.2006 [32] 0610058.0 [31]

GB 23.05.2006 0610246.1

GB 30.04.2007 0708375.1

Int. Cl.(2010.01) A61K 09//10, 31//5415, 31//723, 31//79 [51]

NORBROOK LABORATORIES

LIMITED, IRELAND [71]

WO/2007/135362 [87]



P.O.B. 1352,

JERUSALEM 91013

[74]

An aqueous pharmaceutical suspension comprising: (i) at least one non-steroidal anti-

inflammatory drug; (ii) an aqueous buffer system; (iii) xanthan gum; (iv) polyvinyl

pyrrolidone; and (v) glycerol wherein the suspension is free from pregelatinised starch,

[57]




amino polycarboxylic acid, microcrystalline cellulose, hydroxypropylmethyl cellulose,

polyoxyethylene sorbitan monooleate, silicon dioxide and taste modifying agents

selected from the group consisting of bulk sweeteners, intense sweeteners, flavouring

agents and mixtures thereof.

__________________

194287 [21[]11]

גרנולאט מפוזר במים, תהליך להכנתו והשימוש סדרים נפשיים–בו להכנת תכשיר לטיפול באי

WATER DISPERSIBLE

GRANULATE, A PROCESS FOR

ITS PREPARATION AND ITS USE

IN THE MANUFACTURE OF A

COMPOSITION FOR

TREATMENT OF MENTAL

DISORDERS

[54]

23.03.2007 [22] EP [33] 21.04.2006 [32] 06075938.8 [31]

Int. Cl.(2010.01) A23L 01//304, 02//02, 02//38, 02//385, 02//39, 02//60 [51]

UNILEVER PLC, UNITED

KINGDOM [71]

WO/2007/122053 [87]


רמת החייל


26A HABARZEL ST.,


[74]

One aspect of the invention relates to a water-dispersible granulate having a mass

weighted average diameter of at least 100 m, said granulate comprising: 40-90 wt.% of

carbohydrates; 2-30 wt.% of lipids containing at least 1% unsaturated fatty acids by

weight of the granulate and at least 30 mg/kg of a pro-oxidative metal selected from

the group consisting of iron, copper and combinations thereof; wherein at least 50

wt.% of the lipids is present as non- dispersed lipids. Despite the fact that the present

granulate contains a substantial amount of unsaturated fatty acids as well as a high

level of iron and/or copper, said granulate is nonetheless very stable against oxidation.

The granulate of the present invention is easy to manufacture by a process that does

not employ emulsification or pro-oxidative conditions.; The present invention also

provides a process for the manufacture of the aforementioned granulate.

[57]

__________________




194297 [21[]11]

קצה מיקרוסקופ בעל חיישן סורק מונוליטי עם ודל ננומטרי הנוצר בגידול יחס מימדים גבוה ובג

ננומטרי

MONOLITHIC HIGH ASPECT

RATIO NANO-SIZE SCANNING

PROBE MICROSCOPE (SPM) TIP

FORMED BY NANOWIRE

GROWTH

[54]

08.03.2007 [22] US [33] 23.03.2006 [32] 11/388132 [31]

Int. Cl.(2010.01) G01N 23//00 [51]


WO/2008/054467 [87]


חיפה

IBM LABORATORIES,

HAIFA UNIVERSITY,

HAIFA 31905

[74]

A method of forming a scanning probe comprising: forming an array of cantilevers;

forming a silicon pyramid having sidewalls and a tip by anisotropic etching over each

of said cantilevers; depositing a catalyst on the sidewalls and the tip of said silicon

pyramid; growing a plurality of nanowires from said catalyst over said sidewalls and

said tip of said silicon pyramid; and removing nanowires from said sidewalls of said

silicon pyramid.

[57]

__________________

194299 [21[]11]

–שיטות לקביעת סיכון לעמידות לWARFARIN

METHODS FOR DETERMINING

PREDISPOSITION TO WARFARIN

RESISTANCE

[54]

28.03.2007 [22] US [33] 28.03.2006 [32] 60/786350 [31]

US 01.08.2006 60/834559

Int. Cl.(2010.01) C12Q 01//68 [51]

מחקרים ,תשתית ושירותים -תל השומר גן -רפואיים בע"מ, רמת


RESEARCH INFRASTRUCTURE

AND SERVICES LTD.

[71]

EVA GAK, HILLEL HALKIN [72] אוה ג'ק, הלל הלקין






WO/2007/110869 [87]


רמת גן




RAMAT GAN 52521

[74]

The present invention is of the high association of the 5417T allele of the

VKORC1 gene with high coumarin dose requirements and which can be used to

determine the predisposition of an individual to coumarin resistance .

Specifically, the present invention provides methods and kits for determining

the predisposition of an individual to coumarin resistance and for predicting

the responsiveness of an individual to coumarin treatment.

[57]

__________________

194464 [21[]11]

מסוע סרק לקו ייצור

CONVEYOR IDLER ASSEMBLY

[54]

30.03.2007 [22] AU [33] 31.03.2006 [32] 2006901674 [31]

AU 03.11.2006 2006906126

Int. Cl.(2010.01) B65G 39//12 [51]

ALLENVEE HOLDINGS PTY LTD.,

AUSTRALIA [71]

WO/2007/112484 [87]




279 HAYARKON ST.,

P.O.B. 6451,

TEL AVIV 61063

[74]

A conveyor idler assembly (10) for supporting a conveyor belt (11) comprising a

support frame (12) having at least one elongated linear or longitudinally curved

support beam (16) which extends transversely of the conveyor belt (11) and at least

one idler cassette (13) having an idler roller (30), the cassette (13) being mounted to

the support beam (16) for slidable movement therealong.

[57]

__________________




194656 [21[]11]

פורמולציה שעברה ייבוש בהקפאה המכילה נגיף–צימוד של ניקוטין וחלקיק דמוי

LYOPHILIZED FORMULATION

COMPRISING A NICOTINE-

VIRUS-LIKE PARTICLE

CONJUGATE

[54]

11.05.2007 [22] EP [33] 12.05.2006 [32] 06113895.4 [31]

Int. Cl.(2010.01) A61K 09//19, 39//385, 47//06 [51]

CYTOS BIOTECHNOLOGY AG,

SWITZERLAND [71]

WO/2007/131972 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

The present invention is in the fields of medicine, public health, vaccine and drug

formulation. The invention provides composition formulations comprising a nicotine-

carrier conjugate and a stabilizer, wherein said stabilizer comprises a non-reducing

disaccharide and a non-ionic surfactant. The composition formulations are stable after

a long time of storage at room temperature.

[57]

__________________

194687 [21[]11]

כבתי ושיטה לייצורוש–פילם רב

MULTILAYERED FILM AND

METHOD FOR MANUFACTURING

SAME

[54]

11.04.2007 [22] DE [33] 14.04.2006 [32] 102006018060.7 [31]

Int. Cl.(2010.01) B32B 09//02, 27//36, B65D 65//46 [51]

BIO-TEC BIOLOGISCHE

NATURVERPACKUNGEN GMBH &

CO. KG, GERMANY

[71]

WO/2007/118828 [87]


רמת החייל


26A HABARZEL ST.,


[74]

A multilayered film is shown and described that is used in particular for packaging,

which comprises at least one first layer A and at least one second layer B, wherein

layer A contains thermoplastic polyester and layer B contains thermoplastic starch. The

[57]






multilayered film according to the invention is characterized by excellent barrier

properties, low sensitivity to moisture, and good mechanical strength.

__________________

194909 [21[]11]

מערכת ושיטה לניטור רכבים ונהגים


MONITORING VEHICLES AND

DRIVERS

[54]

17.04.2007 [22] US [33] 26.04.2006 [32] 60/745632 [31]

Int. Cl.(2010.01) G08B 17//00 [51]

ILAN ROSEN [71] אילן רוזן, בנימינה

WO/2007/122607 [87]

ד"ר יורם צביון, , פארק התעשיה 2רח' הטוחן

קיסריה3148, ת.ד.

DR. YORAM TSIVION,

2 HATOCHEN ST.

P.O.B. 3148,

CAESAREA 38900

[74]

Implementing the system and method in accordance with the present invention affords

ability to determine whether a driver is guilty of bearing a faulty set of driving

regulatory documents DRDs. The law-enforcement agent using the system and method

in accordance with the present invention is able to identify remotely vehicles having

faulty DRDs. In accordance with the present invention, the currently used hard copies

of the DRD are supplemented or altogether replaced by stored data in a digital storage

medium. The storage medium can be installed in the driver's car or the data may be

stored in a centralized law enforcement database. The police may access the database

in order to retrieve information regarding the validity of the driver's permits. In the

scenario wherein the digital storage medium is located in the driver's car, typically one

or more smart cards or RFID cards or flash memory devices or discs may be used to

store the current data.

[57]

__________________

195661 [21[]11]






מכשיר הכולל מעבר שאיבה להכנת משקה מחומר אבקתי ונוזל חם וכמו כן מעבר הוצאה

DEVICE WITH A SUCTION DUCT

FOR PREPARING A BEVERAGE

FROM A POWDERY SUBSTANCE

AND A HOT LIQUID AS WELL AS

AN EXTRACTION DUCT

[54]

31.05.2007 [22] NL [33] 02.06.2006 [32] 1031947 [31]

Int. Cl.(2010.01) A47J 31//40, 31//60 [51]

BRAVILOR HOLDING B.V., THE

NETHERLANDS [71]

RAMON EDUARD VERHOEVEN,

JOHANNES JACOBUS VAN

STEENDEREN DE KOK, CARLOS

NICOLAAS JOZEF MARIA

KOOPMAN

[72]

WO/2007/142519 [87]


רמת גן




RAMAT GAN 52521

[74]

Preparing device (1) for preparing a beverage from a powdery substance and a hot

liquid, the device comprising: at least one mixing chamber (11) for mixing a quantity

of the powdery substance and a quantity of the hot liquid; an inlet (38) into the mixing

chamber for the quantity of hot liquid; an inlet (21) into the mixing chamber for the

quantity of powdery substance; an extractor hood (4) placed on the mixing chamber;

an extraction duct connected to the extractor hood and provided with suction means,

such as a ventilating fan, for extracting vapour and dust particles from the mixing

chamber via the extraction duct (3) and the extractor hood; a first housing (26)

accommodating further components of the preparing device, such as electrical

components and pipework, in which the extraction duct extends entirely along the

exterior of the first housing, as well as an extraction duct.

[57]

__________________


196221 [21[]11]

יוני כרום וגליום עבור הגברת קצב הסרת תחמוצת

GALLIUM AND CHROMIUM IONS

FOR OXIDE REMOVAL RATE

ENHANCEMENT

[54]

10.07.2007 [22] US [33] 21.07.2006 [32] 11/491055 [31]

Int. Cl.(2010.01) B24B 01//00, C09K 03//14 [51]



WO/2008/013668 [87]




31 YAVNE ST.,

P.O.B. 1426,

TEL AVIV 61013

[74]

The invention provides a chemical-mechanical polishing composition comprising

silica, a compound in an amount sufficient to provide 0.2 mM to 10 mM of a metal

cation selected from the group consisting of gallium (III), chromium (II), and

chromium (III), and water, wherein the polishing composition has a pH of 1 to 6. The

invention further provides a method of chemically-mechanically polishing a substrate

with the aforementioned polishing composition.

[57]

__________________

196257 [21[]11]

פלטת עצם העקב

CALCANEAL PLATE

[54]

17.07.2007 [22] US [33] 18.07.2006 [32] 60/831647 [31]

US 17.01.2007 60/880910

US 16.07.2007 11/879118

Int. Cl.(2010.01) A61B 17//58 [51]

ORTHO-HELIX SURGICAL

DESIGNS, INC., U.S.A. [71]

WO/2008/011018 [87]




P.O.B. 2273,

REHOVOT 76122

[74]






The present invention is a fully contoured calcaneal plate having substantially no

planar surfaces except at the origin. The contoured plate includes radiused sections,

one extending inferior to superior is curved inferior to superior in a shape which is

close to cylindrical and which approximates the shape of the cuboid bone. The second

radiused section is curved in the vicinity of the anterior strut, and in particular at the

inferior portion of the plate, to accommodate the peroneal tubercle. The plate has a

rectangular or modified ovoid body section and a dog boned shaped tail with triangular

placed holes for fixation.

[57]

__________________

196327 [21[]11]

–1,1,1הידרוגנציה אסימטרית של טריפלואורואצטון

ASYMMETRIC

HYDROGENATION OF 1,1,1-

TRIFLUOROACETONE

[54]

17.07.2007 [22] EP [33] 27.07.2006 [32] 06117928.9 [31]

Int. Cl.(2010.01) C07C 29//145 [51]


SWITZERLAND [71]

WO/2008/012240 [87]





P.O.B. 5352,

BEER-SHEVA 84152

[74]

The invention relates to the preparation of enantiomerically pure (S)-1,1,1-trifluoro-2-

propanol by an asymmetric hydrogenation of 1,1,1-trifluoroacetone which process

comprises hydrogenating 1,1,1-trifluoroacetone in the presence of a ruthenium

phosphine complex represented by formula Ru(E)(E')(L)(A) wherein E, E' are both

chloro or E is hydrogen and E' is BH4; L is a chiral diphosphine ligand; and A is an

optionally chiral diamine comprising the variants a) in the presence of a weak base and

with or without an additive in case when E and E' are both chloro or b) in the absence

of a base and an additive in case when E and E' are hydrogen and BH4.

[57]




__________________

196716 [21[]11]

ארוגים אלסטים וחומר מרוכב –בדים בלתי ארוג הכולל אותם–בלתי

ELASTIC SPUNBONDED

NONWOVEN AND COMPOSITE

NONWOVEN COMPRISING THE

SAME

[54]

06.08.2007 [22] EP [33] 14.08.2006 [32] 06016946.3 [31]

Int. Cl.(2010.01) B32B 27//02, D01F 08//16, D04H 03//00 [51]

ALBIS SPA, ITALY [71]

WO/2008/019775 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The spunbonded nonwoven (W) has high elastic recovery properties and comprises a

plurality of multi-component filaments. Each filament, preferably of the sheath/core

type, comprises at least a first polymeric component and a second polymeric

component. The first polymeric component comprises thermoplastic polyurethane, and

the second polymeric component comprises an elastic propylene-based olefin

copolymer, and more particularly an ethylene propylene copolymer, preferably

comprising at least 80wt% of propylene units. Said spunbonded nonwoven (W) can be

easily thermal- bonded with polyolefin-based nonwoven layer(s), especially

polypropylene-based layer(s), in order to make a composite nonwoven, particularly

suitable for the hygienic industry (e.g., diapers(.

[57]

__________________

197032 [21[]11]

קישורים בעל יכולת ניווט עם ממשקי –התקן רב עבודה מרובים

STEERABLE MULTI-LINKED

DEVICE HAVING MULTIPLE

WORKING PORTS

[54]

14.08.2007 [22] US [33] 14.08.2006 [32] 60/822280 [31]

US 24.10.2006 60/862636






Int. Cl.(2010.01) A61B 01//00 [51]

CARDIOROBOTICS, INC., U.S.A. [71]

WO/2008/022114 [87]

י קבוצת איתן מהולל, עורכי דין ועורכ פטנטים,



10 ABBA EBEN BLVD.,

P.O.B. 2081,

HERZLIYA 46120

[74]

A steerable multi-linked device. The device includes a first multi-linked mechanism

and a second multi-linked mechanism. The first mechanism defines a first plurality of

grooves. The second mechanism defines a second plurality of grooves. The first and

second pluralities of grooves cooperate to define at least two working ports along a

length of the device. At least one of the first and second mechanisms are steerable.

[57]

__________________

197165 [21[]11]

מסרק נגד כינים

LICE COMB

[54]

23.08.2007 [22] AU [33] 23.08.2006 [32] 2006904564 [31]

Int. Cl.(2010.01) A01K 13//00, A45D 24//02, 24//10 [51]

DAVID JACOB SCHWARTZ,

AUSTRALIA

MOSHE MAOR, AUSTRALIA

[71]

MOSHE MAOR, EDWARD JOSEPH

KHOURY, ROBERT CHARLES

ALEXANDER CULLEY

[72]

WO/2008/022387 [87]



SOROKER-AGMON,

14 SHENKAR ST.,


[74]

A lice comb (10) comprising a plurality of parallel teeth (12) having upper surfaces [57]




(16) and lower surfaces (18). Each pair of adjacent teeth (12) includes a first set of

projections (22) on a side surface (24) of one tooth and a second set of projections (26)

on a side surface (28) of the adjacent tooth. The first set of projections (22) are

provided along at least a portion of the length of the tooth such that hair moving

downwardly between the pair of teeth (12) passes through gaps (32) defined between

the first set of projections (22). The second set of projections (26) are interspersed

between and in a direction toward the lower surface (18) of the teeth (12) such that the

strands of hair passing through the gaps (32) are deflected in a direction parallel to the

teeth (12) in use by the second set of projections (26).

__________________

197377 [21[]11]

גן ניאומיצין פוספוטרנספראז שעבר שינוי ושיטות המשתמשות בגן הנ"ל

MODIFIED NEOMYCIN

PHOSPHOTRANSFERASE GENE

AND METHODS USING SAID

GENE

[54]

25.11.2003 [22] DE [33] 29.11.2002 [32] 10256081.1 [31]

DE 08.07.2003 10330686.2

Int. Cl.(2010.01) C12N 09//12, 15//85 [51] DIVISION FROM 168806 [62]


INTERNATIONAL GMBH,

GERMANY

[71]

WO/2004/050884 [87]


רמת החייל


26A HABARZEL ST.,


[74]

Modified neomycin phosphotransferase gene characterized in that the modified

neomycin phosphotransferase gene codes for a different amino acid than the wild-type

neomycin phosphotransferase gene at at least one of the following positions: either at

amino acid position 182, 227 or 261, whereby the modified neomycin

[57]




phosphotransferase gene compared with the wild-type gene codes for glycine at amino

acid position 182, for alanine or valine at amino acid position 227, or for glycine at

amino acid position 261, whereby the modified neomycin phosphotransferase which is

encoded by the neomycin phosphotransferase gene has a lower enzyme activity than

the wild-type neomycin phosphotransferase.

טרם בקשת הורה לבקשה זו ש

פורסמה2466/4 The parent application from which



__________________

197988 [21[]11]

ו פרגמנט של הנוגדן הנקשר ספציפית נוגדן א PC–LECTINלפוליפפטיד

ANTIBODY OR FRAGMENT

THEREOF THAT SPECIFICALLY

BINDS TO A PC-LECTIN

POLYPEPTIDE

[54]

11.08.2000 [22] US [33] 12.08.1999 [32] 60/148935 [31]

Int. Cl.(2010.01) A61K 39//395, C07K 14//435, 14//705, 16//18, C12N 05//12 [51] DIVISION FROM 147902 [62]

AGENSYS, INC., U.S.A. [71]

WO/2001/012811 [87]


רמת החייל


26A HABARZEL ST.,


[74]

An antibody or fragment thereof that specifically binds to a PC-LECTIN polypeptide

encoded by a polynucleotide selected from the group:

a polynucleotide comprising SEQ ID NO:1, wherein T can also be U,

a polynucleotide comprising SEQ ID NO: 1, from nucleotide residue number 201

through nucleotide residue number 2378, wherein T can also be U,

a polynucleotide encoding a PC-LECTIN protein comprising the amino acid sequence

of SEQ ID NO:2.

[57]

__________________

198076 [21[]11]

cPPTקטור רטרווירוס המכיל אזורי שימוש בו של לנטיוירוס ווקטור רטרווירוס CTS–ו

USE OF A RETROVIRAL VECTOR

COMPRISING CPPT AND CTS

[54]






REGIONS OF LENTIVIRAL AND A

RETROVIRAL VECTOR

10.10.2000 [22] US [33] 12.10.1999 [32] 60/158387 [31]

Int. Cl.(2010.01) A61K 48//00, C12N 15//867 [51] DIVISION FROM 148900 [62]

INSTITUT PASTEUR, FRANCE

INSTITUT NATIONAL DE LA

SANTE ET DE LA RECHERCHE

MEDICALE -I.N.S.E.R.M., FRANCE

[71]

WO/2001/027304 [87]


רמת החייל


26A HABARZEL ST.,


[74]

Use of a retroviral vector, comprising cPPT and CTS regions of lentiviral origin in

which the LTR is deleted for the promoter and enhancer of U3, for increasing in vitro

the rate of import of a nucleic acid in a host cell nucleus and medical uses thereof.

[57]

__________________

198861 [21[]11]

1E–תרביות של תאי אלמוות מסוג

CULTURES OF E1-IMMORTALIZED

CELLS

[54]

06.05.2004 [22] WO [33] 09.05.2003 [32] PCT/EP03/50155 [31]

WO 01.09.2003 PCT/EP03/50390

WO 04.12.2003 PCT/EP03/50940

WO 30.01.2004 PCT/EP04/50061

Int. Cl.(2010.01) C12N 05//10 [51] DIVISION FROM 171680 [62]

CRUCELL HOLLAND B.V., THE

NETHERLANDS [71]

CHRISTOPHER ADAM YALLOP [72]

WO/2004/099396 [87]




10 ABBA EBEN BLVD.,

P.O.B. 2081,

HERZLIYA 46120

[74]

A culture of cells wherein the culture of cells is a serum-free suspension culture of

human embryonic retina cells immortalized by adenovirus E1 sequences, wherein cells

[57]




in the culture of cells produce a recombinant protein, the serum-free suspension culture

comprises culture medium exchanged at a rate of at least 1 culture volume/day, said

culture of cells comprises at least 40X106 viable cells/ml which can be maintained for

at least five days without a cell bleed, and at least 80% of the total cells are viable, and

wherein said cells are PER.C6 cells as represented by the cells deposited under

ECACC No. 96022940.

__________________

199658 [21[]11]

להעברת קבצים RTPמערך

RTP PAYLOAD FORMAT

[54]

02.06.2004 [22] US [33] 03.07.2003 [32] 10/612851 [31]

Int. Cl.(2010.01) H04L 29//06 [51] DIVISION FROM 162304 [62]

MICROSOFT CORPORATION,

U.S.A. [71]


רמת החייל


26A HABARZEL ST.,


[74]

A method comprising computer-instructions executable by a processor, the method

changing a plurality of single media packets into a composite packet, wherein: each

single media packet includes: a payload of one data stream, wherein the payload is

encrypted and has an arbitrary block size; a payload header for the payload and

including a boundary for the arbitrary block size; the composite packet corresponds to

the plurality of single media packets and includes: one or more payloads of a like data

stream and corresponding to the respective payloads of the plurality of single media

packets; and a payload profile format header for each payload in the composite packet

and corresponding to the payload headers of the plurality of single media packets,

wherein the payload profile format header has a payload boundary for a respective

payload in the composite packet that identifies an order thereof in the plurality of

single media packets

[57]

__________________

200172 [21[]11]






תהליך להכנת דפטומיצין

PROCESS FOR THE

PRODUCTION OF DAPTOMYCIN

[54]

30.07.2009 [22] EP [33] 01.08.2008 [32] 08161630.2 [31]

Int. Cl.(2010.01) A61K 31//00, C12P 21//04 [51]

ANTIBIOTICOS S.P.A., ITALY [71]


רמת החייל


26A HABARZEL ST.,


[74]

Process for the production of daptomycin by fermentation of Streptomyces

roseosporus in the presence of n-decanal or cuphea oil as sources of the n-decanoyl

side chain.

[57]

__________________

959200 [21[]11]

פורמולציות נוזליות של מלחים –4)–2]–4של

מתילפנילסולפניל(פניל[פיפרדין

LIQUID FORMULATIONS OF SALTS OF 4-[2-(4-

METHYLPHENYLSULFANYL)PHENYL]PIPERIDINE

[54]

14.03.2008 [22] DK [33] 20.03.2007 [32] PA200700423 [31]

WO 15.06.2007 PCT/DK2007/050076

DK 14.12.2007 PA200701790

Int. Cl.(2010.01) A61K 31//451 [51]

H. LUNDBECK A/S, DENMARK [71]

WO/2008/113358 [87]





P.O.B. 11490,

TEL AVIV 62038

[74]

Liquid formulations of the DL-lactic acid, the glutaric acid, the L-asρartic acid and the

glutamic acid salts of 4- [2- (4-methylphenylsulfanyl) phenyl] piperidine and their use in the

manufacture of a medicament to be used in the treatment of CNS diseases are provided.

[57]

__________________




201461 [21[]11]

מערכת ושיטה להתראת בטיחות תינוק

INFANT SAFETY ALERT

SYSTEM AND METHOD

[54]

01.08.2009 [22]

Int. Cl.(2010.01) B60N 02//26, B60R 21//015, G08B 21//24 [51]

עידן נחמני, קרית ביאליק

IDAN NACHMANI

YAMIT NACHMANY, U.S.A.

MOSHE ATTIAS, U.S.A.

[71]

IDAN NACHMANI, YAMIT עידן נחמני

NACHMANY, MOSHE ATTIAS

[72]

גיל לבנה, ניהנת152, ת.ד.

GIL LIVNE,

P.O.BOX 152

NETANYA 42101

[74]

Apparatus for alerting on an infant left in a vehicle, the apparatus comprising: an

occupant sensor installed on an infant seat deployable in a vehicle, configured to sense

presence of an infant within the infant seat, an infrared light sensor installed on the

infant seat, configured to sense infrared light being emitted within the vehicle, and an

alarm activator installed on the infant seat and connected to the occupant sensor and

the infrared light sensor, configured to activate an alarm upon the presence of the

infant being sensed by the occupant sensor and the infrared light being sensed by the

infrared light sensor.

[57]


This specification was examined in

accordance with regulation 35 of the Patent

Regulations, 5728 - 1968

__________________




201639 [21[]11]

חומרי ביניים להכנת גורמים היפנוטיים ים לטווח קצרמשככ

INTERMEDIATES FOR

PREPARATION OF SHORT-

ACTING SEDATIVE HYPNOTIC

AGENTS

[54]

24.01.2003 [22] US [33] 25.01.2002 [32] 60/351385 [31]

US 09.05.2002 60/379219

Int. Cl.(2010.01) C07C 69//614 [51] DIVISION FROM 162862 [62]

THERAVANCE, INC., U.S.A. [71]

WO/2004/037750 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The invention provides compounds compositions and methods useful for inducing or

maintaining general anesthesia or sedation in mammals.

[57]

__________________

201694 [21[]11]

התקן הזרקה

INJECTION DEVICE

[54]

03.06.2008 [22] DE [33] 08.06.2007 [32] 202007008068.9 [31]

DE 08.09.2007 202007012637.9

Int. Cl.(2010.01) A61M 05//20 [51]

BAYER PHARMA

AKTIENGESELLSCHAFT, GERMANY [71]

WO/2008/148518 [87]



P.O.B. 1352,

JERUSALEM 91013

[74]






Disclosed is an injection device comprising parts, the relative movement of which

causes the active substance to be injected. For this purpose, a receptacle (103, 203),

into and in which a carpule/syringe can be inserted and mounted, is retained in a

housing (101, 201), the receptacle (103, 203) can be moved by means of a carriage

(108, 208), and a plunger (104, 204) that applies a force to the piston/s (111A, 111B;

211) of the carpule/syringe is movably retained in the receptacle (103, 203). A traction

rope (114, 214) which is deflected by means of a roll (109, 209) mounted on the

carriage (108, 208) is provided for performing the pricking stroke, injection stroke, and

retracting stroke. One end of the traction rope (114, 214) is connected to the receptacle

(103, 204) while the other end thereof is connected to a tension spring (110, 210) that

is retained on the housing (101, 201). Automatically and/or manually actuatable

mechanisms between the housing (101, 201), the receptacle (103, 203), the plunger

(104, 204), and the carriage (108, 208) control the reciprocal coupling thereof to the

traction rope (114, 214) and thus the sequence of the pricking stroke, injection stroke,

and retracting stroke and are fitted with at least one means that allows the user to adjust

the progress profile of at least one of the strokes.

[57]

__________________

203533 [21[]11]

[פירידין C–3,4פיראזולו ]–תרכובת טטרההידרו XAהמכילה לקטם פעילה כמעכבת פקטור

ותכשירים פרמצבטיים המכילים אותה לטיפול בהפרעות טרומבואמבוליות

LACTAM-CONTAINING

TETRAHYDRO-PYRAZOLO [3,4-

C] PYRIDINE COMPOUNDS

USEFUL AS FACTOR XA

INHIBITORS AND

PHARMACEUTICAL


THE SAME FOR TREATING

THROMBOEMBOLIC DISORDERS

[54]

17.09.2002 [22] US [33] 21.09.2001 [32] 60/324165 [31]

Int. Cl.(2010.01) A61K 31//437, 31//444, A61P 07//02, 43//00, C07D 47/1/04 [51]





BRISTOL-MYERS SQUIBB


WO/2003/026652 [87]





P.O.B. 11490,

TEL AVIV 62038

[74]

The present application describes lactam-containing compounds and derivatives

thereof of Formula I: P¿4?-P-M-M¿4? or pharmaceutically acceptable salt forms

thereof, wherein ring P, if present is a 5-7 membered carbocycle or heterocycle and

ring M is a 5-7 membered carbocycle or heterocycle. Compounds of the present

invention are useful as inhibitors of trypsin-like serine proteases, specifically factor

Xa.

[57]

__________________

204984 [21[]11]

וחומצות גרעין VEGFחלבוני איחוי קושרי הםהמקודדות ל

VEGF BINDING FUSION

PROTEINS AND NUCLEIC ACIDS

ENCODING THE SAME

[54]

29.06.2004 [22] US [33] 30.06.2003 [32] 10/609775 [31]

Int. Cl.(2010.01) A61K 38//17, C07K 14//71, 19//00, C12N 15//12, 15//62 [51] DIVISION FROM 172404 [62]

REGENERON

PHARMACEUTICALS, INC., U.S.A. [71]

WO/2005/000895 [87]


רמת החייל


26A HABARZEL ST.,


[74]

An isolated nucleic acid molecule encoding a fusion polypeptide which binds and

inhibits VEGF consisting of components (RlR2) x, wherein X >= 1, R1 is vascular

endothelial cell growth factor (VEGF) receptor component Ig domain 2 of Flt-1 and

R2 is Ig domain 3 of FIk-1.

[57]

__________________




205242 [21[]11]

אוקסזולידינונים מותמרים, שיטות להכנתם, תכשירים המכילים אותם ושימוש בהם להכנת

תרופות לטיפול במחלות

SUBSTITUTED

OXAZOLIDINONES, PROCESSES

FOR THEIR PREPARATION,


THEM AND USES THEREOF FOR

THE MANUFACTURE OF

MEDICAMENTS FOR THE

TREATMENT OF DISEASES

[54]

11.12.2000 [22] DE [33] 24.12.1999 [32] 19962924.2 [31]

Int. Cl.(2010.01) C07D 41/3/00 [51] DIVISION FROM 149896 [62]

BAYER PHARMA

AKTIENGESELLSCHAFT,

GERMANY

[71]

WO/2001/047919 [87]


רמת החייל


26A HABARZEL ST.,


[74]

The invention relates to the field of blood coagulation, more specifically it relates to

novel oxazolidinone derivatives of the general formula (I), to methods for producing

them as well as to their use as active substances for medicaments for the prophylaxis

and/or the treatment of diseases.

[57]

בקשת הורה לבקשה זו שטרם פורסמה

227674 The parent application from which



__________________




206869 [21[]11]

שיטה ומכשיר לתהליך פוטוכימי

METHOD AND DEVICE FOR A

PHOTOCHEMICAL PROCESS

[54]

27.01.2009 [22] AT [33] 31.01.2008 [32] A152/2008 [31]

AT 03.06.2008 A889/2008

Int. Cl.(2010.01) C12M 01//00 [51]

ECODUNA OG, AUSTRIA [71]

WO/2009/094680 [87]

שילון צוקרשטיין ושות', 19המגדל העגול, קומה 1זריאלי מרכז ע

תל אביב

SHILON ZUCKERSTEIN & CO.,

AZRIELI CENTER 1, ROUND

TOWER, 19TH FLOOR,

TEL AVIV 67021

[74]

The invention relates to a method and a device for a photochemical, such as

photocatalytic and/or photosynthetic process, particularly for the breeding and

production or hydrocultivation of preferably phototrophic microorganisms. A reactor,

particularly a biosolar reactor (1), comprising at least one reactor element (2), is

provided. The reactor element (2) is formed by two perpendicular pipes (3) connected

at the bottom. Furthermore, an inlet (4) and an outlet (5) are provided at the upper

reactor edge. The meander-shaped conductance of the reaction medium (6) is carried

out perpendicularly or inclined at an angle at least once from the top down or in the

direction of gravity, and from the bottom up or against the direction of gravity. Both

the introduction and removal of the reaction medium (6) into and from the reactor are

preferably carried out continuously, without pressure and freely to the atmosphere via

the upper reaction medium surface, wherein due to the hydrostatic pressure

compensation and leveling a flow of the reaction medium (6) that is stress-free for the

microorganisms is produced.

[57]


This specification was examined in accordance

with regulation 35 of the Patent Regulations,

5728 - 1968

__________________

705420 [21[]11]

יהלום גביש יחיד

SINGLE CRYSTAL DIAMOND

[54]

14.07.2004 [22] US [33] 14.07.2003 [32] 60/486435 [31]

Int. Cl.(2010.01) C30B 33//02 [51]







CARNEGIE INSTITUTION OF

WASHINGTON, U.S.A. [71]

WO/2005/007935 [87]



P.O.B. 1352,

JERUSALEM 91013

[74]

A single crystal diamond grown by microwave plasma chemical vapor deposition has a

fracture toughness of 11-20 MPa m 1/2.

[57]

__________________

207067 [21[]11]

מערכת למתן טרנסדרמלי של ביופרנאורפין לשימוש לטיפול בכאב

TRANSDERMAL DELIVERY

SYSTEMS OF BUPRENORPHINE

FOR USE IN TREATING PAIN

[54]

24.02.1998 [22] US [33] 24.02.1997 [32] 60/038919 [31]

US 29.09.1997 60/939068

Int. Cl.(2010.01) A61K 09//70, 31//485, 45//00, A61P 25//04, 25//36, C07D 48/9/12 [51] DIVISION FROM 201437 [62]

EURO-CELTIQUE S.A.,

LUXEMBOURG [71]

WO/1998/036728 [87]



P.O.B. 1352,

JERUSALEM 91013

[74]

The use of buprenorphine in the preparation of a medicament for a method of

effectively treating pain in humans is achieved by administering buprenorphine in a

manner indicative of first order pharmacokinetics over an initial three-day dosing

interval, such that a maximum plasma concentration from about 20 pg/ml to about

[57]




1052 pg/ml is attained, and thereafter maintaining the administration of buprenorphine

for at least an additional two-day dosing interval in a manner indicative of zero order

kinetics, such that the patients experience analgesia throughout the at least two-day

additional dosing interval.

__________________

209736 [21[]11]

שיטות ומערכות לעיבוד תחתית באמצעי סהרון נוזל דינמי


PROCESSING A SUBSTRATE

USING A DYNAMIC LIQUID

MENISCUS

[54]

29.09.2003 [22] US [33] 30.09.2002 [32] 10/261839 [31]

US 24.12.2002 10/330843

US 24.12.2002 10/330897

US 31.03.2003 10/404692

US 24.06.2003 10/603427

Int. Cl.(2010.01) H01G 02//02 [51] DIVISION FROM 161684 [62]


U.S.A. [71]



MICHAEL RAVKIN, FRED C.

REDEKER

[72]

WO/2004/032160 [87]





P.O.B. 45087,

JERUSALEM 91450

[74]

A system and method of moving a meniscus from a first surface to a second surface

includes forming a meniscus between a head and a first surface. The meniscus can be

moved from the first surface to an adjacent second surface, the adjacent second surface

being parallel to the first surface. The system and method of moving the meniscus can

also be used to move the meniscus along an edge of a substrate.

[57]







__________________

209737 [21[]11]

שיטות ומערכות לעיבוד תחתית באמצעי סהרון נוזל דינמי


PROCESSING A SUBSTRATE

USING A DYNAMIC LIQUID

MENISCUS

[54]

29.09.2003 [22] US [33] 30.09.2002 [32] 10/261839 [31]

US 24.12.2002 10/330843

US 24.12.2002 10/330897

US 31.03.2003 10/404692

US 24.06.2003 10/603427

Int. Cl.(2010.01) H01G 02//02 [51] DIVISION FROM 161684 [62]


U.S.A. [71]



MICHAEL RAVKIN, FRED C.

REDEKER

[72]

WO/2004/032160 [87]

ג'יי אמ בי, פקטור אנד קו בע"מ, בים רחוב המרפא, הר חוצ




P.O.B. 45087,

JERUSALEM 91450

[74]

A system and method of moving a meniscus from a first surface to a second surface

includes forming a meniscus between a head and a first surface. The meniscus can be

moved from the first surface to an adjacent second surface, the adjacent second surface

[57]




being parallel to the first surface. The system and method of moving the meniscus can

also be used to move the meniscus along an edge of a substrate.




__________________

210701 [21[]11]



MILITARY VEHICLE

[54]

01.11.2007 [22] IT [33] 15.12.2006 [32] TO2006A

000894

[31]

Int. Cl.(2010.01) B60K 07//00, 17//04 [51] DIVISION FROM 187093 [62]






P.O.B. 5352,

BEER-SHEVA 84152

[74]

The invention relates to a power-driven wheel (1) having an axis (A) and comprising

an axial-flow motor (4) coaxial with said axis (A), a casing (5) housing said motor (4),

and a tubular hub (2) connected functionally to said motor (4). In order to facilitate

repairs, said casing (5) comprises a housing (6) with an open axial end (14) defining a

seat for said motor (4), and an end member (8) releasably engaging said open axial end

(14) of said housing (6) to grip said motor (4) inside said casing (5). The wheel (1) is

connectable to a frame (45) of a vehicle by connecting means (43) interposed between

said wheel (1) and said frame (45) so that, when said end member (8) is removed from

said housing (6), said motor (4) can be withdrawn completely through said open axial

end (14).

[57]




__________________

210702 [21[]11]



MILITARY VEHICLE

[54]

01.11.2007 [22] IT [33] 15.12.2006 [32] TO2006A

000894

[31]

Int. Cl.(2010.01) B60K 07//00, 17//04 [51] DIVISION FROM 187093 [62]






P.O.B. 5352,

BEER-SHEVA 84152

[74]

The invention relates to a power-driven wheel (1) comprising an axial-flow motor (4),

a hub (2) connected functionally to said motor (4) and a tyre (3) angularly integral with

said hub (2). Motion transmission means (22) are interposed functionally between an

output member (7) of said motor (4) and said hub (2), and housed inside said hub (2).

To allow for inflation and deflation of the tyre, the wheel further comprises fluidic

connecting means (50) connecting an inner tube of said tyre (3) to the outside,

extending at least partly through said hub (2) and housed at least partly inside said

transmission means (22).

[57]




__________________


PATENTS פטנטים

פטנטים שניתנו

PATENTS GRANTED

162214 161843 161735 161721 161472 160843 160598 160182

164783 164773 163843 163770 163285 163066 162854 162405

183220 183099 183046 182937 182797 165022 165002 164845

183916 183901 183868 183804 183539 183348 183286 183257

184819 184623 184599 184498 184462 184263 184107 183946

185537 185475 185375 184992 184952 184931 184922 184884

186327 186213 186163 186160 185992 185880 185765 185692

186858 186831 186769 186748 186725 186698 186676 186449

187542 187352 187313 187266 187182 187125 186962 186922

188545 188543 188527 188130 188017 187965 187853 187548

147979 147881 113909 189350 189200 189086 188875 188568

166501 166433 166390 166085 165304 165248 165226 150148

167194 167173 167145 167060 167058 167013 166830 166755

167937 167862 167623 167567 167436 167273 167218 167209

169720 169519 169409 169123 169008 168405 168371 168359

190805 190685 190597 190560 190546 190494 190414 170108

192219 191828 191769 191666 191662 191580 191048 190896

193730 193534 193365 193262 193006 192849 192771 192273

195749 195539 195020 194842 194579 194548 194361 194074

171798 171643 171119 170689 154589 134527 197546 196060

172590 172484 172469 172410 172101 171956 171870 171851

173303 173031 172922 172901 172815 172801 172702 172674

175534 175533 175433 174716 174705 174065 173802 173773

198978 198096 176471 176380 176357 176342 175632 175597

205779 205411 202827 202468 202331 201428 200260 199123

157922 157374 156770 145821 144988 143394 207587 207057

177870 177728 177453 177335 177191 177148 176765 176556

178672 178518 178452 178353 178192 178102 178006 177939

179281 179239 179127 179028 178830 178824 178757 178705

180047 179885 179792 179695 179658 179606 179594 179412

181058 180986 180933 180277 180236 180172 180135 180060

182161 181836 181821 181569 181522 181464 181195 181179

208800 208799 208460 182669 182513 182350 182306 182236


פטנטים שחודשו

PATENTS RENEWED

107977 107974 107969 107967 107870 107868 107822 107675

108014 108013 108007 108003 108002 108000 107999 107980

108118 108115 108061 108051 108029 108027 108018 108017

108240 108235 108234 108204 108171 108154 108129 108126

122420 122375 122327 122300 122292 122273 121280 110388

122587 122578 122563 122556 122529 122497 122430 122429

122671 122669 122666 122632 122631 122630 122602 122601

122776 122771 122768 122767 122732 122716 122711 122695

125635 125386 125281 124478 123012 122871 122840 122777

129695 129694 129558 129338 126531 126016 125866 125715

129999 129979 129938 129937 129912 129911 129836 129792

130187 130178 130125 130120 130109 130085 130026 130013

130293 130278 130277 130267 130255 130247 130243 130239

130418 130403 130351 130345 130330 130311 130309 130298

130515 130501 130492 130482 130464 130459 130450 130449

130594 130575 130558 130549 130534 130533 130528 130524

130918 130793 130764 130734 130657 130653 130629 130601

141877 138708 136934 136396 135242 134356 132194 131429

146924 146823 146737 146694 146386 144988 142009 141916

147102 147100 147058 147050 147016 146999 146985 146981

150282 149933 147506 147276 147221 147213 147137 147110

153558 153187 153145 153114 151159 150629 150617 150381

155689 155662 155497 155428 155373 155097 154577 153816

155939 155922 155900 155806 155805 155771 155760 155709

156085 156084 156083 156080 156076 156058 156055 155992

156175 156171 156154 156103 156102 156091 156088 156086

156243 156242 156241 156240 156239 156238 156206 156204

156277 156270 156258 156251 156248 156247 156245 156244

156331 156325 156310 156308 156306 156303 156280 156278

156395 156389 156371 156369 156361 156353 156346 156341

156427 156423 156421 156415 156410 156403 156398 156396

156480 156476 156456 156446 156444 156440 156437 156432

156550 156542 156532 156531 156523 156516 156508 156505

156630 156588 156586 156568 156564 156563 156562 156553

156678 156661 156658 156657 156646 156644 156640 156635

156889 156878 156810 156766 156764 156723 156694 156693

157505 157201 157164 157161 157002 156975 156967 156928

158526 158376 158352 158309 158102 157867 157741 157633

161031 160843 160784 160659 160498 160432 159451 159305

161784 161746 161741 161735 161589 161379 161084 161051

163653 163600 163102 163066 162405 162376 162111 162063

164910 164845 164803 164377 164228 164222 164135 163843


165528 165510 165309 165304 165264 165248 165038 165022

166981 166802 166445 166433 166243 165966 165719 165717

167465 167382 167273 167218 167173 167103 167082 167060

168359 168323 168207 168118 167937 167750 167652 167641

169337 169032 169024 168980 168739 168632 168631 168555

170354 169775 169704 169683 169677 169657 169575 169535

171693 171666 171638 171520 171192 170972 170721 170689

172470 172469 172454 172447 172323 172101 172075 171870

172674 172644 172591 172586 172571 172542 172541 172500

172856 172838 172837 172819 172805 172702 172695 172680

174062 173773 173505 173303 173031 172995 172917 172904

174848 174797 174729 174676 174642 174618 174606 174510

175859 175552 175508 175507 175228 175217 175077 175070

176610 176512 176433 176357 176336 176270 176150 175925

177327 177191 177119 177033 176765 176717 176655 176635

178050 177986 177980 177939 177808 177684 177648 177557

179109 179080 179028 179006 178830 178810 178576 178353

179451 179402 179395 179356 179286 179255 179124 179117

180047 180046 179955 179830 179779 179749 179658 179466

181047 180740 180670 180556 180413 180384 180172 180116

181850 181643 181522 181503 181460 181239 181195 181058

183156 183091 182924 182860 182690 182494 181864 181863

183391 183360 183348 183286 183264 183257 183256 183220

183574 183573 183550 183548 183547 183546 183437 183435

183763 183745 183722 183707 183689 183683 183655 183640

183950 183946 183930 183924 183917 183872 183812 183786

184081 184080 184068 184044 184019 184009 184007 184005

184823 184784 184770 184462 184300 184297 184245 184156

185635 185475 185452 185341 185233 185230 184952 184886

186895 186882 186858 186550 186382 186317 186226 186213

187965 187853 187653 187542 187402 187313 187294 187030

188815 188527 188408 188403 188169 188130 188017 187994

190494 190164 190070 189559 189552 189463 189197 188875

192052 191886 191874 191662 190720 190685 190597 190546

195446 194548 194274 193365 192827 192765 192687 192273

197059 197052 196372 196048 195677 195539 195448 195447

200260 199438 199123 198448 198051 197993 197520 197164

207492 205693 204960 203892 202308 201967 201966


פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידוש

PATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL

FEES

120388 120380 120361 120358 120350 120332 120328 120295

120455 120442 120436 120435 120430 120425 120420 120407

120652 120612 120554 120523 120512 120504 120492 120465

120746 120723 120719 120709 120700 120696 120688 120656

120838 120824 120821 120817 120813 120806 120796 120751

122647 122565 122526 122525 122520 122318 122139 122011

138499 138011 123629 123201 122931 122916 122823 122699

141740 141727 141676 141638 141632 141592 141584 140951

177775 158522 158490 156650 155664 141822 141777 141758

132616 132071 131019 130955 129789 178204 178018 177777

142416 142325 142227 142208 142156 141989 141963 141961

142825 142784 142774 142773 142732 142611 142455 142431

143997 143217 143073 143042 143013 142994 142892 142884

168162 167726 167646 167193 167179 145799 145774 143998

151095 151084 151083 151075 150985 150792 168588 168462

151416 151392 151373 151336 151329 151311 151249 151248

151630 151626 151596 151524 151492 151471 151447 151428

151699 151695 151687 151674 151669 151668 151647 151637

151786 151766 151756 151751 151736 151708 151706 151703

151913 151899 151894 151878 151864 151850 151822 151789

152050 152045 152023 151989 151983 151976 151948 151922

152172 152149 152132 152124 152085 152077 152073 152063

152376 152327 152307 152300 152298 152249 152229 152215

152482 152463 152461 152459 152448 152392 152388 152379

152615 152600 152551 152550 152534 152495 152488 152487

152789 152745 152730 152728 152677 152664 152657 152650

153057 152971 152932 152868 152835 152817 152814 152798

104829 183570 161963 161962 161961 154072 153233 153205

104965 104957 104954 104915 104891 104880 104839 104830

105062 105061 105058 105056 105017 105009 105003 104984

105306 105204 105203 105183 105146 105141 105131 105063

105449 105403 105382 105371 105369 105345 105344 105329

105554 105516 105513 105498 105470 105468 105465 105456

105622 105619 105614 105607 105593 105592 105591 105588

105709 105695 105684 105658 105642 105637 105627 105625

125764 125709 125590 125504 124848 124572 124426 105710

125912 125911 125895 125893 125869 125850 125796 125772

126054 126028 125987 125986 125969 125968 125954 125939

126146 126120 126115 126097 126091 126086 126075 126057

126248 126237 126219 126212 126207 126204 126180 126176

126354 126338 126337 126304 126296 126283 126282 126262


126423 126420 126403 126395 126371 126368 126363 126358

126581 126556 126541 126497 126496 126486 126478 126470

126628 126614 126607 126605 126596 126591 126584 126582

126853 126823 126770 126754 126717 126677 126646 126643

126969 126968 126944 126918 126917 126911 126897 126854

127015 127013 126989 126976 126975 126973 126971 126970

146001 127726 127218 127177 127130 127111 127044 127033

149030 148538 148537 147532 147430 147339 147226 146935

פטנטים שחודשו לעשרים שנהPATENTS RENEWED FOR 20 YEARS

183176

צווי הארכה שחודשו

EXTENSION ORDERS RENEWED

102138 94634

פטנטים שפג תוקפם

PATENTS EXPIRED

97464 97455 97426 97425 97413 97396 97376 97328

97584 97565 97532 97516 97503 97487 97485 97465

97623 97620 97619 97602 97596 97594 97592 97585

97646 97645 97644 97641 97635 97633 97632 97631

97709 97701 97695 97693 97690 97677 97674 97658

97740 97730 97729 97727 97723 97720 97715 97714

97867 97851 97837 97800 97779 97746 97744 97741

97924 97915 97914 97912 97910 97904 97892 97884

98025 98014 98008 98002 97992 97982 97944 97935

98100 98081 98077 98060 98055 98033 98028 98027

98161 98157 98152 98143 98137 98127 98126 98101

111029 111028 110820 107309 107308 104253 98175 98163

170719 165071 119396 112575 111030


פטנטים שלגביהם הוגשו בקשות להארכת תקופת

ההגנה על פי פרק ד' סימן לחוק הפטנטים 1ב'

Patents for which

applications have been filed

for extension of the patent

term under chapter 4, part

B1 of the Patens Law

מס' פטנט בסיסי?

225353 No. of basic patent:

:Proprietors שם המבקש?

BIOVITRUM AB (PUBL)

:27.11.2011Date of application תאריך הגשת הבקשה?


NOTICE הודעה

לחוק 60לפי סעיף 1967-הפטנטים, תשכ"ז

Under section 60 of the

Patent Law, 5727-1967

הוגשה בקשה להחזר תוקפו של הפטנט המפורט מטה,

שתוקפו פקע מחמת אי תשלום אגרות החידוש

הקבועות:

Application has been filed

for the restoration of the

patent recorded below,

which has lapsed through

non-payment of the

prescribed renewal fees:

No. of Patent 203137 מס' הפטנט

Acceptance published in ///7/0 קיבול פורסם ביומן מס'?

journal no:

:Proprietors שם בעל הפטנט?

CECA S.A.

:Title of invention שם האמצאה? קריוגנית של גזים תעשייתיים -אמצעי סופח5 תהליך לייצורו והשימוש בו להפרדה לא

ADSORBENT, PROCESS FOR THE PRODUCTION THEREOF AND USE THEREOF

FOR THE NON- CRYOGENIC SEPARATION OF INDUSTRIAL GASES

כל אדם רשאי להתנגד שה האמורה תוך לבק

שלושה חודשים מתאריך יומן פטנטים זה, כפי שנקבע

92לחוק ובתקנה 61בסעיף -לתקנות הפטנטים, תשכ"ח

1968

Any person may oppose the

said application within three

months from the date of this

Patents Journal, as

prescribed by section 61 of

the law and by regulation 92

of the Patent Regulations,

5728-1968


NOTICE הודעה






הקבועות:





non-payment of the



Acceptance published in 0//3/0 קיבול פורסם ביומן מס'?

journal no:


אודיס תעשיית אביזרי השקיה בע"מ

ODIS IRRIGATION EQUIPMENT LTD.

:Title of invention שם האמצאה? משקע עבור נוזלים בעלי עכירות גבוהה

SETTLER FOR HIGH-TURBIDITY LIQUIEDS

כל אדם רשאי להתנגד לבקשה האמורה תוך

שלושה חודשים מתאריך כפי שנקבע יומן פטנטים זה,


1968




Patents Journal, as




5728-1968


NOTICE הודעה






הקבועות:





non-payment of the




journal no:


ידע חברה למחקר ופיתוח בע"מYEDA RESEARCH AND DEVELOPMENT CO. LTD.

:Title of invention שם האמצאה?

להכנת תכשירי רוקחות לטיפול במחלות אוטואימוניות של 26Cשימוש באסטרים של חומצות שומניות איברים ספציפיים

USE OF ESTERS OF C18 FATTY ACIDS FOR THE PREPARTION OF

MEDICAMENTS FOR TREATMENT OF ORGAN - SPECIFIC AUTOIMMUNE

DISEASES




1968




Patents Journal, as




5728-1968


NOTICE הודעה




הוגשה בקשה להחזר תוקפו ה, של הפטנט המפורט מטשתוקפו פקע מחמת אי תשלום אגרות החידוש

הקבועות:





non-payment of the




journal no:


מוסד הטכניון למחקר ופיתוח בע"מ

TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.

:Title of invention שם האמצאה? שיטה להכנת קורולים המותמרים באופן סלקטיבי וקורולים מותמרים חדשים

METHOD FOR THE PREPARATION OF SELECTIVELY-SUBSTITUTED CORROLES

AND NEW SUBSTITUTED CORROLES




1968




Patents Journal, as




5728-1968


NOTICE הודעה






הקבועות:





non-payment of the


No. of Patent 241645 הפטנט מס'


journal no:


BASF AKTIENGESELLSCHAFT

:Title of invention שם האמצאה? שיטה לטיהור קוטל חרקים

METHOD OF PURIFYING A PESTICIDE

תנגד כל אדם רשאי להלבקשה האמורה תוך



1968




Patents Journal, as




5728-1968


NOTICE הודעה






:הקבועות





non-payment of the




journal no:

:Proprietors הפטנט?שם בעל

מולטילוק טכנולוגיות בע"מ

MUL-T-LOCK TECHNOLOGIES LTD.

:Title of invention שם האמצאה? כיווני–מנעול צילינדר רב

MULTI-DIRECTIONAL CYLINDER LOCK



92לחוק ובתקנה 61 בסעיף-לתקנות הפטנטים, תשכ"ח

1968




Patents Journal, as




5728-1968


ה לחוק 64לפי סעיף הודעה

1967-הפטנטים התשכ"ז

NOTICE under section 64E of the

Patents Law, 5727-1967

בכוונת רשם הפטנטים ליתן צו להארכת תקופת הגנה ע"פ פרק

לחוק הפטנטים, 1ד', סימן בלגבי הפטנט 1967-התשכ"ז

המפורט מטה:

It is the intention of the

Commissioner of Patents to grant an

order for the extension of the period

of protection of the following patent

in accordance with Chapter Four,

Article Two bis, of the Patents Law,

5727-1967

:No. of basic patent 103098 מס' פטנט בסיסי:

The order will be in effect until 14.04.2017 :הצו יעמוד בתוקפו עד ליום

Acceptance published in Journal 2/1996 קיבול פורסם ביומן מס':

No.:

:Title of invention שם האמצאה:

פירידין פיורו ופירולו אנאלוגים שלהןתהליכים -]C-3,2[-תולדות טטראהידרותיאנו להכנתן ותכשירי רוקחות המכילים אותם

TETRAHYDROTHIENO-[3,2-c]- PYRIDENE DERIVATIVES, FURO AND PYRROLO

ANALOGS THEREOF, PROCESSES FOR THE PREPARATION THEREOF AND

PHARMACEUT

:Proprietors בעלי הפטנט:

UBE INDUSTRIES LTD9 כל המעוניין להתנגד למתן צו

הארכה רשאי תוך שלושה ם מתאריך יומן זה, להגיש חודשי

לרשם הפטנטים הודעה התנגדות ו לחוק, בדרך 64לפי סעיף

לתקנות 3הקבועה בתקנה –הפטנטים )הארכת תקופה הגנה

סדרי דין בבקשה לצו, בהתנגדות -לצו, ובבקשה לביטול(, התשנ"ח

1998

Any person desiring to oppose the

said grant of an order may, within

three months from the date of this

journal, serve to the Commissioner

of Patents a notice of opposition

under Section 64F of the Law, as

prescribed by Rule 3 of the Patent

Regulations (extension of period of

protection – procedure of

application for order, opposition to

order, application to annul) 5758-

1998.


שינויים בפרטים רשומים בפנקס

CHANGES IN PARTICULARS ENTERED IN REGISTER


DESIGNS מדגמים

מדגמים שנרשמוDESIGNS REGISTERED

49052 Class 3(01) סוג פרסום 21.02.2010

MERCK SERONO SA

Tablet dispenser מנפק לגלולות

Convention date (WIPO) 08.09.2009 תאריך האמנה )וויפו(

49168 ,49169 Class 9(03) סוג פרסום 22.03.2010

CAESAREA LANDSCAPE DESIGN קיסריה עיצוב בנוף בע"מ

LTD.

Dustbin אשפתון

49261 Class 26(01) סוג פרסום 11.04.2010

.GISHAY HOLDING LTD גישאי אחזקות בע"מ

Memorial candle נר זיכרון

49066 Class 9(03) סוג פרסום 23.02.2010

CAESAREA LANDSCAPE DESIGN קיסריה עיצוב בנוף בע"מ

LTD.


Dustbin אשפתון

49213 Class 3(01) סוג פרסום 25.03.2010 ALPLAST-PLASTIV SHEETS עיבוד לוחות פלסטיים בע"מ-עלפלסט

CONVERTING LTD.

Case מארז

49214 Class 19(02) סוג פרסום 25.03.2010 ALPLAST-PLASTIV SHEETS עיבוד לוחות פלסטיים בע"מ-עלפלסט

CONVERTING LTD.

Clip case אוגדנית עם תפס לדפים

50110 Class 7(02) סוג פרסום 21.09.2010

.STRAUSS COFFEE B.V

Cooking container כלי בישול

49262 ,49263 Class 24(04) סוג פרסום 11.04.2010

VECTURA DELIVERY DEVICES LIMITED

Inhaler משאף

Convention date (OHIM) 09.10.2009 תאריך האמנה )איחוד אירופי(

49263 Class 24(04) סוג פרסום


11.04.2010

VECTURA DELIVERY DEVICES LIMITED

Inhaler משאף



49597 ,49598 Class 12(16) סוג פרסום 15.06.2010

.T.C. AVISAREI RECHEV B.M ט.ק. אביזרי רכב בע"מ

Vehicle seat cover כיסוי מושב לרכב

49609 ,51395 Class 24(02) סוג פרסום 16.06.2010

.ROCHE DIAGNOSTICS S.L

Portable medical equipment for clinical אבחון קליני מכשיר רפואי נייד לביצוע

analysis

Convention date (U.S.A.) 19.03.2010 תאריך האמנה )ארצות הברית(

49657 Class 3(01) סוג פרסום 21.06.2010

& SHUGON BAGS שוגון תיקים ומוצרי עור בע"מ

LEATHERGOODS LTD.

Backpack תיק גב

49922 Class 7(05) סוג פרסום 03.08.2010

K. VISION SYSTEM SOLUTIONS קיי ויז'ן סיסטם סולושנס בע"מ

LTD.

Dish dryer מייבש כלים

50085 Class 9(01) סוג פרסום 16.09.2010


.GUERLAIN S.A

Bottle בקבוק

Convention date (OHIM) 17.03.2010 ירופי(תאריך האמנה )איחוד א


50177 Class 6(09) סוג פרסום 09.12.2010

DGANIT BODEK LEVI דגנית בודק לוי

AHUVA ZAIRI SHITRIT אהובה זעירי שטרית

Nursing pillow כרית הנקה

50273 Class 21(01) סוג פרסום 11.11.2010

YERACHMEL BERENSHTEIN ירחמיאל ברנשטיין

BINYAMIN HUTA בנימין חוטה

Construction toy צעצוע הרכבה

50410 Class 23(01) סוג פרסום 13.12.2010 ETI SEGEV אתי שגב

A water spraying device מכשיר להתזת מים

50442 Class 7(02) סוג פרסום 21.12.2010

ARGO DEVELOPMENT AND ארגו פיתוח וייצור בע"מ

MANUFACTURING LTD.

Coffee maker מכשיר להכנת קפה

50141 Class 11(02) סוג פרסום 11.10.2010

JOSEFF ZAKARIYA יוסף זקריה

Ornament קישוט


50506 Class 9(01) סוג פרסום 11.01.2011

.SOURCE VAGABOND SYSTEM LTD

Bottle בקבוק

Convention date (U.S.A.) 13.07.2010 תאריך האמנה )ארצות הברית(

50607 Class 25(01) סוג פרסום 07.02.2011

.SHOKET ALUMINIUM LTD שוקת אלומיניום בע"מ

Profile פרופיל

50704 ,50706 ,50707 Class 2(04) סוג פרסום 21.02.2011

.ANTELOPE SHIVUK (1994) LTD ( בע"מ1994אנטילופ שיווק )

Sole סוליה

50738 Class 24(04) סוג פרסום 24.02.2011

SHLOMO NORMATOV שלמה נורמטוב

Apparatus for weakening and/or cessation of התקן להחלשת ו/או הפסקת נחירות

snoring

50770 Class 6(06) סוג פרסום 06.03.2011



Furniture profile פרופיל לרהיט


50812 Class 6(06) סוג פרסום 17.03.2011


Profile for cabinet פרופיל לארון

50857 Class 8(03) סוג פרסום 27.03.2011

KOMET GROUP HOLDING GMBH

Cutting tools כלי חיתוך


50867 ,50868 Class 11(01) פרסום סוג 28.03.2011

H. STERN COMERCIO E INDUSTRIA S.A.

Jewel תכשיט

50911 Class 25(01) סוג פרסום 07.04.2011



50878 Class 8(05) סוג פרסום 29.03.2011 AMIT LEVI עמית לוי

Bottles compressor דוחס בקבוקים


50888 Class 12(16) סוג פרסום 30.03.2011

SAFECAR THEFT PREVANTION סייף קאר מערכות מניעת גניבה בע"מ

SYSTEMS LTD.

Defensive equipment for igniting computer מתקן הגנה למחשב הצתה

49756 Class 25(02) סוג פרסום 06.07.2010

JOSEPH ROKACH AND SONS רוקח יוסף ובניו יבוא ושיווק בע"מ

IMPORT AND DISTRIBUTION

LTD.

Manhole cover כיסוי לתא בקרה

50737 Class 25(01) סוג פרסום 24.02.2011 ARNON BARAK ארנון ברק


50901 Class 2(01) סוג פרסום 05.04.2011 SARAH COHEN שרה כהן

Under garment לבוש תחתון

49899 Class 26(03) סוג פרסום 29.07.2010

KONINKLIJKE PHILIPS ELECTRONICS N.V


Luminaire for road lighting אמצעי תאורה לדרך



50454 Class 25(03) סוג פרסום 27.12.2010

JOSEFF ZAKARIYA יוסף זקריה

Mobile structure מבנה נייד

50814 Class 25(03) סוג פרסום 21.03.2011 .Z. ROTH INDUSTRIES LTD שיות בע"מצ. רוט תע

Passenger shelter סככה לנוסעים

50314 Class 21(01) סוג פרסום 21.11.2010

.KETER PLASTIC LTD כתר פלסטיק בע"מ

Play house בית משחק

50484 Class 21(01) סוג פרסום 04.01.2011

KAMAL HASAN קמאל חסן

ISMAIL TURK אסמעיל טורק

Cube of languages & mathmatics קוביית שפות ומתמטיקה

49982 Class 23(03) סוג פרסום 19.08.2010 TAL KAMIL טל קמיל

Solar collector קולט סולארי


50024 Class 21(01) סוג פרסום 26.08.2010

SOPHIE NESIHA BERMAN נסיכה ברמן סופי

Game משחק

50025 Class 21(01) סוג פרסום 26.08.2010

SOPHIE NESIHA BERMAN סופי נסיכה ברמן

Cube game קוביית משחק


מדגמים שבוטלוDESIGNS VOID

35213 35200 35170 35168 35166 35157 27126 27054

27026 27004 35225 35223 35222 35217 35216 35215

35101 35097 35085 35084 35083 35082 27044 27043

35131 35121 35104

שחודשומדגמים DESIGN RENEWED

43632 43596 43594 43537 43424 43423 35948 35911

43848 43847 43846 43845 43837 43836 43835 43703

43902 43901 43893 43892 43852 43851 43850 43849

44745 44452 44097 44048 43945 43906 43905 43904

35995 35864 44743 45941 45939 49538 49537 44746

43213 43210 40807 36155 36119 36118 36084 36053

43644 43518 43409 43389 43318 43317 43316 43314

43686 43770 43762 43645

Asa Kling אסא קלינג

,Commissioner of Patents רשם הפטנטים, המדגמים

Designs and Trade Marks חר וסימני מס


מפתחות לבקשות שקובלו

INDICES OF APPLICATIONS ACCEPTED

NAME INDEX מפתח שמי

185534 -א.פ.מ. פתרונות אוטומציה בע"מ

193003 -אביב עמירב

אוניברסיטת בן גוריון בנגב הרשות למחקר 172944 -ופיתוח

, 171722 -אי. סי. איי. טלקום בע"מ 189342

איי.בי.איי ישראל ביומדיקל אינוביישנס 188582 -בע"מ

194909 -אילן רוזן

177414 -אלונים אחזקות אגש"ח בע"מ

193059 -אלי הוגו בודמן

183398 -אלתא מערכות בע"מ

167142 -אמנון מאור

167142 -אמנון שילוני

145210 -אפוסנס בע"מ

189284 , 188649 -גאורגי נאומוב

174148 -גדעון אלון

167782 -גיוון אימג'ינג בע"מ

161938 -גל זילכה

184362 -גמסוניק בע"מ

193502 -דויד זילברברג

192011 -דוקול בע"מ

894139 -דקסל בע"מ

172326 -הוק מדיקל טכנולוג'יס בע"מ

-התעשייה האוירית לישראל בע"מ 163609 , 193866

181562 -חניתה מפעלי מתכת בע"מ

168332 -ות בע"מ חסין אש תעשי

168298 -יוסי סלע

179893 -יעקב צרור

174670 -ישקר בע"מ

174670 -ישקר בע"מ

161938 -לייט בוק בע"מ

188067 -ליתוטק מדיקל בע"מ

-מארוול ישראל )אמ.איי.אס.אל( בע"מ 189514

187667 -מדיגייד בע"מ

193848 , 186786 -מדינול בע"מ

181639 -יקל ברוגמן מי

188649 -מיכאל נאומוב

189284 -מיכאל נאומוב

193059 -מרסלו אדריאן אדטו

192005 -סויטרון בע"מ

168686 -סנו מפעלי ברונוס בע"מ

201461 -עידן נחמני

168399 -פואמיקס בע"מ

188645 -פיטרקס בע"מ

177323 -קורנית דיגיטל בע"מ

177323 -קורנית דיגיטל טכנולוגיות בע"מ

170726 -טק בע"מ -קמרו

161938 -רונן כרמונה

-רמות ליד אוניברסיטת תל אביב בע"מ 167400

192005 -טוב -רן סימן

-רפא"ל מערכות לחימה מתקדמות בע"מ 183320

193502 -ש"ח שנאי חולדה

164577 -תדיראן טלקום בע"מ

מחקרים ,תשתית ושירותים -תל השומר





http://www.ilpatsearch.justice.gov.il/UI/MainPage.aspx?kind=2&reqno=%20189342


























































194299 -רפואיים בע"מ

3M INNOVATIVE PROPERTIES

COMPANY - 26212/

A.P.M. AUTOMATION SOLUTIONS

LTD. - 185534

ABBOTT LABORATORIES - 172457

ABGENOMICS COOPERATIEF U.A. -

174172

ABGENOMICS CORPORATION - 174172

ADIR SEGAL, LTD - 192011

AGENSYS, INC. - 197988

AIMSCO LIMITED - 180487

ALBERT EINSTEIN COLLEGE OF

MEDICINE OF YESHIVA UNIVERSITY

- 155791

ALBIS SPA - 196716

ALCATEL LUCENT - 180440

ALCHEMIA ONCOLOGY PTY LIMITED

- 189972

ALCON, INC. - 183323 , 183368

ALLENVEE HOLDINGS PTY LTD. -

194464

ALLERGAN, INC. - 167410

ALONIM HOLDINGS AGRICULTURAL

COOPERATIVE SOCIETY LTD. - 177414

ALPHAMED MEDIZINTECHNIK

FISCHER GMBH - 183030

ALZA CORPORATION - 156090

AMNON MAOR - 167142

AMNON SHILONI - 167142

AMPHENOL CORPORATION - 184200

ANTHROGENESIS CORPORATION -

190731

ANTIBIOTICOS S.P.A. - 200172

APOSENSE LTD. - 145210

APPLIED DESIGN AND ENGINEERING

LIMITED - 173997

AQUARIUS TECHNOLOGIES INC. -

183881

ARES TRADING S.A. - 161309

ARM LIMITED - 189206

ASTELLAS PHARMA INC. - 168121

ASTION PHARMA A/S - 186491

ASTRAZENECA AB - 193071

AVANTOR PERFORMANCE

MATERIALS, INC. - 190088

AVENTIS PHARMA S.A. - 193310

AVENTIS PHARMACEUTICALS INC. -

159506 , 190673

AVIV AMIRAV - 193003

BAE SYSTEMS BOFORS AB - 191614

BASF SE - 186680

BAYER ANIMAL HEALTH GMBH -

183200

BAYER PHARMA

AKTIENGESELLSCHAFT - 183200 ,

201694 , 205242

BAYER S.A.S. - 169527

BEN-GURION UNIVERSITY OF THE

NEGEV RESEARCH AND

DEVELOPMENT AUTHORITY - 172944

BETH ISRAEL DEACONESS MEDICAL

CENTER - 178002

BIOAVAILABILITY, INC - 183157

BIOGEN IDEC MA INC. - 170178

BIONICHE LIFE SCIENCES INC. -

164664

BIOSENSE WEBSTER INC. - 156377

BIOSENSE WEBSTER INC. - 181119

BIOSENSE WEBSTER, INC. - 180516

BIO-TEC BIOLOGISCHE

NATURVERPACKUNGEN GMBH & CO.

KG - 194687

BIOTEMPT, B.V. - 178515

BOARD OF REGENTS, THE

UNIVERSITY OF TEXAS SYSTEM -

174374


INTERNATIONAL GMBH - 166584 ,

175017 , 197377

BOEHRINGER INGELHEIM PHARMA































































GMBH & CO. KG - 157326

BOTULINUM TOXIN RESEARCH

ASSOCIATES, INC. - 168745

BRAVILOR HOLDING B.V. - 195661

BRISTOL-MYERS SQUIBB COMPANY -

157443

BRISTOL-MYERS SQUIBB COMPANY -

203533

BURLE TECHNOLOGIES, INC. - 160873


CORPORATION - 182170 , 196221

CAMERO-TECH LTD. - 170726

CARDIOROBOTICS, INC. - 197032

CARLO CHIAVES - 170438

CARNEGIE INSTITUTION OF

WASHINGTON - 207054

CHEN CHUANO-CHUAN - 187048

CHEN MING-TE - 187048

CHOUDHARY CHARAN SINGH

HARYANA AGRICULTURAL

UNIVERSITY, - 179254

CHUGAI SEIYAKU KABUSHIKI

KAISHA - 187604

CLARIANT FINANCE (BVI) LIMITED -

186384

COLGATE-PALMOLIVE COMPANY -

177761

COLUMBIA LABORATORIES

(BERMUDA) LIMITED - 161513

COMBUSTION SCIENCE &

ENGINEERING INC. - 183500


ATOMIQUE - 175936

COMPOUND PHOTONICS - 193789

CORDIS CORPORATION - 168361


INDUSTRIAL RESEARCH - 171177 ,

171178

CRUCELL HOLLAND B.V. - 146479 ,

198861

CSL BEHRING GMBH - 157360

CVTRON LTD. - 192005

CYTOS BIOTECHNOLOGY AG - 194656

DAS AJEE KAMATH - 171444

DAVID JACOB SCHWARTZ - 197165

DAVID ZILBERBERG - 193502

DENDERAH PHARMA SA - 182747

DEUTSCHE POST AG - 166911

DEXCEL LTD. - 139894

DONG WHA PHARMACEUTICAL CO.,

LTD. - 180524

DUCOOL LTD. - 192011

DURECT CORPORATION - 176649

DYNTEK PTE LTD. - 190071

EATON CORPORATION - 194135

ECI TELECOM LTD. - 171722 , 189342

ECODUNA OG - 206869

EGIS GYOGYSZERGYAR NYRT -

183739

EISAI R&D MANAGEMENT CO., LTD. -

180486 , 184983 , 188670

ELAN PHARMA INTERNATIONAL

LTD. - 163626

ELECTRONIC NAVIGATION

RESEARCH INSTITUTE - 158325

ELEMENT SIX LIMITED - 166905

ELI HUGO BUDMAN - 193059

ELTA SYSTEMS LTD. - 183398

ENZON PHARMACEUTICALS, INC. -

183054

ERNEST FRIEDEN - 192087

ESPERION THERAPEUTICS, INC. -

155213

EURO-CELTIQUE S.A. - 187813 , 207067

F. HOFFMANN-LA ROCHE AG - 154008

, 163563 , 170829 , 174075 , 174513 ,

179370 , 179737 , 181317 , 183594 ,

185631 , 189664 , 196327

FABIO PERINI S.P.A. - 177886

FITRACKS INC. - 188645

FITRACKS LTD. - 188645

FN HERSTAL S.A. - 183891

FOAMIX LTD. - 168399

FRED ZACOUTO - 186988

FUJIKIN INCORPORATED - 191738

FUJIMOTO CO., LTD. - 183028

FUNCTIONAL GENETICS, INC. - 167774

GABA INTERNATIONAL AG - 188246

Gal Zilkha - 161938























































































GALLAHER SNUS AB - 185874

GAMASONIC LTD. - 184362

GE MEDICAL SYSTEMS GLOBAL

TECHNOLOGY COMPANY, LLC -

165619

GEBR. SCHMID GMBH & CO. - 189168

GENENTECH, INC. - 157378 , 170076 ,

174786 , 191077 , 191078 , 191824

GENERAL ELECTRIC COMPANY -

187519

GENSTRUCT, INC. - 167629

GEORGE NAUMOV - 188649 , 189284

GERON CORPORATION - 177324 ,

188264

GIDEON ALON - 174148

GILEAD SCIENCES, INC. - 180758 ,

180781

GIVEN IMAGING LTD. - 167782

GLAXO GROUP LIMITED - 184438

GLAXOSmithKLINE ISTRAZIVACKI

CENTAR ZAGREB D.O.O. - 184438


TECHNOLOGIES LIMITED - 166508


TECHNOLOGIES LIMITED - 185100

GRACEWAY PHARMACEUTICALS,

LLC - 184310

H. LUNDBECK A/S - 200959

H.T. HULDA TRANSFORMERS - 193502

HANITA METAL WORKS LTD. - 181562

HANMI HOLDINGS CO., LTD. - 188600

HANMI PHARM. CO., LTD. - 188600

HARTMUT ENGELMANN - 161309

HASSIN ESH INDUSTRIES LTD. -

168332

HAWK MEDICAL TECHNOLOGIES

LTD - 172326

HERAEUS QUARZGLAS GMBH & CO.

KG - 180213

HUTCHISON WHAMPOA THREE G IP

(BAHAMAS) LIMITED - 184887

I.B.I. ISRAEL BIOMEDICAL

INNOVATIONS LTD. - 188582

IBM CORPORATION - 173422 , 188757 ,

191952 , 194297

IDAN NACHMANI - 201461

ILAN ROSEN - 194909

INDENA S.P.A. - 165436 , 181024 ,

182396

INSERM (INSTITUT NATIONALE DE

LA SANTE ET DE LA RECHERCHE

MEDICALE) - 193310

INSTITUT NATIONAL DE LA SANTE

ET DE LA RECHERCHE MEDICALE -

I.N.S.E.R.M. - 198076

INSTITUT PASTEUR - 198076

INTARCIA THERAPEUTICS, INC. -

156090


CORPORATION - 180004 , 184083 ,

189716

INTERNATIONAL STEM CELL

CORPORATION - 190869

INTEVAC, INC. - 174681

ISCAR LTD. - 174670

ISCAR LTD. - 174670

ISRAEL AEROSPACE INDUSTRIES

LTD. - 163609 , 193866

JACKOB TSROR - 179893

JACOBUS PHARMACEUTICAL

COMPANY, INC. - 168718

JAN BASTIAAN CILLIERS - 153456

JANSSEN PHARMACEUTICA, N.V. -

164003 , 180411

JOHN N. RASSIAS - 163231

JOMA INTERNATIONAL AS - 171363

KAKUICHI SHIOMI - 158325

KISSEI PHARMACEUTICAL CO., LTD. -

171713

KORNIT DIGITAL LTD. - 177323

KORNIT DIGITAL TECHNOLOGIES

LTD. - 177323

KYOCERA AMERICA, INC. - 168429

LABORATOIRES BESINS

INTERNATIONAL - 177778

LAM RESEARCH CORPORATION -

190454 , 209736 , 209737

LAURENTIU DUMITRU BREAZ -

189909



















































































LEHIGH TECHNOLOGIES, LLC - 175722

LG LIFE SCIENCES LTD. - 173638

LIGHT BOOK LTD. - 161938

LITHOTECH MEDICAL LTD. - 188067

LONZA LTD. - 177561


AG - 168606


AG - 184145

LUMEX AS - 193223

LUMIDIGM, INC. - 179699

MALAFON ELECTRONIC (SUZHOU)

CO. LTD. - 190011

MARCELO ADRIAN ADATTO - 193059

MARTHA SOPHIA CILLIERS - 153456

MARVELL ISRAEL (M.I.S.L) LTD. -

189514

MAX-PLANCK-GESELLSCHAFT ZUR

FOERDERUNG DER

WISSENSCHAFTEN E.V. - 185147

MEDA AB - 184310

MEDA AB - 184310

MEDELA HOLDING AG - 168355

MEDESIS PHARMA SA - 182747

MEDIGUIDE LTD. - 187667

MEDINOL LTD. - 186786 , 193848

MEDION DIAGNOSTICS AG - 172998

MEDION DIAGNOSTICS GMBH -

172998

MERCK PATENT GMBH - 159426

MERCK SERONO S.A. - 172354

MERCK SERONO S.A. - 172354

MICHAEL BRUGGEMAN - 181639

MICHAEL NAUMOV - 188649

MICHAEL NAUMOV - 189284

MICROSOFT CORPORATION - 178202 ,

199658

MILLISECOND TECHNOLOGIES

CORPORATION - 184161

MITSUBISHI SPACE SOFTWARE CO.,

LTD. - 158325

MORPHOSYS AG - 163563

MOSHE ATTIAS - 201461

MOSHE MAOR - 197165

MOWAG GMBH - 193387

NATIONAL RESEARCH

DEVELOPMENT CORPORATION -

179254

NATIONAL UNIVERSITY

CORPORATION KYUSHU UNIVERSITY

- 183028

NDS LIMITED - 178041

NDS LIMITED - 186288

NEURALAB LIMITED - 163626

NEXTER SYSTEMS - 191606

NIKKEN SOHONSHA CORPORATION -

189030

NORBROOK LABORATORIES LIMITED

- 194244

NOVARTIS VACCINES AND

DIAGNOSTICS, INC. - 175225

NUTRINOVA NUTRITION

SPECIALTIES & FOOD INGREDIENTS

GMBH - 175521

OBSCHESTVO S OGRANICHENNOI

OTVETSTVENNOSTIYU

"PHARMENTERPRISES" - 163763

ONO PHARMACEUTICAL CO., LTD. -

187840

OOO MILLISEKUNDNIYE

TEKHNOLOGII - 184161

OPED AG - 189804

OPTIMAIR HOLDING B.V.I.O. - 191720

ORTHO-HELIX SURGICAL DESIGNS,

INC. - 196257

OTO MELARA S.P.A. - 187093 , 210701 ,

210702

OXXIUS SA - 174764

PARATEK PHARMACEUTICALS, INC. -

173022

PFIZER PRODUCTS, INC. - 174299 ,

189666

PHARMACIA & UPJOHN COMPANY

LLC - 174414

PROMETHEUS LABORATORIES INC. -

191679

PROTEKTORWERK FLORENZ MAISCH

GMBH & CO. KG - 193932

QUALCOMM INCORPORATED - 173982





































































QUALCOMM INCORPORATED - 178446

, 179802 , 180338

RAFAEL ADVANCED DEFENSE

SYSTEMS LTD. - 183320

RAMOT AT TEL AVIV UNIVERSITY

LTD. - 167400

RAN SIMAN-TOV - 192005

RAYTHEON BBN TECHNOLOGIES

CORP. - 181510

RAYTHEON COMPANY - 152185



RECCONN AG - 192087

RECON OIL INDUSTRIES PRIVATE

LIMITED - 185888

REGENERON PHARMACEUTICALS,

INC. - 172404 , 204984

REIFENHAUSER GMBH & CO. KG

MASCHINENFABRIK - 189823

RESOURCE BALLAST TECHNOLOGIES

(PROPRIETARY) LIMITED - 191066

RIGEL PHARMACEUTICALS, INC. -

166241

ROHDE & SCHWARZ GMBH & CO. KG

- 182301 , 185228

Ronen Carmona - 161938

SAFEAWAKE, LLC - 183500

SANO BRUNO'S ENTERPRISES LTD. -

168686

SANOFI - 174941

SANOFI AVENTIS - 190585


GMBH - 166494


GMBH - 172008

SANTARIS PHARMA A/S - 183054

SANTARIS PHARMA A/S - 183054

SAVIO S.P.A. - 183773 , 183776 , 183777 ,

191839

SCHERING CORPORATION - 191417

SHANGHAI INSTITUTE OF MATERIA

MEDICA, CHINESE ACADEMY OF

SCIENCES - 188199

SHELL INTERNATIONALE RESEARCH

MAATSCHAPPIJ B.V. - 186203 , 186206 ,

186207 , 186211 , 186214

SHIONOGI & CO., LTD. - 180331

SNECMA - 173067 , 193030

SNECMA SERVICES - 173067

SOLVAY PHARMACEUTICALS GMBH

- 174373

SONY CORPORATION - 152589

SOURCE PRECISION MEDICINE, INC. -

147349

SRU BIOSYSTEMS, INC. - 187808

STOKKE AS - 172928

STOREWIZ INC. - 178694

STRAKAN INTERNATIONAL LIMITED

- 169881

STRAKAN LIMITED - 169881

SYNGENTA PARTICIPATIONS AG -

169307 , 177563

TADIRAN TELECOM LTD. - 164577


COMPANY LIMITED - 181462

TECRES S.P.A. - 188469

TEIJIN ARAMID GMBH - 188228



SERVICES LTD. - 194299

TELECOM ITALIA S.P.A. - 182824


ERICSSON (PUBL) - 179003 , 183492 ,

186577

THE BRIGHAM AND WOMEN'S

HOSPITAL, INC. - 178002

THE GERD BORCHERS FAMILY

TRUST - 153456

THE JOHNS HOPKINS UNIVERSITY

SCHOOL OF MEDICINE - 163312

THE REGENTS OF THE UNIVERSITY

OF CALIFORNIA - 180219

THE UNIVERSITY OF MIAMI - 180995

THERAVANCE, INC. - 201639

TRUEPOSITION, INC. - 171217

UCB PHARMA GMBH - 173062

UNILEVER PLC - 194287

UNITED STATES GYPSUM COMPANY

- 179810

UNIVERSITE DE LAUSANNE - 172783














































































UNIVERSITY OF NORTH CAROLINA

AT CHAPEL HILL - 155249

UT-BATTELLE, LLC - 191897

VARLEY AND GULLIVER LIMITED -

186517

VIPERGEN APS - 183013

VLAAMSE INSTELLING VOOR

TECHNOLOGISCH ONDERZOEK

(VITO) - 184877

VLADIMIR EVGENIEVICH NEBOLSIN -

163763

WARNER CHILCOTT (IRELAND)

LIMITED - 172620

WARNER-LAMBERT COMPANY LLC. -

178433

WEBER AIRCRAFT LP - 188641

WERLATONE, INC. - 185696

WESTERN UNIVERSITY OF HEALTH

SCIENCES - 183490

WILLEM MEIJER - 191720

WYETH LLC - 163626 , 176147

YALE UNIVERSITY - 177591

YAMIT NACHMANY - 201461

YM BIOSCIENCES AUSTRALIA PTY

LTD. - 175572

YOSSY SELA - 168298

ZAMBON GROUP S.P.A. - 175765





















SUBJECT MATTER INDEX מפתח ענייני

A01N - 153456, 177563

A23L - 184161, 193059, 194287

A43D - 188645

A44C - 179893

A45D - 197165

A46B - 188246

A47B - 173997

A47C - 172928

A47J - 195661

A61B - 156377, 158325, 165619,

167400, 167782, 172326,

183323, 187667, 188067,

188582, 196257, 197032

A61F - 183030, 186786, 188469

A61G - 189804

A61J - 168355

A61K - 154008, 155213, 155791,

157326, 157360, 157443,

161513, 163312, 164664,

166241, 168399, 168606,

168745, 169881, 171713,

172620, 172783, 173062,

174172, 174374, 176649,

177778, 178002, 178515,

179254, 180487, 182747,

183157, 183200, 183490,

184145, 186491, 187604,

187813, 189030, 189972,

193848, 194244, 194656,

200959

A61M - 156090, 166508, 175017,

180995, 185100, 201694

B21D - 193932

B23B - 174148, 174670, 193030

B23C - 181562

B23P - 187519

B24B - 182170, 196221

B29D - 187048

B32B - 188228, 194687

B41J - 177323

B60K - 187093, 210701, 210702

B60N - 188641, 193387

B60R - 201461

B64G - 182473

B65D - 168361, 185874

B65G - 194464

B65H - 177886

C01G - 171363

C02F - 183881, 191066

C03B - 180213

C04B - 168332

C07C - 168718, 170829, 175765,

177561, 181024, 181317,

186680, 188199, 193071,

196327, 201639

C07D - 139894, 159426, 159506,

164003, 165436, 166494,

166584, 168121, 169307,

169527, 172457, 173022,

173638, 174075, 174299,

174373, 174414, 174513,

174941, 175572, 176147,

178433, 179370, 179737,

180331, 180411, 180486,

180524, 181462, 182396,

183028, 183594, 183739,

184310, 184983, 187840,

188600, 188670, 189664,

189666, 190673, 191417,

203533, 205242, 207067

C07F - 180758, 180781

C07H - 183054, 184438

C07K - 163626, 163763, 167774,

170076, 175225, 185147,

191077, 191078, 191824,

193310, 197988

C08J - 175722

C11B - 185888

C11D - 168686, 177761

C12M - 206869

C12N - 146479, 155249, 157378,

170178, 172404, 174786,

177324, 183013, 186988,

188264, 190088, 190731,

































































































































































































190869, 197377, 198076,

198861, 204984

C12P - 175521, 200172

C12Q - 145210, 167410, 172008,

177591, 190585, 191897,

194299

C22C - 173067

C25D - 177414, 189168

C30B - 166905, 207054

D01F - 196716

D04H - 189823

D21H - 186384

E01F - 186517

E02D - 170438

E04B - 190071

E04C - 189909

E05B - 190011, 191839

E05C - 183773

E05D - 183776, 183777

E21B - 186203, 186206, 186207,

186211, 186214

F01C - 171444

F16H - 192005

F16K - 191738

F21V - 184362

F24F - 191720

F25D - 179810, 192011

F41A - 183891, 191606

F41B - 167142

F41C - 163231

F41G - 152185, 163609

F42B - 191614, 192087

G01C - 188649, 189284

G01F - 185534

G01N - 147349, 161309, 163563,

171177, 171178, 172354,

172998, 175936, 180219,

181119, 185631, 187808,

191679, 193003, 194297

G01S - 170726, 171217, 181510,

193866

G02C - 183368

G02F - 193789

G06F - 161938, 167629, 178202,

178694, 189206, 191952

G06K - 179699, 181639, 193223

G06T - 183320

G07F - 166911

G08B - 194909

G11B - 152589

H01G - 209736, 209737

H01H - 194135

H01J - 160873, 180440

H01J - 174681

H01L - 168429, 173422, 181274,

190454

H01M - 172944

H01P - 185696

H01R - 184200

H01S - 174764

H02J - 193502

H04B - 182301, 183500, 186577

H04L - 178041, 179003, 179802,

180338, 182824, 184887,

185228, 189514, 199658

H04M - 164577, 183492

H04N - 186288, 188757

H04Q - 171722, 189342

H04R - 180516

H04W - 168298, 173982, 178446,

180004, 184083, 189716

H05H - 184877

H05K - 183398




































































































































קודים למדינת המופיעים ביומן

COUNTRY CODES APPEARING IN THIS JOURNAL

Code Country or Organization Code Country or Organization AR Argentina MX Mexico AT Austria MY Malaysia AU Australia NL The Netherlands BA Herzegovina NO Norway BE Belgium NZ New Zealand BR Brazil PL Poland CA Canada PT Portugal CH Switzerland RU Russian Federation CN China SE Sweden CU Cuba SG Singapore CZ Czech Republic SI Slovenia DE Germany SK Slovakia DK Denmark TH Thailand EC Ecuador TR Turkey EP European Patent Office TW Taiwan ES Spain UA Ukraine FI Finland US United States of America FR France UY Uruguay GB United Kingdom UZ Uzbekistan GE Georgia WO World Intellectual Property GR Greece Organization (W.I.P.O.) GT Guatemala ZA South Africa HR Croatia HU Hungary IE Ireland IL Israel IN India IT Italy JP Japan KR Republic of Korea LK Sri Lanka LU Luxembourg LV Latvia


נערך ע"י רשות הפטנטים, משרד המשפטים, ירושלים

EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM

יומן הפטנטים והמדגמים - patents and designs journal

Documents

Transcript of יומן הפטנטים והמדגמים - patents and designs journal